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Cardiovascular disease (CVD) is a group of disorders of the heart, vascular diseases of the brain 
and diseases of blood vessels. CVD is the number one cause of morbidity and mortality 
worldwide. Coronary heart disease (CHD) is the most common type of CVD. The risk factors 
of CVD included behavioural risk factors and other contributing cardiovascular factors. 
Hypertension is the leading cause of heart disease and stroke. It is well-established that stress, 
anxiety and depression are associated with the development of CVD and established CVD. 
Stress, anxiety and depression are frequently undertreated in CVD. Tai Chi may provide a 
treatment option for these conditions in the CVD population. The physical and psychological 
benefits of Tai Chi have been demonstrated in several studies in various populations, but few 
have investigated the effectiveness of Tai Chi on psychological stress, anxiety and depression 
in people with CVD.  
 
Objectives   
Three studies were conducted as part of this doctoral research: one systematic review, one 
randomised controlled trial and one qualitative sub-study of the trial, to answer the following 
research questions. 
(1) What is the existing scientific evidence to support the effects of Tai Chi in improving 
psychological well-being and quality of life in patients with CVD and/or cardiovascular 
risk factors? 
(2) What are the effects of Tai Chi on psychological stress, anxiety, depression and 
cardiovascular function in patients with CHD and/or hypertension? 
(3) What are the perceptions of the trial participants on the facilitators and barriers to trial 





Three studies were conducted in this doctoral project. The first study is a systematic review of 
randomised controlled trials on Tai Chi for psychological well-being and quality of life in 
people with CVD and/or cardiovascular risk factors. Major English and Chinese language 
databases were searched. Data selection and extraction were conducted by two researchers 
independently. The methodological quality of included studies was assessed by the Cochrane 
risk of bias tool and the Grading of Recommendations Assessment, Development and 
Evaluation (GRADE) approach. Statistical analyses were performed with Cochrane’s Review 
Manager software (version 5.3). Data were summarised using mean difference (MD) with 95% 
confidence interval (CI) and presented in forest plots and ‘Summary of Finding’ tables. 
The second study is a randomised controlled trial of Tai Chi in CVD participants. Participants 
(n=120) with CHD and/or hypertension were recruited from Beijing (n=80) and Sydney (n=40), 
and randomly assigned to the Tai Chi group (n=60) or waitlist control group (n=60). The Tai 
Chi group practiced a standardised 24-week Tai Chi intervention consisting of 2-hour Tai Chi 
class twice weekly for the first 12 weeks and once weekly for the rest 12 weeks. The primary 
outcome was psychological stress as measured by the Perceived Stress Scale-10 (PSS-10). The 
secondary outcomes included anxiety as measured by the Zung Self-Rating Anxiety Scale 
(SAS), depression as measured by the Beck Depression Inventory-II (BDI-II), cardiovascular 
function (including blood pressure, heart rate, heart rate variability, lipid and glucose profiles, 
and C-reactive protein), quality of life as measured by the 36-item Short Form Health Survey 
Questionnaire (SF-36) and physical fitness as measured by the 6-Minute Walk test (6MWT). 
All measures were assessed at baseline, week 12 and week 24.  
The third study is a qualitative study using exit interviews with participants from the Tai Chi 
group who completed the study. Semi-structured interviews were chosen to allow in-depth 
interviews that encourage interviewees to answer pre-set open-ended questions or topics to be 
explored by the interviewer. Each semi-structured interview was guided by ten open-ended 
questions in English or Chinese (Mandarin). The interviews were audio-recorded, transcribed 
verbatim and imported into the NVivo (Version 11) software to facilitate coding and data 
analysis. Thematic analysis was chosen for analysing data in this study because it followed a 





The systematic review included 25 studies involving 2,084 participants with CVD and/or 
cardiovascular risk factors. The methodological quality of included studies was generally low 
to moderate. Only one study examined stress in people with CVD, reporting that an 8-week 
short-form Tai Chi program significantly decreased stress in people assessed by PSS-10 (MD -
2.45, 95% CI: -3.06, -1.84). Individual studies found Tai Chi to be superior to control group in 
reducing other psychological measures such as depression, anxiety and improving mood. A 
meta-analysis of Tai Chi plus usual care versus usual care alone in decreasing depression found 
no significant difference. However, meta-analyses did find that Tai Chi significantly improved 
quality of life in all domains of the SF-36 including physical functioning (MD: 5.47, 95%CI: 
0.66, 10.28, I2=84%), role limitation due to physical health (MD: 11.82, 95%CI: 8.26, 15.38, 
I2=32%), role limitation due to emotional health (MD: 8.27, 95%CI: 5.56, 10.98, I2=0%), 
energy/vitality (MD: 7.03, 95%CI: 1.92, 12.14, I2=81%), mental health (MD: 7.86, 95%CI: 
4.29, 11.44, I2=48%), social functioning (MD: 9.81, 95%CI: 5.19, 14.42, I2=68%), bodily pain 
(MD: 6.34, 95%CI: 2.45, 10.23, I2=53%), and general health (MD: 10.04, 95%CI: 7.15, 12.93, 
I2=27%) and the Minnesota Living with Heart Failure Questionnaire (scale from 0 to 105) (MD: 
-11.10, 95%CI: -15.52, -6.68, I2=73%). No adverse events were reported. 
In the randomised controlled trial, we conducted, Tai Chi led to a significant reduction in PSS-
10 scores at week 24 (Mean, 10.44; 95% confidence interval (CI), 8.86 to 12.03) compared with 
the waitlist group (Mean, 11.71; 95% CI, 10.01 to 13.34) (P=0.009). Walking distance 
measured by the 6-minute walk test was significantly improved in the Tai Chi group compared 
to the waitlist group (P=0.001). Significant differences were also detected between the two 
groups in depression, diastolic blood pressure, and quality of life. The between-group 
differences in other secondary outcomes did not reach statistical significance. No severe 
adverse events related to Tai Chi were reported. The attendance rate at Tai Chi classes was 82.5% 
during the 24-week program. Retention of participants was high, with 102 (85%) of all 120 
participants completing the study. 
In the qualitative sub-study, 34 participants were interviewed. Facilitators and barriers were 
identified as the two major domains, and six key themes with 31 codes emerged under the two 
domains. Facilitators to trial participation and adherence to Tai Chi interventions were grouped 
into four themes: internal/external motivation, positive feelings, benefits of Tai Chi, and future 
practice. A major internal motivation was to improve health. Positive feelings had three sub-
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themes: positive feelings toward Tai Chi, the project, and the learning experience. Tai Chi 
instructor(s) were crucial in motivating participants’ adherence to Tai Chi. The participants 
identified the benefits of committing to a regular and sustained Tai Chi practice included 
improvements in psychological well-being, physical health, social life and daily life activities. 
Under the domain of barriers to participation and adherence, subjective and objective concerns 
were the two predominating themes. Subjective concerns included concern learning Tai Chi 
was difficult and that Tai Chi might harm their knees if not practiced properly. Objective 
concerns included time conflict, air pollution, laziness and a lack of group atmosphere.  
Conclusion 
Tai Chi may be effective to improve psychological stress, fitness and quality of life and appears 
safe to practice in people with CHD and/or hypertension. We found a 24-week standardised Tai 
Chi was beneficial and safe in improving psychological stress, and physical fitness in patients 
with CHD and/or hypertension compared with the waitlist control group. In addition, our 
systematic review demonstrated that Tai Chi is potentially effective in improving quality of life 
in people with CVD and/or CVD risk factors and is safe to practise in this population. However, 
there is still lack of strong, well-designed studies demonstrating the beneficial effects of Tai 
Chi on stress, depression, anxiety and mood disturbance. More high-quality randomised 
controlled trials exploring the beneficial effects of Tai Chi on psychological well-being and 
quality of life are warranted. A major facilitator to trial participation and adherence is to 
improve health and Tai Chi instructor(s) is also crucial in motivating participants’ adherence to 
Tai Chi. Barriers are related to subjective and objective concerns of Tai Chi practice, such as 
the difficulty and safety to learn and practice, and time conflict. Future research may seek to 
evaluate these facilitators and barriers further to improve the study design, recruitment and 






Chapter 1: Introduction 
 
 
This chapter presents a general introduction of the research in this doctoral thesis. It provides 
an overview of the background to the research, describes the objectives and research questions, 
and the structure of the thesis.  
 
1.1 Background to the Research 
1.1.1 Cardiovascular disease 
Cardiovascular disease (CVD) is a group of disorders of the heart, vascular diseases of the brain 
and diseases of blood vessels (World Health Organization, 2018a). CVD is the number one 
cause of morbidity and mortality worldwide. An estimated 17.7 million people died from CVDs 
in 2015, representing 31% of all global deaths (World Health Organization, 2017). 
 
Although the mortality rates of CVDs have fallen substantially in many high-income countries 
over the last three decades, they remain a considerable disease burden on both the individuals 
and society as a whole. According to the American Heart Association, the total direct and 
indirect cost of CVDs in the US alone for 2016 was an estimated US$555 billion (American 
Heart Association, 2017). Furthermore, the morbidity rates of CVDs are increasing 
dramatically in developing countries (W. Chen et al., 2018).  
1.1.2 Coronary Heart Disease 
Coronary heart disease (CHD), also known as ischaemic heart disease, is the most common 
form of CVD. Of all mortality due to CVD, CHD is the leading cause of premature death. CHD 
is estimated to be responsible for 41.8% (7.4 million) of the 17.7 million deaths globally in 
2015 (World Health Organization, 2017).  
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In recent years, the prevalence, incidence and mortality rates of CHD in high-income countries 
have decreased dramatically, however, the morbidity of CHD has increased in middle- and low-
income countries. In developing countries, however, the prevalence of CHD continues to 
increase. The mortality rate due to CHD in developing countries increased between 2012 and 
2015 from 93.17 to 110.91 per 100,000 in urban areas and 68.62 to 110.67 per 100, 000 in rural 
areas (Chen et al., 2018).  
1.1.3 Hypertension 
Hypertension, also known as high or raised blood pressure, is a condition in which the blood 
vessels have persistently raised pressure (World Health Organization, 2018d). Hypertension is 
the most important preventable cause of heart disease and stroke (GBD 2015 Risk Factors 
Collaborators, 2016; Redon et al., 2016; Tzoulaki, Elliott, Kontis, & Ezzati, 2016).  
 
Hypertension accounted for an estimated 2.043 million mortalities in China in 2010, accounting 
for 24.6% of all deaths in China (H. Li & Ge, 2014). In 2014-2015, six million adult Australians 
(34%) were hypertensive (Blood pressure > 140/90 mmHg) or taking antihypertensive 
medication (Australian Bureau of Statistics, 2015). The Global Burden of Disease, Injuries, and 
Risk Factor study 2015 found that the rate of elevated systolic blood pressure (SBP) (>110-115 
and >140mm Hg) increased substantially between 1990 and 2015 (GBD, 2015), and the all 
disability-adjusted life-years (DALYs) and deaths associated with SBP also increased 
(Forouzanfar et al., 2017). 
1.1.4 Cardiovascular Risk Factors 
There has been strong scientific evidence demonstrated that behavioural risk factors and other 
contributing risk factors are associated with the development and prognosis of CVD.  
Behavioural risk factors include smoking, unhealthy diet, physical inactivity and harmful use 
of alcohol (Tzoulaki et al., 2016). These unhealthy lifestyle behaviours can cause 
metabolic/physiological changes in the body, leading to other cardiovascular risk factors, such 
as hypertension, overweight/obesity, hyperglycemia/diabetes, and dyslipidaemia.  
Other contributing risk factors such as poverty, aging and psychological factors including stress, 
anxiety and depression. Aging is also a contributing cardiovascular risk factor for clinically 
significant atherosclerotic lesion formation (Head, Daunert, & Goldschmidt-Clermont, 2017). 
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Population aging accelerates the rapid increasing burden of CVDs. Stress, anxiety, depression 
and their relationship with CVDs are discussed in detail below.  
1.1.5 Stress, Anxiety and Depression 
Accumulated scientific evidence has addressed the association between psychosocial factors 
and CVD. Psychological risk factors such as stress, anxiety, and depression are known to play 
an important, and independent role, in the development of CVD and its complications.  
 
Psychological risk factors, particularly depression, are associated with other risk factors, 
including educational level, sedentary lifestyle, smoking, unhealthy diet and reduced 
compliance with risk factor modification (Pogosova et al., 2017). Depression is independently 
associated with increased cardiovascular morbidity and mortality in patients with CHD 
(Baumeister, Hutter, & Bengel, 2011; Gan et al., 2014; Rugulies, 2002). 
 
Anxiety is highly comorbid with depression and both are independently associated with 
increased risk of mortality in CHD patients (Watkins et al., 2013). A recent Cochrane 
systematic review of 35 studies with 10,703 patients with CHD, assessed the effectiveness of 
psychological interventions (alone or with cardiac rehabilitation) compared with usual care 
(including cardiac rehabilitation where available) (Richards et al., 2017). Psychological 
interventions significantly reduced cardiovascular mortality (relative risk: 0.79, 95% 
confidence interval [CI] 0.63 to 0.98) and improved depressive symptoms (standardised mean 
difference [SMD] -0.27, 95%CI -0.39 to -0.15), anxiety (SMD -0.24, 95% CI -0.38 to -0.09) 
and stress (SMD -0.56, 95% CI -0.88 to -0.24). However, the risk of bias in the studies included 
in the review reduced certainty around the findings.  
1.1.6 Tai Chi Intervention 
Tai Chi, also known as Tai Chi Chuan/Quan or Taiji, was developed by a famous martial artist 
Chen Wang-Ting towards the end of Ming Dynasty (17th Century A.D.) (L. Gu & Shen, 2007). 
Chen Wang-Ting comprehensively incorporated the essence of Chinese folk and military 
martial arts, breathing and meditative techniques, Taoist philosophy of yin and yang, and 
traditional Chinese medicine theory (Tang & Gu, 2012). The main components of Tai Chi is 
traditionally described including movements, meditation and imagination, and deep/abdominal 
breathing (Tang & Gu, 2012). The aim being that practitioners gain both physical and 
psychological benefits from Tai Chi. 
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Tai Chi was reported for the first time as an intervention in a clinical study in 1958 in China, 
where a case series demonstrated the beneficial effects of Tai Chi on tuberculosis (D. Wang, 
1958). In recent years, research on Tai Chi for health and well-being has flourished. Numerous 
studies have demonstrated various physical and psychological benefits of Tai Chi intervention, 
including potential improvements in stress, anxiety, depression, quality of life and 
cardiovascular function.  
1.1.7 Knowledge Gap 
Cardiac rehabilitation aims to provide comprehensive, long-term secondary prevention of 
CVDs and is an essential intervention offered to patients with heart disease. Cardiac 
rehabilitation programs include components of medical evaluation, physical activity, cardiac 
risk factor modification, health education, and counselling (Dalal, Doherty, & Taylor, 2015). 
In the past decades, strong evidence has accumulated to suggest that CR reduces mortality, 
morbidity, unplanned hospital admissions in addition to improvements in exercise capacity and 
quality of life (Anderson et al., 2016; Dalal et al., 2015; Dalal, Zawada, Jolly, Moxham, & 
Taylor, 2010; Long et al., 2018). Given these important benefits, CR has been recommended in 
many evidence-based international guidelines. Guidelines from the American College of 
Cardiology and the American Heart Association give a Class I recommendation for referral to 
cardiac rehabilitation for patient education in the hospital setting in all patients with recent 
coronary events or revascularization procedures (Antman et al., 2004).  
Structured exercise has been identified as the core component to the successful treatment of 
cardiac rehabilitation programs (Anderson et al., 2016; Long et al., 2018). However, current 
practice guidelines consistently recommend “comprehensive rehabilitation” programs that 
should include sufficient psychological components to optimise cardiovascular risk reduction, 
foster healthy behaviours and compliance to these behaviours, reduce disability, and promote 
an active lifestyle (Balady et al., 2007; Dalal et al., 2015).  
Cardiac rehabilitation delivery faces substantial challenges such as financially viability due to 
barriers such as consistent and appropriate referral (especially for women, the elderly, ethnic 
minorities, and low socioeconomic status populations), accessibility (transportation, number, 
and geographic distribution of cardiac rehabilitation programs) and affordability (lack of 
insurance coverage, high co-payments, and use of resource-intensive, inefficient and costly 
models) (Balady et al., 2011; Clark et al., 2015; Sandesara et al., 2015). As a result, utilisation 
of cardiac rehabilitation is relatively low. Participation rates in cardiac rehabilitation programs 
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following ST-elevation myocardial infarction (STEMI) is about 25-35% in western countries 
(Urbinati & Tonet, 2018). A large prospective audit in Australia and New Zealand found only 
46% of eligible patients were documented as referred to CR and even fewer were discharged 
with sufficient secondary prevention (Redfern et al., 2014). Significant improvements are 
needed to provide cost-effective, patient-centred, comprehensive secondary prevention for 
patients with CVDs. 
Tai Chi for people with CVD has a number of potential health benefits. A recent systematic 
review and meta-analysis of thirteen studies demonstrated that Tai Chi based cardiac 
rehabilitation led to improved aerobic endurance and quality of life, and reduced anxiety and 
depression in patients with CHD. Tai Chi may be a cost-effective option for patients with or at 
risk of CVD (T. Liu, Chan, Liu, & Taylor-Piliae, 2018). However, only few rigorously designed 
randomised controlled trials (RCTs) exist investigating the impacts of Tai Chi intervention in 
patients with CHD and/or hypertension, particularly on psychological stress, anxiety, 
depression and other neuropsychological outcomes.  
 
The adherence to Tai Chi programs appears to be relatively high. A feasibility, qualitative study 
with 17 veterans with post-traumatic stress disorder (PTSD) found that 93.8% of participants 
reported feeling engaged and satisfied with the Tai Chi program (Niles et al., 2016). Another 
qualitative study evaluated the feasibility of using a pragmatic, community-based Tai Chi 
interventions to enhance recruitment and adherence in a RCT of Tai Chi for women with 
osteopenia (Fischer, Fugate-Woods, & Wayne, 2014). Facilitators that were found to improve 
trial participation and adherence included convenience of class locations and times, alternative 
learning modalities, quality of teaching, community and social support, and perceived health 
benefits, while barriers included time-related issues. However, less is known about the 
influential factors on trial participation and adherence to Tai Chi intervention during and after 
a RCT from the perspective of participants.  
 
1.2 Objectives and Research Questions 
This doctoral research aims to explore the impact of Tai Chi on psychological well-being and 
cardiovascular function in people with CHD and/or hypertension. Three studies were conducted 
as part of this doctoral research: a systematic review, a RCT and a qualitative sub-study of the 




1.2.1 Systematic Review 
The first research question of the doctoral research is “What is the existing scientific evidence 
to support the effects of Tai Chi in improving psychological well-being and quality of life in 
patients with CVD and/or cardiovascular risk factors?” To answer this question, a systematic 
review was conducted.  
The primary objective of the systematic review was to explore the effectiveness and safety of 
Tai Chi on psychological stress in patients with CVD and/or cardiovascular risk factors in 
existing RCTs. The secondary objective was to explore the effectiveness and safety of Tai Chi 
on psychological factors including anxiety, depression, mood disturbance, self-esteem and 
quality of life in patients with CVD and/or cardiovascular risk factors.   
The hypotheses of this systematic review were that Tai Chi is beneficial for the management of 
stress, anxiety, depression, mood disturbance, self-esteem and quality of life in patients with 
CVD and/or cardiovascular risk factors and safe to practice in this population.   
1.2.2 Randomised Controlled Trial 
The second research question of this doctoral research is “What are the effects of Tai Chi on 
psychological stress, anxiety, depression and cardiovascular function in patients with CHD 
and/or hypertension?” To answer this research question, an international multi-centre RCT was 
conducted.  
 
The primary objective of this trial was to determine the effect of a 24-week Tai Chi intervention 
on psychological stress in patients with CHD and/or hypertension. The secondary objective was 
to investigate the effects of a 24-week Tai Chi intervention on anxiety, depression, 
cardiovascular function, quality of life, and fitness measures in patients with CHD and/or 
hypertension. In addition, a close observation of any adverse events as a result of Tai Chi 
practice was conducted to explore the safety of Tai Chi intervention in patients with CHD 
and/or hypertension. 
 
The hypotheses of this trial were that a 24-week Tai Chi intervention is beneficial for reducing 
stress, anxiety, depression and improving cardiovascular function, quality of life, and physical 




1.2.3 Qualitative Sub-Study 
The third research question of this doctoral thesis is “What are the perceptions of the trial 
participants on the facilitators and barriers to trial participation and adherence to Tai Chi 
intervention?” To answer this question, a qualitative sub-study was conducted as an exit 
interview, embedding into the RCT. 
 
The primary objective of this qualitative sub-study was to explore the perceptions of 
participants on facilitators to trial participation and adherence during and after the randomized 
controlled trial. The secondary objective was to explore the perceptions of participants on 
barriers to trial participation and adherence during and after the randomized controlled trial.  
 
The hypotheses of this qualitative sub-study were that from the perceptions of participants, we 
would identify valuable information about the facilitators and barriers to trial participation and 
adherence during and after the randomized controlled trial. 
 
1.3 Structure of the Thesis 
The thesis has seven chapters in total, introducing the background information and knowledge 
gaps, and presenting the results of three main studies: (1) a systematic review, (2) an 
international multi-centre RCT, and (3) a qualitative sub-study of the RCT.  
Chapter 1 is a general introduction of the research in this doctoral thesis. It provides an overview 
of the background to the research, describes the objectives and research questions, and describes 
in more detail the structure of the thesis.  
Chapter 2 presents a literature review on the history and current development of research on 
Tai Chi and cardiovascular disease, to provide a wider context of research. Since the qualitative 
exit interviews was a sub-study embedded in the RCT, the background of this topic is 
summarised briefly in Chapter 2 and described in detail in Chapter 6.   
Chapter 3 outlines the systematic review to explore whether Tai Chi can improve psychological 
well-being and quality of life in patients with cardiovascular disease and/or cardiovascular risk 
factors. The protocol of this systematic review was registered in the International Prospective 
Register for Systematic Reviews (PROSPERO) (NO.: CRD42016042905) and published in 
BMJ Open. After an introduction of the background (Section 3.1) and methods (Section 3.2), 
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the results (Section 3.3) were presented including characteristics of the included studies, 
methodological quality, and effects of interventions. A discussion (Section 3.4) based on the 
findings including interpretation of the results and comparisons with previous studies is also 
provided.   
Chapter 4 describes the RCT entitled ‘The effects of Tai Chi on stress and cardiovascular 
function in patients with coronary heart disease and/or hypertension’. Objectives of the trial 
(Section 4.1), the methodology (Section 4.2) are presented in detail. The methodology presents 
the study design, participants, sample size calculation, recruitment and screening, 
randomisation, intervention, outcome measures, data collection, data management and 
statistical analysis.  
Chapter 5 outlines the results and discussion RCT in detail. The results present enrolment, 
participant discontinuations, baseline characteristics of participants, and the effects of the Tai 
Chi intervention on the primary outcome measure (i.e. stress) and secondary outcome measures 
(i.e. anxiety, depression, blood pressure, heart rate, heart rate variability, lipid and glucose 
profile, C-reactive protein, quality of life, and 6-minute walk test). A discussion of the findings 
including interpretation of the results and comparisons with previous studies is also provided.   
Chapter 6 presents the qualitative sub-study of the RCT. Similarly, after a brief introduction of 
the background, it provides an overview of the RCT and describes the methods of the qualitative 
sub-study in detail (Section 6.2). Section 6.3 presents the results, including characteristics of 
participants who completed the exit interview, and influential factors focusing on facilitators 
and barriers of trial participation and adherence to intervention. A discussion (Section 6.4) by 
comparing and contrasting the findings with that of previous literature is provided.  
Chapter 7 consists of a general discussion of the doctoral thesis. It synthesises and summarises 
the main findings of the systematic review, the RCT and the qualitative sub-study of the trial. 
The strengths and weakness of the studies within the context of research in this area and further 










This chapter presents a literature review on the history and current development of research 
on Tai Chi and cardiovascular disease, to provide a wider context of research. Since the 
qualitative exit interview was a sub-study embedded in the RCT, the background of this topic 
is summarised briefly in Chapter 2 and described in detail in Chapter 5.   
 
2.1 Cardiovascular Disease (CVD) 
2.1.1 Definition and Pathophysiology of CVD 
CVD is the name of a group of disorders of the heart, vascular diseases of the brain and diseases 
of blood vessels (World Health Organization, 2018a), and includes: 
(1) CVDs due to atherosclerosis 
(2) Other CVDs: 
• rheumatic heart disease 
• congenital heart disease 
• cardiomyopathies 
• cardiac arrhythmias 
Atherosclerosis, a complex pathological process of plaque building up in the wall of blood 
vessels, is the main pathological process contributing to CVDs. These plaques cause the inner 
surface of the blood vessels to become irregular and the lumen to become narrow, making it 
harder for blood to flow through. Eventually, the plaque can rupture, triggering the formation 
of a blood clot and resulting in a heart attack or stroke. The atherosclerosis develops over years 
triggered by different risk factors such as hypertension, raised lipid levels (Talbot, Delaney, 
Sandfort, Herrington, & McClelland, 2018), cigarette smoking (Z. Wang, Wang, & Wang, 
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2017), physical inactivity (Florido et al., 2018), unhealthy diet (Kern et al., 2017), alcohol 
consumption (Kwon et al., 2016), diabetes (Katakami, 2018), aging (Head et al., 2017), genetic 
disposition (Peterlin, Petrovic, & Peterlin, 2018) and psychological factors (Chrysohoou, Kollia, 
& Tousoulis, 2018).  
Rheumatic heart disease results from an abnormal autoimmune response to a group A 
streptococcal infection in a genetically susceptible host caused by acute rheumatic fever, which 
can affect different organs and lead to irreversible cardiac valve damage and heart failure 
(Marijon, Mirabel, Celermajer, & Jouven, 2012). Congenital heart diseases are malformations 
of heart structures present at birth (Hunter, 2001). Cardiomyopathies are a heterogeneous group 
of diseases of the myocardium associated with mechanical and/or electric dysfunction that 
usually (but not invariably) exhibit inappropriate ventricular hypertrophy or dilatation and are 
due to a variety of causes that frequently are genetic (Braunwald, 2017; Maron et al., 2006). 
Cardiac arrhythmias are any abnormal heart rate or rhythm, characterized by irregular rhythm 
of heartbeat which could be either too slow (<60 beats/minute) or too fast (>100 beats/minute) 
(D. G. Fu, 2015). These CVDs are less common than CVDs caused by atherosclerosis such as 
CHD and strokes.  
2.1.2 Prevalence and Disease Burden of CVD 
CVDs are the number one cause of morbidity and mortality worldwide. According to World 
Health Organization (WHO), an estimated 17.7 million people died from CVDs in 2015, 
representing 31% of all global deaths (World Health Organization, 2017). Out of the 17.7 
million CVD deaths, CHD and stroke were responsible for 7.4 million and 6.7 million deaths, 
respectively.  
Due to encouraging advances in prevention and successful treatment of acute cardiovascular 
events, the mortality rates of CVDs have fallen substantially in many high-income countries 
over the last three decades (Bhatnagar, Wickramasinghe, Wilkins, & Townsend, 2016). 
However, CVDs remain a considerable disease burden on the individuals and society as a whole. 
More than 4.2 million Australians are affected by CVDs in 2014-2015, namely every one in six 
Australians are affected (Australian Bureau of Statistics, 2015). The total direct and indirect 
cost of CVDs in the US alone for 2016 was around US$555 billion, and is expected to increase 
significantly to $1.1 trillion by 2035 (American Heart Association, 2017).  
On the other hand, the mortality and morbidity rates of CVDs are increasing dramatically in 
developing countries. China is the largest developing country in the world, with a land mass of 
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9.6 million km2 and a population of more than 1.33 billion. In China, morbidity rates due to 
CVD are estimated at 290 million, and the mortality rate between 2005 and 2015 increased 
from 174 to 298 per 100,000 people in rural areas and 209 to 265 per 100,000 people in urban 
areas in 2015 (W. Chen et al., 2018). In India, CHD led to 17% of total deaths and 26% of adult 
deaths in 2001-2003, increasing to 23% of total and 32% of adult deaths in 2010-2013 (Gupta, 
Mohan, & Narula, 2016). 
2.1.3 Strategies of Controlling CVD  
The World Heart Federation, WHO, and the World Stroke Organization articulate three critical 
strategies: (1) surveillance and monitoring, (2) prevention and reduction of risk factors, and (3) 
improved management and health care through early detection and timely treatment (World 
Health Organization, World Heart Federation, & Organization., 2011). In the past three decades, 
both population-wide primary prevention and individual level healthcare intervention strategies 
such as tobacco and alcohol control (Gravely et al., 2017) and salt reduction in diet (Rafieifar 
et al., 2016) have been largely reported for their contributions to the substantial decrease in 
mortality of CVDs.  
At the individual level, interventions need to be targeted to those at high cardiovascular risks 
(World Health Organization, 2017), such as hypertension, raised blood lipid and serum glucose 
to prevent first cardiovascular events. For secondary prevention of cardiovascular events in 
those with established CVDs, including diabetes, necessary treatment with medications 
including aspirin, beta-blockers, angiotensin-converting enzyme (ACE) inhibitors and statins 
may help prevent up to 75% recurrent vascular events and decrease mortality (World Health 
Organization, 2017).  
The use of effective secondary prevention medications is low worldwide, but especially low in 
low-income countries and rural areas. For example, in high-income countries use of antiplatelet 
drugs is 62.0%, beta-blockers 40.0%, ACE inhibitors 49.8%, and statins 66.5%; compared to 
low-income countries: 8.8%, 9.7%, 5.2%, and 3.3%, respectively (Yusuf et al., 2011). 
When diagnosed as acute myocardial infarction or stroke, costly high-technology interventions 
such as coronary artery bypass surgery and other types of vascular surgery may be required for 




2.2 Coronary Heart Disease (CHD) 
2.2.1 Definition and Pathophysiology of CHD 
Coronary heart disease (CHD), also known as ischaemic heart disease, is the most common 
form of CVD. CHD is characterised by inflammation with extravasation of immune cells into 
the sub-endothelial space, leading to the formation and/or progression of atherosclerotic 
plaques and thickening of the coronary artery walls. CHD occurs when there is a reduced supply 
of blood and oxygen to the myocardium resulting from a restriction or occlusion to at least one 
of the coronary arteries. Coronary occlusion secondary to disruption of atherosclerotic plaque 
with subsequent thrombus formation is the most common cause of the life threatening acute 
coronary syndrome (i.e. unstable angina and myocardial infarction) and sudden death (Ambrose 
& Singh, 2015). Clinically, CHD may present as angina, myocardial infarction, sudden death, 
and consequent chronic heart failure (Henderson, 1996).  
Any condition attributed to obstruction of the coronary arteries which reduces blood flow to the 
heart is known as acute coronary syndrome, including unstable angina and myocardial 
infarction. Stable angina is not acute but categorised within ischaemic heart disease.  
The development and progression of atherosclerotic plaque is extremely complex and includes 
a combination of multiple pathological process (Koenig, 2001). In the past decades, coronary 
imaging such as intravascular ultrasound (IVUS), optical coherence tomography (OCT) and 
positron emission tomography (PET) has evolved as a valuable adjunct to angiography, 
allowing the process of atherogenesis, plaque destabilization, and other pathologic conditions 
to be detected and quantified directly (Evans, Tarkin, Chowdhury, Warburton, & Rudd, 2016; 
Sakamoto, Nagamatsu, Yamamoto, Kaikita, & Tsujita, 2018). Pathological studies have 
revealed that rupture of lipid-rich plaque, followed by thrombus formation, is the main 
mechanism of acute coronary occlusion in 70-80% of patients with acute coronary syndrome 
(Naghavi et al., 2003). The rupture of the thin fibrous cap allows platelets to contact the highly 
thrombogenic necrotic core. 
2.2.2 Prevalence and Disease Burden of CHD 
Of all cardiovascular causes of mortality, CHD is the leading cause of premature death. CHD 
was responsible for an estimated 41.8% (7.4 million) of the 17.7 million cardiovascular 
mortality in 2015 (World Health Organization, 2017).  
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The mortality from CHD in developed countries has decreased in recent years. Death rates 
attributable to CVD declined by 28.8% from 2003 to 2013, and the actual number of CVD 
deaths per year declined by 11.7% (Mozaffarian et al., 2016).  In the US, around 15.5 million 
people aged 20 years or above have CHD, and the prevalence increases with age for both 
women and men (Mozaffarian et al., 2016). In developing countries, however, the prevalence 
of CHD continues to increase. For example, in China, the “China Cardiovascular Disease 
Report 2017” (W. Chen et al., 2018) reported that the mortality rate due to CHD increased 
between 2012 and 2015 from 93.17 to 110.91 per 100,000 in urban areas and 68.62 to 110.67 
per 100, 000 in rural areas. In India, the absolute number of deaths from CHD increased from 
0.62 million in 1990 to 0.78 million in 1995, 0.95 million in 2000, 1.01 million in 2005, and 
1.13 million in 2010 (GBD 2013 Mortality Causes of Death Collaborators, 2015; Gupta et al., 
2016). 
 
2.2.3 Current Management of CHD  
Current strategies for impacting risk factors associated with secondary events in patients with 
CHD include smoking cessation, controlling hypertension, abnormal lipid levels, obesity and 
diabetes, psychosocial interventions, physical activity, and cardiac rehabilitation. We divide 
them into non-pharmaceutical therapies, pharmaceutical treatment, and cardiac rehabilitation, 
which are described below.  
2.2.3.1 Non-pharmaceutical therapies 
There is strong evidence suggesting that cigarette smoking cessation after an acute coronary 
event results in decreased morbidity and mortality. A population-based cohort study of 1,521 
patients with a first acute MI a hazard ratio of 0.60 (95%CI 0.43 to 0.75) for death among 
quitters after MI compared with persistent smokers (Gerber, Rosen, Goldbourt, Benyamini, & 
Drory, 2009). However, a recent systematic review of seven RCTs demonstrated that currently 
available smoking cessation therapies are limited in their efficacy in patients hospitalised after 
an acute coronary event (Franck, Filion, & Eisenberg, 2018).  
Psychosocial interventions are part of secondary prevention to facilitate cardiovascular risk 
reduction. A recent Cochrane review involving 35 studies with 10,703 people with CHD found 
no evidence that psychological treatments had an effect on total mortality, the risk of 
revascularisation procedures, or on the rate of non-fatal MI (Richards et al., 2017).  
Psychosocial interventions did reduce the rate of cardiac mortality and prevalence of 
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psychological symptoms (depression, anxiety, or stress). The risk of bias of the studies included 
in the review did result in some uncertainty around these findings. 
Regular moderate or vigorous physical activity has been recommended in clinical practice 
guidelines for secondary prevention of CHD (Smith et al., 2006; Task Force et al., 2013). 
Physical activity is associated with reduced CHD risk (Tanasescu et al., 2002). Using self-
reported data of 15,486 patients from 39 countries with stable CHD who participated in the 
STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) (R. 
A. H. Stewart et al., 2017), it demonstrated that more physical activity was associated with 
lower all-cause mortality (unadjusted hazard ratio [HR]: 0.82; 95%CI: 0.79 to 0.85; adjusted 
HR: 0.90, 95%CI: 0.87 to 0.93) and cardiovascular mortality (unadjusted HR: 0.83, 95% CI: 
0.80 to 0.87; adjusted HR: 0.92, 95%CI: 0.88 to 0.96) in patients with stable CHD during a 
median follow-up of 3.7 years.  
Surgical operations are also performed to treat CHD, including coronary-artery bypass grafting 
(CABG), percutaneous transluminal coronary angioplasty (PTCA), valve surgery, and heart 
transplantation. CABG is a procedure in which autologous arteries or veins are used as grafts 
to bypass coronary arteries that are partially or completely obstructed by atherosclerotic plaque. 
CABG offers significant improvement in survival and quality of life for appropriately selected 
patients with multivessel coronary artery disease, especially those with more advanced 
coronary artery disease (Alexander & Smith, 2016). PTCA requires sophisticated equipment 
and skilled personnel, including cardiothoracic surgical support in the event that emergency 
bypass surgery is necessary (Bucher, Hengstler, Schindler, & Guyatt, 2000; Landau, Lange, & 
Hillis, 1994). A meta-analysis involving 953 patients treated with PTCA and 951 with medical 
treatment from six RCTs demonstrated that angioplasty may lead to a greater reduction in 
angina in patients with CHD than medical treatment but at the cost of more coronary artery 
bypass grafting (Bucher et al., 2000). Heart valve surgery is to cure the problem or lengthen 
life by restoring the function of a damaged or faulty heart value. A heart transplant is an 
operation in which a failing, diseased heart is replaced with a healthier, donor heart, which is 
usually reserved for people who have tried medications or other surgeries, but their conditions 
have not sufficiently improved. However, surgical interventions for CHD are costly and not 
always readily accessible for everyone (Favarato et al., 2003).  
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2.2.3.2 Pharmaceutical treatment 
For people with established CHD, optimal medication include aspirin, beta-blockers, ACE 
inhibitors, and statins for secondary prevention of cardiac events (Pitts et al., 2017; Protty, 
Lacey, Hayes, & Freeman, 2017).  
Aspirin is the classical antiplatelet pharmacotherapy in patients with CVDs because of its well-
established role in secondary prevention of myocardial infarction, stroke, and death from 
vascular causes and its widespread availability and affordability (Gargiulo et al., 2016). Two 
meta-analyses of RCTs demonstrated that low-dose aspirin reduces the morbidity and mortality 
in patients with acute coronary syndromes or previous myocardial infarction (MI) and confers 
a durable long-term benefit (Antithrombotic Trialists' Collaboration, 2002; Antithrombotic 
Trialists' Collaboration et al., 2009). Another systematic review and meta-analysis appraised 
the hazards inherent to aspirin withdrawal or non-compliance in people at risk for or with 
coronary artery disease (Biondi-Zoccai et al., 2006). It found that the non-adherence or 
withdrawal of aspirin was associated with a 3-fold increased risk of major adverse 
cardiovascular events. Despite these convincing findings, some patients may not be receiving 
antiplatelet medications because of valid contraindications such as bleeding risk (Parekh, 
Galloway, Hong, & Wright, 2013).  
Beta-blockers reduce sympathetic nervous system activity through blockade of adrenergic 
receptor subtypes (Poirier & Tobe, 2014). Treatment with beta-blockers remains the standard 
of care for patients with coronary artery disease, especially in patients after MI. Nevertheless, 
beta-blockers are not without adverse effects and their tolerability is not ideal (Bangalore et al., 
2012). According to a national evaluation of adherence to beta-blocker therapy, among 17,035 
patients with commercial health insurance in the US, only 45% of patients were adherent to 
beta-blocker use for one year after acute MI (Kramer et al., 2006). Additionally, a longitudinal, 
observational study of 44,708 patients demonstrated that beta-blocker use was not associated 
with a lower incidence of cardiovascular events among individuals with a prior history of MI, 
among individuals with coronary artery disease but no MI history, or among individuals with 
risk factors only for atherosclerotic disease (Bangalore et al., 2012). 
ACE inhibitors block the activation of the renin-angiotensin system and may reduce the 
progression of both heart failure and atherosclerosis and reduce the rates of death, myocardial 
infarction, stroke, revascularization, cardiac arrest, heart failure, complications related to 
diabetes and new cases of diabetes (Heart Outcomes Prevention Evaluation Study Investigators 
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et al., 2000; White, 2003). In a systematic review and meta-analysis involving 12,763 patients, 
long-term use of ACE inhibitors lowered rates of mortality, myocardial infarction, and hospital 
admission for heart failure in patients with left-ventricular dysfunction or heart failure with or 
without a recent myocardial infarct (Flather et al., 2000). The adverse effects of ACE inhibitors 
include dry cough (Ontarget Investigators et al., 2008), acute renal impairment or renal failure 
(Ritter, 2011), hyperkalaemia (Ritter, 2011), urticarial and angio-oedema (Ontarget 
Investigators et al., 2008), and fetal injury (Ritter, 2011). 
Statins, also called HMG-CoA reductase inhibitors, are used to lower low-density lipoprotein 
(LDL), for the prevention of atherosclerotic conditions such as stroke, myocardial infarction or 
limb ischemia (Psaty & Weiss, 2014). However, the magnitude of the preventive effect of 
statins is controversial. A systematic review involving 6 studies for primary prevention and 5 
for secondary prevention demonstrated that death was postponed between -5 and 19 days in 
primary prevention trials and between -10 and 27 days in secondary prevention trials 
(Kristensen, Christensen, & Hallas, 2015). Side effects of statins include muscle symptoms, 
increased risk of diabetes, liver inflammation, cataracts, decreased energy, sexual dysfunction, 
and exertional fatigue (Abramson, Rosenberg, Jewell, & Wright, 2013). 
2.2.3.3 Cardiac rehabilitation  
Cardiac rehabilitation programs are comprehensive interventions including components of 
medical evaluation, prescribed exercise, cardiac risk factor modification, health education, and 
psychological counselling (Dalal et al., 2015). Cardiac rehabilitation (and secondary prevention) 
programs are designed to limit the physiological and psychological effects of cardiac illness, 
reduce the risk of sudden death or re-infraction, control cardiac symptoms, stabilise or reverse 
the atherosclerotic process, and enhance the psychosocial and vocational status of selected 
cardiac patients (Dalal et al., 2015).  
Exercise training is a core component of cardiac rehabilitation programs. Internationally, 
cardiac rehabilitation programs are implemented through various models and vary in intensity 
and duration. For example, leading cardiac rehabilitation societies in North America and 
Europe recommend that patients progress from moderate- to vigorous-intensity aerobic 
endurance exercise, with resistance training included as an important adjunct, and recommend 
electrocardiograph-monitored exercise stress tests, while those in the United Kingdom, 
Australia and New Zealand specify lower-intensity exercise and less technical assessment of 
functional capacity (Price, Gordon, Bird, & Benson, 2016).  
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There has been an increasing number of clinical studies demonstrating the beneficial health 
effects of cardiac rehabilitation programs in patients with CHD. One recent updated Cochrane 
systematic review and meta-analysis (Anderson et al., 2016) involving 63 studies with 14,486 
participants evaluated the exercise-based cardiac rehabilitation for people with CHD. It 
confirmed that exercise-based cardiac rehabilitation reduces cardiovascular mortality (RR 0.74, 
95% CI 0.64 to 0.86) and the risk of hospital admissions (RR 0.82, 95% CI 0.70 to 0.96) as well 
as improvement in quality of life.  
Unfortunately, given the benefits associated with cardiac rehabilitation, utilization of cardiac 
rehabilitation by patients with CHD historically has been poor, especially in older women 
(Grace et al., 2016; Ruano-Ravina et al., 2016). Barriers to patient referral and subsequent 
program entry and adherence include (1) lack of recognition by healthcare providers as well as 
their patients and families of the value of secondary prevention; (2) economic and logistic 
considerations for those wishing to participate; and (3) limited opportunities for safe and 
effective, reduced-cost programming, such as home-based or community centre programs (M. 
A. Williams et al., 2002). 
Additionally, a substantial proportion of patients have stress, anxiety and depression symptoms 
after CHD events, which are associated with other factors, including sedentary lifestyle, 
smoking, unhealthy diet and reduced compliance with risk factor modification, but are 
undertreated (Pogosova et al., 2017). The American Heart Association and the American 
Association of Cardiovascular and Pulmonary Rehabilitation consistently recommend 
“comprehensive rehabilitation” programs that should include other components to optimise 
cardiovascular risk reduction, foster healthy behaviours and compliance to these behaviours, 
reduce disability, and promote an active lifestyle (Balady et al., 2007).  
2.3 Hypertension 
2.3.1 Definition and Pathophysiology of Hypertension 
According to the definition of WHO, hypertension, also known as high or raised blood pressure, 
is a condition in which the blood vessels have persistently raised pressure (World Health 
Organization, 2018d). Blood pressure is the force of blood pushing against the walls of the 
arteries as the heart pumps blood, and hypertension happens when the force is too high 
(National Heart Lung and Blood Institute, 2018).  
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Hypertension is defined as a systolic blood pressure (the highest pressure in blood vessels and 
happens when the heart contracts or beats while pumping blood) equal to or above 140 mm Hg 
and/or diastolic blood pressure (the lowest pressure in blood vessels in between heart beats 
when the heart muscle relaxes) equal to or above 90 mm Hg. However, the definitions of 
hypertension for the diagnosis and management decisions vary between international guidelines 
(Messerli, Rimoldi, & Bangalore, 2018). Table 2.1 outlines current values for categorisation of 
clinical blood pressure in Australian adults (National Heart Foundation of Australia, 2016).  
Table 2.1 Classification of clinic blood pressure in adults 
Diagnostic category Systolic (mmHg)  Diastolic (mmHg) 
Optimal <120 and <80 
Normal 120-129 and/or 80-84 
High-normal 130-139 and/or 85-89 
Grade 1 (mild) hypertension 140-159 and/or 90-99 
Grade 2 (moderate) hypertension 160-179 and/or 100-109 
Grade 3 (severe) hypertension >180 and/or >110 
Isolated systolic hypertension >140 and <90 
 
There are two main types of hypertension: primary and secondary hypertension. Primary, or 
essential, hypertension is the most common type of hypertension, which tends to develop over 
years as a person ages. Secondary hypertension is caused by another medical condition or use 
of certain medicines, which usually resolves after the causes are treated or removed.  
 
2.3.2 Prevalence and Disease Burden of Hypertension 
Hypertension is a high-risk health disorder and is the most important risk factor for CVD 
mortality and cardiovascular events (GBD 2015 Risk Factors Collaborators, 2016; Redon et al., 
2016; Tzoulaki et al., 2016). Complications of hypertension account for 9.4 million annual 
CVD deaths worldwide every year (World Health Organization, 2013). In China, using data 
from the 2010 National Population Census as a denominator, it is estimated that the total 
number of people with hypertension is approximately 270 million (H. Li & Ge, 2014). 
Hypertension accounted for 2.043 million deaths in China in 2010, representing for 24.6% of 
all deaths (H. Li & Ge, 2014). In 2014-2015, 6 million Australians (34%) aged 18 years and 
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over were hypertensive (Blood pressure > 140/90 mmHg) or taking antihypertensive 
medication (Australian Bureau of Statistics, 2015), and 4.1 million Australians had 
uncontrolled or untreated hypertension.  
The rate of elevated systolic blood pressure (SBP) (>110-115 and >140mm Hg) has increased 
substantially between 1990 and 2015, and the all disability-adjusted life-years (DALYs) and 
deaths associated with SBP has also increased (Forouzanfar et al., 2017). Results from the 
Global Burden of Disease (2015) suggest that an estimated 3.5 billion adults had SBP of at least 
110 to 115 mm Hg and 874 million adults had SBP of 140 mm Hg or higher worldwide.  
2.3.3 Current Management of Hypertension  
There are significant health and economic gains from early detection, adequate treatment and 
good control of hypertension. Early detection of hypertension can minimise the risk of life-
threatening complications such as heart attack, heart failure, stroke and kidney failure (World 
Health Organization, 2013). Despite huge efforts, the levels of awareness, treatment and control 
rates of hypertension remains low, especially in developing countries (Y. Li et al., 2017). A 
recent systematic analysis of data from 178 studies involving 2,901,464 participants covering 
30 provinces of China shows that from 1999 to 2014, the overall rates of prevalence, treatment, 
and control of hypertension were 28.9%, 35.3% and 13.4% in China, respectively (Y. Wang et 
al., 2016).  
Management of hypertension for each individual is determined by numerous factors including 
a thorough clinical investigation to identify the severity of hypertension, the associated clinical 
conditions and/or end-organ damage, as recommended by the National Heart Foundation of 
Australia in Guideline for the Diagnosis and Management of Hypertension in Adults - 2016 
(Gabb, Mangoni, & Arnolda, 2017). 
2.3.3.1 Non-pharmaceutical therapies 
Lifestyle modification is recommended for all patients with or without hypertension and 
regardless of drug therapy. Numerous trials using lifestyle interventions in patients with 
hypertension have shown reductions in blood pressure and a reduction in combined 
cardiovascular events and total mortality (Eriksson, Franks, & Eliasson, 2009; Folta et al., 2009).  
Lifestyle modification includes controlling behaviour risk factors such as the consumption of 
food containing excessive sodium and saturated fat, inadequate consumption of wholegrain 
breads and cereals, vegetables and fruits, harmful levels of alcohol consumption, lack of 
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physical activity, and poor stress management. Controlling these behaviour risk factors assists 
with reducing blood pressure and contributes to reducing other CVD risk factors and improving 
general health (World Health Organization, 2013). Importantly, long-term adherence to 
lifestyle improvement may delay or prevent the onset of hypertension, contribute to the 
reduction of blood pressure in patients with hypertension already on therapy and, in some cases, 
reduce or abolish the need for antihypertensive therapy (Gabb et al., 2017).  
2.3.3.2 Pharmaceutical treatment 
Several guidelines for the management of hypertension in different clinical settings have been 
developed by many professional bodies to inform clinicians (Jarari et al., 2015).  
Thiazide diuretics, ACE inhibitors, angiotensin receptor blockers (ARBs), and calcium channel 
blockers (CCBs) are recommended as suitable first-line drugs for the treatment of hypertension, 
either as monotherapy or in some combinations (Carey & Whelton, 2018; Gabb et al., 2017). A 
2015 meta-analysis involving 55 RCTs (195, 267 patients with hypertension) comparing drug 
classes with placebo demonstrated that blood pressure lowering is accompanied by significant 
reductions in the relative and absolute risk of stroke and major cardiovascular events, 
independent of the specific drug properties (Thomopoulos, Parati, & Zanchetti, 2015).  
Combination therapy, defined as the use at least two antihypertensive drugs, is required in up 
to 50-70% of patients to achieve blood pressure targets (Gabb et al., 2017). It is widely accepted 
that combining two classes of antihypertensive drug lowers blood pressure more than doubling 
the dose of one drug. ACE inhibitors and CCBs are superior to diuretics combined with either 
an ACE inhibitor or a beta-blocker in their effects on various cardiovascular events and 
mortality (Dahlof et al., 2005; Jamerson et al., 2008).  
Since treatment of hypertension is long term, the tolerability and safety of drugs is particularly 
important. However, all effective antihypertensive drugs have adverse effects. In general, after 
starting drug treatment, patients should be reviewed at 4-to 6-week intervals to evaluate 
adherence, adverse effects, tolerability and efficacy (Gabb et al., 2017).    
2.4 Cardiovascular Risk Factors 
Strong evidence exists to support the association between behavioural risk factors and other 
contributing risk factors, and the development and prognosis of CVDs.  
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2.4.1 Behavioural Risk Factors 
Global comparative risk assessment studies have estimated that the major risk factors of CVD 
are related to lifestyle, including smoking, unhealthy diet, physical inactivity and harmful use 
of alcohol (Tzoulaki et al., 2016). These unhealthy lifestyle behaviours may lead to 
metabolic/physiological changes in the body, resulting in other contributing cardiovascular risk 
factors, such as high blood pressure, overweight/obesity, hyperglycemia/diabetes, and 
dyslipidaemia. As a result, coronary and cerebral blood vessel problems may happen due to 
atherosclerosis, a process developing over many years starting in childhood and manifesting as 
heart attacks and strokes in people of middle age (Kwon et al., 2016; Z. Wang et al., 2017).   
Smoking regardless of cigarette type is a major risk factor of CVD (Munro, Tarone, Wang, & 
Blot, 2016). Evidence from large prospective cohort studies with regards to the beneficial 
effects of smoking cessation on CHD mortality has been largely reported (Kondo et al., 2011; 
Luksiene, Tamosiunas, Virviciute, & Radisauskas, 2017). A population-based cohort study 
collected data at the 31-year and 46-year follow-ups with a total of 5038 and 5974 individuals 
demonstrated that, smoking seems to be above all an independent risk factor for CVD in the 
working-age population (Keto et al., 2016).  
Insufficient physical activity is one of the ten leading risk factors for global mortality. Physical 
activity is any bodily movement produced by the muscles which results in energy expenditure. 
Globally in 2010, 23% of adults aged 18 years and above were insufficiently active (World 
Health Organization, 2018f). Based on self-report data from the Australian Bureau of Statistics 
(ABS) 2014-2015 National Health Survey (NHS), over one in two Australian adults (56%) had 
insufficient physical activity (Australian Bureau of Statistics, 2015). In adults, participation in 
at least 150 minutes of moderate intensity physical activity each week (or equivalent) is 
estimated to reduce the risk of CHD by approximately 30% and the risk of diabetes by 27%, as 
recommended by WHO (World Health Organization, 2018g). 
Alcohol consumption is responsible for more than 200 diseases and health conditions, including 
hypertension, myocardial infarction, cardiomyopathy, cardiac arrhythmia, and cirrhosis of the 
liver (World Health Organization, 2014). Annually alcohol consumption was responsible for 
2.5 million deaths worldwide, accounting for 3.8% of all global deaths, and more than half of 
these deaths were due to CVDs, liver cirrhosis and cancer (World Health Organization, 2018c).  
Unhealthy diet is also a modifiable behaviour risk factor of CVD. A considerable body of 
research reported on the nutritional background of atherosclerosis in general and particularly 
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CHD. High dietary intakes of saturated fat, trans-fat cholesterol and salt, and low intake of 
fruits, vegetables and fish are associated with the risks of CVD. In people at high risk of CVD, 
adherence to a Mediterranean diet is recommended. A Mediterranean diet is characterised by a 
high consumption of vegetables, fruits and healthy oil and moderate consumption of protein 
(Erwin et al., 2018; Torres-Pena et al., 2018; Widmer, Flammer, Lerman, & Lerman, 2015). A 
body of evidence supports population-wide salt intake reduction as recommended by current 
guidelines as an essential public health effort to prevent CVD (Aaron & Sanders, 2013; Kanzler, 
Hartmann, Gruber, Lammer, & Wagner, 2014).  
Overweight or obesity is a risk factor of cardiovascular morbidity, mortality and total mortality 
by prospective epidemiological studies (Königstein et al., 2018). In 2010, overweight and 
obesity were estimated to cause 3.4 million deaths, 3.9% of years of life lost, and 3.8% of 
disability-adjusted life-years (DALYs) worldwide (Lim et al., 2012). The number of people 
overweight or obese has increased between 1980 and 2013 from 28.8% to 36.9% in men and 
from 29.8% to 38.0% in women and increased substantially in children and adolescents in both 
developed and developing countries (M. Ng et al., 2014).  
Diabetes is a major risk factor of CVD. Dinesh Shah et al. (Dinesh Shah et al., 2015) used 
linked electronic health records from 1997 to 2010 to investigate the absolute and relative risks 
associated with type 2 diabetes in a cohort of in 1.92 million patients in England. Their findings 
demonstrated that type 2 diabetes was strongly positively associated with many types of CVDs. 
The risk of cardiovascular events is from two to three times higher in people with diabetes and 
the prognosis is poorer, compared with those without diabetes (Emerging Risk Factors 
Collaboration et al., 2010; Karayiannides, Lundman, Friberg, & Norhammar, 2018; Ofstad, 
Atar, Gullestad, Langslet, & Johansen, 2018). A 23-year follow-up study found lifestyle 
intervention for people with impaired glucose tolerance reduced incidence of cardiovascular 
and all-cause mortality and diabetes (G. Li et al., 2014).  
The blood lipid profile includes low-density lipoprotein cholesterol (LDL-C), high-density 
lipoprotein cholesterol (HDL-C), and triglycerides. An increase in concentration of total 
cholesterol and LDL-C and a decrease in HDL-C is associated with raised risk of CVD 
(Mediene-Benchekor et al., 2001). The importance of lipid management for prevention of 
coronary and stroke events has been reported in many clinical studies (LIPID Study Group 
(Long-term Intervention with Pravastatin in Ischaemic Disease), 2002). One meta-analysis of 
randomised trials of statins in combination with other preventive strategies with 165,792 
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individuals shows that each 1 mmol/L (39mg/dL) decrease in LDL cholesterol equates to a 
reduction in relative risk for stroke of 21.1%, and intense reduction of LDL cholesterol by 
statins also significantly reduced the risk of recurrent major cardiovascular events (Amarenco 
& Labreuche, 2009). The side effects of statins include muscle symptoms, increased risk of 
diabetes, liver inflammation, cataracts, decreased energy, sexual dysfunction, and exertional 
fatigue (Abramson et al., 2013). 
2.4.2 Other Contributing Risk Factors 
Other contributing risk factors for CVDs, include family history, aging, gender, socioeconomic 
determinants and psychological wellbeing (Havranek et al., 2015; World Health Organization, 
2017). 
Detailed medical family history (hereditary factors) data have been proposed to be effective in 
identifying high-risk families for earlier detection, management of modifiable risk factors and 
targeted intervention (Kulshreshtha et al., 2015; R. R. Williams et al., 2001). Large population-
based studies have found that most early cardiovascular events occur in families with a positive 
family history of CVD (R. R. Williams et al., 2001). Analysis of data from 1034 children found 
that children with familial hypercholesterolemia (FH) in the highest LDL-C and whose 
lipoprotein as >300 mg/L had a 1.7-times and 1.45-times higher incidence, respectively 
(Wiegman et al., 2003). A case-control study of 1091 male and 531 female aged 40-70 years 
found that family history of CHD is not only a strong risk factor for myocardial infarction in 
both sexes, but that its effect is synergistic with other cardiovascular risk factors as well 
(Leander, Hallqvist, Reuterwall, Ahlbom, & de Faire, 2001).  
Aging is the dominant risk factor for clinically significant atherosclerotic lesion formation 
which is the results of a myriad of independent pathways and their complex interactions (Head 
et al., 2017). Population aging accelerates the rapid increasing burden of CVDs. European 
Union region currently experiences most advanced stage of demographic aging due to related 
net-migration rate changes (Jakovljevic et al., 2018). According to United Nations, in 2025 an 
estimated 44% of population worldwide will live in relatively aged countries, with at least 20% 
of the population aged 60 years or over (United Nations Department of Economic and Social 
Affairs Population Division, 2015).   
Gender is an important determinant of cardiovascular risk, and men generally develop CVD 
earlier than women (Lyngbakken et al., 2016). A prospective population-based cohort study 
with 2888 participants during a follow-up of up to 20.1 years demonstrated that at age 55, 
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though men and women have similar lifetime risks of CVD (men: 67.1%; women: 66.4%), there 
are considerable differences in the first manifestation (Leening et al., 2014). The authors 
concluded that men and women are more likely to develop CHD as a first event (27.2%), while 
women are more like to have cerebrovascular disease (22.8%) or heart failure (14.9%) as their 
first event, although there manifestation appear most often at older ages (Leening et al., 2014).  
Social determinants of CVD include socioeconomic position (encompassing wealth and income, 
education, employment/occupational status, etc.), race and ethnicity, social support, culture, 
access to medical care, and residential environments (Havranek et al., 2015). Overall, lower 
socioeconomic position in the United Sates is associated with a greater prevalence of CVD risk 
factors and a higher incidence of and mortality resulting from CVD (Havranek et al., 2015). 
The prevalence of hypertension in blacks in the United States is among the highest in the world 
(Benjamin et al., 2018). Additionally, evidence from the analysis of 8,492 individuals with self-
reported CVDs from 21 countries enrolled in the PURE study demonstrated that use of 
medication for secondary prevention of CVDs is alarmingly low, especially in low-income 
countries, ranging from 0% in South Africa (95% CI: 0-1.7), Tanzania (0-3.6), and Zimbabwe 
(0-5.1), to 49.3% in Canada (44.4-54.3) (Murphy et al., 2018).  
Stress, anxiety and depression are also important contributing factors to CVDs; their 
relationship with CVDs are discussed in detail below.  
2.5 Stress, Anxiety, Depression and CVD 
There is a large body of evidence addressing the association between psychosocial factors and 
CVD. A recent longitudinal study (Palacios, Khondoker, Mann, Tylee, & Hotopf, 2018) 
involved 803 patients with diagnosis of CHD and followed them up every 6 months for 3 years. 
This study demonstrated that symptoms of anxiety and depression are highly prevalent in 
patients with stable CHD. Another study assessed psychosocial stress and major cardiovascular 
events in patients with stable CHD by a questionnaire in 14,577 patients followed-up 3.7 years 
(Hagström et al., 2018). Psychological stress was associated with increased CVD mortality in 
patients with stable CHD.  
A recent Cochrane systematic review involving 35 studies with 10,703 participants with CHD 
explored the effectiveness of psychological interventions for the management of CHD 
(Richards et al., 2017). Psychological interventions led to a significant reduction in 
cardiovascular mortality (relative risk 0.79, 95% CI 0.63 to 0.98) and improved depressive 
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symptoms (SMD -0.27, 95%CI -0.39 to -0.15), anxiety (SMD -0.24, 95% CI -0.38 to -0.09) 
and stress (SMD -0.56, 95% CI -0.88 to -0.24) in patients with CHD. 
Psychological risk factors such as stress, anxiety, and depression are known to play a significant 
and independent role in the development of hypertension, CHD and its complications (Albus, 
2010; Chida & Hamer, 2008; Korkmaz, Korkmaz, Yildiz, Gundogan, & Atmaca, 2017; 
Nekouei, Doost, Yousefy, Manshaee, & Sadeghei, 2014; Palagini et al., 2016; Player & 
Peterson, 2011; Wiltink et al., 2011). These psychological risk factors, especially depression, 
are associated with other risk factors, including educational level, sedentary lifestyle, smoking, 
unhealthy diet and reduced compliance with risk factor modification (Pogosova et al., 2017). 
The influence of depression in patients with CHD that independently associated with increased 
cardiovascular morbidity and mortality has been extensively documented (Baumeister et al., 
2011; Gan et al., 2014; Rugulies, 2002). Previous research has focused on the role of anxiety 
in depression-related risks. Anxiety is highly comorbid with depression and both are 
independently associated with increased risk of mortality in CHD patients (Watkins et al., 2013). 
As a result, the American Heart Association has recommended that patients who positively 
screen for depression should be evaluated for the presence of anxiety (Lichtman et al., 2008).  
2.5.1 Stress 
2.5.1.1 Definition of stress 
The implication of stress on the risk and prognosis of CHD has been established for over four 
decades (Jenkins, 1971, 1976; Kivimaki et al., 2006; Redmond et al., 2013; Richardson et al., 
2012). There are a number of types of stress defined in the research setting, including work 
stress, environmental stress, marital stress, financial stress, stressful life events, stress 
symptoms (e.g., sleep difficulties) and other stressors (Katsarou, Triposkiadis, & Panagiotakos, 
2013). Definitions of stress focus on two major components: (1) the “cause”, namely 
environmental stressors or stimuli, such as work environment and life events; and (2) the 
“effect”, namely subjective reaction to stress, such as stress appraisal and emotional response 
(Kopp et al., 2010). Broadly speaking, stress measured in research can be classified into three 
perspectives: (1) environmental, focusing on stressors or life events; (2) psychological, 
assessing subjective stress appraisal and affective reactions; and (3) biological, assessing the 
activation of the physiological systems involved in the stress response (E. H. Lee, 2012).  
2.5.1.2 Stress and CVD 
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Reporting on stress and CVD, has primarily focused on work stress.  Numerous studies have 
documented work stress as a high risk factor of CVD and CHD (Gallo, Bogart, Vranceanu, & 
Walt, 2004; Karasek, Collins, Clays, Bortkiewicz, & Ferrario, 2010; Siegrist, 2005) Work stress 
includes job strain or demand-control, effort-reward imbalance, over-commitment, 
organisational injustice, shift work, job insecurity, job satisfaction, and working hours (Backe, 
Seidler, Latza, Rossnagel, & Schumann, 2012; Glozier et al., 2013). One meta-analysis found 
that between 8.8 to 10.2% of CHD morbidity was attributed to work stress, whereby the total 
costs of CHD and mental disorders attributed to work stress exposure ranged from 1.8 to 3 
billion euros in France in 2003 (Sultan-Taïeb, Chastang, Mansouri, & Niedhammer, 2013). 
Employees with work stress had an average of 50% higher risk of the development of CHD 
than those without work stress (Kivimaki et al., 2006). A meta-analysis found that the 
association between work stress and cardiovascular morbidity and mortality was stronger in 
patients under the age of 55 (Backe et al., 2012). Similarly, another study emphasised the 
importance of reducing work stress, and recommended that people work until 65 years old to 
prevent cardiovascular events (Munakata, 2014).  A meta-analysis found that for first CHD 
event, work stress was associated with an increased relative risk of recurrent CHD events of 
65% (J. Li, Zhang, Loerbroks, Angerer, & Siegrist, 2015). Compared with work stress, marital 
stress appears to affect women more strongly, and marital stress was associated with a 2.9-fold 
increased risk of recurrent events in patients with CHD (Orth-Gomer et al., 2000). 
Both epidemiological and prospective studies have generated evidence to support the causal 
relationship between stress and CVD. Flaa et al. (2008) conducted a longitudinal follow-up 
study over 18 years examining the prognostic significance of individual differences in reactions 
to psychological stress, and found that stress-induces sympathetic nervous activity, indicating 
a possible causal factor in the development of essential hypertension (Flaa, Eide, Kjeldsen, & 
Rostrup, 2008). A large-scale cross-sectional study that investigated the relationship between 
the psychosocial work environment and CVD prevalence in 13,779 workers aged between 16 
to 65, found that work stress and a lack of co-worker social support contributed to higher CVD 
prevalence (Johnson & Hall, 1988). Financial stress also increases the incidence of CVD and 
all-cause mortality, especially among men (Carlsson et al., 2014).  
Prognosis for people with CHD and/or hypertension may be worsened by psychological stress. 
A qualitative study involving interviewees with CHD identified that cardiac events were 
significantly more prevalent among patients with both psychiatric problems and biological risk 
factors (Shoja Shafti, 2014). A meta-analysis of 43 studies showed that stress reduction 
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interventions as a psychological treatment in patients with acute myocardial infarction resulted 
in a 2-year reduction in mortality in men and event recurrence in all patients with CHD by 27% 
(Linden, Phillips, & Leclerc, 2007). An observational cohort study found that high stress was 
associated with three-fold increased risk in readmission rates within 30 days in patients with 
acute coronary syndrome, after adjustment for demographic and clinical factors and depression 
(Edmondson, Green, Ye, Halazun, & Davidson, 2014). A cohort study involving 4,204 patients 
with acute myocardial infarction found that patients with moderate/high stress had a higher two-
year mortality compared with those with low stress (Arnold, Smolderen, Buchanan, Li, & 
Spertus, 2012).  
2.5.1.3 Pathophysiological mechanisms 
The pathophysiological mechanisms underlying the association between stress and CVD 
remain unclear. Explanations include both physiological and behavioural responses to stress 
(Inoue, 2014; Lagraauw, Kuiper, & Bot, 2015).  Stress may result in impaired elevated 
fibrinogen (Siegrist, Peter, Cremer, & Seidel, 1997; Vrijkotte, van Doornen, & de Geus, 1999), 
exaggerated cardiovascular reactivity such as increased blood pressure (Djindjic et al., 2013), 
increased lipid profile (Cesana et al., 2003; Evolahti, Hultcrantz, & Collins, 2009; Steptoe & 
Willemsen, 2004; Vrijkotte, van Doornen, & de Geus, 2000; S. C. Yang, Chien, Tsai, Ho, & 
Chen, 2011), endothelial dysfunction (Ushakov, Ivanchenko, & Gagarina, 2016), lower heart 
rate variability (Hintsanen et al., 2007), elevated  hypothalamic-pituitary-adrenal (HPA) axis 
biomarkers (Chandola, Heraclides, & Kumari, 2010), beta-receptor down-regulation (Vrijkotte, 
van Doornen, & de Geus, 2004), heightened acute inflammatory responsivity (Emeny et al., 
2013; Hamer et al., 2006), platelet activation (Brydon, Magid, & Steptoe, 2006), and induction 
in other behaviour (e.g. physical inactivity) or psychological risks (e.g. increased anxiety) 
(Balog et al., 2003; Ushakov et al., 2016). The multiple factors mentioned above can affect the 
clinical courses and outcomes of people with cardiovascular disease.   
2.5.2 Anxiety 
2.5.2.1Definition of Anxiety 
Anxiety has been defined as a stimulus, a trait, a motive and a drive. Anxiety can be 
differentiated into state anxiety which is an emotional condition at a period of time, and trait 
anxiety which is a personality characteristic (Allahverdipour, Asgharijafarabadi, Heshmati, & 
Hashemiparast, 2013). The prevalence of anxiety in CHD patients varies from 12.0% to 41.8% 
in men, and 21.5% to 63.7% in women (Pajak et al., 2013). Research has shown that anxiety 
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has a substantial effect on both the development of CHD as well as an increased risk of 
subsequent cardiovascular events (Kubzansky, Cole, Kawachi, Vokonas, & Sparrow, 2006; 
Player & Peterson, 2011). 
2.5.2.2 Anxiety and CVD 
Anxiety and the development of CVD has been reported in recent years. Two meta-analyses 
confirmed anxiety as an independent risk factor for the development of CHD in healthy subjects, 
as well as for a poorer prognosis among patients with established CHD (Roest, Martens, de 
Jonge, & Denollet, 2010; Roest, Martens, Denollet, & de Jonge, 2010). Large-scale prospective 
studies have demonstrated a significant link between anxiety and sudden cardiac death or 
cardiac events (Janszky, Ahnve, Lundberg, & Hemmingsson, 2010; Kawachi et al., 1994; Nabi 
et al., 2010). Anxiety is a strong, independent predictor of major cardiac events in patients with 
stable coronary disease (Frasure-Smith & Lesperance, 2008; Moser et al., 2011; Phillips, 2011; 
Strik, Denollet, Lousberg, & Honig, 2003). Furthermore, anxiety following a major cardiac 
event can impede recovery and is associated with both higher morbidity and mortality. 
Anxiety has a significant negative relationship with functional status and quality of life in 
patients with CHD (Allahverdipour et al., 2013). Engebretson and colleagues (1999) found that 
CHD patients with a high level of anxiety had a significantly lower quality of life in comparison 
to those with a lower level.  
Anxiety as a CVD risk factor has been found to be independent of depression or other 
psychological factors (Benninghoven et al., 2006; Frasure-Smith & Lesperance, 2008; B. J. 
Shen et al., 2008).  
 
2.5.2.3 Pathological mechanisms 
The precise pathological mechanisms underlying anxiety and CVD are unclear. Several studies 
have demonstrated a link between potential pathological mechanisms including autonomic 
dysfunction such as reduced baroreflex cardiac control (Watkins, Blumenthal, & Carney, 2002), 
dysregulation of the HPA axis (Merswolken, Deter, Siebenhuener, Orth-Gomer, & Weber, 
2013), increased markers of inflammation (Steptoe, Wikman, Molloy, Messerli-Burgy, & Kaski, 
2013), progression of atherosclerosis (Paterniti et al., 2001), impaired vagal control, decreased 
heart rate variability (Martens, Nyklicek, Szabo, & Kupper, 2008), risk of ventricular 
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arrhythmia (van den Broek et al., 2009; Watkins et al., 2006), elevated in the cardiac biomarker 
C-reactive protein (Bankier, Barajas, Martinez-Rumayor, & Januzzi, 2008, 2009), and 
unhealthy behaviours or lifestyle (Bonnet et al., 2005).  
2.5.3 Depression 
2.5.3.1 Definition of Depression 
According to the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV), 
depression is the subjective experience of psychological and somatic symptoms (Davidson, 
2012). Depression is related, not only to the incidence of CHD, but also to the prognosis of 
patients with established heart disease. Depression is associated with an increased risk of 
mortality in patients with CHD (Carney et al., 2016). Depression is also associated with poor 
medical prognosis in CHD patients.  
 
2.5.3.2 Depression and CVD 
The close association between depression and the development of CVD is well documented. A 
meta-analysis involving thirty prospective cohort studies with 893,850 participants (59,062 
CHD cases) during a follow-up period ranging from 2 to 37 years demonstrated that depression 
is independently associated with a significantly increased risk of CHD (relative risk ([RR]: 1.30; 
95% CI: 1.22-1.40) and MI (RR: 1.30; 95%CI: 1.18-1.44) (Gan et al., 2014). 
The prevalence of depression is high in patients with CHD. Rates of major depressive disorder 
of approximately 15% to 30% have been reported in patients after acute myocardial infarction 
or coronary artery bypass grafts (Carney & Freedland, 2003; Thombs et al., 2006), and 20% to 
40% of individuals have significant patient-reported depressive symptoms (Bush et al., 2005; 
Celano & Huffman, 2011). An analysis of longitudinal data from nationwide general practices 
in Germany (n=1072) involving 59,992 patients matched to 59,992 controls demonstrated that 
21.8% of the CHD group and 14.2% of the control group were diagnosed with depression 
(Konrad, Jacob, Rapp, & Kostev, 2016). A meta-analysis found that consistent with the general 
population, the prevalence of major depression is 2-times greater in women than men with CHD 
(Shanmugasegaram, Russell, Kovacs, Stewart, & Grace, 2012).  
Depression in CHD patients has been associated with significant increases in medical utilization, 
loss of productivity and functional disability (Egede, 2007; W. F. Stewart, Ricci, Chee, Hahn, 
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& Morganstein, 2003). The health care costs of outpatient care, emergency room and 
readmission during the first year following myocardial infarction in patients with elevated 
depressive symptoms were 41% higher than for those with few depressive symptoms (Frasure-
Smith et al., 2000).  
Depression may increase other cardiovascular risk factors in people with established CVD. A 
large survey interviewing 8966 CHD patients <80 years of age covering 22 European countries 
found that CHD patients with severe depressive symptoms had lower frequency of regular 
exercise and decreased likelihood of exercise intention (Prugger et al., 2017). A prospective 
cohort study following 667 patients with stable CHD for 5 years demonstrated that greater 
depressive symptoms are linked to a range of poorer lifestyle risk factors (less physical activity, 
lower medication adherence, higher body mass index, higher waist to hip ratio, worse sleep 
quality and smoking), predicting future declines in physical activity, medication adherence and 
sleep quality (Sin, Kumar, Gehi, & Whooley, 2016). 
Large epidemiological studies have convincingly demonstrated that depression is a predictor 
for occurrence and recurrence of CHD. The relative risk of death in depressed patients within 
18 months following a cardiac event is twice as likely than in patients without depression 
(Frasure-Smith, Lesperance, & Talajic, 1995). A meta-analysis showed that those with both 
premorbid and post-CHD depression have 1.5 to 2 times higher risk of mortality and cardiac 
morbidity (Y. W. Leung et al., 2012).  
Depression is associated with diminished health-related quality of life (HRQoL) in patients with 
CHD. A systematic review with 11 studies (Dickens, Cherrington, & McGowan, 2012) found 
that depression predicts subsequent physical HRQoL and this association was not attributable 
to confounding effects of baseline HRQoL or the severity of the CHD.                                                                                                                                 
 
2.5.3.3 Pathological mechanisms 
The underlying mechanisms of the multiple pathophysiological pathways involved in the 
relationship between depression and CHD and hypertension and other CVDs are not yet fully 
understood; and further clarification is needed. A large body of evidence suggests that 
depression increases the risk of CVD morbidity and mortality due to psychological, behavioural 
and biological mechanisms. The hypothesized mechanisms include the link between depression 
and atherosclerosis through the pathways of inflammation and endothelium dysfunction 
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(Chrysohoou et al., 2018), HPA dysregulation and heightened cortisol response, autonomic 
nervous system dysfunction and inflammation (Davidson, 2012; J. T. Wang, Hoffman, & 
Blumenthal, 2011). For example, depressed patients have greater platelet aggregation, reduced 
heart rate variability, erectile dysfunction (Sulistyo, Andiarso, & Hariawan, 2016), and a higher 
level of inflammatory markers such as C-reactive protein (Burg, Martens, Collins, & Soufer, 
2011; Gegenava, Gegenava, & Kavtaradze, 2011; Strike & Steptoe, 2004; Sunbul, Sunbul, & 
Gulec, 2017). Other hypothesized mechanisms include psychosocial factors such as social 
isolation and low perceived social support, as well as negative lifestyle and behavioural factors 
(Lie, Hernandez, Trout, Kleiman, & Bozzay, 2017; J. T. Wang et al., 2011). The psychological 
difficulties associated with depression also exacerbate negative lifestyle factors such as 
smoking, poor diet, sleep architecture disruption and sedentary lifestyle (Davidson, 2012; 
Doyle et al., 2014; Lina & Li, 2016). Medication adherence also has been identified as a 
potential mediator of the depression CHD relationship (J. T. Wang et al., 2011; Ziegelstein et 
al., 2000).  
 
2.6 Tai Chi 
2.6.1 Overview of Tai Chi  
Tai Chi, also known as Tai Chi Chuan/Quan or Taiji, is variously described as a meditative or 
internal martial atrial art or a mind-body exercise that originated in China. Tai Chi was 
developed by a famous martial artist Chen Wang-Ting towards the end of Ming Dynasty (17th 
Century A.D.) (L. Gu & Shen, 2007). Chen Wang-Tingcomprehensively incorporated the 
essence of Chinese folk and military martial arts, breathing and meditative techniques, Taoist 
philosophy of yin and yang, and traditional Chinese medicine theory (Tang & Gu, 2012). 
The characteristics of Tai Chi reflect traditional Chinese medicine theory. Firstly, according to 
traditional Chinese medicine, meridians are passageways for the flow of ‘qi’ and ‘blood’, which 
are the two basic bodily fluids in Chinese medicine (D. Li, 1995). Meridians spread on the 
surface of the whole body vertically and horizontally, integrating the inside with the outside of 
the body and connecting the inner organs, joints and extremities. The movements of Tai Chi 
are required to be led by mind and ‘qi’ and relax the whole body to help ‘qi’ and ’blood’ flow 
smoothly (Tang & Gu, 2012). Secondly, traditional Chinese medicine addresses the concept of 
holism, i.e. all body functions are under the complete state of one organism (G. R. Sun, 2008).  
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The practice of Tai Chi requires the combination of mind, body and breath. Through the 
adjustment of mind, body and breath, Tai Chi enhances the harmony of the whole body. Thirdly, 
traditional Chinese medicine places emphasis on personalised treatment. Tai Chi is often 
adjusted to suit individual’s need through selecting different Tai Chi styles or forms, practicing 
in lower or higher postures, or at slower or quicker speed (L. Gu & Shen, 2007). 
Traditionally, the main components of Tai Chi are movement, meditation and imagination, and 
deep/abdominal breathing (Tang & Gu, 2012). This enables practitioners to benefit both 
physically and psychologically from Tai Chi. Tai Chi movements consist of a sequence of slow, 
continuous, graceful movements with circular and spiral body movements, which are known as 
forms.  
In the past decade, clinical researchers have investigated the multiple components of Tai Chi. 
Wayne et al. (2013) deconstructed the multiple components of Tai Chi as follows: (1) awareness, 
mindfulness, and focused attention; (2) intention, belief and expectation; (3) structural 
integration, dynamic form and function; (4) active relaxation; (5) strengthening and flexibility; 
(6) natural, freer breathing; (7) social support, interaction and community; (8) embodied 
spirituality, philosophy and ritual. These components may work independently and 
synergistically to generate benefits (Wayne et al., 2013). 
Tai Chi was reported for the first time as an intervention in a clinical study in 1958.  This, case 
series conducted in China investigated the beneficial effects of Tai Chi on tuberculosis (D. 
Wang, 1958). In 1988, the first RCT of Tai Chi was conducted to investigate the effect of Tai 
Chi in combination with Qigong in cardiac rehabilitation (Y. Sun et al., 1988). The intensity of 
Tai Chi is regarded as low to moderate, and can be easily adjusted to meet different 
requirements of intensity (L. Gu & Shen, 2007). Therefore, it is a feasible choice for individuals 
who are sedentary or have limited exercise capacity such as the cardiac population.  
Research assessing the safety and physical and psychological benefits of Tai Chi in healthy 
population and various patient cohorts has grown in recent years. We reviewed 507 clinical 
studies of Tai Chi and found that Tai Chi clinical studies have been conducted in 20 countries 
worldwide covering various diseases/conditions such as hypertension, diabetes, heart failure, 
CHD, and depression (G. Yang et al., 2015).  
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2.6.2 Tai Chi Styles 
Tai Chi was traditionally only practiced in the Chen family. It wasn’t until Yang Lu-Chan 
learned Tai Chi from the 14th generation of Chen family and adapted the Chen-style into Yang-
style that Tai Chi was taught in Beijing and promoted to other areas of China (Z. W. Fu, 1963). 
It was not until 1928 when Chen Fa-Ke was invited to Beijing to teach Tai Chi that Chen-style 
Tai Chi was recognized and practiced by a wider population. Today Tai Chi is widely practiced 
for its health benefits both in Eastern and Western countries. Other classical styles include Wu, 
Wu/Hao, and Sun styles that are all derived directly or indirectly from Chen style, based on the 
unique backgrounds of the practitioners and the changes of social environment. For example, 
Sun-style Tai Chi was developed by Sun Lu-Tang, who learned Chen-style Tai Chi when he 
was already an expert in other two traditional martial arts (i.e. Xingyi and Bagua). Therefore, 
we can see the impacts of Xingyi and Bagua in Sun-style Tai Chi movements.  
Each classical style has its own forms. Therefore, the movements and characteristics of different 
styles vary. For example, within Yang style, there are different forms varying with respect to 
the number of movements and postures (e.g., 24-, 37-, 72-, 108-, and 150-movement forms), or 
the overall emphasis (e.g., health maintenance, martial skills, meditation and self-realization, 
competitive performing arts) (Wayne & Kaptchuk, 2008b). However, because all styles and 
forms are derived directly or indirectly from Chen style, the core principles and theories of them, 
such as balance, breathing, coordination, relaxation and concentration are similar.  
After the foundation of People’s Republic of China, to improve the overall health of the general 
public, the Chinese government promoted the generalisation of the five classical styles by 
simplifying these traditional Tai Chi forms and developing several competition forms based on 
them (Chen, Yang, Wu/Hao, Wu and Sun). In 1956, the General Administration of Sports of 
China issued a book titled ‘Simplified Tai Chi’ according to the classical Yang-style Tai Chi, 
which removed difficult and duplicate forms and simplified the 81 forms into 24 forms, which 
are currently the most popular styles worldwide (L. Gu & Shen, 2007). In addition, Tai Chi can 
be practiced with a partner in a more practical manner, which is called ‘pushing hands’ (2-
person interactive practice). There are also variations of Tai Chi, which are practiced with 
weapons, such as a sword, knife, folding fan, wooden staff or spear.   
Consequently, in clinical research, Tai Chi interventions may vary in type, form, training and 
practicing approach, frequency, duration, and intensity. Take the duration as an example, our 
previous comprehensive review (G. Yang et al., 2015) involving 507 clinical studies of Tai Chi 
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reported that the duration of a Tai Chi intervention varied from five days to three years and the 
most common duration was 12 weeks.  
Regardless of specific style, form, or teaching and practicing approach, Tai Chi itself is 
inherently a complex intervention, composed of multiple components each of which have 
potentially independent and synergistic therapeutic value (Wayne & Kaptchuk, 2008a). As a 
result, it is more appropriate to view Tai Chi as a form of whole-systems research rather than a 
single ingredient. Hence, Tai Chi intervention in clinical research is commonly provided as a 
full-course dinner for participants. It often consists of starters (warm-up exercise), main courses 
(Tai Chi practice) and desserts (Cool-down exercise) in each training class.  
2.6.3 Use of Tai Chi for Health Benefits  
Increasing evidence underscores the psychological benefits of Tai Chi intervention for healthy 
individuals and clinically affected populations.  
2.6.3.1 Tai Chi and Psychological Health 
In the past decade, several systematic reviews and meta-analyses of clinical studies have 
demonstrated that Tai Chi intervention is potentially beneficial for various populations on a 
range of psychological outcomes.   
For cancer survivors, one recent systematic review and meta-analysis summarized and critically 
evaluated the effects of Tai Chi and Qigong mind-body exercises on symptoms and quality of 
life (Wayne et al., 2018). The review of 22 studies including 15 RCTs evaluating 1283 
participants, found that Tai Chi and Qigong was associated with significant improvement in 
fatigue, sleep difficulty, depression, and overall quality of life in cancer survivors.  
For individuals with multiple sclerosis, a systematic review investigated the effects of Tai Chi 
on physical and psychological function (Taylor & Taylor-Piliae, 2017). The review included 
three RCTs and five quasi-experimental studies involving 193 participants with multiple 
sclerosis.  The participants in the Tai Chi group had better balance, gait and flexibility, less 
fatigue and depression, and better quality of life after the intervention.  
For students in higher education, a review of 76 non-randomised and RCTs found that Tai Chi 
is beneficial to reduce symptoms of depression and anxiety and improve interpersonal 
sensitivity of students in higher education (Webster, Luo, Krageloh, Moir, & Henning, 2016).  
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Several systematic reviews and meta-analyses have evaluated the overall effects of Tai Chi on 
psychological outcomes in various populations. A systematic review found Tai Chi statistically 
significant reduction in anxiety in 12 included clinical studies (Sharma & Haider, 2015). 
Although the results suggested that Tai Chi might be a promising modality for anxiety 
management, this review had some limitations. Only three English databases were searched, 
not all included studies used a randomised controlled design, some had small sample size, 
different outcome measurements for anxiety, and non-standardized Tai Chi interventions and 
durations. One 2014 systematic review and meta-analysis of 37 RCTs and five quasi-
experimental studies with various populations found that Tai Chi had beneficial effects on a 
range of psychological well-being measures, including depression, anxiety, and general stress 
management (F. Wang et al., 2014). However, the authors concluded that in spite of the positive 
outcomes, the included studies had significant methodological limitations.  
Another meta-analysis of four studies comparing Tai Chi with waitlist control groups on 
depressive symptoms, found that Tai Chi appeared to have a significant impact in reducing 
depressive symptoms (Chi, Jordan-Marsh, Guo, Xie, & Bai, 2013). Two of the included studies 
were assessed as being of high quality, while the remaining two studies were rated as moderate 
quality. The authors recommended future research with larger sample sizes, more clarity on 
trial design and the intervention, longer-term follow up, and concomitant economic evaluations 
to be conducted.  
One 2010 systematic review and meta-analysis involving 40 non-randomised controlled trials, 
RCTs and observational studies found that 21 of 33 randomised and non-randomised controlled 
studies reported that regular Tai Chi practice significantly increased psychological well-being 
including reduction of stress, anxiety, and depression, and enhanced mood in community-
dwelling healthy participants and in patients with chronic conditions (C. Wang et al., 2010). 
The seven observational studies reinforced the beneficial association between Tai Chi and 
psychological health. This review searched eight English and three Chinese databases and 
identified 29 psychological measurements, however, the authors concluded that definitive 
conclusions were still limited due to variation in designs, comparisons, heterogeneous outcomes 
and inadequate controls. Similarly, an earlier systematic review involving fifteen RCTs (eight 
were of high methodological quality) using Tai Chi as intervention and other forms of activities 
or waitlist as control, and found that Tai Chi was reported in 13 studies with a significant effect 
in the management of depression and anxiety (W. C. Wang et al., 2009). 
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Although there is a significant body of evidence suggesting the beneficial effects of Tai Chi on 
psychological outcomes in healthy, psychosocially affected and various pathological 
populations, there are few studies investigating the effects of Tai Chi on psychosocial outcomes 
in people with CVD, especially patients with CHD and/or hypertension. One recent systematic 
review and meta-analyses evaluated the effects of Tai Chi-based cardiac rehabilitation on 
aerobic endurance, psychosocial well-being and cardiovascular disease risk reduction for 
patients with CHD (T. Liu et al., 2018). Although it included thirteen non-randomised 
controlled trials and RCTs, only two studies reported the relationship between Tai Chi and 
psychosocial well-being as measured by Zung Self-rating Anxiety Scale (SAS) for anxiety and 
Zung Self-rating Depression Scale (SDS) for depression. Four of the six studies assessed QoL. 
The meta-analyses of these studies showed that Tai Chi group had a significantly lower level 
of anxiety and depression, and better quality of life, compared with non-active control groups. 
Additionally, the above six studies were assessed as high risk of bias. 
2.6.3.2 Tai Chi and Cardiovascular Health 
Over the past decade, prospective studies of Tai Chi have reported significant improvements in 
a wide range of cardiovascular parameters such as blood pressure, endothelial function, blood 
lipid profiles, heart rate response, heart rate variability, C-reactive protein and poor exercise 
capacity.  
For the overall cardiovascular health, one recent systematic review and meta-analysis assessed 
the effect of Tai Chi on cardiorespiratory fitness for coronary disease rehabilitation (Y. L. Yang, 
Wang, Wang, Shi, & Wang, 2017). It included five studies-two RCTs and three non-randomised 
controlled trials with 291 patients with CHD.  Meta-analyses of three studies showed that 
compared to other types of low- or moderate-intensity exercise, Tai Chi significantly improved 
VO2max. Although one study showed that Tai Chi seemed less effective at improving VO2max 
as compared to high-intensity exercise. A previous systematic review and meta-analysis 
assessed the effect of Tai Chi on cardiorespiratory fitness in healthy adults included 20 studies 
with 1868 participants (G. Zheng, Li, et al., 2015). The study designs were two RCTs, eight 
non-randomised controlled trials, three self-controlled trials and seven cohort studies; the 
majority of them were of low methodological quality. Tai Chi had positive effect on blood 




For the management of cardiovascular risk factors, a 2014 Cochrane systematic review 
comprehensively searched RCTs of Tai Chi lasting at least three months involving healthy 
adults or adults at high risk of CVD to evaluate the effects of Tai Chi for primary prevention of 
CVD (Hartley, Flowers, Lee, Ernst, & Rees, 2014). The authors identified no long-term trials 
examining Tai Chi for the primary prevention of CVD, and found that despite some beneficial 
effects of Tai Chi suggested by 13 small trials (1520 participants) and three ongoing trials, the 
results were not consistent across all studies and no conclusions could be drawn as to the 
effectiveness of Tai Chi on CVD risk factors. Another meta-analysis of RCTs evaluated the 
effect of Tai Chi on blood lipid profiles (X. Pan et al., 2016). Six studies involving 445 
participants found that the Tai Chi group was superior to the control group in lowering blood 
triglyceride and total cholesterol level, but no differences was found in blood LDL-C and HDL-
C. Two previous systematic reviews (M. S. Lee, Lee, Kim, & Ernst, 2010; Yeh, Wang, Wayne, 
& Phillips, 2008) evaluated the effect of Tai Chi for lowering blood pressure. The authors found 
beneficial effects of Tai Chi in reduction of blood pressure, but the conclusion was not definitive.  
For patients with CHD, one 2011 systematic review found that Tai Chi may improve serum 
lipid profiles, lower blood pressure and heart rate in patients with CHD (Dalusung-Angosta, 
2011). However, this review identified limited evidence by searching Medline/PubMed and the 
Cochrane Library database for clinical trials or RCTs published in English between 1985 and 
2008, and all but one of the included studies used a small sample size (n<100).  
For patients with chronic heart failure, a systematic review and meta-analysis evaluating the 
effects of Tai Chi identified eleven trials with 656 patients (Ren et al., 2017). The review found 
that Tai Chi could improve the distance walking within 6 minutes, quality of life, and left 
ventricular ejection fraction and may reduce B-type natriuretic peptide and heart rate. Another 
recent meta-analysis also searched major English and Chinese databases to evaluate evidence 
from RCTs of Tai Chi for patients with chronic heart failure (Q. Gu et al., 2017). It included 
thirteen RCTs, and also found that Tai Chi induced significant improvement in 6-minute 
walking distance, quality of life, left ventricular ejection fraction, and B-type natriuretic peptide. 
Two previous systematic reviews also found Tai Chi may improve exercise capacity and quality 
of life in patients with chronic heart failure (S. M. Ng et al., 2012; L. Pan, Yan, Guo, & Yan, 
2013).  
For patients with stroke and stroke risk factors, one systematic review and meta-analysis 
summarised the evidence of Tai Chi and Qigong for the primary prevention of stroke (Lauche 
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et al., 2017). It included 21 trials involving 1604 patients with hypertension, hyperlipidaemia, 
diabetes, overweight or obesity, or metabolic syndrome, and found significant benefits of Tai 
Chi/Qigong over no intervention for hypertension, the homeostatic model assessment index, 
and fasting blood glucose, and for the body mass index compared with exercise controls. 
However, the risk of bias was unclear or high for the majority of included trials, and 
heterogeneity between trials was high. Another previous systematic review including 36 studies 
with 2393 participants with stroke found similar results (G. Zheng, Huang, et al., 2015). 
For patients with type 2 diabetes, one systematic review and meta-analysis of RCTs found that 
the existing evidence is not convincing enough to suggest that Tai Chi is effective for managing 
patients with type 2 diabetes, because a limited number of studies and inconsistent results (M. 
S. Lee, Jun, Lim, & Lim, 2015). The authors found that compared with sham exercise, one 
study demonstrated that Tai Chi may be not effective in lowering fasting blood glucose or 
HbA1c; compared with anti-diabetic medication, a meta-analysis of five studies favoured Tai 
Chi on fasting blood glucose; compared with standard care alone, Tai Chi in combination with 
standard care showed positive effects on HbA1c and fasting blood glucose; compared with no 
treatment, a meta-analysis of four studies showed positive effects of Tai Chi on HbA1c. 
Previous systematic reviews demonstrated similar results (M. S. Lee, Choi, Lim, & Ernst, 2011; 
Yan, Gu, & Pan, 2013).  
2.6.3.3 Tai Chi and Quality of Life 
A range of clinical studies has demonstrated the beneficial effects of Tai Chi in improving 
health-related quality of life in healthy individuals and patients with difference 
disorders/conditions, such as patients with cancer (Wayne et al., 2018; Yan, Pan, Zhang, Sun, 
& Cui, 2014; Zeng, Luo, Xie, Huang, & Cheng, 2014), multiple sclerosis (Taylor & Taylor-
Piliae, 2017; Zou et al., 2017), perimenopausal syndrome (Y. Wang, Shan, Li, Yang, & Shan, 
2017), Parkinson’s disease (R. Song et al., 2017), chronic heart failure (Q. Gu et al., 2017; L. 
Pan et al., 2013; Ren et al., 2017), chronic obstructive pulmonary disease (W. Wu et al., 2014), 
and type 2 diabetes (M. S. Lee et al., 2011). 
Furthermore, in cardiac populations research into quality of life outcomes seems to be more 
extensive than other psychosocial outcome measures, as well as physical outcomes. Three 
systematic reviews and meta-analyses evaluated the effect of Tai Chi in patients with chronic 
heart failure (Q. Gu et al., 2017; L. Pan et al., 2013; Ren et al., 2017). Their results consistently 
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demonstrated that Tai Chi can significantly improve quality of life in patients with chronic heart 
failure. 
2.6.3.4 Tai Chi and Physical Fitness 
Tai Chi has been widely believed to have beneficial effects on physical fitness. Our previous 
comprehensive review involving available clinical studies on Tai Chi found that a large body 
of research reported Tai Chi resulted in improvements in balance and prevention of falls, 
mobility and postural stability, muscle strength, flexibility, and exercise capacity (G. Yang et 
al., 2015). 
One systematic review and meta-analysis involving five trials has demonstrated positive effects 
of Tai Chi on improving the spine dimension of bone mineral density in patients with 
perimenopausal syndrome (Y. Wang, W. Shan, et al., 2017). For students in higher education, 
a comprehensive review involving 72 clinical studies with 9263 participants showed that Tai 
Chi could increase their flexibility, lung capacity, balance, 800/1000m run time (Webster et al., 
2016). For patients with chronic obstructive pulmonary disease, a systematic review and meta-
analysis involving eleven RCTs with 824 patients demonstrated that compared with the non-
exercise group, Tai Chi group demonstrated significant improvements in walking distance of 
the six-minute walking test (6MWT), and greater reductions in St George’s Respiratory 
Questionnaire and Chronic Respiratory Disease Questionnaire (W. Wu et al., 2014).  
Tai Chi-based cardiac rehabilitation significantly improved aerobic endurance compared with 
both active and non-active control interventions, as well as psychosocial well-being, among 
patients with CHD (T. Liu et al., 2018). Another recent systematic review found in their meta-
analysis of seven trials demonstrated that Tai Chi could significantly improve the walking 
distance in 6MWT using the random-effects model (Ren et al., 2017). Similar beneficial effects 
of Tai Chi on 6MWT were found in another systematic review on Tai Chi for patients with 
chronic heart disease (Q. Gu et al., 2017).  
 
2.6.3.5 Other health benefits 
Our 2015 review of existing clinical evidence found that Tai Chi is beneficial for health 
promotion or preservation, balance control or fall prevention, and for the management of 
physical and mental health covering 93 diseases/conditions (G. Yang et al., 2015). The top 10 
diseases/conditions investigated in clinical studies on Tai Chi is as follows: hypertension, 
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diabetes, osteoarthritis, osteoporosis or osteopenia, breast cancer, heart failure, chronic 
obstructive pulmonary disease (COPD), CHD, schizophrenia, and depression (G. Yang et al., 
2015). 
 
2.6.4 Mechanisms of Action of Tai Chi in CVD 
The underlying mechanisms on how Tai Chi works for people with CVD and cardiovascular 
risk factors remains largely unclear. Fortunately, with the advances in neuroimaging 
technologies, new clues have been provided for understanding the underlying mechanisms of 
the beneficial effects of Tai Chi. Possible effects of Tai Chi included induced modulation of 
brain morphology, functional homogeneity and connectivity, regional activity and macro-scale 
network activity on health from available literature, and identified possible links between the 
alterations in brain and beneficial effects of Tai Chi, such as improved motor functions, pain 
perception, metabolic profile, cognitive functions, mental health and sleep quality (Yu et al., 
2018). 
Other possible explanations are summarised and analysed below.  
2.6.4.1 Psychological Health 
Nuclear factor-kappa B (NF-kB) signalling is an important mediator of the antineurogenic and 
behavioural actions of stress and depressive behaviours (Koo, Russo, Ferguson, Nestler, & 
Duman, 2010). investigated meditation effects of Tai Chi on NF-kB signalling in 26 lonely older 
adults. In an RCT of 26 lonely older adults, the Tai Chi group had significantly decreased the 
levels of stress and increased NF-kB levels, and change in psychological stress was correlated 
with change in NF-kB activation, compared with control group who received a health education 
only (Black et al., 2014). This finding indicates that Tai Chi-induced reduction in stress may 
attenuate increase in NF-kB activation.  
Another potential mechanism may be related to the link between inflammation and depression. 
Inflammation could produce depression in vulnerable individuals by lowering plasma 
tryptophan and diminishing brain serotonin activity, and low serotonin function may 
compromise mechanisms involved in maintaining recovery from depression (Cowen & 
Browning, 2015). A Korea RCT investigated the effects of Tai Chi on serotonin, nicotine 
dependency, depression and anger in 38 hospitalized alcohol-dependent patients (Oh & Kim, 
2016). This study found that the experimental group after 8-week Tai Chi practice significantly 
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increased blood serotonin level (P=0.001) and reduced nicotine dependency, symptoms of 
depression and anger, compared with control group who followed only the routine hospital 
rehabilitation program. It suggests that alternation of blood serotonin level might be involved 
in the mechanism behind Tai Chi-induced depression management.  
Additionally, increased levels of pro-inflammatory marker C-reactive protein (CRP) are 
associated with the development of depression (Kohler-Forsberg et al., 2017; B. M. Song et al., 
2015). A cross-sectional and prospective analyses of data from 73,131 men and women aged 
20 to 100 years also suggested that elevated levels of CRP are associated with increased risk 
for psychological distress and depression (Wium-Andersen, Orsted, Nielsen, & Nordestgaard, 
2013). The effects of Tai Chi in reducing inflammatory markers and CRP in trial where 73 older 
adults with major depression were randomised to either tai chi and medication or education and 
medication (Lavretsky et al., 2011). The Tai Chi plus medication group showed greater 
reduction of depressive symptoms and to achieve a depression remission, as well as 
significantly greater improvements in quality of life and cognitive function, and decline in 
inflammatory markers and CRP. Reduction in inflammatory markers and CRP might be part of 
the underlying mechanism of how Tai Chi improved psychological distress and depression.  
2.6.5.2 Cardiovascular Health 
Oxidative stress has been known with at least two critical roles within the cell, the generation 
of cellular damage and the involvement in several signalling pathways in its balanced normal 
state (Cervantes Gracia, Llanas-Cornejo, & Husi, 2017), which is associated with CVD 
development via endothelial dysfunction (Nair & Gongora, 2017; Nosalski, McGinnigle, 
Siedlinski, & Guzik, 2017; Paneni, Diaz Canestro, Libby, Luscher, & Camici, 2017). A quasi-
randomised controlled study with 55 elderly Mexican individuals (Rosado-Pérez, Santiago-
Osorio, Ortiz, & Mendoza-Núñez, 2012) found that after six months of daily training in Tai Chi 
the experimental group exhibited a statistically significant decrease in glucose levels, total 
cholesterol, LDL-C and systolic blood pressure, as well we an increase in superoxide dismutase 
(SOD) and glutathione peroxidase (GPx) activity and total antioxidant status (TAS) compared 
with the control group, Reducing oxidative stress might be involved in the underlying 
mechanism of Tai Chi. 
Endothelin-1 (ET-1) and circulating hormones play important roles in maintaining 
cardiovascular function. A study with 44 subjects demonstrated that the change in ET-1 and 
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triglyceride was significant after 3-month of Tai Chi training in the Tai Chi group (Lu & Kuo, 
2013; Mao & Sha, 2006).  
It is also reported in a 3-arm study involving patients with essential hypertension (Tai Chi group, 
n=24; hypertensive group, n=16; healthy control group, n=16) demonstrated that 12 weeks of 
Tai Chi practice significantly increased the plasma nitric oxide (NO), carbon monoxide (CO) 
and hydrogen sulphide (H2S) levels and lowered blood pressure (X. Pan, Zhang, & Tao, 2015). 
Correlations were observed in this study between changes of blood pressure and changes in 
these gaseous signalling molecules.   
In addition, one study analysed data of Tai Chi practitioners (n=19) and Tai Chi-naive 
participants (n=13), and found that Tai Chi performance led to acute decreases in sympathetic 
activity which could not be explained by physical activity alone (Motivala, Sollers, Thayer, & 
Irwin, 2006).  
Depression is associated with increased CRP levels in patients with CVD (Y. Wang, Y. Z. Zhen, 
et al., 2017), and elevated CRP levels are associated with increased risk for psychological 
distress and depression (Wium-Andersen et al., 2013) and the development of depression 
(Kohler-Forsberg et al., 2017; B. M. Song et al., 2015). One recent RCT involving women aged 
35 to 50 years at increased risk of CVD demonstrated that compared with waitlist group, 8-
week Tai Chi intervention decreased granulocyte colony-stimulating factor (G-CSF), which 
was also observed 2-month post intervention, indicating that Tai Chi may help down-regulate 
pro-inflammatory cytokines associated with underlying CVD risks including interferon gamma, 
tumour necrosis factor, interleukin (IL)-8 and IL-4 (Robins, Elswick, Sturgill, & McCain, 2016). 
Therefore, the management of the cardiovascular risk factors of depression, elevated 
inflammatory markers and CRP levels might be involved in mechanisms behind the beneficial 
effects of Tai Chi for cardiovascular health.  
2.6.4.3 Physical Fitness 
Physical inactivity has been widely investigated as a behaviour risk factor for CVD. A meta-
analysis and its updated analyses (Taylor-Piliae, 2008; Taylor-Piliae & Froelicher, 2004) 
estimated the effect of Tai Chi in improving aerobic capacity expressed as peak oxygen uptake 
(VO2peak) (mL x kg (-1) x min (-1)). The findings demonstrated that large significant effects 
of Tai Chi on aerobic capacity were found for subjects enrolled in the cross-sectional studies in 
both women and men aged 55 years or older when comparing with sedentary subjects. 
Additionally, one recent three-arm RCT involving 374 middle-aged Chinese subjects found that 
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Tai Chi practice consumed a smaller amount of energy metabolism but produced similar health 
benefits as self-paced brisk walking, by having higher effects on resting energy expenditure 
(REE) and improving maximal oxygen intake (VO2max) and REE-kilocalorie expenditure (Hui, 
Xie, Woo, & Kwok, 2016).  
In addition, one study with 40 elderly individuals demonstrated that the Tai Chi group after 16 
weeks of practice showed a 19.9% increase in muscle strength of the knee flexors (P<0.01) (J. 
X. Li, Xu, & Hong, 2009), indicating the beneficial effects of Tai Chi in improving postural 
stability and proprioception of knee and ankle (J. X. Li, Xu, & Hong, 2008) in old people. 
Similar findings have been reported in a 48-week, single-blind, RCT involving 269 women 
aged 70 years or older (Greenspan, Wolf, Kelley, & O'Grady, 2007). It demonstrated that 
compared with wellness education group, Tai Chi group reported significant improvements in 
their physical dimension and ambulation categories. Furthermore, one study with 28 elder 
adults found that Tai Chi group was superior to resistance training group in increasing serum 
parathyroid hormone at 12 weeks, and reducing the urinary calcium level at 24 weeks, 
indicating that Tai Chi is beneficial for bone metabolism (C. L. Shen et al., 2007). Therefore, 
the impacts in musculoskeletal system might be part of the underlying mechanism of Tai Chi-
induced improvements in balance, strength, and flexibility.  
 
2.7 Summary 
CVD is the leading cause of morbidity and mortality worldwide, which remains a heavy disease 
burden both on the individual and society. CHD is the most common forms of CVD. 
Hypertension is the most important preventable cause of heart disease and stroke around the 
world. Despite huge efforts, the levels of awareness, treatment and control rates of hypertension 
remain extremely low. Psychological risk factors such as stress, anxiety, and depression are 
known to play a significant and independent role in the development of hypertension, CHD and 
its complications. However, a substantial proportion of patients after CHD events suffering 
stress, anxiety and depression symptoms are undertreated.  
Cardiac rehabilitation programs are “comprehensive” interventions including components of 
medical evaluation, prescribed exercise, cardiac risk factor modification, health education, and 
psychological counselling. Exercise training is a core component of cardiac rehabilitation 
programs. Exercise-based cardiac rehabilitation program reduces cardiovascular mortality and 
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the risk of hospital admissions as well as improvement in QoL (Anderson et al., 2016). 
Unfortunately, there is a lack of standardised cardiac rehabilitation programs to manage 
psychological risk factors such as stress, anxiety and depression. In addition, effective 
implementation of cardiac rehabilitation after acute coronary syndrome, coronary 
revascularisation, and heart failure has remained suboptimal, with overall participation rates 
<50% over recent decades despite international recommendations (Dalal et al., 2015). 
Tai Chi could be a promising exercise option for patients with CHD declining cardiac 
rehabilitation programs, considering the multiple components and characteristics of Tai Chi and 
results from related clinical studies (Salmoirago-Blotcher et al., 2017). Several systematic 
reviews and meta-analyses have demonstrated the potential physical and psychological benefits 
of Tai Chi, including improving stress, anxiety, depression, quality of life and cardiovascular 
function. However, these findings are often inconclusive and should be interpreted cautiously, 
given the methodological limitations, variations across included trials in study design,                                                                                                        
outcomes and small sample size. 
Nevertheless, there is a lack of RCTs investigating the effects of Tai Chi on the management 
of stress, anxiety and depression in patients with CHD and/or hypertension. Herein, a robust 
investigation into this area is needed to provide a comprehensive overview and reliable 
evidence of the effect and safety of Tai Chi in patients with CHD and/or hypertension, to 
formulate relevant recommendations for patients, healthcare professionals and researchers. 
The doctoral project is designed to explore the impact of Tai Chi on psychological well-being 
and cardiovascular function in patients with CHD and/or hypertension.  This doctoral project 







Chapter 3: Does Tai Chi Improve Psychological Well-being and 
Quality of Life in Patients with Cardiovascular Disease and/or 
Cardiovascular Risk Factors? A Systematic Review 
 
 
This chapter consists of a systematic review exploring whether Tai Chi can improve 
psychological well-being and quality of life in patients with cardiovascular disease and/or 
cardiovascular risk factors. After a brief introduction of the background and methods, the results 
are presented in detail including characteristics and methodological quality of the included 
studies and effects of interventions. This follows with a discussion of the findings, including an 
interpretation of the results and comparisons with previous studies.  The reporting of this 
systematic review is in accordance with the Preferred Reporting Items for Systematic Reviews 




The rational of this systematic review is provided in detail in Chapter 2. To speak briefly, 
cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide, which 
remains a heavy disease burden both on the individual and society. The major cardiovascular 
risk factors are related to unhealthy lifestyle behaviours, which may lead to other cardiovascular 
risk factors such as hypertension, overweight/obesity, hyperglycemia/diabetes, and 
dyslipidaemia (Tzoulaki et al., 2016). Other contributing risk factors of CVDs include family 
history, aging, gender, socioeconomic determinants and psychological wellbeing (Havranek et 
al., 2015; World Health Organization, 2017). Psychological risk factors such as stress, anxiety, 
and depression are known to play a significant and independent role in the development of CVD. 
In addition, a substantial proportion of patients with CVD suffering from stress, anxiety and 
depression symptoms are undertreated. Tai Chi is a promising option for patients with CVD 
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and/or cardiovascular risk factors, considering the multiple components and characteristics of 
Tai Chi.  
In recent years, an increasing number of studies have demonstrated the beneficial effects of Tai 
Chi on mental health, however, however, it remains unknown on Tai Chi for psychological 
well-being and quality of life (QoL) in people with or at risk of CVD. Five systematic reviews 
(Chi et al., 2013; Sharma & Haider, 2015; C. Wang et al., 2010; F. Wang et al., 2014; W. C. 
Wang et al., 2009) involving various populations have reported the beneficial effects of Tai Chi 
on well-being, but none focused on people with or at risk of CVD. One recent systematic review 
(T. Liu et al., 2018) evaluated the effects of Tai Chi-based rehabilitation on aerobic endurance, 
psychosocial well-being and cardiovascular disease risk reduction for patients with CHD, but 
patients with other CVDs were not included. Another ten systematic reviews (Dalusung-
Angosta, 2011; M. S. Lee et al., 2010; Lin, Lin, & Lien, 2013; Nery et al., 2014; S. M. Ng et 
al., 2012; L. Pan et al., 2013; J. Wang et al., 2013; Yeh, Wang, Wayne, & Phillips, 2009; Yeh, 
Wang, et al., 2008; G. Zheng, Li, et al., 2015) have evaluated Tai Chi for cardiovascular 
population, but only physical outcomes were assessed rather than psychological outcomes and 
quality of life.  
 
3.1.2 Objectives 
To address the above gap in literature, the current systematic review of randomised controlled 
trials is designed to explore the effectiveness and safety of Tai Chi for psychological well-being 
and quality of life in people with CVD and/or cardiovascular risk factors. 
 
3.2 Methods  
3.2.1 Protocol and Registration 
The protocol of this systematic review was registered in the the International Prospective 
Register for Systematic Reviews (PROSPERO) (NO.: CRD42016042905) and has been 
published in BMJ Open (G. Yang et al., 2017).  
3.2.2 Eligibility Criteria 
Type of study 




Type of participants 
We included participants aged 40 years or older with a diagnosis of a cardiovascular disease 
(such as coronary heart disease, stroke, heart failure, myocardial infarction and hypertension) 
or with cardiovascular risk factors (including hypertension, diabetes, and/or dyslipidaemia). No 
gender limitation was applied.  
Type of intervention 
Any types of Tai Chi were eligible for inclusion, regardless of the forms (such as 24-form, 54-
form, 83-form Tai Chi), or styles (such as Chen, Yang, Wu and Sun style). The duration should 
be at least one month with a frequency at least once per week.  
Type of control 
No treatment, waitlist control, sham control, other forms of exercise, and conventional medical 
treatments were eligible types of control. For conventional medical treatments, conventional 
medications recommended by current internationally accepted clinical guidelines are eligible. 
These controls are appropriate to explore the effectiveness of Tai Chi and possibly available 
according to our previous review (G. Yang et al., 2015). Comparisons also included a co-
intervention if applied in all arms.  
Type of outcome 
The primary outcomes were psychological status of stress measured by validated instruments, 
such as the Perceived Stress Scale (PSS), Depression Anxiety Stress Scale (DASS), and 
Standard Stress Scale (SSS). The secondary outcomes were other measures of psychological 
status including anxiety, depression, mood disturbance, self-esteem and quality of life, and 
adverse events. 
3.2.3 Information Sources 
We conducted electronic searches from the following major English and Chinese databases 
from inception to 31st March 2018: Cochrane Heart Review Group Specialised Trials Register, 
Cochrane Central Register of Controlled Trials (CENTRAL), Cochrane Library (2018, Issue 
1), MEDLINE (from 1946), EMBASE (from 1947), PubMed (from 1966), Sino-Med database 
(from 1978), China National Knowledge Infrastructure (CNKI, from 1979), VIP Journal 
Integration Platform (VJIP, from 1989), and Wanfang Data Chinese database (from 1985). 
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We searched grey literature from the following databases and sources from their inception to 
31st March 2018: CNKI database, the System for Information on Grey Literature (OpenSIGLE) 
(opensigle.inist,fr), the Healthcare Management Information Consortium (HMIC) 
(www.ovid.com/site/catalog/DataBase/99.jsp?top=2&mid=3&bottom=7&subsection=10), the 
National Technical Information Service (www.ntis.gov) and the PsycEXTRA 
(www.apa.org/psycextra).   
We also searched the following trials registers to identify unpublished data to 31st March 2018 
from completed trials: Current Controlled Trials (www.controlled-trials.com), US National 
Institutes of Health Ongoing Trials Register (www.clinicaltrials.gov), Australian New Zealand 
Clinical Trials Registry (www.anzctr.org.au), and the World Health Organization International 
Clinical Trials Registry platform (www.who.int/trialsearch). Additional clinical trials were also 
identified by searching the reference lists of relevant studies.  
 
3.2.4 Literature Search 
We searched for relevant RCTs regardless of publication status (e.g. published, unpublished, in 
press, or in progress). The English searching terms include “Tai Chi”, “Tai Chi Chuan”, “Tai 
Chi Chih”, “ta’i chi”, “Tai Ji Quan”, “taijiquan”, “cardiovascular disease”, “coronary heart 
disease”, “stroke”, “heart failure”, “hypertension”, “high blood pressure”, “diabetes”, 
“dyslipidaemia”, “high cholesterol”, "randomised controlled trial", "randomized controlled 
trial", "controlled clinical trial", "randomly", "clinical", "trial", "random", "randomised" and 
"randomized". The Chinese searching terms include “Tai_ji (Tai Chi)”, “Tai_ji_chuan (Tai 
Chi)”, “Xin_xue_guan_bing (cardiovascular disease)”, “Gao_xue_ya (hypertension)”, 
“Tang_niao_bing (diabetes)”, “Gao_xue_zhi (dyslipidaemia)” and “sui_ji (randomized)”. 
Examples of detailed search strategies for one English database and one Chinese database are 
available in Table 3.1. We applied a similar strategy for other electronic databases. 
Table 3.1 Search strategies 
Database Number Search items 
PubMed #1 [Title/Abstract] (“Tai Chi” OR “Tai ji” OR “Tai Chi Chih” OR “Ta’i chi” OR 
“taichi” OR “tai chi chuan” OR “taichi chuan” OR “taiji” OR “Tai Ji Quan” 
OR “taijiquan” OR “martial arts”) 
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#2  [Title/Abstract] (“cardiovascular disease” OR “coronary heart disease” 
OR “stroke” OR “heart failure” OR “hypertension” OR “high blood 
pressure” OR “diabetes” OR “dyslipidaemia” OR “high cholesterol”) 
#3 [All fields] (“randomized controlled trial” OR “randomised controlled 
trial” OR “controlled clinical trial” OR “randomly” OR “clinical” OR 
“trial” OR “random” OR “randomised” OR “randomized”) 
 #4 #1 and #2 and 3# 
CNKI #1 [Abstract] (“Tai_ji” (Tai Chi) OR “Tai_ji_quan” (Tai Chi) 
#2  [Abstract] (“Xin_xue_guan_bing” (cardiovascular disease) OR 
“Guan_xin_bing” (coronary heart disease) OR “Zhong_feng” (stroke) 
OR “Nao_zu_zhong” (stroke) OR “Xin_shuai” (heart failure) OR 
“Gao_xue_ya” (hypertension) OR “Tang_niao_bing” (diabetes) OR 
“Gao_xue_zhi” (dyslipidaemia) 
#3 [All fields] (“sui_ji” (randomized or randomised)) 
 #4 #1 and #2 and 3# 
Note: CNKI, China National Knowledge Infrastructure. 
 
3.2.5 Study Selection  
Two authors (GYY and WYL) selected studies independently. Search results were merged from 
different sources using Endnote X9.2 reference management software. We removed the 
duplicate records of the same report (i.e. records reporting the same journal title, volume and 
pages). Two authors (GYY and WYL) screened titles and abstracts to remove obviously 
irrelevant reports independently. We retrieved full texts of all potentially relevant reports and 
linked together multiple reports of the same study if any. We examined full-text reports for 
compliance of studies with eligibility criteria. We also corresponded with investigators, where 
appropriate, to request further information, such as missing methods information or results. 
Two authors (GYY and WYL) had discussions to make final decisions on study inclusion. Any 
disagreement about the selection of studies was resolved by discussion, and another author 
arbitrated when necessary (NK).  
3.2.6 Data Collection 
Two authors (GYY and WYL) extracted the data from the included trials independently using 
a pre-defined data extraction form (Appendix 2) developed from the recommendation of the 
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Cochrane Collaboration (Cochrane Training, 2017). Any disagreements were resolved by 
discussion with a third author (NK).  
The extracted data included: (1) publication information: authors, country, year of publication; 
(2) study designs: method of random number generation and allocation concealment, blinding 
methods; (3) participants: sample size, characteristics of participants (e.g. age, gender, duration 
of disorder, and severity of disorder); (4) intervention: type and/or form of Tai Chi, details of 
treatment and control; and (5) outcome data: outcomes measures, data from previously 
specified outcomes. In case of missing data or unclear information, we contacted the original 
authors to clarify.  
3.2.7 Risk of Bias Assessment  
To assess the validity of included studies, we emphasize the risk of bias in the results (The risk 
that they will overestimate or underestimate the true intervention effect) (Higgins & Green, 
2011). We used the risk of bias tool recommended by the Cochrane Collaboration (Higgins & 
Green, 2011). This is a specific tool comprising a judgement and a support for the judgement 
for each item. The following items of bias for each study included in this review were assessed:  
• Selection bias (random sequence generation and allocation concealment)-whether: the 
allocation sequence was random; the allocation sequence was adequately concealed; 
baseline differences between intervention groups suggest a problem with the 
randomisation process;  
• Detection bias (blinding of outcome assessment)-whether: the method of measuring the 
outcome was inappropriate; measurement or ascertainment of the outcome could have 
differed between intervention groups; outcome assessors were aware of the intervention 
received by study participants;  
• Attrition bias (incomplete outcome data-whether: data for this outcome were available 
for all, or nearly all, participants randomised; (if applicable) there was evidence that the 
result was not biased by missing outcome data; (if applicable) missingness in the 
outcome was likely to depend on its true value (e.g. the proportions of missing outcome 
data, or reasons for missing outcome data, differ between intervention groups));  
• Reporting bias (selective reporting)-whether: the trial was analysed in accordance with 
a pre-specified plan that was finalised before unblinded outcome data were available for 
analysis; the numerical result being assessed is likely to have been selected, on the basis 
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of the results, from multiple outcome measurements within the outcome domain; the 
numerical result being assessed is likely to have been selected, on the basis of the results, 
from multiple analyses of the data; and  
• Other bias-any important concerns about bias not addressed in the above domains.  
We did not report performance bias, considering the difficulty to blind the participants and 
personnel in Tai Chi study. For each item, there are three potential bias judgements: ‘low risk’, 
‘high risk’, or ‘unclear risk’. A clinical trial that met all criteria was judged as having a low risk 
of bias, a trial that met none of the criteria was judged as having a high risk of bias, and a trial 
with insufficient information to judge was classified as unclear risk of bias. Any disagreements 
were resolved by discussion, with involvement a third author (NK) where necessary. 
 
3.2.8 Grading the Quality of Evidence 
Systematic reviews of the effects of healthcare provide essential, but not sufficient information 
for making well informed decisions. The Grading of Recommendations Assessment, 
Development and Evaluation (GRADE) approach provides a system for rating quality of 
evidence and strength of recommendations that is explicit, comprehensive, transparent, and 
pragmatic (Guyatt et al., 2008). GRADE is increasingly being adopted by many international 
organisations.  
We assessed the quality of evidence in relation to each outcome included in the  ‘Summary of 
findings’ (SoF) tables using the evidence grading system with GRADEPro GDT application 
developed by the GRADE collaboration (Guyatt et al., 2008). 
One reviewer (GY) initially applied the GRADE system and then discussed the quality of 
evidence ratings for each outcome with another member of the review team (NK). We reached 
final decisions on the ratings through discussion and consensus.  
The GRADE classifies the quality of evidence into four levels:  
• High quality: further research is very unlikely to change our confidence in the estimate 
of effect; 
• Moderate quality: further research is likely to have an important impact on our 
confidence in the estimate of effect and may change the estimate; 
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• Low quality: further research is very likely to have an important impact on our 
confidence in the estimate of effect and is likely to change the estimate; 
• Very low quality: any estimate of effect is very uncertain (Guyatt et al., 2008).  
Evidence based on RCTs begins as high quality evidence, and we took the following factors 
into account when deciding whether or not to downgrade the quality of evidence in relation to 
each outcome: study limitations, inconsistency of results, imprecision, indirectness of evidence, 
and reporting bias (Guyatt et al., 2008). 
• Study limitations: Risk of bias can differ across outcomes when, for instance, each 
outcome is informed by a different subset of studies. Study limitation in randomised 
trials include: lack of allocation concealment, lack of blinding, incomplete accounting 
of patients and outcome events, selective outcome reporting, and other limitations (i.e. 
stopping early for benefit, use of invalidated outcome measures, carryover effects in 
crossover trial, and recruitment bias in cluster-randomised trials) (Guyatt, Oxman, Vist, 
et al., 2011).  
• Inconsistency: GRADE suggests rating down the quality of evidence if large 
inconsistency (heterogeneity) in study results remains after exploration of a priori 
hypotheses that might explain heterogeneity. Judgement of the extent of heterogeneity 
is based on similarity of point estimates, extent of overlap of confidence intervals, and 
statistical criteria including tests of heterogeneity and I2 (Guyatt, Oxman, Kunz, 
Woodcock, Brozek, Helfand, Alonso-Coello, Glasziou, et al., 2011). 
• Imprecision: GRADE’s primary criterion for judging precision is to focus on the 95% 
confidence interval (CI) around the difference in effect between intervention and control 
for each outcome. If the optimal information size (OIS) criterion is not met, rate down 
for imprecision, unless the sample size is very large (at least 200 and perhaps 4000 
patients). If the OIS criterion is met and the 95% CI excludes no effect (i.e. CI around 
RR excludes 1.0) precision adequate. If OIS is met, and CI overlaps no effect (i.e. CI 
includes RR of 1.0) rate down if CI fails to exclude important benefit or important harm 
(Guyatt, Oxman, Kunz, Brozek, et al., 2011). 
• Indirectness: quality of evidence decreases when substantial differences exist between 
the population, the intervention, the comparison, or the outcomes measured in relevant 
research studies and those under consideration in a guideline or systematic review 
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(Guyatt, Oxman, Kunz, Woodcock, Brozek, Helfand, Alonso-Coello, Falck-Ytter, et al., 
2011). 
• Publication bias: publication bias should be suspected when available evidence comes 
from a number of small studies, most of which have been commercially funded. The 
most popular approach based on examination of the pattern of data is the funnel plot 
(Guyatt, Oxman, Montori, et al., 2011). If a funnel plot is not appropriate to use because 
there are less than 10 studies included in the meta-analysis, the extent to which we are 
uncertain about the magnitude of the effect due to selective publication of studies would 
be considered by considering the following factors: study design, study size, lag bias, 
and search strategy (Guyatt, Oxman, Montori, et al., 2011). 
Our review included only RCTs and we downgraded the evidence for each outcome from high 
quality by one level if we considered that there was a serious limitation in relation to a particular 
factor or by two levels if we considered there was a very serious limitation.  
3.2.9 Synthesis of Results  
We summarised data using mean difference (MD) with 95% CI for continuous outcomes. 
Clinical heterogeneity was assessed according to the characteristics of the included studies and 
the participants, details of the intervention or control, and types of outcome measurements. We 
assessed statistical heterogeneity by using the I2 statistic. As recommended by the Cochrane 
Collaboration (Higgins & Green, 2011), the statistical heterogeneity was regarded as substantial 
if the I2 statistic was greater than 50%, and considerable if I2 statistic was greater than 75%. 
We performed statistical analyses with Cochrane’s Review Manager software (version 5.3). We 
pooled data if the I2 statistic was less than 75% and the clinical heterogeneity among trials was 
deemed acceptable. We used random-effects model to conduct the meta-analysis unless the I2 
statistic was less than 25%. We did not perform funnel plots to detect publication bias because 
there were no more than 10 included trials in each meta-analysis.  
3.2.10 Additional Analysis  





3.3.1 Study Selection  
We initially identified 534 relevant English and Chinese articles, from which 97 were excluded 
as duplicates. We screened the remaining abstracts and 81 full text articles for potentially 
relevant data. Finally, 56 studies were excluded because of no relevant outcomes, not 
randomised study and duplication. A total of 25 studies met the inclusion criteria (Barrow, 
Bedford, Ives, O'Toole, & Channer, 2007; Caminiti et al., 2011; Ding, Wang, Wang, & Gong, 
2013; Han, Huang, Li, & Chen, 2010; Lam, Dennis, Diamond, & Zwar, 2008; X. Liu, Miller, 
Burton, Chang, & Brown, 2013; Meng, 2014; X.  Pan, 2016; Robins et al., 2016; Sang, Liu, 
Lang, Tian, & Zhang, 2015; H. Song, 2013; F. Sun & Sun, 2014; J. Sun & Buys, 2015; Tsai et 
al., 2003; Tsang, Orr, Lam, Comino, & Singh, 2007; H. Wang, 2014; P. Wang, Han, & Liang, 
2009; X. Wang, Zhang, Ding, & Jiang, 2013; F. Wu, Song, Bao, Xiang, & Jia, 2010; Yao, Li, 
& Ma, 2010; Yeh et al., 2011; Yeh et al., 2004; Yeh et al., 2013; E. Zhang, 2014; S. Zhang & 
Chen, 2011). The selection procedure is shown in a PRISMA Flow Diagram (Figure 3.1). 
 
3.3.2 Study Characteristics  
Of the included studies, 11 were published in English and 14 in Chinese published between 
year 2003 and 2016. The studies were conducted in 5 countries including China, the United 
Kingdom, the United States, Italy and Australia. The sample size of the included studies ranged 
from16 to 300, making a total of 2,084 participants. There were 864 participants with 
cardiovascular disease (including coronary heart disease, myocardial infarction, chronic heart 
failure or symptomatic heart failure), and 1220 with cardiovascular risk factors (including 
documented borderline hypertension or hypertension, impaired glucose metabolism or type 2 
diabetes). Table 3.2 shows the main characteristics of the included 25 studies. 
There are various comparisons in the included 25 studies, including Tai Chi versus waitlist, Tai 
Chi versus education, Tai Chi plus usual care versus usual care, Tai Chi versus sedentary life 
control, Tai Chi plus health education versus health education, Tai Chi versus health education, 
Tai Chi plus usual care versus aerobic exercise plus usual care, Tai Chi plus usual care versus 
health education plus usual care, Tai Chi plus diet guidance and usual care versus diet guidance 
and usual care, Tai Chi versus non-exercise-related activity. The ‘usual care’ is defined as 
conventional medical care. 
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Figure 3.1 PRISMA Flow Diagram Applied to Search Results 
(From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for 































 Records identified through 
database searching 
(n =534) 
Additional records identified 
through other sources 
(n = 0) 
Records after duplicates removed 
(n = 437) 
Records screened 
(n = 437) 
Records excluded 
(n = 356) 
Full-text articles assessed 
for eligibility 










Studies included in 
qualitative synthesis 
(n = 25) 
Studies included in 
quantitative synthesis 
(meta-analysis) 
(n = 11) 
56 
 
Table 3.2 Characteristics of included studies on Tai Chi for CVD and/or risk factors 














65 Wu Chian Chuan style Tai Chi, 
twice 55-min sessions weekly  
+ Usual medical care 
16 Usual medical care 13/65 (20%) in 
total; I: 7/32 
(21.8%);  








60 A modified 10-form Yang style 
Tai Chi, three 50-min sessions 
weekly  
+ Endurance Training  
+ Usual medical care 
12 Endurance Training: 
three 50-min sessions 
weekly  
+ Usual medical care 
3/60 (5.0%) in 
total; I: 0;  









90 42-form Chen style Tai Chi, at 
least five 60-min sessions per 
week  
+ Behaviour guidance  
+ Usual medical care  
+ Jogging 
24 Control 1: Behaviour 
guidance + Usual 
medical care;  
Control 2: Jogging 






60 24 simplified Yang style Tai Chi, 
45-60 minutes per session, 1-2 
sessions daily  
+ Usual medical care 
240 Usual medical care 2/60 (3.3%) in 
total; I: 0;  









53 Tai Chi for Diabetes (a 12-
movement hybrid from Sun and 
Yang styles), two 1-hour classes 
weekly for 12 weeks and then 
once weekly for a further 12 
weeks 






41 Kai Mai Tai Chi, three 90-min 
sessions weekly  
+ Usual medical care 





















200 Tai Chi  
+ Health education  
+ Diet guidance  
+ Usual medical care 
12 Health education  
+ Dietary guidance  
+ Usual medical care 





61 24 simplified Yang style Tai Chi, 
one 30-min session daily  
+ Health education  
+ Diet guidance  
+ Usual medical care 
24 Health education  
+ Diet guidance  
+ Usual medical care 







96 Specially designed short-form Tai 
Chi, one 60-minute session 
weekly & home practice 15 
minutes most days of the week 
8 Wait list  33/96 (34.3%) in 
total;  















100 Specially designed Tai Chi 
program, one 15-minute session 
daily  
+ Usual medical care 








80 24 simplified Yang style Tai Chi, 
one 50-min session daily  
+  Health education 
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90 24 simplified Yang style Tai Chi, 
one 2-hour session daily 
8 Health education  10/90 (11.1%) in 
total; I: 7/45 










300 Tai Chi in group 3 hours & 2 
hours home practice weekly 
48 Active controls: non-
exercise-related 
activities such as 
reading 
35/300 (11.6%) in 
total; I: 14/150 










88 108-form Yang style Tai Chi, 
three 50-min sessions weekly 
12 A sedentary life control: 
usual lifestyle 
behaviours including 
eating habits and 
previous sedentary life 
pattern 
12/88 (13.6%), 
losses were equally 
divided between 
the groups. 









38 Tai Chi for Diabetes (a 12-
movement hybrid from Sun and 
Yang styles), twice 1-hour 
sessions weekly 
16 Sham exercise (e.g. 
seated calisthenics & 
gentle stretching)  
1/38 (2.6%) in 











70 24 simplified Yang style Tai Chi, 
five 40-min sessions weekly  
+ Diet guidance  
+ Usual medical care 
8 Dietary guidance  
+ Usual medical care 







64 24 simplified Yang style Tai Chi, 
45-60 minutes per session, 5-7 
sessions weekly  
+ Health education  
+ Usual medical care 
24 Health education  
+ Usual medical care 







60 42-form Chen style Tai Chi, five 
60-min sessions weekly  
+ Behaviour guidance  
+ Usual medical care 
24 Behaviour guidance  
+ Usual medical care 
NR QoL (SF-36) 
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40 24 simplified Yang style Tai Chi, 
60-min per session, >3 sessions 
weekly  
+ Usual medical care 





150 42-form Chen style Tai Chi, 5-15 
minutes per session (30 minutes 
per session after the first 
month), >5 sessions weekly  
+ Life style guidance  
+ Usual medical care 
24 Life style guidance  
+ Usual medical care 





30 5-form simplified Yang-style Tai 
Chi, twice 60-min sessions 
weekly & home practice >3 times 
weekly  
+ Usual medical care  
+ Dietary guidance  
+ General exercise advice 
12 Usual medical care  
+ Dietary guidance  
+ General exercise 
advice  






100 5-form simplified Yang-style Tai 
Chi, twice 60-min sessions 
weekly & home practice >3 times 
weekly  
+ Usual medical care  
+ General exercise advice 
12 Usual medical care  
+ General exercise 
advice  
+ Health education 
4/100 (4.0%) in 
total; I: 1/50 
(2.0%);  














16 5-form simplified Yang-style Tai 
Chi, twice 60-min sessions 
weekly & home practice >3 times 
weekly  
+ Usual medical care  
+ General exercise advice 
12 Usual medical care  
+ General exercise 
advice  
+ Aerobic exercise, 
twice 1-hour weekly  








40 24 simplified Yang style Tai Chi, 
60-min per session  















132 42-form Chen style Tai Chi, 5-15 
minutes per session (30-min 
session after the first month), > 5 
sessions weekly  
+ Behaviour guidance  
+ Usual medical care 
48 Behaviour guidance   
+ Usual medical care 
NR QoL (MLHF) 
Abbreviations: PCI=percutaneous coronary intervention; QoL=Quality of life; STAI=state and anxiety inventory; PSS=the Perceived Stress Scale; CES-D =the Center for Epidemiological Studies-
Depression; MOS=Medical Outcomes Study; SPS=the revised Social Provision Scale; MAAS=the Mindful Attention Awareness Scale; SCS-R=the revised Self-Compassion Scale; SIBS-R=the 
revised Spiritual Involvement and Beliefs Scale; MLHFQ=the Minnesota Living with Heart Failure questionnaire; WHOQOL-100=the World Health Organization Quality of Life; SAS=Zung Self-
Rating Anxiety Scale; SCL-90=Symptom Chelist-90; SCL-R= Symptom Chelist-90-Revised; POMS=the Profile of Mood States; SEBES= the Self-Efficacy-Barriers to Exercise Scale. 
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Various Tai Chi styles and forms were used. The majority of studies (15/25, 60.0%) 
applied Yang style, and the most popular one was 24-form Simplified Yang style (8/25, 
32.0%). Most studies used a modified or simplified Tai Chi program (16/25, 64.0%), 
including 24-form Simplified Yang style (8/25, 32.0%), 5-form Simplified Yang style 
(3/25, 12.0%), a modified 10-movement Yang style (1/25, 4.0%), Tai Chi for Diabetes 
(a 12-movement hybrid from Sun and Yang styles) (2/25, 8.0%) and specially designed 
Tai Chi program (2/25, 8.0%). Two studies did not report the specific Tai Chi 
style/form used (Meng, 2014; J. Sun & Buys, 2015).  
Twenty-three studies (23/25, 92.0%) reported that participants practiced Tai Chi 
programs in group classes, while two studies (H. Wang, 2014; F. Wu et al., 2010) did 
not reported the practice method. The group classes were guided and supervised by a 
professional Tai Chi instructor (Caminiti et al., 2011; Han et al., 2010; X. Liu et al., 
2013; F. Sun & Sun, 2014; Tsai et al., 2003; P. Wang et al., 2009; Yeh et al., 2011; 
Yeh et al., 2004; Yeh et al., 2013) an experienced trainer/investigator (Barrow et al., 
2007; Robins et al., 2016; J. Sun & Buys, 2015; Tsang et al., 2007) or an exercise 
physiologist (Orr, Tsang, Lam, Comino, & Singh, 2006; F. Wu et al., 2010). In addition, 
for three studies, a physician (Yeh et al., 2004), a trained cardiac rehabilitation nurse 
(Barrow et al., 2007) or a healthcare provider (Sang et al., 2015) was also in attendance. 
Heart rate, blood pressure or electrocardiogram (ECG) of participants were monitored 
in nine studies to measure exercise intensity (Han et al., 2010; X.  Pan, 2016; Tsai et 
al., 2003; P. Wang et al., 2009; X. Wang et al., 2013; F. Wu et al., 2010; Yao et al., 
2010; E. Zhang, 2014; S. Zhang & Chen, 2011).  
Nine studies (9/25, 36.0%) (Barrow et al., 2007; Han et al., 2010; X. Liu et al., 2013; 
X.  Pan, 2016; Robins et al., 2016; J. Sun & Buys, 2015; Yeh et al., 2011; Yeh et al., 
2004; Yeh et al., 2013) encouraged or required home practice in addition to their group 
class, five of which (X. Liu et al., 2013; Robins et al., 2016; Yeh et al., 2011; Yeh et 
al., 2004; Yeh et al., 2013) provided a videotape/DVD to participants demonstrating 
the Tai Chi practice to support home practice.  
Tai Chi programs varied from 5 to 120 minutes per session, and 60 minutes per session 
was the duration in 50% of the 26 studies. In two studies (Yao et al., 2010; S. Zhang 
& Chen, 2011), the time of each session gradually increased from 5-15 minutes 
(learning the movements for the first 4 weeks) to 30 minutes (maintenance practice). 
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The frequency varied from two to fourteen sessions weekly (2 sessions daily); two and 
three sessions weekly were the most common frequencies, accounting for 26.9% and 
19.2% respectively. The duration varied from 8 to 240 weeks, and the most common 
duration was 12 weeks (9/25, 36.0%), followed by 24 weeks (7/25, 28.0%). Tai Chi 
intervention was used in combination with usual medical care in 19 studies (19/25, 
76.0%).  
Amongst the 25 studies, the reported outcomes include physical performance, safety, 
psychological outcomes, and quality of life. Psychological well-being outcomes 
included stress, state and trait anxiety, depression, social support, mindfulness and 
self-compassion, mood, and self-efficacy and psychosocial functioning. Health-related 
quality of life was assessed using five different general or disease-specific instruments, 
including 12-Item Short Form Health Survey (SF-12), the World Health Organization 
Quality of Life (WHOQOL-100), and the Medical Outcomes Study 36-Item Short 
Form Health Survey (SF-36), the MacNew Heart Disease Health-related Quality of 
Life Instrument (MacNew QLMI), and the Minnesota Living with Heart Failure 
Questionnaire (MLHFQ). 




Table 3.3 Tai Chi intervention applied in the included studies  
Study ID Disease/ 
condition 
Tai Chi intervention 








Wu Chian Chuan 
style  
A trained Tai Chi 
trainer, with a trained 
cardiac rehabilitation 
nurse also in 
attendance.  
(1)   Group class: Chi Kung (20 mins) for relaxation, 
stillness of mind & mood; rest period (5 mins); Tai 
Chi (20 mins); cool down (5 mins). The practice 
was gradually increased, reaching full potential on 
week 8. (2)   Home practice encouraged.  
50 min/session; 









An experienced Tai Chi 
instructor 
Group class: warm up (10 mins), Tai Chi (30 mins), 
& cool down (10 mins). Week 1-8 learned the 
movements. Week 9-12 practiced the complete 
sequence, in the same speed. A trained cardiac 
rehabilitation therapist also in attendance.   











NR Group class: a warm-up exercise (15 mins), Tai Chi 
practice (30 mins), and cool down exercise (15 
mins).  
60 min/session; at least 




Hypertension 24 simplified 
Yang-style 
A professional Tai Chi 
instructor 
(1)   Prior to class: introduce the importance & 
methods of Tai Chi practice; (2)   Group class: 
warm up (10-15 mins), Tai Chi (20-30 mins), and 
cool down (5 mins), focusing on the movements, 
breathing and mind/consciousness. Target heart 
rate was monitored.  
45-60 min/session; 7-14 
(1-2 sessions daily) 






Tai Chi for 
Diabetes (a 12-
movement hybrid 
from Sun and 
Yang styles) 
NR Group class: Tai Chi program  60 min/session; 
twice/week for week 1-
12 and once/week for 
week 13-24 
24 
Liu X 2013 Elevated blood 
glucose or 
diabetes 
Kai Mai Tai Chi A Tai Chi/Qigong 
instructor 
(1)   Group class: Tai Chi intervention; (2)   Home 
practice: a video/DVD was provided. 
90 min/session; three 





Study ID Disease/ 
condition 
Tai Chi intervention 




Liu X 2013 Elevated blood 
glucose or 
diabetes 
Kai Mai Tai Chi A Tai Chi/Qigong 
instructor 
(1)   Group class: Tai Chi intervention; (2)   Home 
practice: a video/DVD was provided. 
90 min/session; three 














NR (1)   Tai Chi practice in the morning. The intensity 
could be adjusted based on the target heart rate. 
Target heart rate = resting heart rate + resting 
heart rate x (60%-80%). ECG was provided to 
monitor patients' status;  
(2)   Home practice: heart rate monitored.  











investigator who has 
16 years of experience 
in designing and 
implementing tai chi 
interventions 
(1)   Group class: a warm-up exercise on breathing 
and balance; Tai Chi were taught in a sequence 
focusing on skills in balancing, focused breathing, 
gentle physical posturing and movement, and 
consciousness for relaxation;  
(2)   Home practice: a DVD was provided. 
60 min/session; 
once/week and 15-









Health care providers 
in attendance 
Group class: Tai Chi. Health care providers were 
also in attendance. 










NR Practiced Tai Chi till the heart rate reached >100 
times/min for 10 min.  





Hypertension 24 simplified 
Yang-style 
A professional Tai Chi 
instructor 
Group class: practice in comfortable and quiet 
environment, focusing on correct movements, 
breathing skills and the mind/consciousness.   
120 min/session; seven 
times/week 
8 
Sun J 2015 Hypertension Tai Chi An experienced trainer  (1)   Group class: a variety of meditation 
techniques including breathing, balance, 
flexibility, concentration, calming, and stress-
reduction techniques;  
(2) Home practice 
90 min/session; 
twice/week and 120-




Study ID Disease/ 
condition 
Tai Chi intervention 











A qualified master & a 
Tai Chi instructor 
(1)   Prior to participation: learned Tai Chi from a 
qualified master;  
(2)   Group class: Tai Chi practice, including warm-
up exercises (10 mins), Tai Chi practice at same 
speed (30 mins), and a cool-down exercise (10 
mins). Heart rates were monitored by an ECG 
telemeter. Blood pressure was monitored too. 







Tai Chi for 
Diabetes (a 12-
movement hybrid 




Group class: a specific warm-up exercises for the 
whole body (10 mins); Tai Chi in its entirety (45 
mins). involving breathing techniques and 










NR Group class: Patients could progress at their own 
pace and intensity.  







24 simplified Yang 
style 
A professional Tai Chi 
instructor 
(1)   Prior to class: nurses and volunteers 
introduced the purpose, importance and methods 
of Tai Chi practice;  
(2)   Group class: Tai Chi program (45-60 mins), 
including a warm-up exercise, Tai Chi practice, and 
cool down exercise, focusing on the movements, 
breathing and mind or consciousness. The 
intensity could be adjusted based on the target 
heart rate. Target heart rate = resting heart rate + 
resting heart rate x (50%-70%).  
  











NR Group class: Week 1-4 learned the sequence; 
Week 5-24 maintained practice: warm up (15 
mins), Tai Chi (30 mins), and cool down (15 mins). 
Heart rate, blood pressure & ECG were monitored 
before, during & after class.  
 





Study ID Disease/ 
condition 
Tai Chi intervention 










A physiologist with Tai 
Chi teaching 
experience 
Group class: Practiced Tai Chi before breakfast till 
the heart rate reached 130-140 times /min. 
60 mins/session;  at 








NR Group class: Week 1-4 learned the complete 
sequence; Week 5-24 maintained practice: a 
complete set of Tai Chi (30 mins). The intensity 
could be adjusted based on the target heart rate. 
Target heart rate = resting heart rate + resting 
heart rate *(10%-20%). ECG telemeter was 
provided to monitor patients' status. 
5-15 min/session (30 
mins per session after 









An experienced Tai Chi 
instructor, with a 
physician also in 
attendance 
(1)   Group class: warm up (i.e. weight shifting, 
arm swinging, gentle stretches, visualization 
techniques, and traditional breathing), focusing 
on releasing tension in the physical body, 
incorporating mindfulness and imagery into 
movement, increasing awareness of breathing, 
and promoting overall relaxation of body & mind; 
5-form simplified Tai Chi. Chairs were provided, 
and patients could progress at their own pace.  
(2)   Home practice: videotape provided.  
60 min/session; 
twice/week and at least 
three times of home 








1 or 2 certified and 
experienced 
instructors (6 total 
study instructors with 
average experience of 
20 years) 
(1)   Group class: a warm-up exercise (i.e. weight 
shifting, arm swinging, gentle stretches, 
visualization techniques and tractional breathing 
methods), focusing on releasing tension in the 
body, incorporating mindfulness and imagery into 
movement, increasing awareness of breathing, 
and promoting overall relaxation of body and 
mind; 5 simplified Tai Chi movements. Chairs were 
provided for resting, and patients could progress 
at their own pace.  
(2)   Home practice: videotape provided. 
60 min/session; 
twice/week & at least 
three times of home 




Study ID Disease/ 
condition 
Tai Chi intervention 














(1)   Group class: warm up (i.e. weight shifting, 
arm swinging, gentle stretches, visualization 
techniques & traditional breathing), focusing on 
releasing tension in the physical body, 
incorporating mindfulness and imagery into 
movement, increasing awareness of breathing, 
and promoting overall relaxation of body & mind; 
5-form simplified Tai Chi. Chairs were provided. 
Patients could progress at their own pace.  
(2)   Home practice: videotape provided. 
60 min/session; 
twice/week and at least 
three times of home 










NR Group class: a warm-up exercise (5 mins); Tai Chi 
practice (50-60 mins) with background music 
under guidance in breathing, balance and 
flexibility; cool down exercises (5 mins). Week 1-2 
learned the complete sequence; week 3-5 
practiced single movements; week 6-8 practiced 
the complete sequence, focusing on the 
combination of mind, qi and body; week 9-14 
competitive practice. The intensity could be 
adjusted based on heart rate. The target heart 
rate = (220 -Age) x (65~85%) + resting heart rate.  
60 min/session; NR the 










NR  Group class: Week 1-4 learned the movements; 
Week 5-48 maintained practice: a complete set of 
Tai Chi (30 mins). Adjusted intensity based on the 
target heart rate. Target heart rate = resting heart 
rate + resting heart rate x (10%-20%). ECG 
telemeter was provided to monitor patients' 
status.  
 5-15 min/session (30 
mins per session after 
week 4); at least five 
times per week 
48 




3.3.2 Methodological Quality 
We contacted the corresponding authors by emails to clarify unclear or missing information in 
the papers, and the response rate was low (4/25, 16%). Accordingly, only two studies were rated 
as low risk of bias in all six items, and the majority were rated as unclear risk of bias. The 
methodological quality of the included studies was generally poor.  
Although all included studies mentioned ‘randomised’, only nine studies (Caminiti et al., 2011; 
Lam et al., 2008; X. Liu et al., 2013; X.  Pan, 2016; Tsang et al., 2007; Yeh et al., 2011; Yeh et 
al., 2004; Yeh et al., 2013; E. Zhang, 2014) reported the specific methods for sequence 
generation, including ‘random number table’, and ‘computer-generated allocation method’. 
Three studies (Lam et al., 2008; Tsang et al., 2007; Yeh et al., 2004) reported the allocation 
concealment, in which two studies (Tsang et al., 2007; Yeh et al., 2004) reported their specific 
method by using ‘a sealed, sequentially numbered, opaque envelope’. Five studies (Lam et al., 
2008; J. Sun & Buys, 2015; Tsai et al., 2003; Yeh et al., 2011; Yeh et al., 2013) reported that 
the blinding of outcome assessors. We did not report performance bias, considering the 
difficulty to blind the participants and personnel in Tai Chi study. Thirteen studies (Barrow et 
al., 2007; Caminiti et al., 2011; Han et al., 2010; Lam et al., 2008; Robins et al., 2016; F. Sun 
& Sun, 2014; J. Sun & Buys, 2015; Tsai et al., 2003; Tsang et al., 2007; P. Wang et al., 2009; 
Yeh et al., 2011; Yeh et al., 2004; Yeh et al., 2013) reported information about participants lost 
to follow up, from which the average drop-out rate was 11.6%. Figure 3.2 and 3.3 illustrate the 
summary of risk of bias of the included studies. 









Table 3.4 Effect estimates of Tai Chi program for psychological well-being and quality of life in people with or at risk of CVD 
Outcomes and comparisons Effect estimate  
(MD, 95% CI) 
No. of participants 
(studies) 
Study ID 
Stress     
Tai Chi program versus Waitlist     
Assessed with PSS-10 -2.45 [-3.06, -1.84] * 59 (1 RCT) Robins JL2016 
Depression    
Tai Chi program versus Waitlist    
Assessed with CES-D -6.05 [-6.79, -5.31] * 59 (1 RCT) Robins JL 2016 
Tai Chi program versus Education    
Assessed with SDS -2.06 [-4.09, -0.03] * 80 (1 RCT) Sun F 2014 
Tai Chi program + Usual care versus Usual care    
Assessed with SDS -1.99 [-6.08, 2.09] ∆ 120 (2 RCTs) Zhang EM 2014, Song 
HN 2013 
Anxiety    
Tai Chi program versus Sedentary life control    
Assessed with STAI:    
STAI -Trait Anxiety -7.00 [-9.88, -4.12] * 76 (1 RCT) Tsai JC 2003 
STAI -State Anxiety -6.20 [-8.95, -3.45] * 76 (1 RCT) Tsai JC 2003 
Tai Chi program + Health education versus Health education    
Assessed with SAS -4.72 [-8.26, -1.18] * 80 (1 RCT) Song HN 2013 
Tai Chi program versus Health education    
Assessed with SAS -6.21 [-8.26, -4.16] * 80 (1 RCT) Sun F 2014 
Mood    
Tai Chi program + Usual care versus Usual care + Aerobic exercise    
Assessed with POMS:    
POMS-Total mood disturbance 2.60 [-9.18, 14.38] 16 (1 RCT) Yeh GY 2013 
POMS-Depression -0.70 [-3.20, 1.80] 16 (1 RCT) Yeh GY 2013 
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Outcomes and comparisons Effect estimate  
(MD, 95% CI) 
No. of participants 
(studies) 
Study ID 
Tai Chi program + Usual care versus Usual care + Health education    
Assessed with POMS - 100 (1 RCT) Yeh GY 2011 
Tai Chi program +Diet guidance + Usual care versus Diet guidance + 
Usual care 
   
Assessed with SCL-90:    
SCL-90-Anxiety -0.41 [-0.63, -0.19] * 70 (1 RCT) Wang HF 2014 
Quality of life    
Tai Chi program + Health education versus Health education    
Assessed with WHOQOL-100 10.41 [4.54, 16.28] * 80 (1 RCT) Song HN 2013 
Tai Chi program + Usual care versus Usual care + Health education    
Assessed with MLHFQ - 100 (1 RCT) Yeh GY 2011 
Tai Chi program versus Non-exercise-related activity    
Assessed with SF-12:  266 (1 RCT) Sun J 2015 
Physical functioning 3.36 [-0.61, 7.33]   
Role limitation due to physical health 12.52 [8.62, 16.42] *   
Role limitation due to emotional health 5.15 [0.81, 9.49] *   
Energy/Vitality 9.33 [4.39, 14.27] *   
Mental health 5.54 [1.02, 10.06] *   
Social functioning 4.99 [0.80, 9.18] *   
Bodily pain 14.04 [9.20, 18.88] *   
General health -7.84 [-13.56, -2.12]   
Tai Chi program + Usual care versus Usual care    
Assessed with SF-36:  359 (4 RCTs) Wu F 2010, Meng E 
2014, Han QY 2010, 
Pan XF 2016 
Physical functioning 5.47 [0.66, 10.28] ∆*  
Role limitation due to physical health 11.82 [8.26, 15.38] ∆* 
Role limitation due to emotional health 8.27 [5.56, 10.98] ∆* 
Energy/Vitality 7.03 [1.92, 12.14] ∆* 
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Outcomes and comparisons Effect estimate  
(MD, 95% CI) 
No. of participants 
(studies) 
Study ID 
Mental health 7.86 [4.29, 11.44] ∆*   
Social functioning 9.81 [5.19, 14.42] ∆* 
Bodily pain 6.34 [2.45, 10.23] ∆* 
General health 10.04 [7.15, 12.93] ∆* 
Assessed with MLHFQ -11.10 [-15.52, -6.68] ∆* 428 (5 RCTs) Sang L 2015, Yao CD 
2010, Zhang SQ 2011, 
Yeh GY 2013, Yeh GY 
2004 
Abbreviations: CI, confidence interval; *, the effect estimate favours experimental group; ∆, result from Meta-analysis; -, the study reported median scores of instruments. 
PSS-10, Perceived Stress Scale 10-item; CES-D, Centre for Epidemiological Studies-Depression; SDS, Zung Self-Rating Depression Sale; STAI, State and Trait Anxiety Inventory; 
SAS, Zung Self-Rating Anxiety Scale; POMS, Profile of Mood States; SCL-90, Symptom Checklist-90-Revised; WHOQOL-100, World Health Organization Quality of Life; 
MLHFQ, Minnesota Living with Heart Failure Questionnaire; SF-12, 12-Item Short Form Health Survey; SF-36, 36-Item Short Form Health Survey. 
73 
 
3.3.3 Effects of Interventions 
The effect estimates of Tai Chi for psychological well-being and quality of life in people with 
or at risk of CVD were shown in the Table 3.4.  
3.3.3.1 Primary Outcome: Stress 
One study (Robins et al., 2016) conducted in the USA reported the effects of Tai Chi on stress 
in 96 women with cardiovascular risk by Perceived Stress Scale 10-item (PSS-10) (Range of 
possible scores: 0-40; higher scores reflect higher levels of perceived stress). Compared with 
the waitlist control group, the specially designed 8-week short-form Tai Chi program was 
superior in decreasing the perceived stress (MD -2.45, 95% CI: -3.07, -1.83) at 16 weeks (2 
months following the intervention). Table 3.5 shows the summary of finding of this study. 
 
3.3.3.2 Other psychological well-being outcomes 
Anxiety  
Anxiety was reported in one study (Tsai et al., 2003) conducted in Taiwan measured by the 
State and Trait Anxiety Inventory (STAI). The STAI contains 20 items each on trait (scale from 
20-80) and state anxiety (scale from 20-80); higher scores indicate higher level of anxiety. The 
Tai Chi group had significantly lower scores on both state and trait anxiety compared with the 
sedentary life control group in patients with cardiovascular risks (documented borderline 
hypertension) at week 12. Table 3.4 shows the effect estimates of this study.  
Two other studies (H. Song, 2013; F. Sun & Sun, 2014) involving participants with 
cardiovascular risks (i.e. hypertension and impaired glucose metabolism) conducted in 
mainland China reported anxiety measured by Zung Self-Rating Anxiety Scale (SAS) (scale 
from 20-80); higher scores indicate higher level of anxiety. Compared with health education, 
Song HN et al. (H. Song, 2013) favoured Tai Chi program plus health education group in 
decreasing SAS scores, and Sun F et al. (F. Sun & Sun, 2014) found also Tai Chi group was 




Table 3.5 Summary of findings: Tai Chi versus waitlist group for stress and depression in people with CVD and/or CVD risk factors 
Outcomes Anticipated absolute effects* (95% CI) No of participants  
(studies) 
Quality of the evidence 
(GRADE) 
Risk with Waitlist Risk with Tai Chi Program 
Stress 
assessed with: PSS-10 
Scale from: 0 to 40 [Worse] 
The mean stress score as 
measured by PSS-10 was 15.  
MD 2.45 unit lower  






assessed with: CES-D 
Scale from: 0 to 60 [Worse] 
The mean depression score as 
measured by CES-D was 12. 
MD 6.05 unit lower 





*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention 
(and its 95% CI). CI: Confidence interval; MD: Mean difference; CVD: cardiovascular disease; PSS-10: Perceived Stress Scale 10-item; CES-D: Centre for Epidemiological 
Studies-Depression. 
GRADE Working Group grades of evidence 
High quality: We are very confident that the true effect lies close to that of the estimate of the effect 
Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is 
substantially different 
Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect 
Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect  
Explanations 




One study (Robins et al., 2016) measured depression using the Center for Epidemiological 
Studies-Depression (CES-D) (scale from 0-60, with high scores indicating greater depressive 
symptoms). The specially designed 8-week short-form Tai Chi program significantly decreased 
depressive symptoms scores at week 8 compared with the waitlist control group. Table 3.5 
shows the summary of finding of this outcome.  
Three studies (H. Song, 2013; F. Sun & Sun, 2014; E. Zhang, 2014) conducted in China 
assessed depression with Zung Self-Rating Depression Sale (SDS) (scale from 20-80). Meta-
analysis of two studies (H. Song, 2013; E. Zhang, 2014) involving participants with type 2 
diabetes or impaired glucose metabolism showed no significant difference between a 24 
Simplified Tai Chi program plus usual care and usual care alone in decreasing depression 
(Figure 3.4). Table 3.6 shows the summary of findings of this meta-analysis. Another study (F. 
Sun & Sun, 2014) involving 80 participants with hypertension also reported that there was no 
significant difference in decreasing depression between the 24 Simplified Tai Chi group and 
health education group at week 8.  




Changes in mood in respect to Tai Chi reported in two studies (Yeh et al., 2011; Yeh et al., 
2013) conducted in the USA using the Profile of Mood States (POMS). One study (Yeh et al., 
2013) involving 16 participants with heart failure with preserved ejection fraction found no 
significant differences in mood measured by POMS between a 5-Simplified Tai Chi Program 
plus usual care and usual care alone group. The other study (Yeh et al., 2011) involving 100 
participants with chronic heart failure reported significant improvement in median scores on 
POMS in total mood disturbance, depression and vigour subscales. One study (H. Wang, 2014) 
assessed mood using Symptom Checklist-90-Revised (SCL-R) in 35 elderly people with 
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diabetes and found there was a significant difference in anxiety of SCL-R scores between Tai 
Chi plus usual care and usual care group.  
 
Self-esteem 
No studies reported this outcome. 
 
3.3.3.3 Quality of life  
Twenty-two studies (21/25, 84.0%) reported the changes in quality of life. Thirteen studies used 
general quality of life questionnaires, including the SF-12, the SF-36, and the WHOQOL-100. 
The disease-specific MLHFQ was used in seven studies involving patients with chronic heart 
failure or acute myocardial infarction after percutaneous coronary intervention (PCI). One 
study applied the MacNew QLMI. 
One study (J. Sun & Buys, 2015) found there were significant differences in both physical and 
mental total scores of SF-12 between Tai Chi and non-exercise related activity control groups. 
Another study (H. Song, 2013) reported significant differences between Tai Chi program plus 
health education group and health education alone group in quality of life measured by the total 
score of WHOQOL-100. 
Compared with usual medical care alone, a meta-analysis of four studies (Han et al., 2010; 
Meng, 2014; X.  Pan, 2016; F. Wu et al., 2010) in which quality of life assessed using SF-36 
found a significant between-group difference in favour of Tai Chi program plus usual care in 
all domains of SF-36, including physical functioning (MD: 5.47, 95%CI: 0.66, 10.28, I2=84%), 
role limitation due to physical health (MD: 11.82, 95%CI: 8.26, 15.38, I2=32%), role limitation 
due to emotional health (MD: 8.27, 95%CI: 5.56, 10.98, I2=0%), energy/vitality (MD: 7.03, 
95%CI: 1.92, 12.14, I2=81%), mental health (MD: 7.86, 95%CI: 4.29, 11.44, I2=48%), social 
functioning (MD: 9.81, 95%CI: 5.19, 14.42, I2=68%), bodily pain (MD: 6.34, 95%CI: 2.45, 
10.23, I2=53%), and general health (MD: 10.04, 95%CI: 7.15, 12.93, I2=27%). One small study 
(X. Liu et al., 2013) reported not the scores but the mean between-group differences for each 
domain of SF-36, and found statistically significant improvements in favour of Tai Chi group 
in four domains including physical functioning, role physical, bodily pain and vitality (p<0.05). 
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Compared with sham exercise or waitlist group respectively, two small studies (Lam et al., 
2008; Tsang et al., 2007) found that Tai Chi group was not superior in any domains of SF-36.  
Table 3.6 shows the summary of findings of two meta-analyses on QoL assessed by SF-36 and 
MLFHQ. Figure 3.5 present the forest plot of Tai Chi in combination with usual care compared 
with usual medical care alone for SF-36. 
Subgroup Analysis 
We performed subgroup analyses of SF-36 for patients with CVDs or cardiovascular risks. In 
patients with cardiovascular risks (i.e. hypertension or type 2 diabetes), compared with usual 
care alone, a subgroup meta-analysis of three studies (Han et al., 2010; Meng, 2014; F. Wu et 
al., 2010) in which quality of life assessed using SF-36 found a significant between-group 
difference in favour of Tai Chi plus usual conventional care in only six domains of SF-36, 
including role limitation due to physical health (MD: 9.70, 95%CI: 5.95, 13.46, I2=0%), role 
limitation due to emotional health (MD: 8.50, 95%CI: 4.68, 12.32, I2=20%), energy/vitality 
(MD: 4.81, 95%CI: 0.99, 8.63, I2=40%), mental health (MD: 7.86, 95%CI: 4.29, 11.44, 
I2=48%), social functioning (MD: 10.79, 95%CI: 3.94, 17.65, I2=78%), and general health (MD: 
9.96, 95%CI: 5.16, 14.76, I2=51%), but not the domains of  physical functioning (MD: 4.44, 
95%CI: -0.99, 9.87, I2=82%) and bodily pain (MD: 5.19, 95%CI: -0.02, 10.40, I2=51%). In the 
individual study (X.  Pan, 2016) involving patients with chronic heart failure, compared with 
usual medical care alone, the Tai Chi plus usual care was supervior in all domains of SF-36. 
The heterogeneity could not be explained by the differences of participants.   
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Table 3.6 Summary of findings: Tai Chi program + usual care versus usual care for quality of life and depression in people with CVD and/or cardiovascular 
risk factors 
Outcomes Anticipated absolute effects* (95% CI) No of 
participants  
(studies) 
Quality of the evidence 
(GRADE) 
Risk with Usual Care Risk with Tai Chi Program + Usual Care 
QoL - Physical functioning 
assessed with: SF-36  
from: 0 to 100 [Better] 
Physical functioning 
Mean range: 78-90 
MD 5.47 unit higher 




VERY LOW a,b 
QoL - Role limitation due to physical 
health 
assessed with: SF-36 
Scale from: 0 to 100 [Better] 
Role limitation due to 
physical health 
Mean range: 58-78 
MD 11.82 unit higher 





QoL - Role limitation due to emotional 
health 
assessed with: SF-36 
Scale from: 0 to 100 [Better] 
Role limitation due to 
emotional health 
Mean range: 34-82 
MD 8.27 unit higher 





QoL - Energy/Vitality 
assessed with: SF-36 
Scale from: 0 to 100 [Better] 
Energy/Vitality 
Mean range: 57-76 
MD 7.03 unit higher 




VERY LOW a,b 
QoL - Mental health 
assessed with: SF-36 
Scale from: 0 to 100 [Better] 
Mental health 
Mean range: 64-75 
MD 7.86 unit higher 





QoL - Social functioning 
assessed with: SF-36 
Scale from: 0 to 100 [Better] 
Social functioning 
Mean range: 66-86 
MD 9.81 unit higher 





QoL - Bodily pain 
assessed with: SF-36 
Scale from: 0 to 100 [Better] 
Bodily pain 
Mean range: 67-80 
MD 6.34 unit higher 







Outcomes Anticipated absolute effects* (95% CI) No of 
participants  
(studies) 
Quality of the evidence 
(GRADE) 
Risk with Usual Care Risk with Tai Chi Program + Usual Care 
QoL - General health 
assessed with: SF-36 
Scale from: 0 to 100 [Better] 
General health 
Mean range: 56-69 
MD 10.04 unit higher 






assessed with: MLHFQ 
Scale from: 0 to 105 [Worse] 
MLHFQ 
Mean range: 28-52 
MD 11.1 unit lower 






assessed with: SDS 
Scale from: 20 to 80 [Worse] 
SDS 
Mean range: 45-46 
MD 1.99 unit lower 






Abbreviation: QoL, Quality of life.  
Explanations 
a. Downgraded the risk of bias by 2 levels because three of the four studies in the meta-analysis have unclear risk of bias in randomisation, allocation concealment, blinding 
of outcome assessor, incomplete reporting and selective reporting. Any other limitations related to inconsistency, indirectness and imprecision were negligible.  
b. Downgraded the risk of bias by 1 level because a large heterogeneity was found among the included studies under this outcome.  
c. Downgraded the risk of bias by 2 levels because three of the five studies in the meta-analysis have unclear risk of bias in randomisation, allocation concealment, blinding 
of outcome assessor, incomplete reporting and selective reporting. Any other limitations related to inconsistency, indirectness and imprecision were negligible.  
d. Downgraded the risk of bias by 2 levels because both studies in the meta-analysis have unclear risk of bias in randomisation, allocation concealment, blinding of outcome 
assessor, incomplete reporting, and selective reporting. Any other limitations related to inconsistency, indirectness and imprecision were negligible.  
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Compared with usual medical care alone, a meta-analysis of five studies (Sang et al., 2015; Yao 
et al., 2010; Yeh et al., 2004; Yeh et al., 2013; S. Zhang & Chen, 2011) showed that there was 
a significant difference in MLHFQ total scores in favour of Tai Chi in combination with usual 
care group (MD: -11.10, 95%CI: -15.52, -6.68, I2=73%) (Table 3.6; Figure 3.6).  
Figure 3.6 Forest plot of Tai Chi in combination with usual care compared with usual care for MLHFQ 
 
 
One individual study (Barrow et al., 2007) reported a 15-point change of MLHFQ in the Tai 
Chi program plus usual medical care group and the between-group difference was statistically 
significant (P<0.001). Another individual study (Yeh et al., 2011) also reported Tai Chi group 
experienced a significantly improved median MLHFQ score more than the education group 
(P=0.04). One study (Caminiti et al., 2011) reported the QoL measured by MacNew QLMI and 
found no significant difference between Tai Chi program plus usual medical care group and 
usual medical care alone. 
 
3.3.3.4 Safety 
Eight studies (8/25, 32.0%) involving patients with type 2 diabetes, hypertension, chronic heart 
failure or symptomatic heart failure reported safety information. No adverse events occurred 
related to Tai Chi intervention.  
However, five studies observed adverse events during the study period, including 7 deaths in 
the control group (Barrow et al., 2007; Han et al., 2010; Yeh et al., 2011), 1 death in the 
intervention group (Barrow et al., 2007), 11 hospitalizations due to heart failure 
exacerbation/angina/shortness (3 in the Tai Chi group and 8 in the control group) (Yeh et al., 
2011; Yeh et al., 2004), 2 arrhythmias in the Tai Chi group (Yeh et al., 2011), 2 cases of syncope 
in control group (Yeh et al., 2011), 3 falls (2 in the Tai Chi group and 1 in the control group) 
(Yeh et al., 2011), 3 cases of worsening heart failure (1 in the Tai Chi group and 2 in the control 
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group) (Barrow et al., 2007; Caminiti et al., 2011) and 2 cases of worsening co-morbidities in 
the control group (Barrow et al., 2007).    
 
3.4 Discussion  
3.4.1 Summary of Evidence 
This systematic review included 25 eligible RCTs on Tai Chi for people with CVD and/or 
cardiovascular risk factors. Tai Chi seems potentially effective in improving quality of life in 
people with CVD and/or cardiovascular risk factors. The meta-analyses demonstrated that Tai 
Chi in combination with usual medical care significantly improved all domains of the SF-36 
and the MLHFQ scores. 
The sub-group analyses of SF-36 for people with CVDs are consistent with the main findings. 
However, the sub-group analyses of SF-36 for people with cardiovascular risk factors found a 
significant between-group difference in favour of Tai Chi plus usual medical care in only six 
domains of SF-36, but not the domains of physical functioning and bodily pain. The possible 
reason why Tai Chi plus usual medical care was not superior in improving the two domains of 
SF-36 is related to baseline characteristics of the participants. Two of the three studies in the 
sub-group analyses involved patients with type 2 diabetes and the high scores of these two 
domains of SF-36 at baseline limited the space of change after intervention. 
Our findings support previous literature on Tai Chi for quality of life. One systematic review 
and meta-analysis involving seven trials on Tai Chi for patients with heart failure found that the 
Tai Chi group had significantly lower scores of the MLHFQ than that of the control group (Ren 
et al., 2017).  
Our findings related to SF-36 and MLHFQ may achieve the clinical significance. There is still 
no consensus on the minimal important difference (MID) and minimal clinically important 
difference (MCID) of SF-36 in patients with cardiovascular risk factors or CVDs. A systematic 
review of MID and MCID in health-related quality of life demonstrated that MID for SF-36 in 
patients with pulmonary fibrosis ranged from 2 to 4 points and in patients with prostate cancer 
ranged from 6 for mental health to 14 for role physical (Jayadevappa, Cook, & Chhatre, 2017). 
In our review, we found significant between-group differences in all domains of SF-36 in favour 
of Tai Chi in combination with usual medical care and the mean difference ranged from 5.47 
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to 11.82 points. In addition, the subgroup analysis of SF-36 in patients with cardiovascular risks 
found the between-group mean difference ranged from 4.44 to 10.79 points. Accordingly, our 
findings related to Tai Chi for SF-36 may achieve the clinical significance. For MLHFQ, a 
meta-analysis of disease-specific health-related quality of life questionnaires for heart failure 
demonstrated that interventions with small expected effects such as exercise programs produced 
small score changes and interventions expected to produce large effects such as medications 
produced large score changes (Garin et al., 2009). A study exploring the minimal detectable 
change (MDC) and MCID of the MLHFQ found that the MDC ranged from 7.27 to 16.96 and 
the MCID related to “somewhat better” ranged from 3.59 to 19.14 points (Gonzalez-Saenz de 
Tejada et al., 2019). In our review, we found a significant difference in MLHFQ total scores in 
favour of Tai Chi in combination with usual care and the mean difference was 11.10 points. 
Accordingly, our findings related to Tai Chi for MLHFQ may achieve the clinical significance. 
There is still a lack of strong, well-designed studies that demonstrate unequivocally the 
beneficial effects of Tai Chi in decreasing stress, depression, anxiety, and mood disturbance in 
this population. Individual studies with various measurements found statistically significant 
differences between the Tai Chi and the control groups in decreasing stress, depression, anxiety 
and mood disturbance. Considering the clinical heterogeneity, we did not pool the data together. 
However, a meta-analysis of two studies showed Tai Chi in combination with usual care was 
not superior to the usual care alone in decreasing depression. 
Tai Chi appears safe to practice for people with CVD and/or cardiovascular risk factors. No 
adverse events related to Tai Chi were reported in included studies. However, only 32.0% of 
25 included studies reported safety information. The low reporting rate of safety was consistent 
with findings of previous reviews. Wayne et al. (2014) systematically assessed the frequency 
and quality of adverse events reported in RCTs on Tai Chi, and only 33% of the 153 included 
RCTs reported adverse events information (Wayne, Berkowitz, Litrownik, Buring, & Yeh, 
2014). Similarly, our previous bibliometric review found that only 20.7% of 507 included 
studies reported safety information (G. Yang et al., 2015). Although Tai Chi was unlikely to 
result in serious adverse events, it might be associated with minor musculoskeletal aches and 




The general methodological quality of these studies was poor to moderate. Poor reporting 
allows authors to escape scrutiny of any weak aspects of their trials (Schulz, Altman, & Moher, 
2010), and may limit critically appraisal important aspects of a trial. In this systematic review, 
we classified a certain item of risk of bias as unclear if a trial with insufficient information to 
judge and downgrade the quality of evidence using GRADE criteria. We recommend 
researchers follow the CONSORT (Consolidated Standards of Reporting Trials) 2010 
Statement (Schulz et al., 2010) and its extension for non-pharmacologic treatments (Boutron, 
Altman, Moher, Schulz, & Ravaud, 2017) to improve the research transparency. In addition, 
due to the nature of Tai Chi, blinding of both participants and researchers to the interventions 
is hard to be feasible, so the included studies might have high risk of performance bias.  
Secondly, the results of these individual studies may not achieve clinical significance. Three 
studies (H. Song, 2013; F. Sun & Sun, 2014; E. Zhang, 2014) used SDS (scale from: 20-80) to 
assess depression. Previous studies with cardiovascular disease have often used a cut-off index 
score of 50 as a definition of clinical depression (Parissis et al., 2008; Pihl, Jacobsson, Fridlund, 
Stromberg, & Martensson, 2005; Shiotani et al., 2002). However, only in one (H. Song, 2013) 
study the mean SDS scores of the Tai Chi and control groups at baseline were above 50. 
Although Sun and Sun (2014) found that the Tai Chi group was superior in reducing SDS scores 
(F. Sun & Sun, 2014), it may not achieve clinical significance because the baseline SDS scores 
of both groups were around 30 (Jayadevappa et al., 2017; Garin et al., 2009; Gonzalez-Saenz 
de Tejada et al., 2019).  
Thirdly, we did not perform subgroup analyses to exploring the effectiveness of different Tai 
Chi styles. Therefore, the findings could not provide a specific recommendation based on Tai 
Chi styles/forms. However, because all styles and forms are derived directly or indirectly from 
Chen style, the core principles and theories of them, such as balance, breathing, coordination, 
relaxation and concentration are similar.  
3.4.3 Conclusions 
Tai Chi appears an effective and safe intervention to improve quality of life in people with CVD 
and/or cardiovascular risk factors. It remains uncertain whether Tai Chi is beneficial for the 
management of stress, depression, anxiety, and mood disturbance in this population. Stronger, 
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better designed studies assessing Tai Chi for psychological well-being and quality of life as 







Chapter 4: Methods of the Randomised Controlled Trial 
 
 
This chapter describes the objectives and methodology of a RCT exploring the effects of Tai 
Chi on stress and cardiovascular function in patients with coronary heart disease and/or 
hypertension. The protocol of the trial has been registered with the Australian New Zealand 
Clinical Trials Registry (ANZCTR) (www.anzctr.org.au) (Trial ID: ACTRN12616001204437). 
The methodology section presents the study design, participants, sample size calculation, 
recruitment and screening, randomisation, intervention, outcome measures, data collection, 
statistical analysis and data management. The reporting of this study is in accordance with the 




The detailed background of this study is presented in Chapter 2.  
4.1.2 Objectives 
The primary objective of this study is to determine the effect of a 24-week Tai Chi intervention 
on psychological stress in patients with CHD and/or hypertension.  
The secondary objective is to investigate the effect of a 24-week Tai Chi intervention on anxiety, 
depression, cardiovascular function (including blood pressure, heart rate, heart rate variability 
(HRV), blood lipid profiles, blood glucose profiles and CRP, QoL and physical fitness outcome 




4.2.1 Trial Design 
This was a prospective, randomised, international multi-centre, controlled trial designed to 
investigate the effect of a standardised Tai Chi intervention on psychological stress and 
cardiovascular function. The primary outcome was psychosocial status of stress measured by 
the Perceived Stress Scale 10-item (PSS-10). Secondary outcomes included psychosocial status 
of anxiety measured by Zung Self-Rating Anxiety Scale (SAS), and depression measured by 
Beck Depression Inventory-II (BDI-II), cardiovascular function (including blood pressure, 
heart rate, HRV, blood lipid profiles, blood glucose profiles, and CRP), quality of life measured 
by SF-36, and physical fitness using 6 Minute Walk Test (6MWT). A semi-structured exit 
interview was also conducted to explore participants’ perceptions on facilitators and barriers to 
trial participation and adherence during and after the randomized controlled trial (see Chapter 
5). 
Participants with CHD and/or hypertension were randomly assigned into the Tai Chi group who 
participated in a 24-week Tai Chi intervention, comprising of a 12-week intensive intervention 
and 12-week sustained intervention or the waitlist control group. The study was conducted in 
two locations: Sydney, Australia, and Beijing, China. All study procedures complied with Good 
Clinical Practice guidelines and approval by local human research ethics committees from both 
the Western Sydney University (Ethics approval number: H11189) and Beijing University of 
Chinese Medicine (Ethics approval number: 2015BZHYLL0233) before trial commencement.  
4.2.2 Participants 
Inclusion Criteria: 
(1) ≥40 years of age, regardless of gender; 
(2) With documented diagnosis of CHD (myocardial infarction, angina or 
revascularization) with severity of angina class I to II according to the Canadian 
Cardiovascular Society functional classification, and/or with established diagnosis of 
hypertension according to the Seventh Report of the Joint National Committee on 
Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (Chobanian 
et al., 2003);  
(3) Ability to perform prescribed Tai Chi program; 
(4) Willing to complete the 24-week Tai Chi intervention; 
(5) Not practicing Tai Chi in the past 6 months; 
(6) Ability to speak and read Chinese or English fluently; 
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(2) Previous or current psychological disorders not associated with depression or 
anxiety 
(3) End stage congestive heart failure 
(4) Permanent bed-bound status 
(5) Unstable abdominal, thoracic or cerebral aneurysm 
(6) Acute myocarditis, pericarditis, pulmonary embolus or pulmonary infarction 
(7) Significant limitation of physical activity for reasons other than CHD 
(8) Participation in a clinical trial for an experimental drug within the last 30 days before 
the study 
4.2.3 Sample Size Calculation 
The current study is an exploratory randomized controlled trial focusing primarily on the effect 
of Tai Chi on stress in patients with CHD or hypertension. There are no preliminary data on 
which to base a sample size calculation. A previous study evaluated the effect of a 12-week Tai 
Chi intervention on psychobiological stress response in 70 healthy men and women. This study 
found that the Tai Chi participants exhibited a significantly lower increase in perceived 
stressfulness (P=0.006) and maintained a higher level of calmness (P=0.019) in response to 
psychosocial stress measured by PSS-10 (Nedeljkovic, Ausfeld-Hafter, Streitberger, Seiler, & 
Wirtz, 2012) compared with the waitlist group. The formula we used for sample size calculation 
is as follows: n=2[(a + b)2𝛿2]/𝛥2. In this formula, ‘n’ stands for the sample size in each of the 
groups, ‘δ’ stands for standard deviation, ‘Δ’ stands for the difference in effect size, ‘a’ stands 
for conventional multiplier for alpha of 0.05, ‘b’ stands for conventional multiplier for power 
of 0.80. Based on an alpha of 0.05, sample size estimates indicated that we would be able to 
detect a difference in stress between 3 to 4 with a sample size of 50 participants per group, 
based on standard deviation estimates of 6 to 7 at a power of 0.80. As no previous research was 
available on which to base the standard deviation estimates, the estimates should be considered 
vague approximations. Hence, 100 participants is a conservative estimate to detect a statistically 
significant result. An attrition rate of 20% is expected during the study; consequently, a total of 
120 patients were recruited.  
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4.2.4 Recruitment and Screening 
Patients were recruited from Beijing, China and Sydney, Australia. In Beijing, the target 
number of participants was 80. Potential participants were recruited from Changying 
Community Health Service Centre in Chaoyang District. Ono experienced doctors from 
Changying Community Health Service Centre assisted in the screening and assessment of 
participants. The principal investigator was in charge of all promotion activities and preparation 
of advertisements. Two research assistants from the Centre for Evidence-Based Chinese 
Medicine, Beijing University of Chinese Medicine (BUCM) assisted the patient recruitment. 
Prior to recruitment, an introduction activity was held by the Changying Community Health 
Service focusing on Tai Chi and information about the study conducted as a health education 
program for the community residents, particularly potential participants. Residents were 
informed about this study through notice boards and Health Service Centre websites. Potential 
participants who expressed interest in participating were contacted by phone. Participants were 
identified through newsletter advertisements and community bulletins. Interested persons also 
were encouraged to contact the study investigator for further information and to determine 
eligibility. If subjects meet the eligibility criteria, they were invited for a baseline evaluation. 
In Sydney, the target number of participants was 40. Potential participants were recruited from 
the Cardiac Health Institute (CHI) and Buddhist Compassion Relief Tzu Chi Foundation 
Australia. These participants were identified through poster advertisements placed in CHI and 
Tzu Chi Foundation. Potential community groups were also used to identify participants 
through newsletter advertisements and community bulletins. Additional participants were 
identified through advertisements placed on Western Sydney University’s website and in local 
newspapers. Once participants were identified, they underwent a brief telephone interview to 
provide preliminary details about the study as well as to assess eligibility for basic 
inclusion/exclusion criteria and accessibility to the test site for screening. Figure 4.1 shows the 




Figure 4.1 - CONSORT Flow Diagram in Protocol 
 
Note: CONSORT, Consolidated Standards of Reporting Trials statement, which is used worldwide to 
improve the reporting of randomized, controlled trials. *Eligible participants were randomly assigned 
to either the Tai Chi intervention group or the wait list control group. The allocation ratio was 1:1. 
Participants recruited in Beijing and Sydney were randomly assigned separately. Two independent 
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Then a suitable day and time for a screening session were advised to potential participants. 
Following this, the participant information sheet and an appointment letter detailing the 
arranged time and date, the location and any additional information to bring were sent via email 
and/or post. 
At the screening session, participants were provided with an information sheet. A brief 
introduction of the aim and methodology of the study were also provided orally if possible. 
Participants were required to provide written informed consent before the screening procedure 
begins and were invited and encouraged to ask questions throughout the recruitment procedure 
and whilst the study is in progress. 
4.2.5 Randomisation 
After eligibility assessments, eligible participants were randomly assigned to either the Tai Chi 
intervention group or the wait list control group. The allocation ratio was 1:1. Participants 
recruited in Beijing and Sydney were randomly assigned separately. Two independent 
statisticians generated the random allocation sequence using SPSS (version 24.0, SPSS Inc. 
statistics) software.  
Allocation concealment was achieved by an independent third party using sequentially 
numbered, sealed, and opaque envelopes. Randomisation envelopes were opened sequentially 
only when a participant met the eligibility criteria, provided informed consent, and participant 
details were written on the envelope.  
4.2.6 Intervention 
4.2.6.1 Tai Chi intervention 
The Tai Chi group practiced a standardised Tai Chi program specially designed for patients 
with CVDs over a period of 24 weeks. The Tai Chi program consists of a 12-week intensive 
Tai Chi intervention period and a following sustained Tai Chi intervention period over 12 weeks. 
In the intensive period, each Tai Chi class lasted 2 hours, twice per week for 12 weeks; while 
in the sustained period, each Tai Chi class also lasted 2 hours, but once per week for the 
following 12 weeks. All the classes were held in spacious rooms. Participants were monitored 
for potential adverse events during Tai Chi practice. Attendance was recorded by the Tai Chi 
instructor in each class and tracked the reasons for missed sessions. 
Figure 4.2 shows the main components of the Tai Chi program, including walking, meditation, 
13-form Thumping Techniques, standing posture, and 13-form Chen-style Tai Chi. The 13-
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form Thumping Techniques were derived from meridian/channel theories of traditional Chinese 
medicine. The 13-form Chen-style Tai Chi was modified from the classical 83-form Chen-style 
Tai Chi. In addition, in the classes, Tai Chi history, theories and principles were also introduced. 
Each Tai Chi class consists of: (1) 10 minutes of walking, (2) 10 minutes of meditation, (3) 20 
minutes of 13-form Thumping Techniques, (4) 20 minutes of break and question-and-answer 
session, (5) 10 minutes of standing postures, and (6) 50 minutes of Tai Chi practice. Participants 
learned the entire sequence by the end of the 12th week, and the entire sequence was repeated 
in the following weeks. An outline procedure of the standardised Tai Chi program over 24 
weeks is shown in Appendix 4.  
Figure 4.2 Main components of the 24-week standardised Tai Chi program.  
 
All Tai Chi classes were held by the principal investigator or a Tai Chi master Zhang Peijun 
who has more than 30 years of Tai Chi teaching experience. The principal investigator is a 
qualified Tai Chi instructor who has learned Tai Chi in Beijing from Master Tian Qiutian and 
Master Zhang Peijun since 2006 and is a member of Beijing Huacheng Martial Arts Association. 
To ensure that the two instructors applied a standardised teaching protocol, the principal 
investigator completed the required instructor training in Beijing prior to initiation of the 
intervention classes. The Tai Chi classes in Sydney recruitment centre started after the 
completion of that in Beijing recruitment centre, where Master Zhang Peijun served as the 
primary instructor and the principal investigator was a teaching assistant. In addition, all 
sessions in Sydney recruitment centre were reported regularly by the principal investigator to 
Master Zhang Peijun and timely feedback were received throughout the study to ensure proper 
instruction. Furthermore, two training sessions were delivered by Master Zhang Peijun via 
videoconferencing to the participants in Tai Chi group. 
Participants were encouraged to maintain their routine physical activity, but not to begin new 
additional training. Participants were required to practice at least three other days per week at 
home. Printed handbooks containing instructional pictures and written descriptions of the Tai 
Walking Meditation 13-Form Thumping Techniques
Standing 
Posture




Chi intervention and DVDs were provided to facilitate home practice. Tai Chi instructors 
reminded participants in class to practice the program daily. A WeChat group (a social media 
communication application developed by Tencent) was set up to promote timely feedbacks 
between participants and instructors to support home practice. A self-report patient diary for 
recording the home practice sessions were required to be completed by participants weekly (see 
Appendix 5).  
4.2.6.2 Waitlist Control 
Participants assigned to the waitlist control group were asked to maintain their routine physical 
activities, but not to begin any new exercise programs during the study.  
 
These participants were offered an equivalent 12-week intensive Tai Chi intervention and 12-
week sustained Tai Chi intervention at the termination of the study provided the Tai Chi 
intervention in the treatment is proved to be safe (no severe adverse events directly associated 
with Tai Chi).  
 
4.2.7 Outcome Measures 
4.2.7.1 Primary Outcome Measure 
The primary outcome of this study is stress. The implication of stress on the development and 
prognosis of CHD has been established for over four decades (Jenkins, 1971, 1976; Kivimaki 
et al., 2006; Redmond et al., 2013; Richardson et al., 2012). Tai Chi could be a promising 
exercise option for relieving stress in patients with CHD and/or hypertension, however evidence 
to support this is generally lacking. To address the knowledge gap about Tai Chi for stress in 
patients with CHD and/or hypertension, stress is chosen as the primary outcome of this study.  
• Perceived Stress Scale 10-item (PSS-10) (see Appendix 6) 
The PSS-10 was applied to measure stress in this study, because of its high internal consistency, 
reliability, factorial validity and hypothesis validity of both English and Chinese version in this 
population. The PSS designed by Cohen and colleagues is the most commonly used tool to 
measure perceived stress, with the original scale containing 14 items. The PSS was modified 
by Cohen and Williamson to a 10-item, 5-point Likert scale (0, never; 4, very often), with 
possible scores ranging from 0 to 40. A higher score indicates more perceived stress.  
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The high internal consistency, reliability, factorial validity and hypothesis validity of the PSS 
in CHD patients were reported in a review where 19 articles were identified on psychometric 
evaluation of PSS (E. H. Lee, 2012). High internal consistency of the Chinese version of PSS 
has also been reported (r=0.90) (S. Lee & Crockett, 1994). One study reported adequate test-
retest reliability and construct validity of the PSS among Chinese women (Z. Wang, J. Chen, 
et al., 2011). Another study applied the PSS-10 to assess the perceived stress change among 
ethnic Chinese people with cardiovascular disease risk factors following a 12-week Tai Chi 
exercise also found similar results (Taylor-Piliae, Haskell, Waters, & Froelicher, 2006). The 
satisfactory psychometric properties of all three Chinese version of PSS (PSS-14, PSS-10 and 
PSS-4) have been confirmed by testing in 1,860 Chinese cardiac patients (D. Y. Leung, Lam, 
& Chan, 2010).  
4.2.7.2 Secondary Outcome Measures 
The secondary outcomes of this study include psychological well-being (including anxiety and 
depression), cardiovascular function (including blood pressure, heart rate, heart rate variability 
(HRV), blood lipid profiles, blood glucose profiles and CRP), QoL and physical fitness. As 
discussed in Chapter 2, these outcomes are associated with the development and prognosis of 
CHD and its complications. Tai Chi is potentially beneficial for improving these outcomes. 
However, little is known about the benefits of Tai Chi for these outcomes in patients with CHD 
and/or hypertension. To address the knowledge gap in existing literature, these secondary 
outcomes and the following outcomes measures were applied in this study. 
Psychological status 
• Zung Self-Rating Anxiety Scale (SAS) (see Appendix 7) 
SAS is a self-report instrument that measures levels of anxiety in patients who have anxiety-
related symptoms. The SAS has 20 questions. Each question is scored using a 4-point scale, 
from ‘none of the time’ to ‘most of the time’. There are 15 increasing anxiety level questions 
and 5 decreasing anxiety questions.  
The high reliability and validity of the English version of SAS and its Chinese version has been 
reported (F.  Wang, 1994). Researchers have widely used the Chinese version of SAS among 
Chinese population in various trials (Y. W. Liu & Tsui, 2014; Luo et al., 2013; Shi, Liu, Wang, 
& Wang, 2015; G. Wang et al., 2013; K. Zhang et al., 2013).  
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• Beck Depression Inventory-II (BDI-II) (see Appendix 8) 
The BDI-II is a 21-item self-report rating inventory that measures the existence and severity of 
symptoms of depression, which is in line with the depression criteria of the Diagnostic and 
Statistical Manual of Mental Disorders-Fourth Edition (DSM-IV). This study used the revised 
edition of the BDI and BDI-1A. Each of the 21 items is a list of four statements arranged in 
increasing severity about a particular symptom of depression, except for two items (16 and 18) 
where seven points are provided to indicate either an increase or decrease of appetite and sleep. 
Each item is assigned a score of 0-3, with 3 indicating the most severe symptoms. A cumulative 
score is determined by adding the scores of the individual items. The total score can range from 
0 to 63.  
The BDI-II is a reliable and well-validated measure for depression in adults (Jaksic, Ivezic, 
Jokic-Begic, Suranyi, & Stojanovic-Spehar, 2013; Krefetz, Steer, Gulab, & Beck, 2002; Osman, 
Kopper, Barrios, Gutierrez, & Bagge, 2004; Steer, Ball, Ranieri, & Beck, 1997). The reliability 
and validity of the Chinese version of BDI has also been confirmed in previous studies (Shek, 
1990; Y. P. Wang, Andrade, & Gorenstein, 2005; Y. X. Zhang, Wang, & Qian, 1990; Y. P. 
Zheng, Wei, Goa, Zhang, & Wong, 1988). The validity of a Chinese version of the BDI-II for 
use with Chinese community adolescents based on the cross-validated factor structure has been 
tested (Byrne, Stewart, & Lee, 2004). Findings related to internal consistency reliability, 
stability over 6 months, and associations with relevant external criteria and provided strong 
support for the valid use of Chinese version of BDI-II. Wang Z. and colleagues evaluated that 
reliability and validity of the Chinese version of BDI-II in 142 patients with depression, and 
confirmed the valid use of Chinese version of BDI-II (Z. Wang, C. Yuan, et al., 2011). 
Cardiovascular function 
• Blood Pressure and Heart Rate 
Blood pressure and heart rate are two important measurements of overall heart health. All blood 
pressure and heart rate measurements were calculated using automatic sphygmomanometers, 
designed for professional use. 
Brachial blood pressure was taken following a 5-minute rest period. This has been done with 
an automatic sphygmomanometer whilst the participant was sitting comfortably. Blood 
pressure was measured three times consecutively and a mean result obtained. 
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• Heart Rate Variability (HRV) 
HRV reflects the modulation of cardiac function by autonomic and other physiological systems 
(Hamaad, Lip, & MacFadyen, 2004). Abnormalities in HRV have been reported in various 
settings of ischaemic heart disease, and the most important current application of HRV analysis 
is in post-infarction phase where abnormal HRV indicates an increased risk of cardiac mortality 
(Huikuri, 1995). Most studies involving patients with stable CHD or patients with a recent acute 
coronary event have found that HRV was lower in depressed patients than in their counterparts 
with no depression (Carney & Freedland, 2009; Harris, Sommargren, Stein, Fung, & Drew, 
2014; Stapelberg, Hamilton-Craig, Neumann, Shum, & McConnell, 2012). 
The SphygmoCor HRV System was used to conduct HRV measurement (SphygmoCor, AtCor 
Medical Pty, Sydney, Austrialia). The SphygmoCor HRV System is a sophisticated system for 
non-invasively assessing the Autonomic Nervous System (ANS) based on HRV analysis. HRV 
analysis is based on measuring variability in intervals between the R-R intervals. The system 
uses a 3-lead electrocardiogram (ECG) connected to the electronics module to non-invasively 
record a continuous 10-minute ECG waveform. After a 5-minute rest with regular and calm 
breathing pattern, participants were asked to lay in a supine resting position in a quiet room 
with a stable room temperature. Participants remained awake, whilst the SphygmoCor system 
captured data. 
The SphygmoCor HRV system provides HRV time and frequency domain parameters. Time 
domain measures are the means and standard deviations of R-R intervals recorded by the 
continuous ECG, where normal-to-normal (NN) intervals represent all the R-R intervals. Key 
parameters of time domain measures include: heart rate, RMS SD (m/s) (the square root of the 
man squared differences of successive NN intervals; estimate of the short-term components of 
HRV, HRV Index and PNN50 (%) (the proportion of RR intervals having a difference of >50 
msec; is virtually independent of circadian rhythms).  
Spectral analysis of a series of successive R-R intervals provides the frequency domain analysis. 
This technique separates the heart rate spectrum into various components and quantifies 
sympathetic and vagal influences on the heart. Key parameters of frequency domain measures 
include: Total Power (ms2) (reflecting all cyclic components of HRV), High Frequency (HF) 
(generally representing parasympathetic activity and is therefore generally considered to be a 
marker of vagal activity), Low Frequency (LF) is influenced by both sympathetic and 
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parasympathetic activity, and the ratio of HF: LF (representing the balance of parasympathetic 
and sympathetic activity). 
• C - Reactive Protein (CRP) 
CRP is a well-accepted systemic marker of inflammation (Pepys & Hirschfield, 2003). 
Modestly elevated baseline levels of CRP are associated with the long-term risk of CHD, whilst 
the changes in CRP following myocardial infarction are associated with death and cardiac 
complications (Abd et al., 2011; Casas, Shah, Hingorani, Danesh, & Pepys, 2008; Strang & 
Schunkert, 2014). A meta-analysis found that early increased plasma CRP moderately 
correlates to long-term risk of recurrent cardiovascular events or death, and may be a valuable 
prognostic indicator in patients after acute coronary syndromes (He, Tang, Ling, Chen, & Chen, 
2010).  
In Beijing, blood samples were taken from participants by suitably qualified nurses and 
couriered to Changying Community Health Service Centre Pathology Laboratories where 
pathology testing was conducted. 
In Sydney, the participants were asked to visit a local Laverty Pathology Laboratory where 
pathology testing was conducted. 
• Lipid Profile and Glucose Profile 
The lipid profile (primarily low high-density lipoprotein cholesterol (HDL-C), elevated 
triglycerides, elevated low-density lipoprotein cholesterol (LDL-C), and elevated total 
cholesterol) are important factors in CHD (McCullough, 2005). The relationship between low-
density lipoprotein cholesterol (LDL-C) and CHD event rates has been well established 
(O'Keefe, Cordain, Harris, Moe, & Vogel, 2004). 
Blood collection procedures for this outcome measure are identical to that of C-reactive protein 
described above.  
Quality of life (QoL) 
• Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) (see Appendix 9) 
QoL is a patient-important outcome. We used SF-36 to measure QoL in this study considering 
that SF-36 is a generic outcome measure designed to examine functional health and well-being 
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from the patient’s point of view. It is a practical, reliable and valid measure of physical and 
mental health that can be completed in five to ten minutes.  
The SF-36 includes the following eight health concepts: (1) physical functioning; (2) role 
limitations because of physical health problems; (3) bodily pain; (4) social functioning; (5) 
general mental health (psychological distress and psychological well-being); (6) role limitations 
because of emotional problems; (7) vitality (energy/fatigue); and (8) general health perceptions. 
Answers to each question are scored (some items need to be recoded). These scores are then 
summed to produce raw scale scores for each health concept which are then transformed to a 
0-100 scale.  
The reliability and validity of the Chinese version of SF-36 has also been confirmed in previous 
studies (P. Wang, Chen, Yang, & Wu, 2015; R. Wang et al., 2011; Xiao et al., 2016; Y. Zhang, 
Qu, Lun, Guo, & Liu, 2012), and SF-36 has been widely by Chinese researchers to measure 
quality of life in patients with CHD or hypertension (S. Gu, Hu, & Dong, 2016; W. Ma et al., 
2010; R. Wang et al., 2009). 
Physical fitness 
• 6-Minute Walk Test (6MWT) 
The 6MWT was used to measure the physical exercise capacity and fitness of participants 
because it addresses physical activity, a modifiable risk factor for secondary prevention of CHD. 
It is a widely used valid test among the CHD population. The 6MWT measures the distance an 
individual is able to walk over a total of six minutes on a hard, flat surface. The goal is for the 
individual to walk as far as possible in six minutes. The individual is allowed to self-pace and 
rest as needed as they traverse back and forth along a marked walkway.   
In this study, the 6MWT was measured with a measuring wheel. At least two practice walks 
were administered (with adequate time for rest and recovery) prior to recording measurements. 
Participants were instructed prior to the test to wear comfortable clothing and shoes and to use 
their typical walking aid during the test if appropriate. The American Thoracic Society 
(American Thoracic Society, 2002) recommends an indoor, 30-meter corridor or walkway with 
cones placed at the beginning and end of the 30-meter boundary to indicate turns. In the 
literature, the corridor distance across studies varies, which is likely due to the need to use what 




Participants were asked to complete a weekly diary documenting their practice at home. Their 
attendance of each Tai Chi class was also documented by the instructor and the attendance rate 
was calculated at the end of study.  
Other Assessments 
Participants were asked to complete a weekly diary documenting the changes with regards to 
medication use, diet, exercise and negative behaviours such as alcohol consumption and 
smoking to assess potential confounding variables (see Appendix 10).  
4.2.7.3 Safety Measures 
The standardised Tai Chi intervention is specifically tailored to the target individuals with CHD 
and/or hypertension. Tai Chi instructors of this trial are appropriately qualified and experienced. 
All Adverse Events (AE) were recorded and signed off by the principal investigator. During 
home practice, all potential adverse events were recorded in diaries by the participants. If there 
is a Serious Adverse Event (SAE), the participant contacted the principal investigator (contact 
details were provided on Participant Information Sheets). SAEs were immediately reported to 
local Human Research Ethics Committees in accordance with the guidelines.  
All outcome assessments in this study are non-invasive, except blood lipid profile and C-
reactive protein. Blood samples were taken from participants by trained and qualified nurses in 
Beijing and Sydney recruitment centres respectively, and couriered to pathology laboratories 
for testing. 
4.2.7.4 Exit Interview 
Semi-structured exit interviews were conducted as a qualitative sub-study of this RCT with 
participants from Tai Chi group who completed the study. The objective of the exit interviews 
was to explore participants’ perceptions on factors influencing trial participation and adherence 
to Tai Chi intervention during and after the RCT. Ten core questions were asked in the exit 
interviews in Chinese or English. Transcripts were recorded, transcribed and imported into the 
NVivo version 11 software for coding and analysis. The detailed methods and results of the 
qualitative sub-study were described in Chapter 5.  
4.2.8 Data Collection 
All assessment procedures and data collection were adhered to our pre-defined standardised 
operating procedures (SOPs). Data were collected at baseline, mid-treatment and post-treatment 
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sessions on week 0, 12 and 24 of the study. Data collection in Beijing was performed by the 
principal investigator and two research assistants. In Sydney data collection was performed by 
the principal investigator.  
We collected data of psychological stress, anxiety, depression and quality of life, using printed 
psychometric questionnaires including PSS-10, SAS, BDI-II and SF-36, respectively. Blood 
samples were taken by two trained and qualified nurses in Beijing and Sydney respectively, and 
pathology tests conducted by Changying Community Health Service Centre in Beijing and the 
Laverty Pathology in Sydney, respectively. Data of heart rate and heart rate variability were 
collected using proprietary software employed by equipment manufacturers for the 
SphygmoCor system. The 6MWT distanced was collected with a measuring wheel. 
We had a record of identified information to be able to monitor safety of participants, such as 
determine which participants experience adverse events, as well as which intervention group 
the participant has been allocated to. Coded information was used for data collection of 
pathology testing.  
Table 4.1 presents the time-points of data collection and assessment procedures. 
 
Table 4.1 Assessment procedures and Time-points. 








Screening (medical history, randomization, inclusion, 
exclusion, consent forms) 
x    
Psychosocial status     
    Perceived Stress Scale 10-item (PSS-10)  x x x 
    Zung Self-Rating Anxiety Scale (SAS)  x x x 
    Beck Depression Inventory-II (BDI-II)  x x x 
Cardiovascular function     
    Blood pressure  x x x 
    Heart rate  x x x 
    Heart rate variability  x x x 
    Lipid and glucose profile  x x x 
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    C-creative protein  x x x 
Quality of life     
    36-item Short Form Health Survey (SF-36)  x x x 
Physical fitness     
     6-Minute Walk test (6MWT)  x x x 
Compliance     
    Participant diary (to be completed daily)  x x x 
    Attendance rate (to be completed weekly)  x x x 
Exit interview    x 
 
4.2.9 Statistical Analysis 
SPSS software (version 25.0, SPSS Inc. statistics) was used to perform data analyses. The 
significance level was set at a P value of less than 0.05. All statistical testing was 2-sided.   
Demographic characteristics and medical history of participants were described using means 
and standard deviations (SD) for continuous variables, and frequencies and percentages for 
categorical variables. Baseline comparisons between the two groups were performed using t-
tests analyses for continuous variables and chi-square tests for categorical variables. 
In the current study, a mixed linear model was used to assess differences between the two 
groups in the primary outcome for repeated measurements. The effects of the intervention and 
time points were considered as fixed effects, with treatment effects represented as interaction 
effects (time*group), while the participants were regarded as random effects. Normality was 
confirmed following the analyses. The general linear mixed model models for group means as 
fixed effect while simultaneously modelling for individual subject variables as random effects 
(Krueger & Tian, 2004). Compared with repeated measures ANOVA, the mixed model has the 
strength of accommodating missing data points in longitudinal datasets (Krueger & Tian, 2004). 
Furthermore, rather than treating time as a categorical variable, the mixed model is capable of 
treating time as either a continuous variable or a categorical variable or both (Krueger & Tian, 
2004).  
Similarly, we also analysed the main secondary outcomes using linear mixed effects models 
with interaction tests. Normality was confirmed by examining the distribution of residuals 
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following the analyses. When there was significant skewness of data, we performed log 
transformation or winsorising to dealing with outliers.  
The secondary outcome CRP were categorized into binary data based on the original laboratory 
reports of <4.0 mg/L or >4.0 mg/L, because the standard of laboratory reports from Beijing and 
Sydney were different. According to the Australian Bureau of Statistics, the test reference range 
for normal CRP levels is <5.0 mg/L, while CRP levels >10.0 mg/L are indicative of an acute 
infection or inflammation (Australian Bureau of Statistics, 2014). However, the Centers for 
Disease Control and Prevention (CDC) and the AHA recommended that: low risk, <1.0 mg/L; 
average risk, 1.0-3.0 mg/L; and high risk, >3.0 mg/L; if the CRP level is >10 mg/L, then the 
test should be repeated and the patient examined for sources of infection or inflammation (G. 
L. Myers et al., 2004). Therefore, CRP was analysed using the generalised linear model (GZLM) 
with a binary logistic model. The effects of the intervention and time points were considered as 
fixed effects, with treatment effects represented as interaction effects (time*group), and the 
participants were regarded as random effects.  
 
Once significant differences among the means between the Tai Chi and waitlist control groups 
were determined, one-way ANCOVA analysis was conducted to determine the response at 
week 12 and week 24. Partial η2 represents the proportion of the variation which could be 
explained by the predictor variable after correcting for all other predictors in the model. Effect 
size was calculated by Cohen’s 𝑑 =
𝑀1−𝑀2
𝑆𝐷
 (Cohen, 1988). Cohen (1988) suggested that d=0.2 
be considered a ‘small’ effect size, 0.5 represents a ‘medium’ effect size and 0.8 a ‘large’ effect 
size (Cohen, 1988). Subgroup analyses was also conducted for these outcomes by breaking 
down the sample size into subset of participants with or without hypertension. 
We also conducted intention-to-treat (ITT) analyses for these outcomes, in which all 
participants as originally allocated after randomisation were included, assuming no 
improvements for missing data. All tests were 2-sided. A P value of less than 0.05 was 
considered as statistically significant. 
4.2.10 Data Management 
During the PhD project, data were recorded in participant source document files and an 
electronic database. Electronic data were stored on a hard drive, on a password-protected 
computer with backups on portable hard disc drives kept in a locked cabinet in the NICM Health 
Research Institute (NICM) which is only accessible to researchers directly involved in the 
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project. Specific requests for access to the data by any other person would be considered after 
formal application to the PhD supervisor.  
Participants were not given their individual results. However, they were given the overall group 
results through a workshop which they were invited to after completion of the study. Any 
incidental findings on a participant’s results were communicated to the participant and 
communicated to their local doctor via letter when needed. 
Information on all participants was maintained in a locked filing cabinet within the NICM, 
along with other documents related to the clinical trial, for a period of 15 years. All participant 
paper files and electronic data files would be deleted or destroyed after 15 years as per the 
National Statement on Ethical Conduct in Human Research (2007-Update May 2015) issued 
by the National Health and Medical Research Council (NHMRC) (National Health and Medical 












This chapter describes a results and discussion of the RCT exploring the effects of Tai Chi on 
stress and cardiovascular function in patients with coronary heart disease and/or hypertension. 
The results section presents the enrolment, participant discontinuations, baseline characteristics, 
and the effects of the Tai Chi intervention on the primary outcome measure (i.e. stress) and 
secondary outcome measures (i.e. anxiety, depression, blood pressure, heart rate, heart rate 
variability, lipid and glucose profile, C-reactive protein, quality of life, and 6-minute walk test). 
A discussion for the findings including interpretation of the results and comparisons with 
previous studies is also provided. The reporting of this study is in accordance with the 
Consolidated Standards of Reporting Trials (CONSORT) statement (Appendix 3). 
 
5.1 Results 
5.1.1 Participant Flow 
Eighteen participants (15.0%) out of the 120 recruited withdrew from the study over 24 weeks, 
including 15 (15/18, 83.3%) participants at the 12-week assessment and 3 (3/18, 16.7%) 
participants at the 24-week assessment. There was no significant difference between the two 
groups with regards to the lost to follow-up rates over 24 weeks (P=0.306), using a Chi-square 
test. The reasons of participant discontinuations were presented in Table 5.1.  
Table 5.1 Reasons for withdrawal over 24 weeks (n=18) 
Reasons for Withdrawal Tai Chi Group Waitlist Group 
 Week 0-12 Week 13-24 Week 0-12 Week 13-24 
Family and domestic 
responsibility  
3 0 4 0 
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Travel difficulty 1 0 3 0 
Cancer diagnosis  0 0 2 0 
Participation in an intensive 
stroke rehabilitation program 
1 0 0 0 
Tiny fracture of rib bone 1 0 0 0 
Subtotal 6 0 9 0 
Work transferred to overseas 0 0 0 1 
Pace-maker installation 
surgery 
0 1 0 0 
Loss of interest in Tai Chi 0 0 0 1 
Subtotal 0 1 0 2 
Total 7 11 
 
As shown in Table 5.1, among the eighteen participants withdrew from the study over 24 weeks, 
seven were from the Tai Chi group and eleven were from the waitlist group. The reasons for 
participant discontinuations include: (1) family and domestic responsibility (3 participants in 
Tai Chi group and 4 in waitlist group); (2) difficulties to travel to the recruitment site (1 in Tai 
Chi group and 3 in waitlist group); (3) work transferred to overseas (1 in waitlist group); (4) 
cancer diagnosis during the study (2 in waitlist group); (5) time conflict due to participation in 
an intensive stroke rehabilitation program (1 in Tai Chi group); (6) pace-maker installation 
surgery (1 in Tai Chi group); (7) loss of interest in Tai Chi (1 in waitlist group); and (8) tiny 
fracture of rib bone (1 in Tai Chi group) during the 24-week waiting period. 






Figure 5.1 CONSORT Flow Diagram 
 
Note: CONSORT, Consolidated Standards of Reporting Trials statement, which is used worldwide to improve the 
reporting of randomized, controlled trials. 
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5.1.2 Recruitment  
The recruitment in Beijing started in August 2015 and finished in November 2015. In Sydney 
the recruitment commenced August 2016 and closed in January 2017. During these periods, a 
total of 151 participants were screened including 103 in Beijing and 48 in Sydney recruitment 
centres. At the screening session, participants were provided with an information sheet 
outlining the details of the trial and a copy of written informed consent form. The aims, 
methodology, potential risks and requirements of the study were discussed with the participants. 
Participants were encouraged to ask questions throughout the screening session. Participants 
were required to sign the informed consent form before the screening procedure begins. 
One hundred and twenty participants met the criteria, of which 80 (80/120, 66.7%) participants 
were from Beijing recruitment centre and 40 (40/120, 33.3%) from Sydney recruitment centre. 
Eligible participants were randomly assigned to either Tai Chi group (n=60) or the wait-list 
control group (n=60). The allocation ratio was 1:1. Randomisation was carried out separately 
in the two recruitment centres. An independent statistician generated the random allocation 
sequence by SPSS software (version 25.0, SPSS Inc. statistics). Allocation concealment was 
achieved by using sequentially numbered, sealed, and opaque envelopes.  
The last patient completed the study in November 2017. Out of the 120 participants, 102 (85.0%) 
completed the study. Of the 102 participants who completed the study, 53 (52.0%) were in the 
Tai Chi group (37 in Beijing centre and 16 in Sydney centre), and 49 (48.0%) were in the 
waitlist control group (35 in Beijing centre and 14 in Sydney centre).  
 
5.1.3 Baseline Data 
5.1.3.1 Demographic Characteristics 
No statistical difference was identified in demographic characteristics including age, sex, body-
mass index (BMI), education, smoking and alcohol consumption, except the occupation status 
between the Tai Chi and waitlist control groups (P>0.05). The demographic characteristics of 





Table 5.2 Demographic characteristics of the study participants. 





Age, mean±SD, y 65.08±6.38 63.55±9.01 0.284 
Female, n (%) 37(61.7) 36(60.0) 0.852 
Body-mass index (BMI)*, mean±SD, 
kg/m2 
25.63±2.60 25.33±2.81 0.545 
Higher education, n (%) 29(48.3) 32(53.3) 0.584 
Retired, n(%) 56(93.3) 48(80.0) 0.032 
Smoker, n (%) 9(15.0) 10(16.7) 0.803 
Regular alcohol drinker, n (%) 1(1.7) 6(10.0) 0.114 
Abbreviation: *BMI: The body-mass index is the weight in kilograms divided by the square of the height in meters; 
y, year; n, number. 
 
The mean age of participants in the two groups was similar, 65.08 ±6.38 years in the Tai Chi 
group and 63.55±9.01 years in the waitlist control group. There was no significant difference 
between the two groups in age (P=0.284).  
Out of the 120 participants, 73 (60.8%) were women. The proportion of female participants in 
both groups was balanced at baseline, 37 (61.7%) participants in the Tai Chi group and 36 
(60.0%) in the waitlist control group. No significant difference was identified between the two 
groups (P=0.852). 
All the 120 participants were Chinese descent. The number of participants who possess higher 
education qualifications in the two groups was similar (P=0.584). There were 29 (48.3%) 
participants in the Tai Chi group had a higher education qualification compared to 32 (53.3%) 
in the waitlist control group.  
There were more retirees in the Tai Chi groups (56/60, 93.3%) than in the waitlist group (48/60, 
80.0%). The difference reached statistical significance (P=0.032).  
Smoking was reported in only a few participants in both groups. The proportion of non-smokers 
in both groups are very similar (P=0.803), 51 (85.0%) participants in the Tai Chi group and 50 
(83.3%) in the waitlist control group. Majority of the participants reported alcohol consumption 
109 
 
not on a regular base, 59 (98.3%) in the Tai Chi group and 54 (90.0%) in the waitlist group. No 
significant differences were identified between the two groups (P=0.114).  
5.1.3.2 Medical History 
Out of the 120 participants randomised, 107 (89.2%) had hypertension (53 in Tai Chi group 
and 54 in waitlist control group), 31 (25.8%) had CHD (14 in Tai Chi group and 17 in waitlist 
control group), and 18 (15.0%) had both hypertension and CHD (7 in Tai Chi group and 11 in 
waitlist group). At baseline, there was no statistical difference between the two groups in 
medical history (P>0.05), including family history of CVDs and current disease and medication 
status (see Table 5.3).  
Table 5.3 Medical history between the Tai Chi and waitlist groups at baseline 





Has family history of CVD, n (%) 55(91.7) 59(98.3) 0.207* 
Disease, n (%)a    
Hypertension 53(88.3) 54(90.0) 0.769 
    CHD 14(23.3) 17(28.3) 0.532 
Both hypertension and CHD 7(11.7) 11(18.3) 0.306 
Self-reported coexisting disease, n (%)b    
Diabetes or hyperglycaemia 13(21.7) 9(15.0) 0.345 
High cholesterol 10(16.7) 13(21.7) 0.487 
Stroke 1(1.7) 3(5.0) 0.619* 
Depression 2(3.3) 2(3.3) 1.000* 
Current medication taken, n (%)c    
Medication taken for hypertension 42(70.0) 48(80.0) 0.206 
Medication taken for cholesterol 22(36.7) 21(35.0) 0.849 
Medication taken for CHD 14(23.3) 15(25.0) 0.831 
Medication taken for diabetes or 
hyperglycaemia 
10(16.7) 6(10.0) 0.283 
Medication for depression 2(3.3) 2(3.3) 1.000* 
    Dietary supplements or herbal medicine 6(10.0) 4(6.7) 0.509 
    Nil 4(6.7) 5(8.3) 1.000* 
Abbreviation: CVD, cardiovascular disease; CHD, coronary heart disease; n, number.  
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*Fisher’s exact test. 
a Some participants had both hypertension and CHD.  
b Some patients self-reported more than one coexisting diseases/conditions. 
c Some participants self-reported more than one medication taken.  
 
No significant difference was identified between the two groups in self-reported coexisting 
diseases and/or conditions (P>0.05). Out of 120 participants, 22 participants (22/120, 18.3%) 
had diabetes or hyperglycaemia (13/60, 21.7% in Tai Chi group; 9/60, 15.0% in waitlist group), 
23 (23/120, 19.2%) had high cholesterol (10/60, 16.7% in Tai Chi group; 13/60, 21.7% in 
waitlist group), 4 (4/120, 3.3%) had stroke (1/60, 1.7% in Tai Chi group; 3/60, 5.0% in waitlist 
group), and 4 (4/120, 3.3%) had depression (2/60, 3.3% in Tai Chi group; 2/60, 3.3% in waitlist 
group).  
5.1.4 Primary Outcome Measure: Stress  
Baseline assessment 
The baseline comparison of mean PSS-10 scores of participants in the Tai Chi and waitlist 
control groups were presented in Table 5.4.  
Table 5.4 Baseline comparisons of PSS-10 scores between the two groups. 





PSS-10, mean ± SD, score 12.73±6.08 11.55±6.18 0.292 
Abbreviation: PSS-10, the Perceived Stress Scale 10-item; SD, standard deviation. 
 
PSS-10 is the most commonly used tool for measuring perceived stress. PSS-10 score ranges 
from 0 to 40, with higher score indicating more perceived stress. At baseline, the mean PSS-10 
scores of participants in the Tai Chi and waitlist control groups were 12.73±6.08 and 
11.55±6.18, respectively. There was no significant difference between the two groups 
(P=0.292). 
Week 12 
The comparison of PSS-10 scores at baseline, 12 and 24 weeks between the Tai Chi and waitlist 
groups are presented in Table 5.5. 
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Table 5.5 Stress as measured by PSS-10 in the Tai Chi and waitlist groups at baseline, week 12 and 24. 
 Tai Chi Group  Waitlist Group 
 No. Mean 
(95% CI) 
 No. Mean 
(95% CI) 
Baseline 60 12.73 
(11.21, 14.25) 
 60 11.55 
(10.03, 13.07) 
Week 12 54 10.38 
(8.81, 11.97) 
 51 12.46 
(10.85, 14.07) 
Week 24* 53 10.44 
(8.86, 12.03) 
 49 11.71  
(10.08, 13.34) 
Note: PSS-10, the Perceived Stress Scale 10-item. PSS-10 score ranges from 0 to 40, with higher score indicating 
more perceived stress. CI, confidence interval. *Using a mixed linear model, the Tai Chi group demonstrated a 
significantly greater reduction in PSS-10 scores over 24 weeks (P=0.009). 
 
The mean PSS-10 score in the Tai Chi group decreased from 12.73 (95% CI: 11.21 to 14.25) at 
baseline to 10.38 (95% CI: 8.81 to 11.97) at week 12, while the mean stress score of the waitlist 
group had a slight increase from 11.55 (95% CI: 10.03 to 13.07) at baseline to 12.46 (95% CI: 
10.85 to 14.07) at week 12. The Tai Chi group was superior to the waitlist group in decreasing 
PSS-10 mean scores at week 12; the differences reached statistical significance (P=0.006).  
In the ITT analysis, we included all participants originally randomised, assuming no 
improvements for missing data. Similarly, significant differences in PSS-10 mean scores were 
identified between the two groups at week 12 (P=0.018), favouring the Tai Chi group. 
In summary, the above analyses consistently suggested that Tai Chi intervention resulted in a 
statistically significant decrease of the mean scores of PSS-10 over 12 weeks, compared with 
the waitlist group.  
 
Week 24 
The Tai Chi group demonstrated a greater reduction in PSS-10 scores over 24 weeks (mean, 
10.44; 95%CI, 8.86 to 12.03) compared with the waitlist group (mean, 11.71; 95%CI, 10.08 to 
13.34). There were statistically significant differences between the two groups in PSS-10 at 
week 24 (P=0.009). The residuals of PSS-10 scores were normally distributed after checking 
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the histogram of residuals. The stress as measured by PSS-10 of the Tai Chi group and waitlist 
group at baseline, week 12 and 24 was illustrated in Figure 5.2.  
 
Figure 5.2 Changes in Perceived Stress Scale 10-item (PSS-10) score change over 24 weeks. The error bars indicate 
95% confidence intervals (CI). Using a linear mixed model, there was a significant difference over 24 weeks 
between the Tai Chi and waitlist control group in stress level as measured by PSS-10 (a linear mixed model: 
P=0.009), favouring Tai Chi group.  
 
As shown in Figure 5.2, the mean PSS-10 score in Tai Chi group decreased from 12.73 (95% 
CI: 11.21 to 14.25) at baseline to 10.38 (95% CI: 8.81 to 11.97) at week 12 and maintained at 
a similar level at week 24 (mean 10.44; 95% CI: 8.86 to 12.03). In contrast, the mean PSS-10 
score of the waitlist group increased from 11.55 (95% CI: 10.03 to 13.07) at baseline to 12.46 
(95% CI: 10.85 to 14.07) at week 12 and to 11.71 (95% CI: 10.08 to 13.34) at week 24, 
compared with baseline data.  
Compared with the waitlist control group, although participants in Tai Chi group experienced 
significantly improvements in the PSS-10 mean scores at week 12 (P=0.006, partial η2=0.073), 
there was no significant between-group difference in the PSS-10 mean scores at week 24 
(P=0.077, partial η2=0.031). The mean difference at week 24 was 1.27 points. The Cohen’s 𝑑 
at week 24 was 0.21. 
Subgroup analyses for participants with hypertension demonstrated that using a linear mixed 
model, the Tai Chi intervention significantly decreased the PSS-10 mean scores over 24 weeks, 
Baseline Week 12 Week 24
Tai Chi 12.73 10.39 10.44






























compared with waitlist group (P=0.029). Significant differences between the two groups were 
both detected at week 12 (P=0.014) and week 24 (P=0.044). 
In the ITT analysis which included all participants originally randomised, assuming no 
improvements for missing data, and using a linear mixed model, the Tai Chi intervention 
significantly decreased the PSS-10 mean scores over 24 weeks, compared with waitlist group 
(P=0.024). However, similarly, significant differences between the two groups were detected 
at week 12 (P=0.018), but not at week 24 (P=0.168).  
In summary, the above analyses suggested that the 24-week standardised Tai Chi intervention 
was superior to waitlist group in reducing stress as measured by PSS-10 over 24 weeks. It is 
noteworthy that the between-group differences reached statistically significance at week 12 
when there were two Tai Chi classes per week, while no further between-group differences 
were detected at week 24 when there was once per week (between week 12 to 24).  
 
5.1.5 Secondary Outcome Measure 
5.1.5.1 Psychological status 
Anxiety 
Baseline assessment 
SAS is a self-report instrument that measures levels of anxiety in patients who have anxiety-
related symptoms. Score ranges from 25 to 100, with higher scores indicating worse symptoms 
of anxiety. At baseline, the mean SAS scores were very similar between the two groups 
(P=0.976), 45.25±8.83 scores in the Tai Chi group and 45.20±9.61 scores in the waitlist control 
group. The comparisons of anxiety as measured by SAS between the two groups at baseline are 
presented in Table 5.6. 
Table 5.6 Baseline comparisons of SAS scores between the two groups. 





SAS, mean ± SD, score 45.25±8.83 45.20±9.61 0.976 





Anxiety as measured by SAS scale in the Tai Chi and waitlist groups at baseline, week 12 and 
24 is presented in Table 5.7. 
Table 5.7 SAS scores at baseline, week 12 and 24 in the Tai Chi and waitlist groups 
 Tai Chi Group  Waitlist Group 
 No. Mean  
(95% CI) 
 No. Mean  
(95% CI) 
Baseline 60 45.25 
(43.17, 47.33) 
 60 45.20 
(43.12, 47.28) 
Week 12 54 39.95 
(37.79, 42.10) 
 51 42.20 
(40.00, 44.40) 
Week 24 53 39.38 
(37.21, 41.55) 
 49 41.90 
(39.67, 44.12) 
Note: SAS, the Zung Self-Rating Anxiety Scale; SAS score ranges from 25 to 100, with higher score indicating 
worse symptoms of anxiety.  
 
As shown in Table 4.8, the mean SAS score of the waitlist control group decreased from 45.20 
(95% CI: 43.12 to 47.28) scores at baseline to 42.20 (95% CI: 40.00 to 44.40) scores at week 
12. The Tai Chi group had a greater decrease in SAS scores, with 45.25 (95% CI: 43.17 to 
47.33) scores at baseline to 39.95 (95% CI: 37.79 to 42.10) scores at week 12, when compared 
to that of the waitlist control.  
 
Week 24 
At week 24, the mean SAS scores in both the Tai Chi and waitlist groups continued to decrease 
from week 12, and the Tai Chi group had a lower mean SAS score than the waitlist control 
group (39.38 vs 41.90, respectively). However, there was no significant between-group 
difference in anxiety as measured by SAS scale over 24 weeks (P=0.155). The residuals of SAS 
scores were normally distributed after checking the histogram of residuals. 




In summary, although the Tai Chi group had a greater decrease in anxiety at week 12 and 24 
than that of the waitlist group, statistical analyses demonstrated no between-group differences 




BDI-II is a 21-item self-report rating inventory that measures the existence and severity of 
symptoms of depression. Score ranges from 0 to 63, with higher scores indicating worse 
symptoms of depression. The comparisons of level of depression as measured by BDI-II 
between the two groups at baseline were presented in Table 5.8. 
Table 5.8 Baseline comparisons of BDI-II scores between the two groups. 





BDI-II, mean ± SD, score 11.10±9.05 9.98±8.66 0.491 
Abbreviation: BDI-II, the Beck Depression Inventory-II; SD, standard deviation. 
 
The mean BDI-II scores were 11.10 ± 9.05 scores in the Tai Chi group and 9.98 ± 8.66 scores 
in the waitlist group. Although the BDI-II score of the Tai Chi group appeared higher than that 
of the waitlist group indicating worse symptoms of depression, there were no statistical 
differences in level of depression between the two groups at baseline (P=0.491). 
 
Week 12 
In this study, the level of depression was measured by BDI-II in the Tai Chi and waitlist groups 
at baseline, week 12 and 24 respectively and the results are summarised in Table 5.9. 
Table 5.9 BDI-II scores at baseline, week 12 and 24 in the Tai Chi and waitlist groups 
 Tai Chi Group  Waitlist Group 
 No. Mean 
(95% CI) 




Baseline 60 11.20 
(8.94, 13.26) 
 60 9.98 
(7.82, 12.14) 
Week 12 54 6.34 
(4.12, 8.57) 
 51 9.88 
(7.62, 12.14) 
Week 24* 53 7.28 
(5.05, 9.52) 
 49 10.22 
(7.94, 12.51) 
Note: BDI-II, the Beck Depression Inventory-II; BDI-II score ranges from 0 to 63, with higher score indicating worse 
depression. Using a mixed linear model, significant differences were detected between the Tai Chi group and 
waitlist group in decreasing BDI-II score at week 24 (P=0.001), favouring the Tai Chi group. 
 
As shown in Table 5.9, the mean BDI-II scores of the Tai Chi group was markedly decreased, 
from 11.20 (95% CI: 8.94 to 13.26) at baseline to 6.34 (95% CI: 4.12 to 8.57) at week 12, while 
the mean BDI-II scores of the waitlist control group maintained at the similar level as the 
baseline scores (mean: 9.98; 95% CI: 7.82 to 12.14 at baseline vs 9.88 (7.62, 12.14) at week 
12). There was a significant difference between the two groups in decreasing BDI-II mean 
scores between the two groups at week 12 (P<0.001), favouring the Tai Chi group.  
Using ITT sample, a similar difference between the two groups was identified at week 12 
(P=0.001) in decreasing BDI-II mean scores.  
 
Week 24 
At week 24, as shown in Table 5.9 and Figure 5.3, the mean BDI-II score in both the Tai Chi 
and waitlist control group had a slight increase from week 12. Compared with the waitlist group, 
the Tai Chi group had a lower mean BDI-II score (7.28 vs 10.22). Significant differences were 
detected between the Tai Chi group and waitlist group in BDI-II score at week 24 (P=0.001). 





Figure 5.3 BDI-II score at baseline, week 12 and 24 of the Tai Chi and Waitlist group. Error bar indicate 95% 
confidence intervals (CI). 
 
There were significant difference between the two groups in BDI-II mean scores between the 
two groups at week 12 (P<0.001) and week 24 (P=0.011), both favouring the Tai Chi group.  
In the ITT analysis, we found that Tai Chi intervention significantly decreased the BDI-II mean 
scores over 24 weeks, compared with the waitlist control group (P=0.002). Significant 
differences were identified between the two groups both at week 12 (P=0.001) and week 24 
(P=0.018), favouring the Tai Chi group. 
Although there were significant differences between the Tai Chi group and waitlist control 
group in depression as measured by BDI-II, the interpretation of the findings should be with 
caution. One limitation of our data of BDI-II scores is that the data was not normally distributed 
and had significant skewness. However, because the sample size was relatively large, and the 
sample was similar between the two groups in this study, the findings appear to be reliable. 
After dealing with outliers using the winsorising method, there was still significant skewness 
and no change in direction of the results. 
In summary, the analyses demonstrated that participants in the Tai Chi group experienced 
significantly greater decrease of BDI-II scores over the 24 weeks, and at week 12 and 24, 
respectively, indicating the beneficial effects of Tai Chi in reducing depression. In spite of that, 
Baseline Week 12 Week 24
Tai Chi 11.1 6.34 7.28





























our data of BDI-II scores did not satisfy normal distribution and the substantial skewness did 
not disappear after dealing with outliers. 
 
5.1.5.2 Cardiovascular function 
Blood Lipid Profile 
Baseline assessment 
The comparisons of blood lipid profile, including total cholesterol, triglyceride, HDL-C and 
LDL-C, between the two groups are presented in Table 5.10.  
Table 5.10 Baseline comparisons of blood lipid profile between the two groups. 





Blood lipid profile, mean ± SD, mmol/L         
Total cholesterol 5.19±1.17 4.74±0.93 0.021 
Triglyceride 1.54±0.85 1.39±0.58 0.248 
HDL-C 1.38±0.30 1.31±0.26 0.184 
LDL-C 2.99±0.85 2.77±0.93 0.187 
Abbreviation: HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; SD: 
standard deviation. 
 
The mean triglyceride, HDL-C and LDL-C values in Tai Chi and waitlist groups were similar 
at baseline. There was no significant difference between the two groups. However, the mean 
total cholesterol in the Tai Chi group was significantly higher than that in the waitlist group 
(5.19 mmol/L in Tai Chi group vs 4.74 mmol/L in waitlist group), and the difference has 
reached a statistical significance (P=0.021).  
 
Week 12 
From baseline to week 12, the mean value of total cholesterol, triglyceride and LDL-C in Tai 
Chi group decreased slightly, while the mean value of those parameters maintained at the same 
level or slightly increased in waitlist group. The mean HDL-C in Tai Chi group slightly 
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increased from 1.38 (95% CI: 1.12 to 1.65) mmol/L at baseline to 1.41 (95% CI: 1.12 to 1.70) 
mmol/L at week 12, while in the waitlist group it remained at the similar level at 1.31 mmol/L. 
The comparisons of blood lipid profile at baseline, week 12 and 24 between the two groups are 
summarised in Table 5.11. 
Table 5.11 Blood lipid profile at baseline, week 12 and 24 in the Tai Chi and waitlist groups 
 Tai Chi Group  Waitlist Group 
 No. Mean  
(95% CI) 
 No. Mean  
(95% CI) 
TC      
Baseline 60 5.19  
(4.93, 5.45) 
 60 4.71 
(4.45, 4.97) 
Week 12 54 4.98 
(4.71, 5.25) 
 51 4.71 
(4.44, 4.99) 
Week 24 53 4.95 
(4.68, 5.22) 
 49 4.93 
(4.66, 5.21) 
TG      
Baseline 60 1.54 
(1.38, 1.71) 
 60 1.39 
(1.22, 1.55) 
Week 12 54 1.49 
(1.32, 1.66) 
 51 1.40 
(1.22, 1.58) 
Week 24 53 1.47 
(1.29, 1.65) 
 49 1.39 
(1.21, 1.57) 
HDL-C      
Baseline 60 1.38 
(1.12, 1.65) 
 60 1.31 
(1.04, 1.58) 
Week 12 54 1.41 
(1.12, 1.70) 
 51 1.31 
(1.00, 1.61) 
Week 24 53 1.43 
(1.12, 1.73) 
 49 1.67 
(1.36, 1.98) 
LDL-C      
Baseline 60 2.99 
(2.75, 3.23) 
 60 2.75 
(2.51, 2.99) 
Week 12 54 2.89 
(2.64, 3.13) 
 51 2.86 
(2.60, 3.11) 
Week 24 53 2.95 
(2.69, 3.20) 
 49 3.01 
(2.76, 3.27) 
Notes: TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density 






There was no significant difference between the two groups in triglyceride (P=0.752), HDL-C 
(P=0.418) and LDL-C (P=0.073) over 24 weeks, except total cholesterol (P=0.007), estimated 
by a mixed linear model. The residuals of blood lipid profile including TC, TG, HDL-C and 
LDL-C were normally distributed after checking the histogram of residuals. 
In the ITT analysis, we found that there was no significant difference between the two groups 
in total cholesterol (P=0.162), triglyceride (P=0.125), HDL-C (P=0.485) and LDL-C (P=0.495) 
over 24 weeks. 
In summary, our results demonstrated that compared with waitlist group, Tai Chi intervention 
had no significant impact on blood lipid profile over 24 weeks. 
 
Fasting Blood Glucose 
Baseline assessment 
The comparisons of fasting blood glucose at baseline between the two groups are presented in 
Table 5.12.  
Table 5.12 Baseline comparisons of fasting blood glucose between the two groups. 





FBG, mean ± SD, mmol/L      5.85±1.19 5.93±0.94 0.689 
Abbreviation: FBG, fasting blood glucose; SD: standard deviation. 
 
The fasting blood glucose was comparable between the Tai Chi and waitlist control groups at 
baseline (5.85 ± 1.19 mmol/L in the Tai Chi group compared with 5.93 ± 0.94 mmol/L in the 
waitlist group). There was no significant difference between the two groups in fasting blood 






In this study, fasting blood glucose of participants in the Tai Chi and waitlist control group at 
baseline, week 12 and 24 were summarised in Table 5.13.  
Table 5.13 Fasting blood glucose over 24 weeks in the Tai Chi and waitlist groups 
 Tai Chi Group  Waitlist Group 
 No. Mean  
(95% CI) 
 No. Mean 
(95% CI) 
Baseline 60 5.86 
(5.54, 6.17) 
 60 5.92 
(5.60, 6.24) 
Week 12 54 6.32 
(6.00, 6.65) 
 51 6.16 
(5.83, 6.50) 
Week 24 53 6.37 
(6.03, 6.70) 




As shown in Table 5.13, from the baseline to week 12, the mean value of fasting blood glucose 
increased slightly in both the Tai Chi and waitlist groups. The mean fasting blood glucose in 
Tai Chi group increased from 5.86 (95% CI: 5.54 to 6.17) mmol/L at baseline to 6.32 (95% CI: 
6.00 to 6.65) mmol/L at week 12, and in waitlist group increased from 5.92 (95% CI: 5.60 to 
6.24) mmol/L at baseline to 6.16 (95% CI: 5.83 to 6.50) mmol/L at week 12. 
 
Week 24 
There was no significant difference between the Tai Chi and waitlist control group in fasting 
blood glucose over 24 weeks (P=0.182). The residuals of FBG data were normally distributed 
after checking the histogram of residuals. 
In the ITT analysis, we found that there was no significant between-group difference in fasting 
blood glucose over 24 weeks (P=0.572).   
By checking for normality of both visually through plots and Shapiro-Wilk test, we found that 
the baseline data of fasting blood glucose did not match normal distribution. After log 




In summary, our above analyses consistently demonstrated that Tai Chi intervention was not 
superior to waitlist group in changing fasting blood glucose over 24 weeks.  
 
C-Reactive Protein (CRP) 
Baseline assessment 
Fifty-six (56/60, 93.3%) participants had a CRP < 4 g/L in Tai Chi group, and 54 (54/60, 90.0%) 
in waitlist group. There was no significant difference in CRP between the Tai Chi and waitlist 
groups at baseline (P=0.509). The comparisons of CRP at baseline between the two groups are 
presented in Table 5.14. 
Table 5.14 Baseline comparisons of C-reactive protein between the two groups. 





C-reactive protein (<4.0)-No. (%) 56(93.3%) 54(90.0%) 0.509 
Abbreviation: SD: standard deviation. 
 
Week 12 
The comparisons of CRP at baseline, 12 and 24 weeks between the two groups were presented 
in Table 5.15.  
Table 5.15 C-reactive protein at baseline, 12 and 24 weeks of Tai Chi and waitlist groups 










Baseline     
    <4 56/60 (93.3) 54/60 (90.0) 
0.64 (0.17, 2.40) 
0.144 
 
    >4 4/60 (6.7) 6/60 (10.0) 
Week 12    
    <4 46/52 (88.5) 45/46 (97.8) 
5.87 (0.68, 50.72) 
    >4 6/52 (11.5) 1/46 (2.2) 
Week 24    
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<4 41/47 (87.2) 43/45 (95.6) 
3.15 (0.60, 16.49) 
    >4 6/47 (12.8) 2/45 (4.4)  
Note: CRP, C-reactive protein. Using generalized linear model with binary logistic model, there was no significant 
difference between the two groups in CRP over 24 weeks (P=0.144). 
 
At week 12, the number of participants in the two groups who had a CRP < 4 mg/L was similar, 
with 46 (46/52, 88.5%) participants in Tai Chi group, and 45 (45/46, 97.8%) in waitlist group.   
Week 24 
At week 24, the number of participants who had a CRP < 4 mg/L in the two groups was similar, 
with 41 (41/47, 87.2%) participants in Tai Chi group, and 43 (43/45, 95.6%) in waitlist group. 
There was no significant difference between the Tai Chi and waitlist groups in CRP over 24 
weeks (P=0.144).  
Similarly, in the ITT analysis, we found that there was no significant between-group difference 
in CRP over 24 weeks.   
In summary, there was no statistically significant difference in CRP between the Tai Chi and 




The comparisons of blood pressure at baseline between the two groups are presented in Table 
5.16.  
Table 5.16 Comparisons of blood pressure at baseline between the two groups. 





Blood pressure, mean ± SD, mmHg         
Systolic 126.03±15.31 124.58±17.16 0.626 
Diastolic 79.55±10.12 76.43±9.98 0.092 
Abbreviation: SD: standard deviation. 
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The mean systolic and diastolic blood pressures in Tai Chi group were both slightly higher than 
that of the waitlist control group at baseline (systolic: 126.03 mmHg vs 124.58 mmHg, 
respectively; diastolic: 79.55 mmHg vs 76.43 mmHg, respectively). However, there were no 
significant differences between the two groups in both systolic and diastolic pressures at 
baseline (P>0.05).  
 
Week 12 
The comparison of systolic and diastolic blood pressures at baseline, week 12 and 24 between 
the two groups are presented in Table 5.17.  
Table 5.17 Blood pressure at baseline, week 12 and 24 in the Tai Chi and waitlist groups 
 Tai Chi Group  Waitlist Group 
Blood Pressure No. Mean  
(95% CI) 
 No. Mean  
(95% CI) 
Systolic       
Baseline 60 126.03 
(122.28, 129.78) 
 60 124.58 
(120.83, 128.33) 
Week 12 54 126.41 
(122.49, 130.32) 
 51 123.74 
(119.66, 127.81) 
Week 24 53 124.79 
(120.84, 128.73) 
 49 124.07 
(119.99, 128.14) 
Diastolic       
Baseline 60 79.55 
(77.10, 82.00) 
 60 76.43 
(73.98, 78.89) 
Week 12 54 79.84 
(77.30, 82.38) 
 51 73.87 
(71.24, 76.49) 
Week 24* 53 76.74 
(74.18, 79.29) 
 49 75.44 
(72.81, 78.06) 
Note: *Using a linear mixed model, there were significant differences between the two groups in diastolic blood 
pressure over 24 weeks (P=0.031). 
 
As shown in Table 5.17, from the baseline to week 12, the mean systolic blood pressure in both 
the Tai Chi and waitlist groups maintained at the similar level, 126.03 (95% CI: 122.28 to 
129.78) mmHg at baseline and 126.41 (95% CI: 122.49 to 130.32) mmHg at week 12 in Tai 
Chi group, and 124.58 (95% CI: 120.83 to 128.33) mmHg at baseline and 123.74 (95% CI: 
119.66 to 127.81) mmHg at week 12 in waitlist group. 
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The mean diastolic blood pressure in Tai Chi group maintained at the similar level over the first 
12 weeks, 79.55 (95% CI: 77.10 to 82.00) mmHg at baseline and 79.84 (95% CI: 77.30 to 82.38) 
mmHg at week 12 in Tai Chi group. In contrast, the mean diastolic blood pressure in the waitlist 
group slightly decreased from 76.43 (95% CI: 73.98 to 78.89) mmHg at baseline to 73.87 (95% 
CI: 71.24 to 76.49) mmHg at week 12.  
There were significant differences between the two groups in diastolic blood pressure over 24 
weeks. At week 12, there were significant difference between the two groups in the mean 
diastolic blood pressure between the two groups (P=0.010), indicating participants in the Tai 
Chi group controlled their diastolic blood pressure in a more stable status.  
In the ITT analysis, similarly, there were no significant differences between the two groups in 
systolic blood pressure, but significant between-group differences were detected in diastolic 
blood pressure (P=0.017).  
 
Week 24 
There were significant differences between the two groups in diastolic blood pressure over 24 
weeks (P=0.031), while no significant between-group differences were found in systolic blood 
pressure. The residuals of systolic and diastolic blood pressure data were normally distributed 
after checking the histogram of residuals. 
As shown in Figure 5.4, the mean diastolic blood pressure in the Tai Chi group at baseline, 
week 12 and week 24 were all higher than that of the waitlist control group. However, over the 
24 weeks, the mean diastolic blood pressure in the Tai Chi group exhibited a downward trend, 




Figure 5.4 Diastolic pressure at baseline, week 12 and 24 of the Tai Chi and waitlist group. Error bar 
indicate 95% confidence intervals (CI). 
We found significant between-group differences at 12 weeks (P=0.010), but no significant 
difference between the two groups at week 24 (P=0.910).  
In the ITT analysis, there were significant differences in mean diastolic blood pressure between 
the two groups over 24 weeks (P=0.035). Similarly, using ITT sample, significant differences 
between the two groups in mean diastolic blood pressure were identified at week 12 (P=0.017) 
but not week 24 (P=0.837).  
In summary, our above analyses demonstrated that there was no significant difference between 
the two groups in systolic blood pressure but in diastolic blood pressure at 12 weeks and over 
24 weeks, indicating that Tai Chi intervention results in a more stable control of blood pressure 




The comparisons of heart rate at baseline between the two groups are presented in Table 5.18. 
The mean heart rate in Tai Chi group was slightly higher than that in waitlist group (70.30 vs 
68.97 BPM). However, this difference did not reach statistical significance (P>0.05). 
 
Baseline Week 12 Week 24
Tai Chi 79.55 79.84 76.74





































Table 5.18 Baseline comparisons of heart rate between the two groups. 





Heart rate, mean ± SD, BPM      70.30±10.26 68.97±10.49 0.483 
Abbreviation: SD: BPM, beats per minute. 
 
Week 12 
From the baseline to week 12, the mean beats of heart rate in Tai Chi group slightly decreased 
from 70.30 (95% CI: 67.84 to 72.76) BPM at baseline to 69.39 (95% CI: 66.85 to 71.94) BPM 
at week 12. In contrast, in the waitlist group it maintained at the similar level, from 68.97 (95% 
CI: 66.50 to 71.43) BPM at baseline to 68.52 (95% CI: 65.90 to 71.13) BPM at week 12. The 
comparisons of heart rate at baseline, 12 and 24 weeks between the two groups are shown in 
Table 5.19.  
Table 5.19 Heart rate at baseline, week 12 and 24 weeks in the Tai Chi and waitlist groups 
 Tai Chi Group  Waitlist Group 
 No. Mean 
(95% CI) 
 No. Mean 
(95% CI) 
Baseline 60 70.30 
(67.84, 72.76) 
 60 68.97 
(66.50, 71.43) 
Week 12 54 69.39 
(66.85, 71.94) 
 51 68.52 
(65.90, 71.13) 
Week 24 53 69.18 
(66.63, 71.74) 




There were no significant differences in heart rate between the two groups over week 24 
(P=0.957). As shown in Table 4.20, although there were slight decreases in both groups at 24 
weeks, the mean beats of heart rate per minute in both groups maintained around the similar 
level. The residuals of heart rate data were normally distributed after checking the histogram of 
residuals. 
In the ITT analysis, there were also no significant between-group differences in heart rate over 
24 weeks (P=0.256). 
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In summary, the analyses demonstrated that there was no significant difference in changing 
heart rate between the Tai Chi and waitlist groups over 24 weeks. Participants in both groups 
experienced a slight decrease in the beats of heart rate per minute.  
 
Heart Rate Variability (HRV) 
Baseline assessment 
There were substantial missing data for the baseline HRV parameters due to recording issues. 
LF norm, HF norm, and LF/HF ratio were recorded in 88 participants (38 in Tai Chi group and 
50 in waitlist group); total power was recorded in 57 participants (27 in Tai Chi group and 30 
in waitlist group); and RMS SD, HRV index, and PNN50 were measured in 87 participants (48 
in Tai Chi group and 39 in the waitlist group).  
The baseline HRV parameters were all comparable between the two groups (P>0.05). Table 
5.20 presents the baseline comparisons of HRV parameters between the two groups. 
Table 5.20 Baseline comparisons of HRV parameters between the two groups. 





HRV*    
    LF norm, mean ± SD, n.u.      55.56±21.47 51.43±20.99 0.367 
    HF norm, mean ± SD, n.u. 44.47±21.48 48.58±20.98 0.371 
    LF/HF ratio, mean ± SD    2.03±2.04 1.69±1.84 0.427 
    TP, mean ± SD, ms2      2202.26±6553.81 1713.23±3760.71 0.728 
    RMS SD, mean ± SD, ms     35.22±44.15 34.89±41.48 0.972 
    HRV index, mean ± SD      6.85±4.22 7.89±4.18 0.253 
    PNN50, mean ± SD, %      7.59±14.76 8.59±18.38 0.777 
Abbreviation: HRV, heart rate variability; SD: standard deviation; n.u.: normalized unit; ms: millisecond. 
*HRV reflects the modulation of cardiac function by autonomic and other physiological systems. Key parameters 
of HRV include time domain and frequency domain parameters:  
a) LF norm, normalised low frequency-the ratio between absolute value of the low frequency and 
difference between total power and very low frequency;  
b) HF norm, normalised high frequency-the ratio between absolute value of the high frequency and 
difference between total power and very low frequency;  
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c) LF/HF ratio-the ratio of low frequency and high frequency bands, indicating overall balance between 
sympathetic and parasympathetic systems;  
d) TP, total power-a short-term estimate of the total power of power spectral density in the range of 
frequencies between 0 and 0.4 Hz, reflecting overall autonomic activity where sympathetic activity is a 
primary contributor;  
e) RMS SD-the square root of the mean square of successive R-R interval differences;  
f) HRV index, integral of the density of the R-R interval histogram divided by its height;  
g) PNN50, percentage of successive R-R intervals that differ by more than 50 milliseconds 
HRV data at baseline had many missing data for each of the key parameter because of recording issues (LF norm 




The comparisons of HRV parameters between the two groups at baseline, week 12 and 24 are 
summarised in Table 5.21. 




































































































PNN50 Tai Chi 7.412 5.10 6.96 0.244 
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Notes: LF norm, low frequency normalized; HF norm, high frequency normalized; LF/HF ratio, the ratio of low 
frequency and high frequency; RMS SD, root mean square of successive R-R interval differences; HRV index, 
integral of the density of the R-R interval histogram divided by its height; PNN50, percentage of successive R-R 
intervals that differ by more than 50 ms.  
From the baseline to week 12, the mean LF norm in Tai Chi group decreased from 55.09 to 
49.72, and in waitlist group decreased from 51.46 to 49.86. However, the mean HF norm 
increased in both groups over the first 12 weeks, from 44.90 to 50.15 in Tai Chi group, and 
48.52 to 50.14 in waitlist group. Correspondingly, the LF/HF ratio decreased from baseline to 
week 12 slightly.  
For the time domain, the mean RMS SD in Tai Chi group slightly decreased, while in the 
waitlist group slightly increased. The mean HRV index in Tai Chi group had a slight increase, 
whilst in the waitlist group maintained almost in the same level. The mean PNN50 in the Tai 
Chi group decreased from 7.41% at baseline to 5.10% at week 12, while increased from 8.64% 
at baseline to 8.97% at week 12. 
 
Week 24 
As estimated by a mixed linear model, there was no significant difference between the Tai Chi 
group and waitlist group in all HRV parameters at week 24 (P>0.05), including LF norm, HF 
norm, LF/HF ratio, total power, RMS SD, HV index and PNN50 (Table 5.21). The residuals of 
all HRV parameters were normally distributed after checking the histogram of residuals. 
Similarly, in the ITT analysis, consistent findings were identified that no significant between-
group differences in all the HRV parameters over 24 weeks (P>0.05). 
In summary, our analyses demonstrated that Tai Chi group had no more significant changes in 
HRV parameters over 24 weeks compared with waitlist group.  
 
5.1.5.3 Quality of life 
Baseline assessment 
The comparisons of SF-36 scores between the two groups were presented in Table 5.22. SF-36 
was used to measure the quality of life of participants in this study. SF-36 is a generic outcome 
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measure designed to examine self-reported functional health and well-being, including concepts 
of physical functioning, role limitations due to physical problems, social function, bodily pain, 
general mental health, role limitations due to emotional problems, vitality, and general health 
perceptions. Score ranges from 0 to 100 in each of the eight domains, with higher scores 
indicating better health status. 
Table 5.22 Baseline comparison of SF-36 between the Tai Chi and waitlist groups. 





SF-36, mean ± SD, score    
    Physical function 76.22±18.10 84.02±13.25 0.008 
Role limitation (physical problems) 59.58±43.69 77.92±35.08 0.013 
Bodily pain 73.73±20.06 79.43±20.01 0.112 
General health 52.17±20.93 55.11±21.48 0.448 
Vitality 68.33±18.33 72.08±18.90 0.272 
Social functioning 78.67±22.83 81.25±21.48 0.524 
Role limitation (emotional problems) 70.30±33.73 76.52±34.42 0.320 
Mental health 69.33±20.70 72.00±18.86 0.462 
Abbreviation: SF-36, the 36-item Short Form Health Survey Questionnaire; SD: standard deviation. 
 
At baseline, there was no significant difference between the two groups in six domains of SF-
36 (Score ranges from 0 to 100 in each of the eight domains, with higher scores indicating better 
health status) (P>0.05), except two domains (i.e. physical function and role limitation due to 
physical problems). The mean scores of the physical function and role limitation (physical 
problems) domains in the Tai Chi group was significantly lower than that of the waitlist control 
group (P=0.008 and P=0.013, respectively). 
 
Week 12 
From the baseline to week 12, the mean scores of all domains of SF-36 in Tai Chi groups had 
an obvious increase, while the mean scores of most domains of SF-36 in the waitlist group had 
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a decrease except general health, vitality, social functioning and mental health domains, which 
had a slight increase over the first 12 weeks. 
Table 5.23 shows the quality of life as measured by SF-36 at baseline, 12 and 24 weeks in the 
two groups.  













































































































































Notes: SF-36, the 36-item Short Form Health Survey. #As estimated by a mixed linear model, there were 
significant differences at 24 weeks between the two groups in following four domains of SF-36 scores: physical 
function (P=0.016), role limitation (physical problems) (P<0.001), bodily pain (P=0.015) and vitality (P=0.003), 
favouring the Tai Chi group.   
 
Significant between-group differences were detected in the following four domains of SF-36 
scores: physical function, role limitation (physical problems), bodily pain and vitality. For these 
four domains, there was no significant between-group difference in mean scores of the physical 
function and bodily pain domains at week 12 (P=0.305, P=0.093, respectively), while 
significant between-group differences were detected in the mean scores of the role limitation 
due to physical problems and vitality domains (P=0.004 and P=0.004, respectively), favouring 
the Tai Chi group.  
In the ITT analysis, similar findings were identified. There was no significant difference 
between the two groups in mean scores of the physical function and bodily pain domains at 
week 12 (P=0.341, P=0.206, respectively); however, the mean scores of the role limitation 
(physical problems) and vitality domains in the Tai Chi group were significant higher than that 
in the waitlist control group (P=0.018 and P=0.005, respectively). 
 
Week 24 
There were significant differences at 24 weeks between the two groups in following four 
domains of SF-36 scores: physical function (P=0.016), role limitation (physical problems) 
(P<0.001), bodily pain (P=0.015) and vitality (P=0.003), favouring the Tai Chi group. No 
significant difference was observed in other domains of SF-36 scores (P>0.05). The four 
domains of SF-36 were all related to physical health. The residuals of all the domains of SF-36 
scores were normally distributed after checking the histogram of residuals. 
The changes of mean scores (95% CI) of the four mentioned domains of SF-36 are presented 








Baseline Week 12 Week 24
Tai Chi 76.22 79.98 78.66




















A. Physical function domain of SF-36
Baseline Week 12 Week 24
Tai Chi 59.58 75.51 67.76






















B. Role limitation (physical problems) domain of SF-36
Baseline Week 12 Week 24
Tai Chi 73.73 79.66 79.5





























Figure 5.5 Four domains of SF-36 scores at baseline, week 12 and 24 in the Tai Chi and Waitlist group. 
Error bars indicate 95% confidence intervals (CI). Using a mixed linear model, there were significant 
differences at 24 weeks between the two groups in following four domains of SF-36 scores: physical 
function (P=0.016), role limitation (physical problems) (P<0.001), bodily pain (P=0.015) and vitality 
(P=0.003).  
There is a markedly increase in physical function (Figure 5.5A), role limitation (physical 
problems) (Figure 5.5B), and bodily pain domains (Figure 5.5C) in the Tai Chi group over the 
first 12 weeks, and then a slight decrease from during week 12 and 24; while the mean scores 
of the three domains in the waitlist group experienced continuous decreases over 24 weeks.   
While the mean scores of the vitality domain of SF-36 increased continuously in both groups 
over 24 weeks, the change was sharper in Tai Chi group. As shown in Figure 5.5D, compared 
with the waitlist group, the mean vitality scores in the Tai Chi group markedly increased from 
68.33 at baseline to 79.31 at week 12, and continued the increase to 80.26 scores at week 24. 
In the waitlist group, the mean scores slightly increased from 72.08 at baseline to 72.90 at week 
12, and 75.57 scores at week 24.  
For the four domains which showed significant between-group differences over 24 weeks, only 
the mean scores of vitality in the Tai Chi group was superior to the waitlist group  at week 24 
(P=0.018). There was no significant difference between the two groups was identified at week 
24 in other three domains: the physical function domain (P=0.255), role limitation (physical 
problems) (P=0.074) and bodily pain (P=0.050). 
Baseline Week 12 Week 24
Tai Chi 68.33 79.31 80.26






















D. Vitality domain of SF-36
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In the ITT analysis, our findings were similar.  We found that the mean scores of the above four 
domains of SF-36 in the Tai Chi group were superior to that of the waitlist group over 24 weeks, 
as estimated with a linear mixed model. There were significant between-group differences over 
24 weeks in physical function (P=0.028), role limitation (physical problems) (P=0.001), and 
vitality (P=0.003), except the bodily pain domain (P=0.054). For the four domains, there was 
no significant difference between two groups both at week 12 and 24 in physical function 
(P=0.341 and P=0.309, respectively) and bodily pain domains (P=0.206 and P=0.167, 
respectively); significant differences in role limitation (physical problems) were identified at 
week 12 (P=0.018) but not week 24 (P=0.188); while significant between-group differences 
were identified in vitality at week 12 (P=0.005) and 24 (P=0.022), favouring Tai Chi group.  
In summary, our findings demonstrated that there were significant differences between the Tai 
Chi and waitlist groups in the physical function, role limitation (physical problems), bodily pain 
and vitality domains of SF-36 over 24 weeks, indicating the beneficial effects of Tai Chi 
intervention in improving quality of life in people with CHD and/or hypertension.  
 
5.1.5.4 Physical fitness 
Baseline assessment 
6MWT measures the distance (in meter) covered during the 6-minute walk as an objective 
assessment of physical fitness, with higher scores indicating better fitness. The comparisons of 
6MWT at baseline between the two groups were presented in Table 5.24. 
Table 5.24 Baseline comparison of 6MWT between the Tai Chi and waitlist groups. 





6MWT, mean ± SD, meter 494.77±79.61 518.83±94.01 0.133 
Abbreviation: 6MWT: the 6-Minute Walk Test; SD: standard deviation. 
 
The mean distance during the 6-minute walk in the Tai Chi group was lower than that of the 
waitlist control group, 494.77±79.61 meters in the Tai Chi group and 518.83±94.01 meters in 




The physical fitness as measured by 6MWT at baseline, 12 weeks and 24 weeks in the two 
groups was shown in Table 5.25. 
Table 5.25 Physical fitness measured by 6MWT from baseline to 12 weeks and 24 weeks in the Tai Chi 
and waitlist groups. 







Baseline 60 494.77 
(470.82, 518.71) 
 60 518.83 
(494.88, 542.77) 
Week 12 54 558.41 
(533.48, 583.34) 
 51 513.59 
(488.59, 538.58) 
Week 24* 53 552.81 
(528.17, 577.44) 
 49 519.63 
(494.42, 544.84) 
Notes: 6MWT, 6 Minute Walk Test. The 6-minute walking test measures the distance (in meter) covered during 
the 6-minute walk as an objective assessment of physical fitness, with higher scores indicating better fitness. 
*Using a linear mixed model, there was a significant difference between the Tai Chi and waitlist groups in the 
mean walking distance during the 6-minute walk over week 24 (P<0.001), favouring the Tai Chi group.  
 
Participants in the Tai Chi group had obvious improvements in their physical fitness from 
baseline to 12 weeks. The mean value of the walking distance changed from 494.77 (95% CI: 
470.82 to 518.71) meters at baseline to 558.41 (95% CI: 533.48 to 583.34) meters at 12 weeks. 
In contrast, the mean distance during the 6-minute walking in the waitlist group slightly 
decreased from 518.83 (95% CI: 494.88 to 542.77) meters at baseline to 513.59 (95% CI: 
488.59 to 538.58) meters at 12 weeks. Significant differences were detected between the two 
groups in 6MWT distance at week 12 (P<0.001), favouring the Tai Chi group.  
In the ITT analysis with all participants originally randomised and assuming no improvements 
for missing data, similarly, the mean walking distance during the 6-minute walk in Tai Chi 
group was significantly higher than that of the waitlist control group at week 12 (P<0.001). 
Week 24 
As shown in Table 5.25, there was a significant difference between the Tai Chi and waitlist 
groups in the mean walking distance during the 6-minute walk over week 24 (P<0.001), 
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favouring the Tai Chi group. The residuals of 6MWT data were normally distributed after 
checking the histogram of residuals. Figure 5.6 presents the 6MWT at baseline, 12 weeks and 
24 weeks of the Tai Chi and waitlist groups. 
 
 
Figure 5.6 Walking distance during 6-minute walk at baseline, week 12 and 24 of the Tai Chi and 
waitlist group. Error bar indicate 95% confidence intervals (CI). 
 
As shown in Figure 5.6, the mean distance during the 6-minute walk in the Tai Chi group 
experienced a dramatically increase over the first 12 weeks and then a slight decrease in the rest 
of the program. The mean distance of 6MWT increased from 494.77 (95% CI: 470.82 to 518.71) 
meters at baseline to 558.41 (95% CI: 533.48 to 583.34) meters at 12 weeks in Tai Chi group, 
and slightly decreased from 12 weeks to 552.81 (95% CI: 528.17 to 577.44) meters at 24 weeks. 
In contrast, the mean distance of 6MWT of participants in the waitlist group almost maintained 
at the similar level over 24 weeks. The mean distance slightly decreased from 518.83 (95% CI: 
494.88 to 542.77) meters at baseline to 513.59 (95% CI: 488.59 to 538.58) meters at 12 weeks, 
and then increased from 12 weeks to 519.63 (95% CI: 494.42 to 544.84) meters at 24 weeks.  
We found that there were significant differences between the two groups in the mean walking 
distance of 6MWT at week 12 (P<0.001, partial η2=0.214) and week 24 (P=0.002, partial 
η2=0.096), favouring the Tai Chi group. The Cohen’s 𝑑 at week 24 was 0.38. 
Baseline Week 12 Week 24
Tai Chi 494.77 558.41 552.81


































Subgroup analyses for participants with hypertension demonstrated that using a linear mixed 
model, the Tai Chi intervention significantly increased the mean walking distance within the 6-
minute walk over 24 weeks, compared with waitlist group (P<0.001). Significant differences 
between the two groups were both detected at week 12 (P<0.001) and week 24 (P=0.002), 
favouring the Tai Chi group. 
In the ITT analysis including all participants originally randomised and assuming no 
improvements for missing data, similarly, there were significant differences between the two 
groups in the mean walking distance within the 6-minute walk over 24 weeks (P<0.001). 
Significant between-group differences were also identified at week 12 (P<0.001) and week 24 
(P=0.001), favouring the Tai Chi group. 
In summary, our above analyses consistently demonstrated that participants in the Tai Chi group 
experienced much more significant improvements of 6MWT distance than that of the waitlist 
group, indicating the beneficial effects of Tai Chi intervention in improving physical fitness.  
 
5.1.6 Safety Outcomes 
In this study, participants reported ten adverse events: eight in the Tai Chi group and two in the 
waitlist control group (see Table 5.26).  
Table 5.26 Adverse events summary 
Adverse Events Tai Chi Group Waitlist Group 
 Week 0-12 Week 13-24 Week 0-12 Week 13-24 
Minor muscle soreness 3 0 0 0 
Knee pains 2 0 0 0 
Cancer  0 0 2* 0 
Tiny fracture of rib bone 1 0 0 0 
Ankle sprain 0 1 0 0 
Bradycardia 0 1* 0 0 
Subtotal 6 2 2 0 
Total 8 2 
*Severe adverse events. 
Five adverse events were related to the Tai Chi intervention. These include three minor muscle 
soreness and two knee pains which were reported in the Tai Chi group during the first 4 weeks 
of intervention. The symptoms of all participants affected disappeared after the correction of 
the wrong postures by the Tai Chi instructor.  
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Two adverse events were not related to the Tai Chi intervention. One participant (No. 204) aged 
67 years old in the Tai Chi group experienced ankle sprain after one Tai Chi class on his way 
home. The participant returned to the Tai Chi class after one week of rest, and completed the 
study. Another participant (No. 229) with CHD aged 76 years old whose medical investigation 
revealed a tiny fracture of a rib bone at week 12. The reason of the fracture is unclear, and the 
participant reported that it might be related to his regular self-massage with a tapping tool at 
home. 
Three serious adverse events were reported, but none of these were related to the Tai Chi 
intervention. These included two cases of cancer in the waitlist control group, one case of 
bradycardia (HR <40 BPM) in the Tai Chi group, and one case of a tiny fracture of a rib bone 
in the Tai Chi group. A participant in the Tai Chi group (No. 239), aged 77 years, experienced 
bradycardia after one of his regular swims in winter. This led to a pace-maker installation 
surgery at week 14, and a second surgery at week 20 to control the infection caused by the first 
surgery. The reason for the bradycardia remains unclear and the participant reported that it 
might be associated with his winter swimming. These three participants withdrew from the 
study as a result of adverse events.  
 
5.1.7 Compliance 
5.1.7.1 Class Attendance 
Participants in the Tai Chi group were provided with 36 group classes with 72 hours in total 
over 24 weeks, consisting of 24 classes in the first 12 weeks (2 hours per session, two times per 
week) and 12 classes in the rest of the program (2 hours per session, one time per week).  
The attendance rate of the 53 participants in the Tai Chi group who completed the study was 
82.5% (1575/1908 sessions, n=53) over the 24-week Tai Chi program, with 83.5% (1113/1332 
sessions, n=37) in Beijing recruitment centre and 80.2% (462/576 sessions, n=16) in Sydney 
recruitment centre. Missed sessions were typically attributable to time conflict, such as doctor’s 
visit and family responsibility, based on the records of class attendance and patient diaries. 




Figure 5.7 Class attendance rate of participants in the Tai Chi group who completed the 24-week Tai 
Chi program. A total of 53 participants completed the 24-week Tai Chi program (36 sessions with 72 
hours in total).  
 
5.1.7.2 Home Practice 
Participants in the Tai Chi group were required to practice at least three other days outside of 
Tai Chi group classes at home each week. According to the weekly diaries of by the 53 
participants in the Tai Chi group who completed the study, the average frequency of home 
practice was 3.98 days per week, varying from 0 to 7 days per week. Six (6/53, 11.3%) 
participants in Tai Chi group who completed the study reported that they did not practice at 
home at all or practiced less than three days per week over 24 weeks.  
The Tai Chi program in our study consisted of warm-up exercises including walking lunges, 
13-form thumping techniques, meditation, standing posture, and the 13-form modified Chen-
style Tai Chi. Of the 53 participants in Tai Chi group who completed the 24-week program, 
90.6% (48/53) of participants in Tai Chi group practiced the 13-form modified Chen-style Tai 
Chi in their home practice, while walking lunges, 13-form tapping exercise, meditation, and 
standing postures were practiced by 66.7% (36/53), 60.4% (32/53), 62.3% (33/53) and 41.5% 
(22/53) participants, respectively. The home practice rate for each component of the Tai Chi 
program of the 53 participants in Tai Chi group who completed the program over 24 weeks is 
presented in Figure 5.8.  
82.5%
17.5%
Attendance Rate of Tai Chi Class




Figure 5.8 Home practice rate of each component of the Tai Chi program over 24 weeks. Of 53 
participants in the Tai Chi group completed the 24-week randomised controlled trial, 90.6% practiced 
the 13-form modified Chen-style Tai Chi, 66.7% walking lunges, 60.4% 13-form thumping techniques, 
62.3% meditation, and 41.5% standing posture in home practice. 
 
5.2 Discussion 
In this section, the main results are summarised, followed by an interpretation of these findings 
and comparisons with similar studies. The trial limitations and generalisability of the trial 
findings are presented in Chapter 7 General Discussion and Conclusion. 
In this study, both English and Chinese versions of questionnaires were used for measuring 
stress, anxiety, depression and quality of life. We considered the cross-cultural equivalence was 
ensured because the high internal consistence, reliability and validity of both English and 
Chinese versions of questionnaires in the target population were both reported. In addition, the 
participants were all Chinese or Chinese-Australian and the majority of them completed the 
Chinese version of questionnaires. 
5.2.1 Primary outcome measure: PSS-10 
In the present study, we detected a statistically significant difference between the Tai Chi and 
waitlist groups in PSS-10 using a linear mixed model. Currently, there is no consensus on the 
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minimal clinically important change of the Danish version of PSS-10 were 11 points among 
participants with work-related stress complaints (Eskildsen et al., 2015). In the current study, 
the mean difference of PSS-10 at week 24 was only 1.27 points. Similarly, the Cohen’s 𝑑 at 
week 24 was 0.21, which was considered as a ‘small’ effect size (Cohen, 1988).  All these 
appear to suggest that the change of PSS-10 in the present study is of little clinical significance.  
The PSS-10 score ranges from 0 to 40, with higher scores indicating more perceived stress. 
Since the PSS-10 is not a diagnostic tool, cut-off ranges for high and low levels of stress do not 
apply. Previous literature suggests that an individual who experiences a marked level of stress 
is identified as PSS-10 score >20 (D. Y. Leung et al., 2010). However, in the current study, the 
baseline PSS-10 scores in the Tai Chi and waitlist groups were 12.73±6.08 scores and 
11.55±6.18 scores, respectively. Accordingly, this lower PSS-10 score at baseline suggested 
that our participants did not experience a marked level of stress at baseline, which may limit 
the space for improvement in the current study.  
The findings are similar to results of a previous RCT (Robins et al., 2016). Robins et al. (2016) 
found “marginally significant” (P=0.061) differences in decreasing the perceived stress as 
measured by PSS-10 at two months following the 8-week Tai Chi intervention between the Tai 
Chi and waitlist control groups, favouring the Tai Chi group. The baseline level of PSS-10 score 
in the latter study was also lower than 20. 
Of interest in our study, improvements in PSS-10 were more marked during the first 12 weeks 
compared to the subsequent 12 weeks where classes were reduced to once per week. The 
possible explanation is ‘dose-response relationship’ of Tai Chi and its effectiveness. The 
reduced intensity of Tai Chi intervention during the second 12 weeks may have reduced benefits 
for stress release. In contrast, Wang et al. (2018) found no significant increase in benefits for 
groups who received Tai Chi twice weekly compared with once weekly at 24 weeks in their 
recent RCT involving 226 adults with fibromyalgia (C. Wang et al., 2018). This study was 
designed to test whether the effectiveness of Tai Chi depends on its dosage or duration (C. 
Wang et al., 2018). Participants were randomly assigned to either supervised aerobic exercise 
(24 weeks, twice weekly) or one of four classic Yang style supervised Tai Chi interventions (12 
or 24 weeks, once or twice weekly). Salmoirago-Blotcher et al. (2017) also reported that 
increasing class frequency (twice versus three sessions/week) did not affect aerobic fitness after 
12 weeks of Tai Chi training in people with CHD (Salmoirago-Blotcher et al., 2017). More 
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rigorously designed research is needed to explore the ‘dose-response relationship’ of Tai Chi 
interventions.  
In addition, the effects of Tai Chi may have plateaued by the end of the first 12 weeks. ‘Plateau 
effect’ is a force of nature that lessens the effectiveness of once effective measures over time. 
In the current study, we found that there were statistically significant differences between the 
Tai Chi and waitlist groups at week 12, but no further between-group differences were detected 
at week 24. In contrast to our findings, Wang et al. (2018) found that participants with 
fibromyalgia who practised Tai Chi for a longer duration (24 weeks) experienced better 
improvements in the primary outcome, as measured with the revised fibromyalgia impact 
questionnaire (FIQR) scores, than those who practised for a shorter duration (12 weeks) (C. 
Wang et al., 2018). More rigorously designed research is needed to explore the plateau effects 
of Tai Chi and its effectiveness.  
The underlying mechanism on how Tai Chi works for stress remains largely unclear. Previous 
literature suggested that Tai Chi-induced stress reduction may be associated with a lower level 
of cortisol (Lai, Liu, Lin, Tsai, & Chien, 2017).  In addition, it has been reported that Tai Chi 
could enhance parasympathetic/vagal modulation (Lu & Kuo, 2014; Vaananen et al., 2002; Yeh, 
Wayne, & Phillips, 2008) and decrease the sympathetic modulation (Kalsaria et al., 2012; Lu 
& Kuo, 2003, 2006; Motivala et al., 2006), although this does not receive support from the 
results of heart rate variability in the current study (see Sections 5.1.5.2). 
 
5.2.2 Secondary outcome measures 
5.2.2.1 Psychological status 
Anxiety 
In the current study, the Tai Chi and waitlist control groups were balanced in anxiety levels as 
measured by SAS scores at baseline. Participants in the Tai Chi group demonstrated a greater 
decrease in anxiety as measured by SAS at 12 and 24 weeks. 
Our findings are consistent with that of previous studies. One study conducted in Taiwan 
involving 76 people with high-normal or stage I hypertension demonstrated that the Tai Chi 
group had significantly lower levels of state and trait anxiety at week 12 as measured with the 
State and Trait Anxiety Inventory (STAI), compared with the baseline (Tsai et al., 2003). 
However, Tsai et al. (2003) did not report the comparison between Tai Chi group and the 
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sedentary life control group after intervention. More recently, a 3-arm RCT involving 50 
healthy but stressed participant was conducted to determine the effects of 12-weeks of Tai Chi 
practice on anxiety as measured by STAI (S. Zheng et al., 2018). Similarly, this study 
demonstrated significant improvements in state and trait anxiety from baseline for both Tai Chi 
and exercise groups (P<0.01) at week 6 and 12, while the waitlist group had no significant 
changes; the Tai Chi group was superior to the waitlist group in improving state and trait anxiety 
(P<0.01).   
Two other studies conducted in mainland China also used SAS to measure anxiety outcome (H. 
Song, 2013; F. Sun & Sun, 2014). Song (2013) investigated the effects of a 12-week Tai Chi 
program on anxiety, depression, QoL, and glucose metabolism outcomes in 40 Chinese 
participants with impaired glucose metabolism (H. Song, 2013). Song (2013) found that Tai 
Chi program plus health education group was superior to the health education alone group in 
decreasing SAS scores at week 12 (H. Song, 2013). The mean SAS scores of the intervention 
and the control groups decreased 14.58 and 8.9 scores from baseline to week 12, respectively 
(H. Song, 2013). Similarly, Sun and Sun (2014) involving 90 participants with primary 
hypertension found that compared with the health education group, the Tai Chi group had better 
SAS reduction scores at week 8 (P<0.01) (F. Sun & Sun, 2014). Sun and Sun (2014) found the 
mean SAS scores of the Tai Chi group and the health education group decreased 4.79 and 0.67 
from baseline to week 8, respectively (F. Sun & Sun, 2014).   
The lack of replication of these findings in the current study could be due to two reasons. First, 
the characteristics of participants were different. Song (2013) investigated a clinical population 
with impaired glucose metabolism and a higher baseline SAS scores (55.09+11.25 and 
54.13+11.69 in the intervention and the control group) (H. Song, 2013), while Sun and Sun 
(2014) investigated participants with primary hypertension and a lower baseline SAS scores 
(33.58+6.37 and 35.67+5.43, in Tai Chi and health education groups, respectively), compared 
with participants with CHD and/or hypertension in our study (45.25+8.83 and 45.20+9.61, in 
the Tai Chi and waitlist groups, respectively) (F. Sun & Sun, 2014). Second, the samples of the 
previous studies were smaller than that of our study, in which the estimate of the magnitude of 






In the present study, participants in the Tai Chi group experienced a slightly higher depression 
level than that of the waitlist control group at baseline, but this was not statistically significant. 
At week 12, the Tai Chi group showed a marked decrease in depression as measured by the 
BDI-II score while the waitlist group maintained at the original level. At week 24, there was a 
slight increase of BDI-II scores in both groups, but the BDI-II scores of the Tai Chi group 
continued to be lower. There were significant differences between the two groups at 12 and 24 
weeks, in the favour of the Tai Chi group.  
The current findings support the finding in Robins et al.’s study (Robins et al., 2016). Robins 
et al. (2016) used the Center for Epidemiological Studies-Depression (CES-D) (scale from 0-
60, with high scores indicating greater depressive symptoms) to measure the effects of Tai Chi 
on depression in 96 women with increased cardiovascular risks (Robins et al., 2016). 
Participants who randomly received an 8-week Tai Chi program had a significantly lower level 
of depression at 16 weeks compared to participants in the waitlist group (P=0.001). As 
identified earlier, the two studies shared some similarities, including study design (i.e. 
prospective RCT), comparison (i.e. Tai Chi group versus waitlist control), major statistical 
analysis method (i.e. a mixed linear model), Tai Chi intervention (i.e. instructor-led group 
classes plus encouraged home practice) and subject population (i.e. participants with CVD 
risks). 
Our findings are also consistent with results of two other studies (H. Song, 2013; E. Zhang, 
2014) conducted in China using the Zung Self-Rating Depression Sale (SDS) (scale from 20-
80) to assess depression. These studies found significant between-group differences. However, 
Sun and Sun (2014) found no significant differences between the Tai Chi and health education 
groups in reducing depression measured by SDS at week 8 in participants with hypertension (F. 
Sun & Sun, 2014). The inconsistency could be due to the differences in measurements and time-
points for measuring depression. In addition, this study was underpowered due to the small 
sample size.  
The underlying mechanism of Tai Chi for depression remains unclear. Previous literature 
suggested that it may be related to the link between inflammation and depression. Inflammation 
could produce depression in vulnerable individuals by lowering plasma tryptophan and 
diminishing brain serotonin activity, and low serotonin function may compromise mechanisms 
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involved in maintaining recovery from depression (Cowen & Browning, 2015). A Korean RCT 
suggested that alteration of blood serotonin level might be involved in the mechanism behind 
Tai Chi-induced depression management (Oh & Kim, 2016). Another study also reported Tai 
Chi could reduce inflammatory markers and CRP in older adults with major depression 
(Lavretsky et al., 2011). 
 
5.2.2.2 Cardiovascular function 
Blood Lipid Profile 
We tested the total cholesterol, triglyceride, HDL-C, LDL-C of all participants at baseline, 12 
and 24 weeks. At baseline, the two groups were balanced regarding the mean triglyceride, HDL-
C and LDL-C values, but the mean total cholesterol was higher in the Tai Chi group than that 
of the waitlist group; the difference was statistically significant. At week 12, the Tai Chi group 
had a slight decrease in the level of total cholesterol, triglyceride and LDL-C, while the waitlist 
group maintained the same level or had a slight increase in these blood lipid parameters. The 
level of HDL-C showed a slight increase in the Tai Chi group, while it remained at a similar 
level in the waitlist group. No significant between-group differences in the blood lipid profile 
were found at week 24.  
Previous literature has assessed the potential benefits of Tai Chi for blood lipid profile in people 
with CHD, diabetes, overweight and obesity. Our findings are consistent with the results 
published in majority of previous studies. One RCT involving 53 patients with type 2 diabetes 
found that although there was a significant within-group difference for total cholesterol in the 
Tai Chi group, there was no significant between-group difference at week 24 (Lam et al., 2008). 
Similarly, a 3-arm RCT involving 374 middle-aged adults (<40% with overweight or obesity) 
found the Tai Chi group had no statistical improvement in blood lipid profile, compared with 
no treatment (Hui, Xie, Woo, & Kwok, 2015). 
In contrast, one previous study involving 60 patients with CHD found that Tai Chi combined 
with standard care was superior to standard care alone in improving total cholesterol, 
triglyceride, LDL-C and HDL-C at 12 weeks (F. Chen & Lv, 2013). Considering these 
inconsistent findings, more studies are needed to confirm the effects of Tai Chi on blood lipid 
profiles.   
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Fasting Blood Glucose (FBG) 
In the present study, participants in the Tai Chi and waitlist groups at baseline had similar FBG 
levels and were in the normal range. At week 12, the level of fasting blood glucose in both 
groups increased slightly but still in the normal range. At week 24, there was no significant 
between-group difference in fasting blood glucose. The lower FBG at baseline may have limited 
the space for improvement in the study.  
Similar findings have been reported in previous literature. Robins et al. (2016) also found no 
significant difference in changing FBG between the Tai Chi and waitlist groups at 8 and 16 
weeks in their RCT involving 96 women with cardiovascular risks aged 35 to 50 years (Robins 
et al., 2016). Similarly, the FBG of Tai Chi and waitlist groups at baseline was also in the 
normal range. Another RCT involving 300 Chinese adults aged 45-80 years with diagnosed 
hypertension also showed no significant difference in lowering FBG between the Tai Chi and 
the control groups (participants who attended non-exercise-related activities such as reading 
and learning computer software applications) at 12 months (J. Sun & Buys, 2015). The FBG of 
both groups at baseline was also in the normal range.  
In contrast, potential benefits of Tai Chi on FBG have been reported in a non-randomised 
controlled trials with a small sample (n=39) of people with diagnosed type 2 diabetes (Ahn & 
Song, 2012). This study found that a standardized 12-week Tai Chi significantly improved FBG 
and HbA1c. Considering the inconsistent findings in literature, more rigorously-designed 
research is needed to explore the benefits of Tai Chi on FBG.  
 
C-Reactive Protein (CRP) 
In the present study, there was no significant difference in CRP levels between the Tai Chi and 
waitlist groups at baseline assessments. At 24 weeks, there was no significant difference in CRP 
levels between the two groups. CRP data in this present study were categorized into less than 
4.0 and equal to or more than 4.0 mg/L, because the pathology results from Beijing and Sydney 
Pathology Laboratories were reported based on different value ranges. According to the 
Australian Bureau of Statistics, the test reference range for normal CRP levels is <5.0 mg/L, 
while CRP levels >10.0 mg/L are indicative of an acute infection or inflammation (Australian 
Bureau of Statistics, 2014). However, the Centers for Disease Control and Prevention (CDC) 
and the American Heart Association (AHA) recommend: low risk, <1.0 mg/L; average risk, 
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1.0-3.0 mg/L; and high risk, >3.0 mg/L; if the CRP level is >10 mg/L, then the test should be 
repeated and the patient examined for sources of infection or inflammation (G. L. Myers et al., 
2004). Accordingly, CRP levels in the present study were categorized into binary data based on 
the original laboratory reports of CRP levels <4.0 mg/L or >4.0 mg/L.  
 
Our findings are consistent with the results of Robins et al.’s RCT with a similar population 
(Robins et al., 2016). This study involving 96 women with cardiovascular risks demonstrated 
no statistical difference in hsCRP (high-sensitivity assay) level between the Tai Chi group and 
the waitlist group at weeks 8 and 16.  
 
Blood Pressure 
In the current study, the mean systolic and diastolic blood pressures in the Tai Chi group were 
slightly higher than that of the waitlist control group at baseline. However, the differences did 
not reach statistical significance. At week 12, the average systolic and diastolic blood pressures 
in both groups maintained at a similar level. At week 24, there were significant differences in 
diastolic blood pressure but not in systolic blood pressure between the two groups. The average 
systolic and diastolic blood pressure of both groups were in the normal range at baseline, which 
may have limited the space for improvement in the study.  
Similar to our findings, Nery et al. (2015) found that a 12-week Tai Chi program did not change 
systolic and diastolic blood pressure (Nery et al., 2015). One recent 3-arm trial involving 50 
healthy but stressed participants also found no significant between-group differences in blood 
pressure (S. Zheng et al., 2018). Similarly, this cohort had normal blood pressure so a significant 
finding was unlikely.  
Potential benefits of Tai Chi in the management of blood pressure have been previously 
reported. One recent RCT involving 158 older Chinese adults with essential hypertension 
demonstrated a significant decline in blood pressure and body mass index were found in the 
Tai Chi group when compared with the usual care group (C. Ma, Zhou, Tang, & Huang, 2018). 
In comparison with our cohort, although taking antihypertensive agents, the baseline SBP and 
DBP of participants in this study was higher than that of our participants and in Grade I (mild) 
hypertension (systolic: 140-159mmHg and/or diastolic: 90-99 mmHg). This lower blood 
pressure at baseline may impact on the space for improvement in the current study. 
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Another recent RCT involving a sample of 300 Chinese adults aged >45 years and diagnosed 
with hypertension also found significant between-group differences in lowering SBP and DBP 
using the general linear model analysis (J. Sun & Buys, 2015). Compared to baseline, the Tai 
Chi group had a 10-point difference for SBP (from 130.71+16.65 to 120.28+14.63 mmHg) and 
7 points for DBP (82.21+7.94 mmHg to 75.31+14.53 mmHg) at 12 months. In this study the 
Tai Chi group attended group training for a relatively long duration, namely 12 months, 3 hours 
per week, and 2-hour home practice, while the control group attended non-exercise-related 
activities such as reading and learning computer software applications for the same period. In 
contrast, the shorter duration of Tai Chi intervention may be a reason why no change of blood 
pressure was found in the current study.  
The mechanism of Tai Chi for blood pressure remains unclear. Endothelin-1 (ET-1) is a 
powerful vasoconstrictor peptide and regulator of blood flow that plays an important role in 
blood pressure (BP) elevation (Schiffrin, 2001). Previous studies reported that the change in 
ET-1 was significant after 3-month of Tai Chi training in the Tai Chi group (Lu & Kuo, 2013; 
Mao & Sha, 2006). Another study demonstrated that Tai Chi practice significantly increased 
the plasma nitric oxide (NO), carbon monoxide (CO) and hydrogen sulphide (H2S) levels (X. 
Pan et al., 2015) and lowered blood pressure. Correlations were observed in this study between 
he changes of blood pressure and changes in these gaseous signalling molecules. Tai Chi could 
also decrease sympathetic activity (Motivala et al., 2006) and in particular stress-induces 
sympathetic nervous activity (Flaa et al., 2008), indicating another possible mechanism of Tai 
Chi for reducing blood pressure. 
Heart Rate 
In the current study, participants in both groups had similar baseline heart rate, which was in 
normal range. At 24 weeks, the mean beats of heart rate in the Tai Chi and waitlist groups 
experienced a slight decrease. There was no significant difference at week 24 in heart rate 
between the Tai Chi and waitlist control group.  
Our findings are consistent with the results of some previous studies. One recent quasi-
experimental study involving a sample of 110 older sedentary adults with a clinical diagnosis 
of metabolic syndrome showed no significant changes in resting heart rate in the Tai Chi group 
compared with the non-exercise control group at 24 weeks (Mendoza-Núñez, Arista-Ugalde, 
Rosado-Pérez, Ruiz-Ramos, & Santiago-Osorio, 2018). Another study involving 60 patients 
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aged 73.8+6 years with chronic heart failure demonstrated that resting heart rate decreased by 
11.2% in the Tai Chi combined with endurance training group and by 6.8% in the endurance 
training alone group, with no significant between-group difference at 12 weeks (Caminiti et al., 
2011). One 25-week randomised trial involving 32 older adults (Motivala et al., 2006) and 
another 12-week quasi-experimental trial involving 39 Chinese adults aged >45 years with 
cardiovascular risks (Taylor-Piliae, Haskell, & Sivarajan Froelicher, 2006) demonstrated 
similar results. Additionally, one systematic review and meta-analysis found the pooled results 
of six studies (including one randomised controlled, one non-randomised controlled trial, and 
four case series) with 986 healthy participants showed a significant decline in resting heart rate 
(SMD=-0.72, 95% CI -1.27, -0.18, P=0.01, I2=89%) (G. Zheng, Li, et al., 2015). It is 
noteworthy that the population in this systematic review was healthy adults, the heterogeneity 
among the pooled studies was relatively high, and the methodological quality of the included 
studies was limited. Hence, more future research is needed to confirm the effects of Tai Chi for 
resting heart rate.  
The potential reason why no significant changes were found in the current study may be related 
to the lower baseline level. In Wolf et al.’s study, the baseline resting heart rate was 74 (SE: 
1.2) and 73 (SE: 1.2) in the Tai Chi and control groups, respectively (Wolf et al., 2006). In 
contrast, the average resting heart rate at baseline in the present study was around or less than 
70. This may impact the space for improvement in this current study.  
Heart Rate Variability 
In the present study, the HRV parameters were similar at baseline between the Tai Chi and 
waitlist groups. At 12 and 24 weeks, no significant differences in all HRV parameters were 
found between the Tai Chi and waitlist control groups.  
Similar results were observed in three previous longitudinal studies on Tai Chi. No statistically 
significant differences were found in the resting HRV parameters in patients with chronic heart 
failure (Yeh, Wayne, et al., 2008), coronary artery disease (Chang et al., 2008), or CHD (Sato, 
Makita, Uchida, Ishihara, & Masuda, 2010). However, these three studies found the positive 
acute effects on HRV immediately after practice (Chang et al., 2008), possible enhancements 
in parasympathetic modulation (Yeh, Wayne, et al., 2008), and a significant increase in 
baroreflex sensitivity which is an alternative marker of autonomic activity (Sato et al., 2010). 
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Deep breathing has been reported to increase the parasympathetic modulation and enhance the 
vagal modulation (Modesti, Ferrari, Bazzini, & Boddi, 2015). It is well known that deep 
breathing is a component of Tai Chi practice. This may be an underlying mechanism of the 
beneficial effects of Tai Chi on HRV.  
 
5.2.2.3 Quality of life 
At baseline, the two groups in the present study were balanced in quality of life as measured 
with SF-36, except in two domains (i.e. physical function and role limitation due to physical 
problems). The mean scores of the physical function and role limitation due to physical 
problems domains in the Tai Chi group were significantly lower than that of the waitlist control 
group. At week 12, the mean scores of all domains of SF-36 in the Tai Chi group significantly 
increased, while that of the waitlist group slightly decreased except general health, vitality, 
social functioning and mental health domains. At week 24, significant between-group 
differences were detected in the physical function, role limitation due to physical problems, 
bodily pain and vitality domains of SF-36, favouring the Tai Chi group. The increase of mean 
scores was more dramatic at week 12 in which there were two Tai Chi classes per week as 
opposed to only one Tai Chi class per week for the second 12 weeks.  
Our findings support previous literature on Tai Chi for quality of life. The meta-analyses of 
four RCTs (Han et al., 2010; Meng, 2014; X.  Pan, 2016; F. Wu et al., 2010) involving 359 
participants with CVD and/or cardiovascular risks demonstrated that compared with usual care 
alone, a Tai Chi program in combination with usual care significantly improved quality of life 
in all domains of the SF-36, including physical functioning (mean difference [MD]: 5.47, 95% 
CI: 0.66, 10.28, I2=84%), role limitation due to physical health (MD: 11.82, 95% CI: 8.26, 
15.38, I2=32%), role limitation due to emotional health (MD: 8.27, 95% CI: 5.56, 10.98, I2=0%), 
energy/vitality (MD: 7.03, 95% CI: 1.92, 12.14, I2=81%), mental health (MD: 7.86, 95% CI: 
4.29, 11.44, I2=48%), social functioning (MD: 9.81, 95% CI: 5.19, 14.42, I2=68%), bodily pain 
(MD: 6.34, 95% CI: 2.45, 10.23, I2=53%), and general health (MD: 10.04, 95% CI: 7.15, 12.93, 
I2=27%) and the Minnesota Living with Heart Failure Questionnaire (MLHFQ) (scale from 0 
to 105) (MD: -11.10, 95%CI: -15.52, -6.68, I2=73%).  
Similar findings were also observed in a healthy but stressed population. In this 3-arm (Tai Chi, 
exercise and waitlist groups) RCT of 50 healthy but stressed adults (mean age 33.9 years), the 
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Tai Chi group had significant improvements in both the mental health domain (P<0.01) and the 
vitality domain (P<0.01) of SF-36 at weeks 6 and 12; when compared with the waitlist groups, 
Tai Chi was superior in improving mental health domain (P<0.05) (S. Zheng et al., 2018).  
These positive findings are supported by our meta-analyses of five studies (Sang et al., 2015; 
Yao et al., 2010; Yeh et al., 2004; Yeh et al., 2013; S. Zhang & Chen, 2011), which showed a 
significant difference in the MLHFQ total scores in favour of Tai Chi in combination with usual 
care group (MD: -11.10, 95%CI: -15.52, -6.68, I2=73%). Similarly, in the population with heart 
failure, one recent systematic review and meta-analysis involving seven trials found that the 
Tai Chi group had significantly lower scores of the MLHFQ than that of the control group, 
indicating the Tai Chi group had a better quality of life (Ren et al., 2017). Although the QoL 
was measured by a different instrument; it might enhance the strength of evidence that Tai Chi 
is beneficial for improving QoL. 
The mechanism as to how Tai Chi impacts QoL has not yet been well understood. According 
to WHO, QoL is defined as individual’s perception of their position in life in the context of the 
culture and value systems in which they live and in relation to their goals, expectations, 
standards, and concerns (World Health Organization, 2018h). QoL is affected by complex 
factors including physical health, psychological state, independence level, social relationships, 
personal beliefs and their relationship to salient features of the environment (World Health 
Organization, 2018h). In this current study, the physical function, role limitation due to physical 
problems, bodily pain and vitality domains of SF-36 improved significantly in the Tai Chi group 
when compared with the control group. In addition, the perceived stress decreased significantly 
in the Tai Chi group. The decreased stress may be associated with the increased QoL (Achat et 
al., 1998; Colovic, Lecic-Tosevski, Mandic, & Toskovic, 2009). These findings indicate that 
improvements in physical function and vitality (energy), decreases in bodily pain and stress, 
and increases in activity levels and social support may play a role in Tai Chi-related 
improvements in quality of life.  
 
5.2.2.4 Physical fitness 
In the present study, participants in both groups had similar baseline levels of physical fitness. 
The mean distance of the 6-minute walk in the Tai Chi group was lower than that of the waitlist 
group. At week 12, the Tai Chi group experienced significant improvements in the 6MWT 
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compared with that of the waitlist group at week 12. At week 24, the Tai Chi group had 
maintained a similarly high level of physical fitness.  
In the present study, the mean 6MWT distance of participants in the Tai Chi group increased 
63.64 meters from baseline to week 12 and increased 58.04 meters from baseline to week 24; 
while the distance of the waitlist group stayed at a similar level over 24 weeks. The Cohen’s 𝑑 
at week 24 was 0.38, which indicating a ‘small’ effect size. However, a change of 14.0 to 30.5 
meters in the 6MWT is suggested as being a clinically important difference across multiple 
patient groups (Bohannon & Crouch, 2017). Accordingly, our findings in 6MWT are clinically 
meaningful. 
This result is consistent with those of previous studies. Caminiti et al. (2011) found that Tai Chi 
plus endurance training was superior to endurance training alone in improving the 6MWT at 12 
weeks in people with chronic heart failure (Caminiti et al., 2011). One recent meta-analysis 
involving seven trials demonstrated that Tai Chi is associated with a significantly improved 
6MWT in people with heart failure (Ren et al., 2017). These findings indicate that Tai Chi may 
be an alternative option for improving physical fitness.  
Three other RCTs of Tai Chi for physical fitness in people with chronic heart failure, conducted 
by the same research group, reported contradictory results (Yeh et al., 2011; Yeh et al., 2004; 
Yeh et al., 2013). Two RCTs were favourable, but the third failed to detect a significant 
difference between groups. One trial involving 30 patients with chronic heart failure 
demonstrated that patients in Tai Chi in combination with usual care group showed a significant 
increase in the distance walked in 6 minutes (P=0.001) at 12 weeks, compared with the usual 
care, including pharmacologic therapy and dietary and exercise counselling (Yeh et al., 2004). 
Similarly, one trial involving 16 participants with heart failure with preserved ejection fraction 
demonstrated that the 6-minute walk distance in the Tai Chi group significantly increased more 
at 12 weeks (P=0.02), compared with aerobic exercise (Yeh et al., 2013). However, in the third 
study with 100 participants with CHF, no significant between-group difference in 6MWT 
distance was detected at 12 weeks, when compared Tai Chi with a time-matched education 
group (Yeh et al., 2011).  
The underlying mechanism on Tai Chi for physical fitness remains unclear. A meta-analysis 
demonstrated that Tai Chi could significantly impact aerobic capacity expressed as peak oxygen 
uptake (VO2peak) (Taylor-Piliae, 2008; Taylor-Piliae & Froelicher, 2004). Additionally, one 
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recent three-arm RCT involving 374 middle-aged participants found that Tai Chi practice 
consumed a smaller amount of energy metabolism but produced similar health benefits as self-
paced brisk walking, by having higher effects on resting energy expenditure (REE) and 
improving maximal oxygen intake (VO2max) and REE-kilocalorie expenditure (Hui et al., 
2016).  
Another mechanism may be related to the impact on musculoskeletal system. A 16-week Tai 
Chi practice resulted in a 19.9% increase in muscle strength of the knee flexors in old people 
(J. X. Li et al., 2009), indicating the beneficial effects of Tai Chi in improving postural stability 
and proprioception of knee and ankle (J. X. Li et al., 2008). Similar findings have been reported 
in a 48-week, single-blind RCT, which demonstrated that Tai Chi significantly improved the 
physical dimension and ambulation categories (Greenspan et al., 2007). Another study found 
that Tai Chi was superior to resistance training in increasing serum parathyroid hormone and 
reducing the urinary calcium level, indicating that Tai Chi is beneficial for bone metabolism (C. 
L. Shen et al., 2007).  
 
5.2.3 Safety Outcomes 
In the present study, no severe adverse events associated with Tai Chi intervention were 
reported, indicating that Tai Chi appears to be safe in a population with CHD and/or 
hypertension.  
One important and effective strategy used to promote the safe practice of Tai Chi among 
participants in our study was close supervision to avoid incorrect practices in each class 
throughout the study period. In the Tai Chi group, three participants reported minor muscle 
soreness and two reported knee pains within the first four weeks; after correcting the incorrect 
postures/practice by the instructions and under the close supervisions of the Tai Chi instructor, 
these instances of pain disappeared.  
The findings are consistent with that of previous studies. Wayne et al. (2014) systematically 
assessed the frequency and quality of adverse events reported in RCTs on Tai Chi, and only 33% 
of the 153 included RCTs reported adverse events information (Wayne et al., 2014). Tai Chi 
was unlikely to result in serious adverse events, but might be associated with minor 
musculoskeletal aches and pains (Wayne et al., 2014). Similarly, our previous bibliometric 
review involving 507 clinical studies on Tai Chi identified that only 20.7% of the studies 
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reported safety information and of those, 65 (12.8%) studies identified no adverse events during 
the study period, 40 (7.9%) studies reported adverse events not related to the Tai Chi 
intervention, and no serious adverse events were reported (G. Yang et al., 2015).  
5.2.4 Compliance 
5.2.4.1 Class Attendance 
In our study, the overall class attendance rate of the Tai Chi group was 82.5% and the attendance 
was good in both Australia and China. This high attendance rate demonstrates the feasibility of 
the 24-week Tai Chi program for patients with CHD and/or hypertension.  
A high adherence to Tai Chi classes was also reported in previous studies conducted outside of 
China. Taylor-Piliae et al. (2006) found a high adherence (87%+0.18) to a 12-week community-
based Tai Chi class among ethnic Chinese adults aged >45 years old with cardiovascular risk 
factors, living in the San Francisco Bay Area of the USA (Taylor-Piliae, Haskell, & Sivarajan 
Froelicher, 2006). Yeh et al. (2011; 2013) reported a good adherence among patients with 
chronic heart failure in their studies conducted in the USA, with a mean attendance of 75% and 
66.7% in the 12-week Tai Chi and education groups, respectively (Yeh et al., 2011), and with 
a mean attendance of 89% and 88% in the Tai Chi and aerobic exercise groups, respectively 
(Yeh et al., 2013). Our previous comprehensive review involving 507 clinical studies on Tai 
Chi intervention identified that Tai Chi clinical studies have been conducted in 20 countries 
worldwide and have involved a variety of population, indicating the potential wide acceptance 
of Tai Chi (G. Yang et al., 2015).  
The high adherence rate may be an advantage of Tai Chi when compared with CR programs. 
As mentioned before, utilization of CR by people with CHD historically has been poor (Grace 
et al., 2016; Ruano-Ravina et al., 2016). In addition, effective implementation of CR after acute 
coronary syndrome, coronary revascularisation, and heart failure has remained suboptimal, with 
overall participation rates <50% over recent decades despite international recommendations 
(Dalal et al., 2015). This indicates a need for other effective therapeutic options. Tai Chi may 
be better accepted by this cohort. Even for people with CHD declining CR, the retention rate of 
Tai Chi program was 90.0% in a 9-month study (Salmoirago-Blotcher et al., 2017).  
Influential factors to trial participation and adherence to the Tai Chi program from the 
perspectives of our participants were explored by a qualitative sub-study and are reported in 
detail in Chapter 5. We assumed that one possible reason for a relatively high compliance to 
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the Tai Chi program in our study may be related to availability. The majority of participants in 
our study were older adults, with an average age of 65.08±6.38 years in the Tai Chi group and 
63.55±9.01 years in the waitlist control group. In addition, retirees were predominant in both 
groups (i.e. 93.3% and 80.0%, respectively). Secondly, it was convenient for participants to 
come to the group-based Tai Chi classes in the present study. The Tai Chi classes were held in 
a community hospital in Beijing and in a charity foundation located in a Chinese community in 
Sydney. As such, most participants had a low burden of travel time and expense.  
Another possible reason for the relatively high attendance may be associated with the 
characteristics of Tai Chi interventions. Wang et al. (2018) found that participants with 
fibromyalgia assigned to the Tai Chi training maintained higher and more consistent attendance 
than those assigned to supervised aerobic exercise which is used as a current standard treatment 
(C. Wang et al., 2018). Wang et al. (2018) thus suggested that “Tai Chi, which consists of the 
gentler, low impact meditative sequence of movements with minimal side effects, may be better 
embraced by patients with fibromyalgia in the long term” (C. Wang et al., 2018). Similarly, 
people with CHD and/or hypertension often have limited exercise capacity and few exercise 
options, but proper exercise is important for the management of CVD and cardiovascular risks 
in this population. In addition, it is reported that Tai Chi can improve exercise self-efficacy in 
people with heart failure (Yeh, Chan, Wayne, & Conboy, 2016). Hence, Tai Chi, a low-to-
moderate intensity exercise program, with multiple therapeutic components, may a safe and 
effective choice to this cohort (Wayne et al., 2013). 
5.2.4.2 Home Practice 
In the present study, we assessed the compliance of home practice using the weekly diaries of 
participants. Participants in the Tai Chi group were required to practice at least three other days 
when there were no classes. The overall compliance of home practice was high with the average 
frequency (i.e. 3.98 days per week). However, 11.3% participants in the Tai Chi group did not 
practice at home at all during the study. In addition, the rates of walking, 13-form thumping 
techniques, meditation, and standing postures at home practice were relatively low (66.7%, 
60.4%, 62.3%, and 41.5%, respectively), which may potentially affect the outcomes of this 
study.  
Unfortunately, in most studies where participants were encouraged or required to do home 
practice (Barrow et al., 2007; Han et al., 2010; X. Liu et al., 2013; X.  Pan, 2016; Robins et al., 
2016; J. Sun & Buys, 2015; Yeh et al., 2011; Yeh et al., 2004; Yeh et al., 2013), the frequency 
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and length of home practice was not monitored or reported. Corresponding strategies to support 
and monitor the home practice are needed, since home practice is important to promote 
independent practice for long-term benefits and to achieve sufficient “dosage/intensity”.  
Several strategies have been proposed to enhance the adherence to home practice. 
Telecommunication-based exercise and community centre-based exercise groups have 
demonstrated higher rates of compliance, fall reduction and balance, and health improvements 
among community-dwelling elders, compared with home video-based exercise (G. Wu, Keyes, 
Callas, Ren, & Bookchin, 2010). The differences might be attributed to the lack of real-time 
supervision and social interaction in the home-based exercise group (G. Wu et al., 2010). In the 
present study, the communication/interaction through WeChat (a multi-purpose social media 
and mobile application) was regarded as a facilitator to home practice by most participants, as 
presented in Chapter 6. Future studies are recommended to consider some supporting strategies 
for home-based practice.  
 
5.2.5 Implication for Clinical Practice  
Tai Chi appears effective in reducing stress as measured by PSS-10 and improving physical 
fitness as measured by 6MWT, compared with waitlist control. As discussed in previous section, 
the findings in 6MWT are clinically meaningful, however, the change of PSS-10 in the present 
study is of little clinical significance.  
Tai Chi appears safe for people with CHD and hypertension to practice in a group class and at 
home. No adverse events related to Tai Chi practice were observed during the study. Close 
supervision and the specially designed Tai Chi program are helpful strategies for safety of 
participants in the current study. Previous studies involving participants with CVD and/or 
cardiovascular risk factors reported that a physician (Yeh et al., 2004), a trained cardiac 
rehabilitation nurse (Barrow et al., 2007) or a healthcare provider (Sang et al., 2015) were also 
in attendance in addition to the Tai Chi instructors to monitor the safety during the class sessions. 
Several studies monitored the heart rate, blood pressure or ECG of participants to control 
exercise intensity (Han et al., 2010; X.  Pan, 2016; Tsai et al., 2003; P. Wang et al., 2009; X. 
Wang et al., 2013; F. Wu et al., 2010; Yao et al., 2010; E. Zhang, 2014; S. Zhang & Chen, 
2011). These strategies could be considered in a clinical setting if necessary.  
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Tai Chi practice seems enjoyable and well accepted by people with CHD and/or hypertension. 
The high adherence and retention rate in the current study indicates the acceptance of Tai Chi 
by this population. In contrast, the utilisation of cardiac rehabilitation is relatively low. 
Participation rates in cardiac rehabilitation programs following ST-elevation myocardial 
infarction (STEMI) is about 25-35% in western countries (Urbinati & Tonet, 2018). A large 
prospective audit in Australia and New Zealand found only 46% of eligible patients were 
documented as referred to CR and even fewer were discharged with sufficient secondary 
prevention (Redfern et al., 2014). In addition, since Tai Chi requires no dedicated equipment, 
time or environment, it is an accessible, convenient, long-term choice for people with CVD 
and/or cardiovascular risk factors and a wider population.  
Nevertheless, this study has some limitations and the results should be interpreted with caution. 
Due to the characteristics of Tai Chi, a double-blind study design was not applied in this study. 
The lack of blinding might lead to biases in the results, since participants in the Tai Chi may 
have positive beliefs and high expectations with respect to the benefits of Tai Chi, while the 
effect size across outcomes of the waitlist control group may deteriorate due to nocebo effect. 
The placebo and nocebo effects are seen as psychobiological phenomena that arise from the 
therapeutic context in its entirety, including sham treatments, the treatment expectations and 
previous experience of patients, and physician-patient verbal and non-verbal communications 
(Colloca, Sigaudo, & Benedetti, 2008). Although participants in the waitlist control group were 
offered an equivalent were offered and equivalent Tai Chi program at the termination of the 
study, the nocebo effects may still exist in this study.  
 
5.2.6 Summary and Conclusions 
CVD is the leading cause of morbidity and mortality worldwide. Although the mortality rates 
of CVDs have fallen in many high-income countries over the last three decades, they remain a 
considerable disease burden on both individuals and society as a whole. CHD represents the 
most common type of CVD. Hypertension is the number one contributor of CVD.  
Psychological risk factors such as stress, anxiety, and depression have been known to play a 
significant and independent role in the development and pathogenesis of CVD and its 
complications. However, current management strategies for people with CVD and its 
complications often focus on physical outcomes and lack components to manage the 
psychological factors, such as stress, anxiety and depression.  
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Tai Chi may be a beneficial option for this population. The main components of Tai Chi include 
movements, meditation and imagination, and deep/abdominal breathing, so practitioners may 
gain both physical and psychological benefits from Tai Chi. In recent years, an increasing 
number of studies have demonstrated potential benefits of Tai Chi interventions on stress, 
anxiety, depression, quality of life and cardiovascular function.  
This international multi-centre RCT involving 120 participants with CHD and/or hypertension 
conducted in Beijing and Sydney was designed to assess the impacts of a 24-week standardised 
Tai Chi intervention on psychological stress as measured by PSS-10, anxiety as measured by 
SAS, depression as measured by BDI-II, cardiovascular function (including blood pressure, 
heart rate, HRV, blood lipid profile, fasting blood glucose, and CRP), quality of life as measured 
by SF-36 and physical fitness as measured by 6MWT, compared with the waitlist group. All 
outcomes were measured at baseline, 12 and 24 weeks. The cross-cultural equivalence was 
achieved considering both English and Chinese versions of measurements used in this study 
have high internal consistency, reliability, validity and reliability. In addition, all participants 
enrolled in this study are Chinese and Chinese-Australian.  
Using a mixed linear model, our findings demonstrate that a 24-week standardised Tai Chi 
intervention resulted in statistically significant improvements in PSS-10 scores and the 6MWT 
distance in patients with CHD and/or hypertension compared with the waitlist group at week 
24. Significant differences were also observed in depression, diastolic blood pressure and 
quality of life between the Tai Chi and waitlist groups. The compliance to the Tai Chi class and 
home practice in the Tai Chi group was relatively high. No severe adverse events related to Tai 
Chi were reported during the study.  
Furthermore, compliance to Tai Chi intervention was relatively high. In older adults, especially 
those with CHD and/or hypertension who often have limited exercise capacity and few exercise 
options, Tai Chi could provide an accessible and enjoyable option for this population.  
In conclusion, a 24-week standardised Tai Chi intervention appears to be beneficial and safe in 









Chapter 6: Perceptions of Participants on Trial Participation and 
Adherence to Tai Chi Intervention: A Qualitative Study 
 
 
This chapter presents a qualitative study embedded into our randomised controlled trial (RCT 
of Tai Chi in people with CHD and/or hypertension). After a brief introduction, this chapter 
describes the methods of the qualitative study in detail. Section 6.3 presents the results, 
including characteristics of participants who completed the exit interview, and facilitators and 
barriers to trial participation and compliance. Section 6.4 discusses the findings within the 
context of previous literature. The reporting of this study is in accordance to the Standards for 
Reporting Qualitative Research (SRQR) (Appendix 16).  
 
6.1 Introduction 
6.1.1 Problem Formulation 
Successful trial recruitment of participants and adherence to interventions is critical to evaluate 
outcomes and to practice an effective intervention among the target population in real world. 
Unfortunately, in people with CVD, little is known about the factors influencing trial 
participation and adherence to Tai Chi intervention. Factors that influence trial participation 
and adherence to Tai Chi intervention have been explored in previous qualitative studies with 
diverse populations. 
One qualitative study conducted semi-structured focus group interviews with 87 older, low-
income, and ethnically diverse individuals to identify barriers and promoters for enrolment to 
a community-based Tai Chi program before the initiation of a 16-week Tai Chi program 
(Manson, Tamim, & Baker, 2017). Manson et al (2017) identified six categories, including 
physical and mental health, time of day, socialization, program pairing, accessibility, and 
appropriate leadership/teacher (Manson et al., 2017). The participants in focus groups of this 
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study were not from a Tai Chi clinical trial. Therefore, the findings may have the potential to 
elucidate the facilitators and challenges this vulnerable population has with respect to enrolling 
in community-based Tai Chi program, but not for clinical trial participation and adherence.  
One recent qualitative study examined the appropriateness and acceptability of 14-week 
modified Tai Chi and yoga programmes in an Australian residential aged care setting by 
exploring experiences and perspectives of 16 frail older residents and three staff participants 
(Saravanakumar, Higgins, Van Der Riet, & Sibbritt, 2018). Saravanakumar et al. (2018) 
identified nine themes that reflected the uniqueness of the programs including (1) novel, new 
and exciting; (2) smoothness, rhythm and flow; (3) slow and mindful; (4) gentle but rewarding; 
(5) moving whole body; (6) perceived benefits; (7) worthwhile; (8) feeling alive; (9) calming 
and relaxing, which indicated that modified Tai Chi and yoga was acceptable, appropriate, 
enjoyable and helpful (Saravanakumar et al., 2018). The focus groups were undertaken with 
residents and staff who participated in the yoga and Tai Chi arms of a three-arm RCT. However, 
the findings inform whether Tai Chi and yoga programs are appropriate in a residential aged 
care setting from the experience and perspectives of participants, but not for clinical trial 
participation and adherence involving people with CVDs.  
A four-session “introduction to Tai Chi” for veterans with post-traumatic stress symptoms 
examined feasibility, qualitative feedback and satisfaction associated (Niles et al., 2016). Niles 
et al (2016) found that almost 90% (17/19) of those eligible following the telephone screen 
enrolled in the program, three-quarters (76.4%) of the participants attended at least three of the 
four Tai Chi sessions, and 93.8% endorsed being very or mostly satisfied with the program 
(Niles et al., 2016). Themes emerged in their qualitative data analysis indicate favourable 
impressions of the Tai Chi program, and the perceived benefits are associated with high rates 
of satisfaction. The focus groups and individual interviews were undertaken with 17 veterans 
with post-traumatic stress symptoms. The findings of this qualitative study indicate that Tai Chi 
appears to be feasible and safe for this population and is perceived to be beneficial and is 
associated with high rates of satisfaction. However, little is known about the influential factors 
for clinical trial participation and adherence involving people with CVDs.  
An investigation of the motivations for practising Tai Chi among 34 survivors of severe acute 
respiratory syndromes (SARS) in post-SARS Hong Kong (Siu, 2016) revealed that health 
concerns and social experiences motivated the participants to practice Tai Chi. These included 
experiencing health deterioration in relation to SARS-associated sequelae, coping with 
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unpleasant experiences during follow-up biomedical treatments, a desire to regain an active role 
in recovery and rehabilitation, overcoming SARS-associated stigmas by establishing a new 
social network and preparing for potential future stigmatization and discrimination. The 
findings of this qualitative study provide insights of the motivations of SARS survivors for 
practicing Tai Chi, but more investigation is needed to inform the influential factors for clinical 
trial participation and adherence involving people with CVDs.  
A qualitative study evaluated the feasibility of using a pragmatic network of community-based 
Tai Chi schools to deliver a 9-month Tai Chi intervention to women with osteopenia and 
explored the impact of this design feature on facilitators and barriers to trial recruitment and 
participant adherence during and after the trial (Fischer et al., 2014). Exit interviews were 
conducted with 43 participants randomised to the Tai Chi group. Fischer et al. (2014) found 
that direct facilitators included convenience of class locations and times, alternative learning 
modalities, quality of teaching, community and social support, and perceived health benefits, 
while barriers consisted primarily of time-related issues (Fischer et al., 2014). This qualitative 
study suggests factors related to the use of pragmatically delivered interventions for fostering 
both study participation and posttrial adherence to the Tai Chi program among participants with 
osteopenia, but little is known about the perception of people with CVDs. 
The existing qualitative studies provide valuable insights of some influential factors of enrolling 
in Tai Chi practice from the perspectives of  diverse populations, including older, low-income, 
and ethnically diverse individuals, frail older residents, veterans with post-traumatic stress 
symptoms, survivors of severe acute respiratory syndromes (SARS), and women with 
osteopenia. These factors can not only inform researchers how to improve trial recruitment and 
implementation of intervention for a target population, but also be useful to enhance the 
adherence and promote effective treatments. However, less is known about the factors that 
influence trial participation and adherence to Tai Chi during and after a randomised controlled 
trial in people with CVD.  
6.1.2 Purpose 
The integration of qualitative research into clinical research introduced distinct formats of 
interviews, which greatly expanded the process of data collection and enhanced the depth of 
information being gathered (DiCicco-Bloom & Crabtree, 2006). Hence, through incorporating 
a qualitative sub-study in the main randomised controlled trial and using semi-structured 
interviews we aimed to explore the participants’ perceptions of their trial participation and 
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adherence to Tai Chi. The research question of this qualitative study is “What are the 
perceptions of the trial participants on the facilitators and barriers to trial participation and 
adherence to Tai Chi intervention?” 
 
6.2 Methods 
6.2.1 Qualitative Approach 
We conducted exit interviews to explore participants’ perceptions of what influenced their trial 
participation and adherence to the Tai Chi intervention during and after the randomised 
controlled trial.  
6.2.2 Sampling Strategy 
A purposive sampling was applied to maximise the depth and richness of the data. Participants 
of the Tai Chi group from the main randomised controlled trial who completed the 24-week Tai 
Chi program in Beijing and Sydney were invited to voluntarily participate in the interviews. No 
incentives were offered for participation.  
6.2.3 Ethical Considerations 
Ethical approval for this qualitative sub-study was covered in the approval for the randomised 
controlled trial (Ethics approval number: H11189; 2015BZHYLL0233). Written informed 
consent was obtained from each interviewee before the interview. In addition, verbal 
confirmation to record the interview was obtained at the beginning of each session.  
6.2.4 Data Collection  
The data source in this qualitative study was semi-structured interviews that are the most widely 
used interviewing format for qualitative research (DiCicco-Bloom & Crabtree, 2006). 
Semi-structured interviews were chosen to allow in-depth interviews that encourage 
interviewees to answer pre-set open-ended questions or topics to be explored by the interviewer 
(Mason, 1994). Open-ended questions are used for seven main primarily purposes: 
understanding reasons for reluctance or refusal; determining the range of options to be used in 
closed-ended questions; evaluating how well questions work; testing methodological theories 
and hypothesis; checking for errors; encouraging more truthful answers; and providing an 
opportunity for feedback (Singer & Couper, 2017). Most commonly, semi-structured interviews 
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are conducted once with an individual or a group to uncover rich descriptive data on the 
personal experiences of participants (Corbin & Strauss, 2008). 
Establishing rapport with participants is important for the interviewer to collect meaningful data 
(Merriam, 1998). In qualitative research, rapport is described as ‘a feeling of connection, mutual 
comfort, and conversational ease’ (Cappella, 1990), or ‘a distance reducing, anxiety-quieting, 
trust-building mechanism’ (Glesne, 1999), which facilitates the data collection process. When 
a researcher and interviewee have established rapport, the relationship is marked by confidence 
and trust (Glesne, 1999). Rapport is important because in a qualitative study, ‘the researcher is 
the primary instrument for gathering and analysing data and as such, can respond by 
maximizing opportunities for collecting and producing meaningful information’ (Merriam, 
1998). In the present study, the semi-structured interviews took place in the same location as 
where the participants had Tai Chi classes had been held to create a sense of familiarity and 
security. The principal investigator (GYY) conducted all the face-to-face individual interviews. 
Interviewees were familiar with the interviewer, in her role as the researcher of the study and 
one of the Tai Chi instructors of the 24-week Tai Chi classes. The established relationship and 
the familiar environment enhanced rapport and trust, creating a relaxed, comfortable 
atmosphere during interviews. 
The semi-structured interview schedule was applied flexibly to gather focused, qualitative data. 
Each interview began with warm-up or demographic questions to help the participants feel 
comfortable; then moving on to focused questions using the interview guide. Further prompts 
were rarely required as most participants freely shared and described their experiences and 
perspectives on the Tai Chi program. The interviews allowed flexibility for dialogue and toward 
the end each interviewee was asked - “Is there anything else you would like to tell me?”. Hence, 
the interviews varied in length from 10 minutes to 30 minutes, with the average lasting 28 
minutes.  
Each semi-structured interview was guided by ten open-ended questions in English or Chinese 
(Mandarin). The questions were developed following two underlying principles: (1) avoid 
leading the interview or imposing meanings, and (2) create a relaxed, comfortable conversation 
(Zorn, 2010). Table 6.1 presents the core questions used as the interview guide for the semi-




Table 6.1 Core questions as the interview guide for the semi-structured exit interview 
Question 1: How did you know about Tai Chi before your participation in this program? 
Question 2: How did you find out about this Tai Chi program? 
Question 3: What was your expectation for participating in this program? 
Question 4: Did participating in the Tai Chi program have any impacts on your daily life? 
Question 5: What physical benefits did you find from participating in the Tai Chi program?  
Question 6: Were there any benefits from participating in the Tai Chi program on coping with 
stress or any other emotions? 
Question 7: Did participating in the Tai Chi program have any influence on your social life? 
Question 8: Would you recommend the Tai Chi program to other cardiovascular patients? 
Question 9: Would you like to continue the Tai Chi practice after the completion of the study?  
Question 10: What do you think would be the main barriers to hindering your future Tai Chi 
practice?  
 
To capture the interview data more effectively and accurately, the interviews were audio-
recorded. The researcher checked that the recording device was functioning properly 
throughout the interview by checking the recording time during each interview. The recording 
of the interview made it easier for the researcher to focus on the interview process and enabled 
the researcher to generate ‘verbatim transcripts’ of the interviews.  
6.2.5 Data Processing 
The interviews were audio-recorded, transcribed verbatim and imported into the NVivo 
(Version 11, QSR International Pty Ltd.) software. NVivo is a popular computer-assisted 
qualitative data analysis software program. It enables researchers to: 
• Store and organize: Store, sort and retrieve all data in one platform, from quantifiable 
demographic information to qualitative open-ended questions and interviews. 
• Categorize and analyse: With powerful data management tools to categorize and 
classify data, NVivo automatically sorts sentiment, themes and attributes in seconds.  
• Visualize and discover: Easily cross tabulate mixed methods data and visualize the 
results to brainstorm and map ideas, explore connections between project items and 
discover new paths of investigation with query and visualization tools (NVivo, 2018). 
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As a result, NVivo helps researcher back up findings with evidence and work more efficiently 
(Bergin, 2011). The use of NVivo software and manual procedures facilitated the thematic 
coding and analysis process throughout the research.  
6.2.6 Data Analysis 
Thematic analysis was chosen for analysing qualitative data in this study because it followed a 
standard procedure for conducting qualitative analysis to ensure clarity and rigour in process 
(Coffey & Atkinson, 1996). This consists of six steps, including familiarising with the data, 
generating initial codes, searching for themes, reviewing potential themes, defining and naming 
themes, and producing the report (Braun & Clarke, 2006).  
Step 1. Familiarising with the data 
‘Verbatim transcripts’ of the interviews were generated by the researcher (GYY) in English or 
Chinese depending on the language spoken by the participants. Two researchers (GYY and XL), 
both fluent in Chinese and English, independently read each transcript carefully several times, 
and took notes on initial ideas on the text.  
Step 2. Generating initial codes 
Code is defined as “shorthand labels – usually a word, short phrase, or metaphor – often derived 
from the words of participants, which are assigned to data fragments defined as having some 
common meaning or relationship” (Carpenter & Suto, 2008). This initial coding process 
involved reading the transcripts and allocating codes to segments of the data that conveyed what 
was happening in concise terms. Two researchers (GYY and XL) independently coded four 
transcripts (two from Beijing participants and two from Sydney participants) manually as a 
pilot, and generated as many codes as possible for the data. Coded text was highlighted, and the 
corresponding codes were listed in the margins of the transcripts. The percentage of agreement 
between the two researchers in the initial analysis was low, ranging from 20% to 40%. 
The two researchers had a meeting to discuss the codes each week to collaboratively develop a 
code list. Interrelated codes were integrated to form a category to delimit the number of codes 
and categories. Constant comparing and contrasting techniques were facilitated across codes by 
recording memos and queries to establish category boundaries, systematically assign data 
segments to categories, and summarise the content of each category (Tesch, 1990). Since 
categories identified could be influenced by the literature and background reading, and the 
experience and value of researchers (Ryan & Bernard, 2000), caution was taken by the two 
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researchers to ensure the categories reflected the data instead of forcing the data to fit in with 
the categories. In this way, the code list was refined and reinforced within the first month of the 
data analysis. 
The principal investigator (GYY) then coded all transcripts using NVivo software according to 
the code list. Appendix 17 demonstrates examples of the coding process. 
Step 3. Searching for themes 
The two researchers sorted the different codes into potential themes using NVivo software and 
focused on the broader level of themes. This step was a continuation of the bottom-up process 
in which the broader themes fit the categories. This resulted in a collection of themes and sub-
themes. 
Step 4. Reviewing potential themes 
The two researchers refined the themes by reviewing at the level of the coded data and the level 
of the themes. All codes and data extracts were reviewed to ensure that all data formed a 
coherent pattern. Each theme in relation to the data and the relationship between themes was 
reviewed to ensure the themes reflect the meaning of the data as a whole. 
Step 5. Defining and naming themes  
After continuous revision of the themes, the two researchers focused on capturing the essence 
of what each theme was about and what aspect of the data each theme captured. Sub-themes 
were identified where appropriate. Interrelated themes were integrated into domains. Themes 
and sub-themes were named in a concise way, to immediately give the reader a sense of what 
the theme is about. Themes and sub-themes are described below. 
• Internal/external motivation captures the internal or external driving force of 
participants that triggers them to participate in the trial and adhere to the Tai Chi 
protocol.  
• Positive feeling relates to the positive emotions of participants. This theme has three 
sub-themes, including positive feelings toward Tai Chi, positive feelings toward this 
project, and positive feelings about the learning experience.  




• Future practice refers to the willingness of participants to continue the Tai Chi practice 
after the study.  
• Subjective concerns are the internal factors that participants worried about, which may 
influence their action of trial participation and adherence. 
• Objective concerns relate to the external factors that participants worried about, which 
may influence their action of trial participation and adherence. 
 
Step 6. Producing the report 
The final analysis of the data and the results were reported in the below section. Evidence was 
provided to support each theme using quotations from the data.  
 
6.3 Results 
This section presents the findings, with selected illustrative quotations from the interviews. The 
principle investigator (GYY) selected illustrative quotations, and discussed and confirmed their 
appropriateness with the second researcher (XL). All Chinese quotations were translated into 
English by the principle investigator (GYY) and verified by the other researcher (XL).  
6.3.1 Participant Characteristics 
Thirty-four participants in the Tai Chi group who completed the study agreed to participate in 
an interview. Of the 34, 19 (55.9%) were from the Beijing recruitment centre and 15 (44.9%) 
from the Sydney recruitment centre.  
The mean age of participants was 66.35+4.87 years, and 55.9% were women. Of the 34 
participants, 31 (91.2%) had hypertension, 8 (23.5%) had CHD, and 5 (14.7%) had both 
hypertension and CHD. Participant characteristics of the qualitative sub-study are presented in 
Table 6.2. 
Table 6.2 Characteristics of the study population involved in the exit interview (n=34) 
Characteristic Value 
Age-yr (mean ± SD) 66.35±4.87 
Female sex-No. (%) 19 (55.9) 
Body-mass index (BMI) (mean ± SD) 25.35±2.49 
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Higher education-No. (%) 17 (50.0) 
Retired- No. (%) 32 (94.1) 
Smoker-No. (%) 0 
Family history of CVD- No. (%) 27 (79.4) 
Disease-No. (%)*  
Hypertension 31 (91.2) 
CHD 8 (23.5) 
Both 5 (14.7) 
Baseline PSS-10 score (mean ± SD) 12.38±5.43 
Baseline SAS score (mean ± SD) 42.71±8.76 
Baseline BDI-II score (mean ± SD) 10.32±2.10.03 
Baseline SF-36 total score (mean ± SD) 565.74±134.62 
Baseline 6MWT-meter (mean ± SD) 490.78±71.93 
Notes: BMI, the body-mass index; CHD, coronary heart disease; PSS-10, the Perceived Stress Scale 10-item; SAS, 
the Zung Self-Rating Anxiety Scale; BDI-II, the Beck Depression Inventory-II; SF-36, the 36-item Short Form Health 
Survey Questionnaire; 6MWT, the 6-minute walking test measures the distance (in meter). 
* Some participants had both hypertension and CHD. 
 
6.3.2 Synthesis and Interpretation 
The analysis identified two major domains - facilitators and barriers with six key themes and 
31 codes.  
The four themes under the domain of facilitators were:  
• Theme 1: internal/external motivation 
• Theme 2: positive feeling. Positive feeling has three sub-themes: feelings toward Tai 
Chi, feelings toward the project and feelings about the learning experience. 
• Theme 3: benefits of Tai Chi 
• Theme 4: future practice  
Under the domain of barriers, two themes were dominant: 
• Theme 5: subjective concerns, and 
• Theme 6: objective concerns 
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The sub-themes, themes and domains were presented in Table 6.3. 







Code Sub-theme Theme Domain 







Interested in exercise for 
heath 
8 8 
Long-cherished wish to 
learn Tai Chi 
7 7 Curiosity toward Tai Chi 
3 3 Family support 
3 3 Chinese culture 
Feelings 
toward Tai Chi 
Theme 2:  
Positive feeling 
2 1 Easy to learn 
4 3 Extensive and profound 
2 2 Long history 
8 6 Suitable for the elderly 
12 11 Good for health 
3 3 Convenient to practice 
6 6 Formal organization Feelings 
toward the 
project 
3 3 Target population 




12 9 Environment 
13 9 Communication platform 
9 7 Tai Chi protocol 
16 14 Daily activity 
- 
Theme 3:  
Benefits of Tai Chi 
37 25 Physical health 
46 27 Psychological wellbeing 
17 16 Social life 
29 25 Wish to continue practice 
- 
Theme 4:  
Future practice 22 21 Wish to promote Tai Chi 







Harm to knees if not 
practiced properly 
2 2 No group atmosphere 





1 1 Health problem 
2 2 Air pollution 
2 2 Travel difficulty 
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6.3.2.1 Facilitators to Participation and Adherence 
Theme 1: Internal/external Motivation  
The majority of participants expressed that improving health was a major motivator for them 
to participate in the project and to adhere to the Tai Chi program. Some participants reported 
that although they would have liked to improve their health through exercise in the past, they 
felt they now had more limited choices because of their age and health conditions. Some 
participants expressed that they were interested in any activity that was good for their health, 
and later they realised that Tai Chi was a good choice for them.  
I hope I can pick up some exercise, relaxation techniques, and meditation, which will 
improve my mental and psychosocial aspects. (Male, 75 years, Sydney) 
Only in recent years I feel my body, physical movement does not coordinate with my 
mind, I start to explore some means…It stays in my mind to learn Tai Chi, to improve 
my physical health, to coordinate my mind and my arms and legs, to prevent falling, 
when I was invited to this class. (Male, 66 years, Sydney)  
Learning Tai Chi was a long-cherished wish of some participants. They have heard of Tai Chi 
and its potential benefits for health or watched Tai Chi practice, but had not had any opportunity 
to learn it previously.  
I once watched Tai Chi practice many years ago, Yang style, so I always want to learn 
Tai Chi. However, not until this time, the opportunity never comes. (Female, 63 years, 
Beijing) 
Since some participants were interested in Tai Chi and had been looking for an opportunity to 
learn it for a long time, they cherished the learning opportunity offered to them in this project. 
This, in return, enhanced their participation and adherence to the Tai Chi program. 
Some participants were curious about Tai Chi and its potential benefits for health; for these 
participants, one motivation for them to participate was to see what would happen in relation 
to their health.  
Try and see. I never learned Tai Chi before. I had no idea of Tai Chi in the past. Because 
I have hypertension, I think Tai Chi might be helpful…So I participated to try and see 
what would happen to me. (Male, 71 years, Sydney) 
I wanted to try and see what on earth is Tai Chi? I heard that Tai Chi could be beneficial 
for this or that, for health, for peaceful mind and calm, so I participated in this program. 
(Male, 64 years, Sydney)  
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Curiosity motivated participants to engage in the Tai Chi program. Moreover, their curiosity 
about the potential impacts on their health during the learning process enhanced their adherence 
to the Tai Chi intervention both during and after the completion of the research.  
Family support, either emotional or practical, was also a facilitator for some participants to 
participate and adhere to the Tai Chi program, particularly for those who were usually 
preoccupied with family and domestic responsibilities.  
My husband helped with housework or other matters, as a support. He supports me to 
learn Tai Chi, so I am very happy. (Female, 64 years, Beijing)  
Theme 2: Positive Feeling 
Feelings toward Tai Chi. Most participants explained their perception of Tai Chi had changed 
over the 24-week intervention duration. Prior to participation, most had little understanding of 
Tai Chi.  
Participants in Sydney with Chinese heritage mentioned their passion for Chinese culture. They 
regarded Tai Chi, with its long history, as “an essential treasure of Chinese culture”; this was a 
big motivator for them to participate in the Tai Chi program. 
Before I leant Tai Chi, I had already known that Tai Chi is a treasure of our Chinese 
culture, with a long history. Without this belief I don’t think I would join the class. (Male, 
64, Sydney) 
During and after their participation, some participants established new views on Tai Chi. The 
terms “profound”, “unlimited”, and “regularly” were frequently used to describe the Tai Chi 
intervention by some participants. 
After I learnt Tai Chi, I started to realize that Tai Chi is so profound, not just movements. 
I only know a little about it, so I very much want to know more, all of them. This is the 
beginning. Later, I found I can’t bite off more than I can chew. So I just want to master 
the Tai Chi program I learned from the class, and have a deeper understanding. 
(Female, 67 years, Beijing)    
It’s hard at the beginning. It’s hard and easy. It takes time, step by step, to fully 
digest…After I know the basics of Tai Chi, Wow, I see, Tai Chi is such an unlimited 
world. It can bring so many beautiful benefits to people and their life. (Male, 64 years, 
Sydney) 
Because you know it is good for you. Tai Chi, you have to do it regularly, in every day, 
definitely. Then I think you will get the full benefits from it, otherwise it’s useless to do 
it for 24 weeks, you will forget it. (Female, 66 years, Sydney) 
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In addition, participants reported the specially designed 13-form Tai Chi was easy to learn and 
convenient to practice due to no strict requirements of time, location and equipment. 
Specifically, some participants reported that they felt the Tai Chi protocol used in the trial was 
well suited to their health condition and exercise capacity.  
Tai Chi is particularly suitable for the elderly to practice. No very vigorous movement 
such as kicking legs. I dare not to bend my knees too much, because I heard it will do 
harm to the knees. There is no such problem in our 13-form Tai Chi program. (Male, 
67 years, Sydney) 
Feelings toward the project. Many participants felt the target disease/condition (i.e., 
hypertension or coronary heart disease) of the Tai Chi randomised trial matched their health 
situation. Some participants felt positively to the program, because it was held by health 
researchers from the university and doctors from hospitals, and considered it would be well 
designed. One participant felt the project involved a very qualified Tai Chi instructor, which 
motivated her to participate in the program.  
It was organized by the university and hospitals, so it should be very formal or authentic. 
(Female, 67 years, Beijing)  
I thought this was such a good opportunity, because the teacher was from Western 
Sydney University, a PhD candidate, and had a background of Chinese medicine. I 
thought the teacher should be very qualified. Where can you find such a good teacher? 
(Female, 63 years, Sydney) 
Some participants expressed a wish for more sessions per week and for a longer duration.  
I am strongly satisfied with the project. I never met such terrific teacher, such 
fabulous environment, and such excellent teaching before. However, the duration is 
too short. Is it? There should be some following series. (Female, 66 years, Beijing) 
Feelings about the learning experience. All participants reported satisfaction with their learning 
experience with most identifying the characteristics and teaching quality of the Tai Chi 
instructors as major factors in motivating them to complete the half-year program. Participants 
frequently used the terms “earnest”, “responsible”, “patient”, “selfless”, “knowledgeable”, 
“nice”, and “dedicated” to describe the characteristics of the Tai Chi instructors. Participants 
felt their Tai Chi instructor gave them “clear”, “precise”, “detailed” instructions, explanations 
and demonstrations, which were essential in developing and maintaining their learning interest 
and adherence to the Tai Chi program.  
I was completely a layman, ho ho. I know nothing about Tai Chi. Two main reasons can 
explain why I can complete the half-year program. Two factors, I think, are very 
important. Firstly, I met a very good teacher. She gave us Tai Chi instruction very 
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patiently and earnestly…so that I gradually become interested in Tai Chi and had a 
deeper understanding of it. (Male, 64 years, Sydney) 
The teaching was very precise and very earnest. I find I can understand [the instruction]. 
In addition, what’s the purpose of the movements and how to experience the peace and 
stillness, [the instructors] gave very detailed explanation… To my surprise, really, I 
could meet such terrific teachers, so qualified and so excellent. (Female, 67 years, 
Beijing) 
I was so touched, because the instructor was earnest, selflessly dedicated, and hard-
working. I thought the classes were well organized. In addition, [the instructor was] 
wholehearted and very responsible. I was so touched, so I would like to study hard. If 
not study well, I would feel guilty for my instructor, and feel sorry for Tzu Chi’s support. 
(Female, 72 years, Sydney) 
The learning environment of the Tai Chi class was another important facilitator identified in 
our study. The venue of the Tai Chi class was described by some participants as “good”, “quite”, 
and “clean”, which all contributed as facilitators for participants to attend the class. Moreover, 
participants reported that they benefited from the group-learning “atmosphere” in the Tai Chi 
program. Participants found it was “encouraging” when classmates around were learning and 
practicing earnestly, and they could learn from each other. Timely responses from the 
instructors through face-to-face or online communications were also important.  
I feel it’s different from practicing at home. There is an atmosphere when we practice 
together, and we can help each other. More importantly, the face-to-face instruction. I 
am interested in the timely correction and instruction…We have a WeChat group, it’s 
good that the Tai Chi instructor shares some knowledge there. We can ask questions, 
share our experience and have discussions. (Male, 71 years, Sydney) 
I think everyone learn earnestly in the class. So, when we organize to practice together 
after class, we are very united. We are all glad to learn, and happy to practice. In the 
park of our community, very good, we practice together every day. (Female, 63 years, 
Beijing) 
The use of a social media communication tool on smart phones among the participants further 
facilitated adherence to the Tai Chi program indirectly. In the Tai Chi group of the randomised 
controlled trial, a WeChat group (a Chinese multi-purpose social media mobile application 
developed by Tencent Holdings Ltd) was set up to promote timely feedbacks between 
participants and Tai Chi instructors to support the home practice. Even though some participants 
had never used it before, the application was widely accepted and used once the researchers 
introduced WeChat in the study.  
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Theme 3: Benefits of Tai Chi  
All participants reported they benefited to some extent from participating in the Tai Chi 
program, including psychological well-being, physical health, social life and daily life activity.  
Participants frequently used the terms “calm”, “peaceful”, “happy”, “relaxed”, “bright”, 
“pleasure”, and “joyful” to describe in the interviews to talk about their mood or state of mind 
because of their Tai Chi practice. In addition, some participants reported they found it “easier 
to control the temper”, “not take things too hard” or were “less stressed and depressed”.  
I was very emotional and easy to be anxious in the past. Now, I cannot say nope. There 
are always some different things in life and work stress. But, I feel better…Tai Chi 
broadens my mind. Human should be harmonious with the environment… I would not 
take things too hard. (Female, 63 years, Sydney) 
My body becomes relaxed, so mentally I feel better and be more confident in whatever 
I do than before. In the past, I always regarded myself as a severely sick person, and I 
was different from others…especially after the stent-installation. I was a bit depressed 
in the past two years, very stressed and didn’t want to communicate with others. After 
Tai Chi practice, daily practice, I feel my body gets better and my well-being has 
improved. (Male, 64 years, Beijing) 
Notably, two participants expressed their perceived benefits in other psychosocial aspects. 
I find I’m more alert, mentally. May be because of the music and the slow movement, I 
found I had calm effects. Particularly, strange, I found my short-memory is not quite 
good because when doing Tai Chi, I can’t remember the sequences. And since then, I 
found there is improvement. It definitely improves my short-term memory. (Male, 75 
years, Sydney) 
Tai Chi helps me to concentrate. When practice Tai Chi, I concentrate on the movements 
and details, such as the principles of moving hands and arms, so it stops my mind from 
wandering. (Male, 67 years, Sydney) 
Participants frequently reported perceived physical benefits such as improvements in balance, 
flexibility, strength, sleep quality and duration, or better control of blood pressure, blood sugar 
or the blood lipid profile. Only one participant perceived his physical health unchanged.  
Social aspects of the Tai Chi program were also praised. Participants enjoyed the social 
interaction in the physical Tai Chi group class, during their group practice outside of class, and 
through WeChat. 
We get together to practice Tai Chi on Monday, Wednesday and Friday in the 
playground. After practice, we often have a discussion on how to improve. We also 
share our own experience and always feel very happy…We miss each other if two days 
no see, so we contact online through WeChat. (Female, 67 years, Beijing) 
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Furthermore, they identified their participation in the Tai Chi program had some positive 
impacts on their daily activity because they felt happier and more energetic after Tai Chi 
practice.   
In the past, I could only do small amounts of activity. My body was not able to do more, 
or my whole body felt uncomfortable at night. In the evening I always wanted to have a 
walk, but I couldn’t…Now, I can, and after walking I feel very relaxed and comfortable. 
(Female, 61 years, Beijing) 
After practice, I am often in very good mood. I feel it’s easier to do some housework. 
(Female, 67 years, Beijing) 
Some participants who found that nothing obvious had changed, did note that when they added 
Tai Chi practice into their daily life, there was a structure of a daily “routine activity” or a hobby, 
this made their “boring” retired life more “regular” and “interesting”.  
In the past, I had nothing to do, just stay at home and had no activity. Now, I practice 
Tai Chi, meditation, standing posture etc. every day. It takes around one and a half hour. 
After the practice, my mood becomes bright and I want to go out and walk around. 
(Male, 69 years, Sydney) 
 
Theme 4: Future Practice 
All participants expressed a desire to continue the Tai Chi practice. Three participants reported 
that they would immediately start their advanced Tai Chi classes after the trial.  
 I will continue to practice Tai Chi. For me, Tai Chi and the 13-form Thumping 
Techniques, I would practice them for the rest of my life. I would say, they will be a part 
for the rest of my life, an important part. Particularly, for the elderly, it’s much 
necessary for us to learn Tai Chi and the 13-form Thumping Techniques, so that we can 
be peace and calm. (Male, 64 years, Sydney)  
I used half a year to learn it. If I forgot it, it’s a waste of my time. In addition, Tai Chi 
practice has many benefits to me. Why not continue to practice it? I learned it for free 
and I can continue to practice it for free. (Male, 67 years, Sydney) 
I notice that I improve a lot. I feel I still have many space to improve at the end of the 
program. I will sort them out by watching the DVD. (Male, 75 years, Sydney) 
We have a group with around 10 people to practice together in the park…We practice 




Throughout the intervention period, the Tai Chi instructors repeatedly stressed that Tai Chi 
learning is an endless process, which had impacts on the decision of some participants with 
respect to future long-term practice.  
‘My movements are very stiff, so it might take me a long time to become soft and graceful. 
Therefore, it’s inevitable for me to practice ‘for three years to lay a solid foundation 
and ten years to achieve greater success, or even for a longer time’ (Male, 64 years, 
Sydney). 
All participants reported that they were extremely satisfied with their participation in the Tai 
Chi program and would recommend the program to others if there were more classes in the 
future.  
I am sure I would like to recommend the Tai Chi class to others, no matter they have 
cardiovascular diseases or not. For example, I would suggest my wife to come. (Male, 
67 years, Sydney)  
If there is such Tai Chi class again in the future, I will recommend it to others. … It is 
better to learn Tai Chi in a class. You can’t learn it by yourself. (Male, 64, Beijing) 
6.3.2.2 Barriers to Participation and Adherence  
Theme 5: Subjective Concerns 
Subjective concerns included possible adverse effects, difficulty of learning the Tai Chi 
sequence due to perceived complexity and maintaining self-discipline for home practice.  
A few participants thought the Tai Chi practice may harm their knees because they heard it 
from television news, so they preferred not to start learning until they found a good teacher. 
I heard from television news, several times that some people visited the orthopaedic 
department because their knees were painful. Why? They all practiced Tai Chi. These 
people didn’t know how to practice appropriately, and they didn’t master the right 
postures and skills. So I dare not to start learning it. (Male, 66 years, Beijing) 
A few participants thought Tai Chi was a complex exercise and would be too difficult for them 
to learn at first. One described her past failed learning experience of Tai Chi. Another 
participant recalled his experience of watching his sister practicing the 108-form Yang-style 
Tai Chi when he was young, which impressed him but intimidated him with its complexity. 
However, their worries alleviated by learning that this intervention was a specially designed 
Tai Chi program with only 13 movements.  
Tai Chi is too difficult to learn. In the past, I tried three times to learn Tai Chi in my 
community, but finally I gave up. I thought, alas, why was it so hard to learn? I learned 
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the movements in class but I forgot all of them when I went home. So I gave up three 
times. (Female, 66 years, Beijing) 
The participants who had often practiced outdoors with group members were very keen to 
continue practicing Tai Chi. However, when probed about the different parts of the Tai Chi 
program (i.e. 13-form Tai Chi, walking, meditation, standing posture and the 13-form 
Thumping Techniques), some participants explained it was very challenging for them to 
practice meditation and the 13-form Thumping Techniques by themselves at home, due to 
laziness or their lack of motivation without the group atmosphere.  
The 13-form Thumping Techniques, for me, it’s hard to do the whole set of it. Actually, 
I have plenty of time, but I think I lack willpower. It’s hard to practice at home. For 
example, when I just sit there for meditation, my minds were wandering, such as boiling 
a kettle of water. So I stand up to boil the water and then do other housework. (Male, 
62 years, Beijing) 
Theme 6: Objective Concern 
Objective barriers which were expressed as potentially inhibiting Tai Chi practice included 
concerns about the possible poor quality of the outdoor air due to high levels of fine particulate 
matter (PM2.5) (Beijing participant), being sick or occupied by work or other activities, family 
responsibilities (such as looking after their grandchildren). 
 I have a grandson to look after. If he is sick, I would be worried about him and not go 
out. (Female, 60 years, Beijing) 
Other possible barriers to participating and recommending Tai Chi to others included travel 
distance and time conflicts.   
 
6.4 Discussion 
6.4.1 Summary of Main Findings 
Our study identified six facilitators and barriers influencing participants’ trial participation and 
adherence to the Tai Chi intervention both during and after the study. Facilitators included 
internal/external motivation, positive feelings, benefits of Tai Chi, and future practices. Barriers 
related to subjective and objective concerns. A clear understanding of these factors, of what has 
worked and what hasn’t, can aid in the development of robust strategies to proactively address 
these factors to promote trial recruitment, retention and adherence to Tai Chi intervention and 
similar mind-body therapies, in order to support the robust evaluation of outcomes. 
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6.4.2 Facilitators to Trial Participation and Adherence 
Important themes emerged under the domain of facilitators for trial participation and adherence, 
including internal/external motivation, positive feelings towards Tai Chi, the project, the 
learning experience, benefits of Tai Chi, and future practice. Some factors support previous 
qualitative studies (Fischer et al., 2014; Yeh et al., 2016), while others may provide additional 
insight into the beneficial factors influencing the trial participation and adherence of 
participants. The details are discussed below. 
6.4.1.1 Internal/external motivation 
Improving health was the major motivator for the majority of our participants with CHD and/or 
hypertension to participate and complete the Tai Chi program. Health improvement was also 
identified as a significant facilitator in a community-based Tai Chi program provided to 87 
older adults from lower socioeconomic backgrounds in Canada (Manson, Tamim, & Baker, 
2017). 
In contrast, Fischer, Fugate-Woods and Wayne (2014) found that accessibility and convenience 
(such as situating the classes in community-based schools) were the primary motivators to 
participate and adhere to a Tai Chi program for women with osteopenia (Fischer et al., 2014). 
Our participants with CHD and/or hypertension who attended Tai Chi classes held at a fixed 
location and time, did not name accessibility and convenience as their priority. Perhaps as the 
majority of our participants came from the same community and classes were held in facilities 
close by this was less of an issue. In our CVD cohort, although accessibility and convenience 
may have been a concern, the desire to participate in a health promoting activity was the 
powerful driving force sustaining their trial participation and adherence. Demonstrating 
scientific evidence about the potential benefits of the intervention for health improvement may 
be considered as a key factor in the success of future trials and enrolment in Tai Chi programs. 
Learning Tai Chi was a long-cherished wish for some study participants. The interactive 
learning process involved in Tai Chi may be considered as a motivating component for some 
participants, which may enhance and sustain trial participation and adherence (Cook & Artino, 
2016). Helping potential participants identify any internal motivations for learning may help 
assist and sustain their enrolment and performance during future trials or programs.  
6.4.1.2 Positive feelings 
Our participants frequently expressed that their perception of Tai Chi had changed gradually 
over the study period. Most participants had minimal knowledge of Tai Chi before participating 
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in the trial, although most had perceived Tai Chi as “good for health”. When their knowledge 
deepened they developed more skills of Tai Chi through the learning experience and came to 
regard Tai Chi as “profound” and “unlimited” mind-body exercise. Learning as a motivator can 
be seen as two-fold.  Initially, the ‘idea’ or ‘concept’ of learning is a motivator, and secondly, 
the ‘actual’ learning during the intervention can be seen to sustain engagement in the Tai Chi 
program over the longer term.   
Several participants mentioned Chinese culture, regarding Tai Chi as “an essential treasure of 
Chinese culture”. Tai Chi, with its long history, has multiple attractive components, integrating 
the essence of Chinese culture including Chinese folk and military martial arts, breathing and 
meditative techniques, philosophy of yin and yang, and theory of traditional Chinese medicine 
(Tang & Gu, 2012). For some, Tai Chi may be seen as a way in which to open a door of learning, 
to understand and experience Chinese culture.  
The Tai Chi program used in our study was perceived as particularly suitable for participants’ 
health conditions and exercise capacity. The 13-movement Tai Chi program was designed to 
be easy to learn and convenient to practice, with no strict requirements of time, location and 
equipment for home practice. The program design enhanced confidence to continue to 
participate, particularly for older adults with limited physical capacity. Other advantages of Tai 
Chi, such as low-to-moderate intensity, should be articulated to potential participants during 
the recruitment period. Designing or selecting a Tai Chi program suitable for the target 
population, according to their health, mental and cognitive conditions, and exercise capacity is 
considered likely to improve engagement and compliance.  
In our study the Tai Chi instructor(s) were crucial in motivating participants’ adherence to the 
Tai Chi intervention; this finding is consistent with that of previous literature. Fischer et al. 
(2014) identified characteristics of Tai Chi instructors, such as their expertise, knowledge and 
authenticity, patience and providing support, inspired the attendance and performance of 
participants with osteopenia (Fischer et al., 2014). Similarly, in a qualitative study in veterans 
with post-traumatic stress symptoms, Niles et al. (2016) found the positive energy and 
supportive comments from the Tai Chi instructor contributed to ongoing participation and 
adherence to the Tai Chi program (Niles et al., 2016). Individual attention and modification of 
movements based on individual needs from Tai Chi instructors were also considered important 
in sustaining engagement.  
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Our findings support previous literature that has reported the importance of a helpful learning 
environment. Fischer et al. (2014) identified that community and social support from Tai Chi 
instructors, teaching assistants and classmates was an incentive for class attendance and regular 
practice (Fischer et al., 2014). Yeh et al. (2016) also suggested that social support in the Tai 
Chi classes, including motivation from others, shared understandings and difficulty contributed 
to self-efficacy and empowerment with additional gains being internal focus of control, self-
awareness and stress management for participants with heart failure (Yeh et al., 2016). A 
longitudinal epidemiological study followed up 1,636 people with CHD over 13 years and 
found that social support may function as a resilience factor against the long-term 
cardiovascular risk associated with depression (Lie et al., 2017). Community, practical and 
emotional supports may thus explain to some extent why Tai Chi is beneficial for cardiovascular 
health and psychosocial wellbeing in participants with CHD and/or hypertension.  
6.4.1.3 Benefits of Tai Chi 
The benefits of committing to a regular and sustained Tai Chi practice for participants include 
psychological wellbeing, physical health, social life and daily life activities. These finding are 
similar to other studies in other population groups. Women with osteopenia experienced 
improvements in balance and flexibility, a reduction in pain related to less joint stiffness or 
postural imbalances, an increase in energy and endurance for daily activities and strength, fewer 
headaches and improved sleep, an increase in mental alertness, and being calmer and more 
relaxed mentally (Fischer et al., 2014). In people with heart failure, perceived benefits included 
improvements in strength, energy, flexibility, balance, and endurance; a decrease in pain and 
stiffness; awareness/mindfulness; and relaxation and calmness (Yeh et al., 2016).  
Tai Chi addresses all biopsychosocial aspects of health. The WHO defines health as “a state of 
complete physical, mental and social well-being and not merely the absence of disease or 
infirmity” (World Health Organization, 2018b). Results from our study and other studies, 
indicate that Tai Chi covers all three of these dimensions of health from the perspective of 
participants. 
Self-reported benefits of Tai Chi may help the generation of hypotheses for future research on 
the effects of Tai Chi interventions. For example, a possible future hypothesis may explore the 
impact of a Tai Chi intervention on sleep, loneliness and social isolation for people at risk of 
CHD. The association of sleep duration and quality with CHD has been widely reported in 
previous epidemiological studies (Strand et al., 2016). A recent large-scale cohort study 
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following a total of 60,5686 participants aged 40 years or older for an average of 5.6 years also 
demonstrated that short sleep duration and poor sleep quality are associated with the risk of 
CHD (Lao et al., 2018). One systematic review and meta-analysis (Valtorta, Kanaan, Gilbody, 
Ronzi, & Hanratty, 2016) of longitudinal observational studies demonstrated that poor social 
relationships are associated with a 29% increase in risk of incident CHD (pooled RR: 1.29, 
95%CI: 1.04 to 1.59).  
Physical activity plays an important role in the prevention and control of CVD and in addressing 
overweight and obesity (Koolhaas et al., 2017; J. Myers et al., 2015). However, the increasingly 
busy environment is reducing opportunities for physical activity, particularly in urban settings 
(J. Myers et al., 2015). Our findings indicate that Tai Chi practice is one enjoyable option for 
people to improve their regular physical activity, which in the long term may be likely improve 
their cardiovascular and general health. 
6.4.1.4 Future practice 
In the present study, all interviewees expressed a strong desire to continue with their Tai Chi 
practice after the 24-week study. One underlying reason for this may be because we continually 
stressed the importance of the long-term learning and regular practice of Tai Chi throughout 
the intervention. Most importantly, in comparison with other physical activities, Tai Chi has a 
special advantage in that it is a life-long enjoyable learning process with multiple levels to 
achieve rather than the simple repetition of movements. Furthermore, the intensity and structure 
of a Tai Chi program can be easily tailored to health conditions and the personalised 
requirements of practitioners. Enhancing perceptions and understandings of the necessity and 
feasibility of maintaining a Tai Chi program may therefore improve long-term adherence after 
study completion.  
Regular physical activity is a key to preventing and treating non-communicable diseases (NCDs) 
and some mental disorders. WHO recommended adults aged 18 years and above should do at 
least 150 minutes of moderate-intensity physical activity throughout the week, or do at least 75 
minutes of vigorous-intensity physical activity throughout the week, or an equivalent 
combination of moderate- and vigorous-intensity activity (World Health Organization, 2018e). 
WHO has launched several plans addressing this issue since 2004. The recent “WHO Global 
action plan on physical activity and health 2018-2030: More active people for a healthier world” 
(World Health Organization, 2018g) provides an opportunity to refocus and renew efforts at 
promoting physical activity. Considering the potential benefits to individuals and wider society 
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of long-term commitment to Tai Chi programs and their sustainable development, Tai Chi is a 
sound and appropriate option for long-term health and economic benefits in this population in 
particular, and in the wider population more generally.  
6.4.3 Barriers to Trial Participation and Adherence 
Our study also identified some subjective and objective concerns as barriers to trial participation 
and adherence, including concerns related to the Tai Chi intervention, personal reasons, 
environmental factors, travel distance and time conflicts. Fischer et al. (2014) also identified 
travel considerations and time-related factors (time required for Tai Chi practice and the 9-
month duration of the study) as barriers to participation and adherence in some participants 
(Fischer et al., 2014).  
In the present study, some participants expressed concerns about the potential harm of 
inappropriately practicing Tai Chi. The safety of Tai Chi has been examined and although Tai 
Chi was unlikely to result in serious adverse events, it might be associated with minor 
musculoskeletal aches and pains (Wayne et al., 2014). Accordingly, future researchers would 
need to ensure appropriate communication and discussion on the potential risks and benefits of 
Tai Chi interventions with potential participants. A proactive approach to developing strategies 
to deal with the potential risks should be considered. These strategies could include selecting 
an experienced Tai Chi instructor and developing a suitable Tai Chi program for a special cohort.  
Other barriers such as ‘laziness’, the lack of group atmosphere in home practice, may be 
addressed through the development of more robust and remote support strategies to more 
effectively support and facilitate independent practice at home.  
Some participants identified air pollution as a potential barrier to have outdoor Tai Chi practice. 
The “WHO Global action plan on physical activity and health 2018-2030: More active people 
for a healthier world” (World Health Organization, 2018g) highlights the contributions of all 
relevant sectors, including environment, education, health, sport and technology to accelerate 
progress to control non-communicable diseases. Notably, Tai Chi is convenient to practice and 
has no limitations of time, location and equipment. When the outdoor environment is not 
optimal, indoor practice can be an alternative.  
6.4.4 Limitations 
This qualitative study has some limitations. Firstly, the relationship between the interviewer 
and participants may influence the results, because the interviewer is also one of the Tai Chi 
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instructors. As a result, a reporting bias from participants may exist because the participants 
(“students”) might report what they thought the interviewer (“instructor”) expected. Therefore, 
the positive results generated from this qualitative study should be interpreted with caution. 
However, the exit interviews were conducted in the end of the study, which may reduce this 
reporting bias because of the completion of Tai Chi class.  In addition, interview responses were 
consistent with those self-reported in the weekly patient diaries.  
Secondly, the interview participants did not include those who refused to participate in this trial. 
They would potentially provide valuable information for developing strategies to improve 
enrolment. Consequently, some factors associated with the trial participation and adherence to 
the Tai Chi intervention from the participants’ point of view may not have been identified.  
Thirdly, there may be a potential interviewer bias. Although the interview was designed to be 
semi-structured and the questions were open-ended, around half the questions were about the 
‘benefits’ of Tai Chi, which may lead participants to report more positive results.  
Finally, the generalizability of the results may be limited considering the participants were all 
Chinese or Chinese-Australian. More research involving other background or ethnic origin are 
needed to confirm our findings. 
 
6.4.5 Implications for Future Research 
Recruitment is a key challenge in all clinical trials. Effective strategies to improve recruitment 
of Tai Chi studies or other exercise studies may be address the concerns of potential participants. 
The current qualitative study identified certain concerns of participants about Tai Chi, such as 
harming knees if not practiced properly. Therefore, during recruitment, future researchers are 
suggested to have appropriate communication with potential participants on the potential risks 
and benefits of Tai Chi and the strategies to ensure safety in the study. The other concern of 
participants identified in this qualitative study was that Tai Chi was too complex to learn. 
Accordingly, it is strongly recommended to develop or select a Tai Chi protocol tailored to the 
target participants. In addition, it is important to explain the requirements of physical capacity 
to potential participants and allow participants to ask questions to solve their concerns in 
recruitment. 
Our findings suggested some strategies of promoting adherence in clinical trials of Tai Chi, 
including identifying motivations of participants and improving the learning experience. The 
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current qualitative study found that a strong internal motivation of participants was to improve 
their health. In addition, reducing concerns of participants by guiding them to practise Tai Chi 
appropriately to ensure their safety, such as protecting their knees, during the study period. The 
characteristics and teaching of the Tai Chi instructors were also an important stimulus to the 
adherence. It is strongly suggested that an experienced Tai Chi instructor should be involved in 
the protocol development and intervention instructions. 
Tai Chi practice seems enjoyable and well accepted by people with CVD and/or cardiovascular 
risk factors. The high adherence and retention rate in the current study indicates the acceptance 
of Tai Chi by this population. All participants in the qualitative study reported that they enjoyed 
the learning experience and would like to continue with Tai Chi after the completion of the 24-
week study. CVD and other non-communicable chronic diseases require long term prevention 
and management which may be addressed by adoption of Tai Chi for the longer term. In 
addition, since Tai Chi requires no dedicated equipment, time or environment, it is an accessible, 
convenient, long-term choice for people with CVD and/or cardiovascular risk factors and a 
wider population.  
6.4.6 Influences on Cultural Context 
Although from different geographic locations, namely Beijing and Sydney, our participants are 
all Chinese or Chinese-Australian. They shared great similarities in perception of participation 
and adherence to Tai Chi, including internal/external motivations, positive feelings towards Tai 
Chi, the project and the learning experience, benefits of Tai Chi, future practice and concerns. 
The major differences due to the influences on cultural context among our participants are as 
follows: 
(1) Beijing participants mentioned their motivations included family support or their 
concerns included time conflict because of ‘looking after the grandchildren’. The 
possible reason is because it is a tradition in China that ‘the grandparents are expected 
to help look after their grandchildren’ and there is a high expectation of their family 
responsibilities.  
(2) Sydney participants mentioned their positive feelings toward Tai Chi, regarding Tai Chi 
as “an essential treasure of Chinese culture”. For some participants outside of China, 
Tai Chi may be seen as a way in which to open a door of learning, to understand and 
experience Chinese culture. 
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(3) Participants in two sites expressed their positive feelings toward the venue and group-
learning ‘atmosphere’, but the majority of Beijing participants also mentioned the 
benefits of WeChat. The possible reason is that WeChat is a popular Chinese social 
media communication tool in China but not in Australia. However, even though some 
Sydney participants had never used it before, the application was widely accepted and 
used once introduced in the study. 
(4) Beijing participants expressed one of their facilitators of Tai Chi practice is ‘group 
atmosphere’ and ‘no group atmosphere’ outside of class or after the study is a concern 
of barrier for home practice and future practice. The underlying reason is that the 
population in Beijing is much larger and denser than that of Sydney. It is easier for 
participants in Beijing to form a group after class to practice together compared to 
participants in Sydney. They were accustomed to practice in a group and it would be a 
challenge for them to continue the practice by themselves at home.  
(5) Beijing participants expressed a subjective concern about the possible adverse events of 
Tai Chi practice due to improper practice as indicated by media coverage. The possible 
reason is that it is common in China to see people practice Tai Chi, but not all people 
learn Tai Chi from a good teacher who would address important skills such as how to 
protect their knees during practice. Therefore, some improper practice did harm to their 







Chapter 7: General Discussion and Conclusion 
 
 
This chapter consists of a general discussion of the thesis. It synthesises and summarises the 
main findings of the systematic review, the RCT and the qualitative study. The strengths and 
weaknesses of the studies are discussed, and further research directions are suggested. Based 
on the general discussion, a conclusion is drawn.   
 
7.1 Summary of Findings 
This doctoral research was designed to explore the impact of a Tai Chi intervention on 
psychological well-being and cardiovascular function in people with CHD and/or hypertension. 
There are three main components including a systematic review, a multicentre RCT, and a 
qualitative sub-study. The results support the beneficial effects of Tai Chi for this population.  
The systematic review of 25 RCTs demonstrated that Tai Chi may be effective and safe in 
improving quality of life in people with CVD and/or cardiovascular risk factors. However, there 
was a lack of strong, well-designed studies that demonstrate unequivocally the beneficial effects 
of Tai Chi in decreasing stress, depression, anxiety and mood disturbances in this population. 
The methodological quality of studies included in this systematic review was generally poor to 
moderate.  
In our RCT, psychological stress and physical fitness in people with CHD and/or hypertension 
were all significantly improved by the 24-week Tai Chi program compared to the waitlist group 
(P<0.01). No adverse events related to the Tai Chi intervention were observed. 
The qualitative study involving 34 interviewees from the Tai Chi group of the RCT identified 
the factors influencing participants’ trial participation and adherence to Tai Chi during and after 
the study. The facilitators of undertaking and continuing Tai Chi fall under four themes: 
internal/external motivation, positive feelings (toward Tai Chi, the project, and the learning 
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experience), benefits of Tai Chi, and future practices. The barriers of practice related to several 
subjective and objective concerns.  
The main findings of this doctoral research are summarised below.  
7.1.1 Main Findings of the Systematic Review 
To the best of our knowledge, this is the first systematic review comprehensively evaluating 
the effects of Tai Chi on psychological well-being and quality of life in people with CVD and/or 
cardiovascular risk factors. Twenty-five RCTs involving 2,084 participants published between 
2003 and 2016 were included in this systematic review. The methodological quality of the 
studies included was generally low to moderate as assessed by Cochrane risk of bias tool and 
GRADE.  
Tai Chi appears to be potentially effective in improving QoL in people with CVD and/or 
cardiovascular risk factors. The meta-analyses demonstrated that Tai Chi significantly 
improved all domains of the SF-36 (scale of each domain from 0 to 100) including physical 
functioning (MD: 5.47, 95%CI: 0.66, 10.28, I2=84%), role limitation due to physical health 
(MD: 11.82, 95%CI: 8.26, 15.38, I2=32%), role limitation due to emotional health (MD: 8.27, 
95%CI: 5.56, 10.98, I2=0%), energy/vitality (MD: 7.03, 95%CI: 1.92, 12.14, I2=81%), mental 
health (MD: 7.86, 95%CI: 4.29, 11.44, I2=48%), social functioning (MD: 9.81, 95%CI: 5.19, 
14.42, I2=68%), bodily pain (MD: 6.34, 95%CI: 2.45, 10.23, I2=53%), and general health (MD: 
10.04, 95%CI: 7.15, 12.93, I2=27%) and the MLHFQ (scale from 0 to 105) (MD: -11.10, 95%CI: 
-15.52, -6.68, I2=73%).  
The evidence to support beneficial effects of Tai Chi for stress, depression, anxiety and mood 
disturbances in this population is inconsistent. One study on stress showed that a specially 
designed 8-week short-form Tai Chi program significantly decreased stress in people with 
cardiovascular risks, as assessed by the PSS 10-item (scale from: 0 to 40) (MD -2.45, 95% CI: 
-3.06, -1.84) (Robins et al., 2016). Other studies demonstrated that Tai Chi reduced 
psychological measures including depression, anxiety and improved mood compared to the 
control group (Robins et al., 2016; H. Song, 2013; F. Sun & Sun, 2014; Tsai et al., 2003). In 
contrast, a meta-analysis of two studies demonstrated no significant difference in decreasing 




Tai Chi appears safe to practice in this population. No adverse events related to Tai Chi were 
reported. However, only 32.0% studies included in this systematic review reported safety 
information.  
The majority of studies included in this systematic review had high or unclear risk of bias. 
Stronger, better-designed studies exploring the effects of Tai Chi for psychological well-being 
and quality of life in people with CVD and/or cardiovascular risk factors are warranted. 
7.1.2 Main Findings of the RCT 
In this international, multicentre, randomised, controlled trial of participants with CHD and/or 
hypertension, 85% of 120 randomised participants completed the trial, 53 in the Tai Chi group 
and 49 in the waitlist group. The Tai Chi group demonstrated a significant reduction in PSS-10 
scores at week 24 (Mean, 10.44; 95% CI, 8.86 to 12.03) compared with the waitlist group (Mean, 
11.71; 95% CI, 10.01 to 13.34) (P=0.009). The findings suggest that a 24-week standardised 
Tai Chi intervention results in a significant reduction in psychological stress over 24 weeks in 
people with CHD and/or hypertension. 
The mean 6MWT distance increased 58.04 meters over the 24 weeks in the Tai Chi group, 
while the waitlist group maintained at the similar level. The difference in 6MWT distance 
between groups is statistically significant (P<0.01).  
We also detected significant differences in depression, diastolic blood pressure, and quality of 
life between the Tai Chi and waitlist control groups. The between-group differences in other 
secondary outcomes did not reach significance. No severe adverse events related to Tai Chi 
were observed during the study.  
Compliance and attendance to the Tai Chi was high at 82.5% of all classes being attended by 
the 53 participants during the 24-week program. Compliance with home practice was also high, 
with 90.6% of participants practicing the 13-form Tai Chi. The proportion of practicing the 
walking, 13-form thumping techniques, meditation, and standing postures at home was 66.7%, 
60.4%, 62.3% and 41.5%, respectively. 
7.1.3 Main Findings of the Qualitative Sub-study 
In the qualitative study, 34 participants in the Tai Chi group who completed the 24-week study 
agreed to be interviewed. Facilitators and barriers were identified as the two major domains, 
and six key themes with 31 codes emerged under the two domains.   
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Four themes that facilitated trial participation and adherence were identified. They were 
internal/external motivation, positive feelings, benefits of Tai Chi, and future practice. A major 
internal motivation was to improve health. Positive feelings had three sub-themes: positive 
feelings toward Tai Chi, the project, and the learning experience. Tai Chi instructor(s) were 
crucial in motivating participants’ adherence to Tai Chi. The participants identified the benefits 
of committing to a regular and sustained Tai Chi practice included improvements in 
psychological well-being, physical health, social life and daily life activities.  
Under the domain of barriers to participation and adherence, subjective and objective concerns 
were the two predominating themes. Subjective concerns were fears relating to the practice 
such as learning Tai Chi was difficult for them and that Tai Chi might harm their knees if not 
practiced properly. Objective concerns included time conflict, air pollution, laziness and a lack 
of group atmosphere. 
7.2 Strengths and Weaknesses 
One unique feature of this doctoral project was using a combination of qualitative and 
quantitative methods. This enabled the analyses of the existing RCTs and the rigorously 
designed RCT, to be further understood through the insights provided by participants through 
interviews. Specific strengths and limitations in each of the three qualitative and quantitative 
studies are discussed below.  
7.2.1 Strengths and Weaknesses of the Systematic Review 
A strength of the current systematic review is the comprehensive, bilingual literature search. 
We searched the major English and Chinese databases and trial registers, and screened reference 
lists of relevant studies to identify eligible studies.  
A further strength is that we followed rigorous methodology in interpreting findings from our 
systematic review and meta-analyses. The methodological quality of the included studies was 
assessed by the risk of bias tool provided by the Cochrane Handbook for Systematic Reviews 
of Intervention. This tool considers selection bias, detection bias, attrition bias, reporting bias 
and other bias. The overall quality of the body of evidence for each outcome was assessed using 
GRADE criteria, considering study limitations, consistency of effect, imprecision, indirectness, 
and publication bias. 
There are several limitations of this systematic review. Firstly, we did not conduct meta-
analysis for some psychological outcomes due to significant heterogeneity among the included 
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studies. For those outcomes, results from individual studies were summarised and analysed. 
Secondly, most studies included did not apply blinding of outcome assessors. It is difficult to 
blind the participants and personnel in Tai Chi study, however, blinding the outcome assessors 
can minimise the performance bias. Thirdly, although the 25 studies reported outcomes of 
psychological well-being and quality of life, most of them focused more on physical outcomes 
as their primary outcomes. Consequently, there might be a risk of underpowered evaluation in 
some of the psychological outcomes, and we can only summarise related outcomes based on 
the limited evidence. 
7.2.2 Strengths and Weaknesses of the RCT 
This trial followed a rigorous methodology and has a set of well-defined research questions. 
We minimised the selection bias in this RCT and balanced known and unknown confounding 
factors through randomisation and allocation concealment. Eligible participants were randomly 
assigned to either the Tai Chi or waitlist group at a ratio of 1:1. An independent statistician 
generated the random allocation sequence, using a computer program that generated random 
number. Allocation concealment was achieved by using sequentially numbered, sealed, and 
opaque envelopes.  
Another advantage of this trial is that the Tai Chi intervention used was specifically designed 
by a Tai Chi master with more than 30 years of Tai Chi experience – Master Zhang Peijun. The 
protocol took into consideration the physical capacity and psychological requirements of the 
target population. The relatively high adherence to the Tai Chi protocol in attendance to the 
group classes and home practice indicates the feasibility and acceptance of the Tai Chi 
intervention.  
This RCT has several limitations. Firstly, the inability to provide a double-blind study design 
which might lead to biases in the results, since participants may have positive beliefs and high 
expectations with respect to the benefits of Tai Chi. In addition, the effect size across outcomes 
of the control group may deteriorate due to nocebo effect. It is a challenge to design a ‘sham 
Tai Chi’, considering the multiple components within a Tai Chi intervention. Tsang et al. (2007) 
used sham exercise (calisthenics and gentle stretching) as control in a single-blinded, RCT to 
control factors such as attention/social interaction (with classmates and Tai Chi instructor) and 
participation in movement activities/classes (Tsang, Orr, Lam, Comino, & Singh, 2008; Tsang 
et al., 2007). However, it remains uncertain whether a ‘sham exercise’ is appropriate as a 
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placebo control for Tai Chi, as the sham intervention failed to mimic the multiple components 
of Tai Chi such as intention, expectation, social support, interaction and community. 
Secondly, the fact that the Tai Chi intervention was delivered by two different Tai Chi 
instructors in the two recruitment centres may influence the results. In the Beijing recruitment 
centre, Master Zhang Peijun was the primary instructor, while in the Sydney recruitment centre, 
the principle investigator, who has learned Tai Chi from Master Zhang Peijun for 10 years, was 
the primary instructor. Since the implementation of a Tai Chi intervention is an interactive 
teaching and learning process, efforts from both the Tai Chi instructors and the participants can 
influence the outcomes. To minimise these influences, we performed the following strategies 
in this study:  
(1) A well-designed standardised protocol of a Tai Chi intervention was applied in Beijing 
and Sydney recruitment centres.  
(2) The recruitment started in the Beijing centre first. Master Zhang Peijun worked as the 
primary instructor in the Beijing centre. These training sessions were mirrored by the 
principal investigator who worked as the primary instructor at the Sydney recruitment 
centre. By doing so, consistency was maximised between the two centres. 
(3) In the Sydney recruitment centre, two training sessions were delivered by Master Zhang 
Peijun via videoconferencing to the participants in the Tai Chi group. In addition, 
Master Zhang frequently provided teaching support to the primary instructor in Sydney 
recruitment centre.  
 
The attendance rate of Tai Chi classes was high and similar in the two centres, indicating that 
the Tai Chi intervention may have been successfully delivered by the two instructors. 
 
Thirdly, home practice, contributing to part of the ‘dosage/intensity’ of the Tai Chi intervention, 
measured by frequency and practice time, may have varied among participants in the Tai Chi 
group. Although the adherence to Tai Chi at home practice was relatively high, the home 
practice was not done under supervision. Furthermore, since efforts from participants can 
influence their proficiency, the extent of mastering the important principles of Tai Chi 
intervention such as relaxation, concentration and meditative skills into their practice may have 
varied among participants. To minimise the influence of the variation of home practice, we 
utilised the following strategies:  
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(1) Participants in the Tai Chi group were encouraged to have at least three days of home 
practice and record it in their weekly diary. 
(2) DVDs and instructional handbooks were provided to support home practice.  
(3) A smartphone multi-purpose social media application called WeChat was used to give 
timely feedback from the instructors to participants to support their home practice.  
(4) A question-and-answer session was integrated into the 20-minute break in each class to 
help participants enhance their understanding of the intervention.  
Finally, the duration of this study, although longer than most previous trials (G. Yang et al., 
2015), may have not been sufficiently long to maximise the benefits. It is widely believed by 
many life-long Tai Chi practitioners that the health benefits of Tai Chi improve with time as 
the practitioners master more skills and principles of Tai Chi. This is supported by recent 
clinical studies (Han et al., 2010; Y. Li et al., 2014; Wayne et al., 2015). Consequently, the 
long-term beneficial effects of Tai Chi in people with CHD and/or hypertension are still 
unknown.  
7.2.3 Strengths and Weaknesses of the Qualitative Sub-Study 
The semi-structured interview encouraged participants to discuss their perceptions of their trial 
participation and their adherence to the Tai Chi intervention. These inputs helped inform more 
in-depth understanding of the intervention.  
There are several limitations of the qualitative sub-study. First, the interviewer who is the 
principal investigator was also one of the Tai Chi instructors. This may lead to a reporting bias 
from participants. Participants may say what they think the interviewer wishes to hear. This 
bias may have been reduced by conducting the interviews at the end of the study.  Interview 
responses were similar to those self-reported in the weekly patient diaries.  
Second, we did not interview people who refused to participate in this trial. They probably 
provide valuable information source for developing strategies for improving enrolment. This 
means that some factors influencing trial participation and adherence to the Tai Chi intervention 
may not have been identified in this study.  
The third limitation of the qualitative sub-study is that, although the interview was semi-
structured and the questions were open-ended, around half the questions were related to the 
‘benefits’ which may lead participants to report more positive results, leading to a potential 
interviewer bias.  
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Finally, our interviewees were all Chinese or Chinese-Australian, which may limit the 
generalizability of our results. However, facilitators to trial participation and adherence to Tai 
Chi intervention were similar among the population as those previously reported among 
Western population (Fischer et al., 2014; Yeh et al., 2016).  
7.3 Implications  
7.3.1 Implications for Clinical Care 
The findings of this doctoral project support the use of a Tai Chi intervention as an option for 
the prevention and management of people with established CVD and/or cardiovascular risk 
factors. Tai Chi improved quality of life and physical fitness, and reduced psychological stress 
and depression in our RCT (Chapter 4 and 5) and these findings were supported by our 
systematic review (see Chapter 3).  
Tai Chi appears safe for people with CVD and/or risk factors to practice in a group class and at 
home. No adverse events related to Tai Chi practice were observed in our trial or found in the 
systematic review. Most previous studies applied a modified or simplified Tai Chi program for 
the participants with CVD and/or risk factors. In three previous studies, a physician (Yeh et al., 
2004), a trained cardiac rehabilitation nurse (Barrow et al., 2007) or a healthcare provider (Sang 
et al., 2015) were also in attendance in addition to the Tai Chi instructors to monitor the safety 
during the class sessions. Several studies monitored the heart rate, blood pressure or ECG of 
participants to control exercise intensity (Han et al., 2010; X.  Pan, 2016; Tsai et al., 2003; P. 
Wang et al., 2009; X. Wang et al., 2013; F. Wu et al., 2010; Yao et al., 2010; E. Zhang, 2014; 
S. Zhang & Chen, 2011). These strategies could be considered in a clinical setting if necessary.  
Tai Chi practice seems enjoyable and well accepted by people with CVD and/or cardiovascular 
risk factors. The high adherence and retention rate in the current study indicates the acceptance 
of Tai Chi by this population. All participants in the qualitative study reported that they enjoyed 
the learning experience and would like to continue with Tai Chi after the completion of the 24-
week study. CVD and other non-communicable chronic diseases require long term prevention 
and management which may be addressed by adoption of Tai Chi for the longer term. In 
addition, since Tai Chi requires no dedicated equipment, time or environment, it is an accessible, 
convenient, long-term choice for people with CVD and/or cardiovascular risk factors and a 
wider population.  
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Nevertheless, the findings of the current systematic review and the RCT should be interpreted 
with caution. Although several individual studies in the systematic review showed statistical 
differences between Tai Chi and control groups in reducing stress and depression, the results 
might not achieve clinical significance.  
7.3.2 Implications for Future Work 
More studies are needed to assess the effects of Tai Chi in improving psychological well-being 
and quality of life as their primary outcomes in people with CVD and/or cardiovascular risk 
factors. Most studies included in the systematic review assessed the psychological outcomes 
and quality of life as secondary outcomes. It is not clear whether a Tai Chi intervention 
specifically designed to target psychological benefits would be of more effective in reducing 
stress and depression. In addition, the sample size calculations for these studies were based on 
physical biomarkers such as blood pressure not psychological measures. Consequently, there 
may be a risk of underpowered evaluation in these trials on the effects of psychological well-
being and quality of life in this cohort.  
The combination of quantitative and qualitative methods balance weaknesses of each 
methodology. Mixed methods may enhance the evaluation of potential benefits of Tai Chi, since 
the multiple mind-body components of Tai Chi may work independently and synergistically 
(Wayne et al., 2013). Alternatively, psychosocial outcomes which can address patient-centred 
experiences may be applied in future clinical studies, as well as using physical biomarkers. 
The design of a double-blind, placebo-controlled, randomised trial for a Tai Chi intervention 
for CVD is a methodological challenge. To date, most clinical studies on Tai Chi utilised no 
treatment, waitlist control or conventional exercises (such as endurance, resistance/strength, 
flexibility exercises or brisk walking) as control groups. ‘Sham-exercise control’ has yet been 
widely accepted. Considering the multiple components of Tai Chi such as social interaction and 
community, the necessity for sham-exercise controls is debatable. However, more research is 
needed to explore the design of control groups in future Tai Chi trials.  
Patients with chronic non-communicable disease like CVD often suffer from other concomitant 
conditions/diseases and needs long-term management tools. Tai Chi, with multiple mind-body 
components, may be a potential option for the long-term prevention and management. However, 
less is known about the long-term effects of Tai Chi in this population. A pragmatic RCT with 
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a long follow-up period might be one possible study design option to determine the overall 
effectiveness of Tai Chi and the long-term benefits of Tai Chi in this cohort.  
 “Dosage/intensity” of Tai Chi is another issue in clinical trials. Our previous bibliometric 
review of Tai Chi clinical studies found that Tai Chi practice varied from 10 minutes to 2 hours 
each session, three 60-minute sessions per week (61/464, 13.1%) and two 60-minute sessions 
per week (58/464, 12.5%) were most popular, and the most common duration was 12 weeks 
(122/464, 26.3%), followed by 24 weeks (83/464, 17.9%) (G. Yang et al., 2015). In most studies 
included in our systematic review, Tai Chi was mostly practiced in group classes, and only 36.0% 
of studies encouraged or required home practice. Safety considerations may have been the 
reason for not including home practice in some of these studies (i.e. people with or at risk of 
CVDs practicing Tai Chi with no appropriate supervision from instructors or healthcare 
providers). However, lack of home practice generates concerns regarding the intensity of Tai 
Chi in these studies. In addition, home practice is important to promote independent practice 
for long-term benefits and to achieve sufficient “dosage/intensity”, and should thus be strongly 
encouraged in future research.  
An additional variable is the extent to which participants are able to master the Tai Chi skills. 
Our program was closely supervised and introduced in a progressive manner to secure the 
learning, but we did not measure the extent participants master the skills. A cross-sectional 
study investigated physiological parameters in 10 high-level (about 10-year experience) male 
Tai Chi practitioners and 10 ordinary-level (about 2-year experience) male Tai Chi practitioners 
aged 20-24 years during Tai Chi practice (Xiong, He, & Ni, 2013). This study demonstrated 
that the high-level group had significantly higher energy expenditure, heart rate, oxygen uptake 
and tidal volume, and less inhalation time, when compared with the ordinary-level group. More 
research is needed to confirm the findings.  
Standardisation of a Tai Chi intervention for a specific cohort and reporting in details is crucial 
for the interpretation and repetition of the results of clinical trials. Since a Tai Chi intervention 
is an interactive learning process, the contents of the program, the expertise of Tai Chi 
instructors, and the efforts of participants may all influence the outcomes of the intervention. 
We found most studies included in our systematic review did not report sufficient details of the 
Tai Chi intervention, such as the components of the Tai Chi program and the expertise of the 
Tai Chi instruction providers.  
198 
 
Many people with CVD and/or risk factors might have poorer physical capacity than that of 
healthy individuals. In our trial, we allowed participants to progress at their own comfortable 
pace and intensity if they could not achieve the standardised requirement. Participants were also 
provided with chairs for resting during the break, and if necessary, at any time during the group 
classes. Several studies included in our systematic review reported using similar strategies. We 
recommend to consider the degree of variability for a standardised Tai Chi program in clinical 
trials and report in details. 
Recruitment is the key challenge in all clinical trials. The current qualitative study identified 
that some participants had certain concerns about Tai Chi, such as harming knees if not 
practiced properly. Future research needs to ensure appropriate communication and discussion 
on the potential risks and benefits of a Tai Chi intervention during recruitment. The other 
concern of participants was that Tai Chi was too complex to learn. To address this concern, we 
suggest tailoring the Tai Chi protocol to the target participants, and to explain the requirements 
of physical capacity to potential participants in recruitment.  
Strategies should be developed to promote adherence in future research. These could include 
identifying motivations of participants and improving the learning experience. The current 
qualitative study identified that a strong internal motivation of participants was to improve their 
health. In addition, reducing concerns of participants by guiding them to practise Tai Chi 
appropriately to ensure their safety, such as protecting their knees, during the study period. The 
characteristics and teaching of the Tai Chi instructors was also an important stimulus to the 
adherence. It is suggested to invite an experienced Tai Chi instructor to be involved in the 
protocol development and intervention instructions. 
Additionally, all participants reported in the current qualitative study that they benefited from 
committing to regular and sustained Tai Chi practice to some extent, covering psychological 
well-being, physical health, social life and daily life activity. These self-reported benefits of Tai 
Chi may help the generation of hypothesis for future research. A possible hypothesis may 
explore the beneficial effects of a Tai Chi intervention on improving sleep quality and duration 





Cardiovascular disease (CVD) is the number one cause of morbidity and mortality worldwide. 
Coronary heart disease (CHD) is the most common type of CVD. Hypertension is the leading 
cause of heart disease and stroke. Stress, anxiety and depression are associated with the 
development and progression of CVD and its complications, reduces health-related quality of 
life, impedes physical functioning, and increases recurrent cardiac events and risk of mortality. 
People with established CVDs often suffer from stress, anxiety and depression, which are 
frequently undertreated with current management strategies.  
 
In recent years, research on Tai Chi for health and well-being has increased. Numerous studies 
have demonstrated various physical and psychological benefits of Tai Chi, including 
improvements in psychological stress, anxiety, depression, quality of life and cardiovascular 
function. However, there is still a lack of studies primarily investigating the effectiveness of a 
Tai Chi intervention on psychological stress, anxiety and depression, particularly in patients 
with CHD and/or hypertension.  
This doctoral project was conducted to explore the effects of a Tai Chi intervention on 
psychological well-being and cardiovascular function in people with CHD and/or hypertension. 
It included a systematic review, an international, multicentre RCT and a qualitative sub-study 
undertaken during 2015 to 2017. 
The current systematic review demonstrated that Tai Chi is potentially effective and safe in 
improving quality of life in people with CVD or cardiovascular risk factors. Individual studies 
reported the benefits of Tai Chi in decreasing stress, depression, anxiety and mood disturbance. 
The methodological quality of included studies was generally poor to moderate. More high-
quality RCTs exploring the beneficial effects of Tai Chi on psychological well-being and 
quality of life in this population are warranted. 
The current RCT demonstrated that a 24-week standardised Tai Chi intervention is effective in 
improving psychological stress and physical fitness in patients with CHD and/or hypertension 
when compared with the waitlist control group. The Tai Chi intervention was safe to practice 
under the supervision of Tai Chi instructors during class and at home. 
The current qualitative study identified several facilitators and barriers influencing trial 
participation and adherence from the perspectives of participants. Future research is needed to 
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further evaluate these facilitators and barriers to improve the study design, recruitment and 
implementation.   
To sum up, Tai Chi may be effective to improve psychological stress, fitness and quality of life 
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Appendix 1 – PRISMA Checklist 
Section/topic  # Checklist item  
Reported 
on page #  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  45 
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, 
participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and 
implications of key findings; systematic review registration number.  
xii-xv 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  45-46 
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, 
outcomes, and study design (PICOS).  
46 
METHODS   
Protocol and registration  5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide 
registration information including registration number.  
46 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, 
language, publication status) used as criteria for eligibility, giving rationale.  
47 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify 
additional studies) in the search and date last searched.  
47-48 
Search  8 Present full electronic search strategy for at least one database, including any limits used, such that it could be 
repeated.  
48-49 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, 
included in the meta-analysis).  
49 
Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes 




Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and 
simplifications made.  
47 
Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was 
done at the study or outcome level), and how this information is to be used in any data synthesis.  
50-51 
Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).  53 
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including measures of consistency 
(e.g., I2) for each meta-analysis.  
53-54 
Section/topic  # Checklist item  
Reported 
on page #  
Risk of bias across studies  15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective 
reporting within studies).  
50-53 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating 
which were pre-specified.  
54 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at 
each stage, ideally with a flow diagram.  
54, 
Figure 1 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and 




Risk of bias within studies  19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).  69-70, 
Figure 
3.2, 3.3 
Results of individual studies  20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.  
69-70, 
Table 3.4 









Risk of bias across studies  22 Present results of any assessment of risk of bias across studies (see Item 15).  69-70, 
Figure 
3.2, 3.3 
Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 16]).  78 
DISCUSSION   
Summary of evidence  24 Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to 
key groups (e.g., healthcare providers, users, and policy makers).  
83-84 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of 
identified research, reporting bias).  
84-85 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications for future research.  85 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the 
systematic review.  
N/A 
 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): 
e1000097. doi:10.1371/journal.pmed1000097  
For more information, visit: www.prisma-statement.org.  
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Appendix 2 – Data extraction form 
Review title or ID  
Study ID (surname of first author 
and year first full report of study 
was published e.g. Smith 2001) 
 
General Information 
Date form completed (dd/mm/yyyy)  
Name/ID of person extracting data  
Reference citation  
Study author contact details  
Study Methods (extract information from descriptions as stated in report/paper) 
Design (e.g. parallel, 
crossover) 
 
Start date  
End date  
Duration of 
participation (from 
recruitment to last 
follow-up) 
 
Participants (extract the description as stated in report/paper. Include comparative information 
for each intervention or comparison group if available) 
Setting (including 
location and social 
context) 
 
Inclusion criteria   
Exclusion criteria  
Total no. randomised   
Baseline imbalances  
Withdrawals and 
exclusions (if not 












Subgroups measured  
Subgroups reported  
Intervention groups (extract the description as stated in report/paper. Copy and paste table for 
each intervention and comparison group) 
Group name  




sufficient details, e.g. 
style, form, components) 
 
Duration of treatment   
Timing (e.g. frequency, 
duration of each 
practice) 
 
Learning method (e.g. 
DVD, instructors, one-
to-one, in group) 
 
Providers (e.g. a Tai 
Chi instructor with 10 





Outcomes (extract the description as stated in report/paper. Copy and paste table for each outcome.) 
Outcome name  
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Time points measured 
(specify whether from 
start or end of 
intervention) 
 
Time points reported  
Outcome definition 






Scales: upper and lower 
limits (indicate whether 





Yes No Unclear 
Imputation of missing 
data (e.g. assumptions 
made for ITT analysis) 
 
Assumed risk estimate 
(e.g. baseline or 













Total in group 





Mean SD No. 
Participants 
Mean SD No. 
Participants 
      
Risk of Bias assessment 
Domain Risk of bias Support for judgement (include direct 
quotes where available with explanatory 






    
Allocation concealment 
(selection bias) 
    
Blinding of outcome 
assessment (detection 
bias) 
    
Incomplete outcome 
data (attrition bias) 




    
Other bias     
Other information (extract the description as stated in report/paper) 








Appendix 3 – CONSORT Checklist 
 
CONSORT 2010 checklist of information to include when reporting a randomised trial* 
 
Section/Topic Item No Checklist item 
Reported 
on page No 
Title and abstract 
 1a Identification as a randomised trial in the title 86 
1b Structured summary of trial design, methods, results, and conclusions (for specific guidance see 





2a Scientific background and explanation of rationale 85 & Chapter 
2 
2b Specific objectives or hypotheses 86 
Methods 
Trial design 3a Description of trial design (such as parallel, factorial) including allocation ratio 87 
3b Important changes to methods after trial commencement (such as eligibility criteria), with 
reasons 
Appendix 13 
Participants 4a Eligibility criteria for participants 87-88 
4b Settings and locations where the data were collected 89 
239 
 
Interventions 5 The interventions for each group with sufficient details to allow replication, including how and 
when they were actually administered 
91-93 
 
Outcomes 6a Completely defined pre-specified primary and secondary outcome measures, including how 
and when they were assessed 
93-99, Table 
4.1 
6b Any changes to trial outcomes after the trial commenced, with reasons Appendix 13 
Sample size 7a How sample size was determined 88 
7b When applicable, explanation of any interim analyses and stopping guidelines N/A 
Randomisation:    
 Sequence 
generation 
8a Method used to generate the random allocation sequence 91 





9 Mechanism used to implement the random allocation sequence (such as sequentially 





10 Who generated the random allocation sequence, who enrolled participants, and who assigned 
participants to interventions 
91 
Blinding 11a If done, who was blinded after assignment to interventions (for example, participants, care 
providers, those assessing outcomes) and how 
91 
11b If relevant, description of the similarity of interventions N/A 





12b Methods for additional analyses, such as subgroup analyses and adjusted analyses 101-102 
Results 
Participant flow 
(a diagram is 
strongly 
recommended) 
13a For each group, the numbers of participants who were randomly assigned, received intended 
treatment, and were analysed for the primary outcome 
104-107, 
Figure 5.1 
13b For each group, losses and exclusions after randomisation, together with reasons 104-5, Table 
5.1 
Recruitment 14a Dates defining the periods of recruitment and follow-up 107 
14b Why the trial ended or was stopped N/A 
Baseline data 15 A table showing baseline demographic and clinical characteristics for each group 107-110, 
Table 5.2, 5.3 
Numbers 
analysed 
16 For each group, number of participants (denominator) included in each analysis and whether 





17a For each primary and secondary outcome, results for each group, and the estimated effect 
size and its precision (such as 95% confidence interval) 
110-143 
17b For binary outcomes, presentation of both absolute and relative effect sizes is recommended 122-123 
Ancillary 
analyses 
18 Results of any other analyses performed, including subgroup analyses and adjusted 
analyses, distinguishing pre-specified from exploratory 
114, 138 




Limitations 20 Trial limitations, addressing sources of potential bias, imprecision, and, if relevant, multiplicity 
of analyses 
162, 189-191 
Generalisability 21 Generalisability (external validity, applicability) of the trial findings 161-162 
Interpretation 22 Interpretation consistent with results, balancing benefits and harms, and considering other 
relevant evidence 
143-161 
Other information  
Registration 23 Registration number and name of trial registry 86 
Protocol 24 Where the full trial protocol can be accessed, if available 86 
Funding 25 Sources of funding and other support (such as supply of drugs), role of funders N/A 
 
*We strongly recommend reading this statement in conjunction with the CONSORT 2010 Explanation and Elaboration for important clarifications on all the items. If 
relevant, we also recommend reading CONSORT extensions for cluster randomised trials, non-inferiority and equivalence trials, non-pharmacological treatments, herbal 
interventions, and pragmatic trials. Additional extensions are forthcoming: for those and for up to date references relevant to this checklist, see www.consort-statement.org.
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Appendix 4 – Description of the Tai Chi intervention 
English Version 
Instruction: The standardized Tai Chi intervention is offered over a period of 24 weeks, consisting of a 
12-week intensive Tai Chi intervention period (from week 1 to 12) and a 12-week sustained Tai Chi 
intervention period (from week 13 to 24). In the intensive period the Tai Chi class lasted 120 minutes 
per session, twice weekly; in the sustained period the Tai Chi class also lasted 120 minutes per session, 
once weekly. The classes were held both in a capacious room. The details are showed in the following 
table. 
Week Activities Duration, min 
1 Introductory session: overview of program  
 1st Class: 120 
 a) Tai Chi history, theories and principles 30 
 b) Demonstration of Tai Chi intervention 30 
 c) Questions and answers 20 
 d) Description of class format 10 
 e) Learning walking lunges 15 
 f) Learning standing posture 15 
 2nd Class: 120 
 a) Tai Chi theories and principles 20 
 b) Learning meditation 20 
 c) Learning standing posture 20 
 d) Learning 13-form of Thumping Techniques 30 
 e) Learning the 1st movement of the 13-form Chen-style Tai Chi 30 
2-12 Walking lunges (Repeated during all sessions) 10 
 Meditation (Repeated during all sessions) 10 
 13-form of Thumping Techniques (Repeated during all sessions) 30 
 Short break and Question-and-Answer 20 
 Review and learning the 2nd-13th movement of the 13-form Chen-style 
Tai Chi consecutively (1-2 new movement(s) each week) 
50 
13-24 Walking lunges (Repeated during all sessions) 10 
 Meditation (Repeated during all sessions) 10 
 13-form of Thumping Techniques (Repeated during all sessions) 30 
 Short break and Question-and-Answer 20 
 Review the sequence of the 13-form Chen-style Tai Chi, focusing on 













Chinese Version 中文版本 
      说明：太极拳干预持续时间为 24 周，包括 12 周的强化干预期（从第 1 到 12 周）和
12周的持续干预期（从 13到 24周）。在强化干预期，每次太极拳课为 120分钟，一周
两次；在持续干预期，每次太极拳课为 120分钟，一周一次。太极拳课均为室内教学。
具体干预内容和安排如下表： 
周 活动项目 时间（分钟） 
1 介绍太极拳干预  
 第一节课: 120 
 1. 介绍太极拳的历史、理论和原则 30 
 2. 太极拳干预的示范 30 
 3. 问答环节 20 
 4. 介绍上课形式 10 
 5. 学习打坐 15 
 6. 学习站桩 15 
 第二节课: 120 
 1. 太极拳理论和原则 20 
 2. 学习打坐 20 
 3. 学习站桩 20 
 4. 学习养生十三功 30 
 5. 学习十三式太极拳的起式 30 
2-12 大步走(每节课练习) 10 
 打坐 (每节课练习) 10 
 养生十三功(每节课练习) 30 
 休息和问答环节 20 
 复习和学习十三式陈式太极拳的第 2-13 个动作(每周学习
1-2 个新动作) 
50 
13-24 大步走 (每节课练习) 10 
 打坐(每节课练习) 10 
 养生十三功(每节课练习) 30 






Appendix 5 – Participant Diary 
We collected the data using pre-designed participant diary. The participant diary sample is as follows: 
Sample of Participant Diary 
Date 
(DD/MM/YY) 
Meditation Walking 13-form Chen-






     ⃝Yes, ___min; 
    ⃝No, Reason: 
____________ 
    ⃝Yes, ___min; 
    ⃝No, Reason: 
___________ 
    ⃝Yes, ___min; 
    ⃝No, Reason: 
___________ 
    ⃝Yes, ___min; 
    ⃝No, Reason: 
_____________ 
    ⃝Yes, ___min; 
    ⃝No, Reason: 
_____________ 
     ⃝Yes, ___min; 
    ⃝No, Reason: 
_____________ 
    ⃝Yes, ___min; 
    ⃝No, Reason: 
_____________ 
    ⃝Yes, ___min; 
    ⃝No, Reason: 
_____________ 
    ⃝Yes, ___min; 
    ⃝No, Reason: 
_____________ 
    ⃝Yes, ___min; 
    ⃝No, Reason: 
_____________ 
     ⃝Yes, ___min; 
    ⃝No, Reason: 
_____________ 
    ⃝Yes, ___min; 
    ⃝No, Reason: 
_____________ 
    ⃝Yes, ___min; 
    ⃝No, Reason: 
_____________ 
    ⃝Yes, ___min; 
    ⃝No, Reason: 
_____________ 
    ⃝Yes, ___min; 
    ⃝No, Reason: 
_____________ 
     ⃝Yes, ___min; 
    ⃝No, Reason: 
_____________ 
    ⃝Yes, ___min; 
    ⃝No, Reason: 
_____________ 
    ⃝Yes, ___min; 
    ⃝No, Reason: 
_____________ 
    ⃝Yes, ___min; 
    ⃝No, Reason: 
_____________ 
    ⃝Yes, ___min; 
    ⃝No, Reason: 
_____________ 
     ⃝Yes, ___min; 
    ⃝No, Reason: 
_____________ 
    ⃝Yes, ___min; 
    ⃝No, Reason: 
_____________ 
    ⃝Yes, ___min; 
    ⃝No, Reason: 
_____________ 
    ⃝Yes, ___min; 
    ⃝No, Reason: 
_____________ 
    ⃝Yes, ___min; 














   ⃝练习,__分钟 
⃝未练, 原因: 
_____________ 
  ⃝练习,__分钟 
⃝未练, 原因: 
____________ 
  ⃝练习,__分钟 
⃝未练, 原因: 
____________ 
  ⃝练习,__分钟 
⃝未练, 原因: 
____________ 
  ⃝练习,__分钟 
⃝未练, 原因: 
____________ 
   ⃝练习,__分钟 
⃝未练, 原因: 
_____________ 
  ⃝练习,__分钟 
⃝未练, 原因: 
____________ 
  ⃝练习,__分钟 
⃝未练, 原因: 
____________ 
  ⃝练习,__分钟 
⃝未练, 原因: 
____________ 
  ⃝练习,__分钟 
⃝未练, 原因: 
____________ 
   ⃝练习,__分钟 
⃝未练, 原因: 
_____________ 
  ⃝练习,__分钟 
⃝未练, 原因: 
____________ 
  ⃝练习,__分钟 
⃝未练, 原因: 
____________ 
  ⃝练习,__分钟 
⃝未练, 原因: 
____________ 
  ⃝练习,__分钟 
⃝未练, 原因: 
____________ 
   ⃝练习,__分钟 
⃝未练, 原因: 
_____________ 
  ⃝练习,__分钟 
⃝未练, 原因: 
____________ 
  ⃝练习,__分钟 
⃝未练, 原因: 
____________ 
  ⃝练习,__分钟 
⃝未练, 原因: 
____________ 
  ⃝练习,__分钟 
⃝未练, 原因: 
____________ 
   ⃝练习,__分钟 
⃝未练, 原因: 
_____________ 
  ⃝练习,__分钟 
⃝未练, 原因: 
____________ 
  ⃝练习,__分钟 
⃝未练, 原因: 
____________ 
  ⃝练习,__分钟 
⃝未练, 原因: 
____________ 





Appendix 6 – Perceived Stress Scale (PSS-10) 
English Version Sample of PSS-10 
Name: ___________               ID: __________     Date: ____/_____/______ 
INSTRUCTION: The questions below ask you about your feelings and thoughts during THE LAST 
MONTH. In each case, please indicate your response by placing a check mark “√” over the circle 











0 1 2 3 4 
1. In the last month, how often have you been upset 
because of something that happened 
unexpectedly? 
□ □ □ □ □ 
2. In the last month, how often have you felt that you 
were unable to control the important things in your 
life? 
□ □ □ □ □ 
3. In the last month, how often have you felt nervous 
and “stressed”? 
□ □ □ □ □ 
4. In the last month, how often have you felt 
confident about your ability to handle your 
personal problems? 
□ □ □ □ □ 
5. In the last month, how often have you felt that 
things were going your way? 
□ □ □ □ □ 
6. In the last month, how often have you found that 
you could not cope with all the things that you had 
to do?  
□ □ □ □ □ 
7. In the last month, how often have you been able to 
control irritations in your life? 
□ □ □ □ □ 
8. In the last month, how often have you felt that you 
were on top of things? 
□ □ □ □ □ 
9. In the last month, how often have you been 
angered because of things that were outside your 
control? 
□ □ □ □ □ 
10. In the last month, how often have you felt 
difficulties were piling up so high that you could 
not overcome them? 





Chinese Version 中文版本-应激感受量表（PSS-10） 





偶尔 经常 非常多 
0 1 2 3 4 
1.在过去的一个月里，你有多少时间因为
发生意外的事情而感到心烦意乱？ 
□ □ □ □ □ 
2.在过去的一个月里，有多少时间你感到
无法掌控生活中重要的事情？ 
□ □ □ □ □ 
3.在过去的一个月里，有多少时间你感觉
到神经紧张或“快被压垮了”？ 
□ □ □ □ □ 
4.在过去的一个月里，有多少时间你对自
己处理个人问题的能力感到有信心？ 
□ □ □ □ □ 
5.在过去的一个月里，有多少时间你感到
事情发展和你预料的一样？ 
□ □ □ □ □ 
6.在过去的一个月里，有多少时间你发现
自己无法应付那些你必须去做的事情。  
□ □ □ □ □ 
7.在过去的一个月里，日常生活中有多少
时间你能够控制自己的愤怒情绪？ 







































本量表译自 Cohen, S., Kamarck, T., & Mermelstein, R. (1983). A global measure of perceived stress. Journal of Health and 
Social Behavior. 24, 385-396. 王振（2008）上海交通大学医学院附属精神卫生中心 
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Appendix 7 – Zung Self-Rating Anxiety Scale (SAS) 
English Version Sample of SAS 
For each item below, please place a check mark (√) in the column which best describes how often you 
felt or behaved this way during the past several days. Bring the completed form with you to the office 
for scoring and assessment during your office visit. 










1. I feel more nervous and anxious than usual.     
2. I feel afraid for no reason at all.     
3. I get upset easily or feel panicky.     
4. I feel like I’m falling apart and going to pieces.     
5. I feel that everything is all right and nothing bad 
will happen. 
    
6. My arms and legs shake and tremble.     
7. I am bothered by headaches neck and back pain.     
8. I feel weak and get tired easily.     
9. I feel calm and can sit still easily.     
10. I can feel my heart beating fast.     
11. I am bothered by dizzy spells.     
12. I have fainting spells or feel like it.     
13. I can breathe in and out easily.     
14. I get feelings of numbness and tingling in my 
fingers and toes. 
    
15. I am bothered by stomach aches or indigestion.     
16. I have to empty my bladder often.     
17. My hands are usually dry and warm.     
18. My face gets hot and blushes.     
19. I fall asleep easily and get a good night’s rest.     





Chinese Version 中文版本-焦虑自评量表（SAS） 









    
2. 我无缘无故地感到害怕。     
3. 我容易心里烦乱或觉得惊恐。     
4. 我觉得我可能将要发疯。     
5. 我觉得一切都好，也不会发生什么不幸。     
6. 我手脚发抖打颤。     
7. 我因为头痛、劲痛和背痛而苦恼。     
8. 我感觉容易衰弱和疲乏。     
9. 我觉得心平气和，并且容易安静坐着。     
10. 我觉得心跳很快。     
11. 我因为一阵阵头晕而苦恼。     
12. 我有晕倒发作或觉得要晕倒似的。     
13. 我呼气吸气都感到不容易。     
14. 我手脚麻木和刺痛。     
15. 我因为胃痛和消化不良而苦恼。     
16. 我常常要小便（尿意频繁）。     
17. 我的手常常是干燥温暖的。     
18. 我脸红发热。     
19. 我容易入睡并且整夜睡的很好。     





Appendix 8 – Beck Depression Inventory-II (BDI-II)  
English Version Example of BDI-II 
Name: __________                   ID: _________           Date: ______/______/______     
Instruction: Please read each group of statements carefully, and then pick out the one statement in 
each group that best describes the way you have been feeling during the past two weeks, including 
today. Circle the number beside the statement you have picked.  
1. Sadness  
0 I do not feel sad. 
1 I feel sad much of the time. 
2 I am sad all the time. 
3 I am so sad/unhappy that I can’t stand it. 
 
12. Loss of Interest 
0 I have not lost interest in other people or 
activities. 
1 I am less interested in other people or things 
than before. 
2 I have lost most of my interest in other people 
or things. 
3 It’s hard to get interested in anything. 
 
2. Pessimism 
0 I am not discouraged about my future. 
1 I feel more discouraged about my future than 
I used to be. 
2 I do not expect things to work out for me. 




0 I make decisions about as well as ever. 
1 I find it more difficult to make decisions than 
usual 
2 I have much greater difficulty in making 
decisions than I used to. 
3 I have trouble making any decisions. 
 
 
3. Past failure 
0 I do not feel like a failure. 
1 I have failed more than I should have. 
2 As I look back, I see a lot of failures. 
3 I feel I am a total failure as a person. 
 
14. Worthlessness 
0 I do not feel I am worthless. 
1 I don’t consider myself as worthwhile and 
useful as I used to. 
2 I feel more worthless as compared to other 
people. 
3 I feel utterly worthless. 
 
4. Loss of Pleasure 
0 I get as much pleasure as I ever did from the 
things I enjoy. 
1 I don’t enjoy things as much as I used to. 
2 I get very little pleasure from the things I used 
to enjoy. 
15. Loss of Energy 
0 I have as much energy as ever. 
1 I have less energy than I used to have. 
2 I don’t have enough energy to do very much. 




3 I can’t get any pleasure from the things I used 
to enjoy. 
 
5. Guilty Feelings 
0 I don’t feel particularly guilty. 
1 I feel guilty over many things I have done or 
should have done. 
2 I feel quite guilty most of the time. 
3 I feel guilty all of the time. 
 
16. Changes in Sleeping Pattern 
0 I have not experienced any change in my 
sleeping pattern. 
1 I sleep somewhat less than usual. 
2 I wake up 1-2 hours early and can’t get back 
to sleep. 
3 I wake up a few hours early and can’t get back 
to sleep. 
 
6. Punishment Feelings 
0 I don’t feel I am being punished. 
1 I feel I may be punished. 
2 I expect to be punished. 




0 I am no more irritable than usual. 
1 I am more irritable than usual. 
2 I am much more irritable than usual. 
3 I am irritable all the time. 
 
7. Self-Dislike 
0 I feel the same about myself as ever. 
1 I have lost confidence in myself. 
2 I am disappointed in myself. 
3 I dislike myself. 
 
18. Changes in Appetite 
0 I have not experienced any change in my 
appetite. 
1 My appetite is somewhat less than usual. 
2 My appetite is much less than before. 
3 I have no appetite at all. 
 
8. Self-Criticalness 
0 I don’t feel I am any worse than anybody else. 
1 I am critical of myself for my weakness or 
mistakes. 
2 I blame myself all the time for my faults. 
3 I blame myself for everything bad that 
happens. 
 
19. Weight Loss 
 
0 I haven’t lost much weight, if any, lately. 
1 I have lost more than five pounds. 
2 I have lost more than ten pounds. 
3 I have lost more than fifteen pounds. 
 
9. Suicidal Thoughts or Wishes 
0 I don’t have any thoughts of killing myself. 
1 I have thoughts of killing myself, but I would 
not carry them out. 
2 I would like to kill myself. 
3 I would kill myself if I had the chance. 
 
20. Tiredness or Fatigue 
0 I am no more tired or fatigued than usual. 
1 I get more tired or fatigued more easily than 
usual. 
2 I am too tired or fatigued to do a lot of the 
things I used to do. 
3 I am too tired or fatigued to do most of the 





0 I don’t cry any more than I used to. 
1 I cry more than I used to. 
2 I cry over every little thing. 
3 I feel like crying, but I can’t. 
 
21. Loss of Interest in Sex 
0 I have not noticed any recent change in my 
interest in sex. 
1 I am less interested in sex than I used to be. 
2 I am much less interested in sex now. 
3 I have lost interest in sex completely. 
 
11. Agitation 
0 I am no more restless or wound up than usual. 
1 I feel more restless or wound up than usual. 
2 I am so restless or agitated that it’s hard to stay 
still. 
3 I am so restless or agitated that I have to keep 












2. 选择 4 种情况中的一种（0、1、2、3）;  





























1. 我担心自己在变老或失去魅力。  
2. 我感到青春已逝而失去魅力。 
3. 我确信自己很丑。  
（四） 
0. 我对做过的事，没有什么不满意的。  
1. 我对做过的事，不太满意。 















1. 我不如以前睡得香。  

































1．我的体重减轻了 2 公斤多。  
2．我的体重减轻了 5 公斤多。 















0. 我不象一般人那样爱哭。  
1. 我比过去爱哭了。  











1. 我现在比过去更容易生气发火。  








Appendix 9 – Medical Outcomes Study 36-Item Short Form 
Healthy Survey (SF-36) 
Name: ______________       ID: ___________       Date: _____/______/______ 
 





1. In general, would you say your health is: 
    ⃝ Excellent              ⃝ Very Good                  ⃝ Good                 ⃝ Fair                  ⃝ Poor 
 
2. Compared to one year ago, how would you rate your health in general now? 
    ⃝ Much better now than one year ago 
    ⃝ Somewhat better now than one year ago 
    ⃝ About the same 
    ⃝ Somewhat worse now than one year ago 
    ⃝ Much worse than one year ago 
 
LIMITATIONS OF ACTIVITIES: 
3. The following items are about activities you might do during a typical day. Does your health 
now limit you in these activities? If so, how much? 
 
(1) Vigorous activities, such as running, lifting heavy objects, participating in strenuous sports. 
    ⃝ Yes. Limited a lot                   ⃝ Yes. Limited a Little                  ⃝ No. Not limited at all 
 
(2) Moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing 
golf 
    ⃝ Yes. Limited a lot                   ⃝ Yes. Limited a Little                  ⃝ No. Not limited at all 
 
 
(3) Lifting or carrying groceries 
    ⃝ Yes. Limited a lot                   ⃝ Yes. Limited a Little                  ⃝ No. Not limited at all 
 
(4) Climbing several flights of stairs 
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    ⃝ Yes. Limited a lot                   ⃝ Yes. Limited a Little                  ⃝ No. Not limited at all 
 
(5) Climbing one flight of stairs 
    ⃝ Yes. Limited a lot                   ⃝ Yes. Limited a Little                  ⃝ No. Not limited at all 
 
(6) Bending, kneeling, or stooping 
    ⃝ Yes. Limited a lot                   ⃝ Yes. Limited a Little                  ⃝ No. Not limited at all 
 
(7) Walking more than a mile 
    ⃝ Yes. Limited a lot                   ⃝ Yes. Limited a Little                  ⃝ No. Not limited at all 
 
(8) Walking several blocks 
    ⃝ Yes. Limited a lot                   ⃝ Yes. Limited a Little                  ⃝ No. Not limited at all 
 
(9) Walking one block 
    ⃝ Yes. Limited a lot                   ⃝ Yes. Limited a Little                  ⃝ No. Not limited at all 
 
(10) Bathing or dressing yourself 
    ⃝ Yes. Limited a lot                   ⃝ Yes. Limited a Little                  ⃝ No. Not limited at all 
 
PHYSICAL HEALTH PROBLEMS: 
4. During the past 4 weeks, have you had any of the following problems with your work or other 
regular daily activities as a result of your physical health? 
(1) Cut down the amount of time you spent on work or other activities 
    ⃝ Yes                                           ⃝ No 
 
(2) Accomplished less than you would like 
    ⃝ Yes                                            ⃝ No 
 
(3) Were limited in the kind of work or other activities 
    ⃝ Yes                                           ⃝ No 
 
(4) Had difficulty performing the work or other activities (e.g., it took extra effort) 
    ⃝ Yes                                           ⃝ No 
 
EMOTIONAL HEALTH PROBLEMS: 
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5. During the past 4 weeks, have you had any of the following problems with your work or other 
regular daily activities as a result of any emotional problems (such as feeling depressed or 
anxious)? 
(1) Cut down the amount of time you spent on work or other activities 
    ⃝ Yes                                           ⃝ No 
 
(2) Accomplished less than you would like 
    ⃝ Yes                                           ⃝ No 
 
(3) Didn't do work or other activities as carefully as usual 
    ⃝ Yes                                           ⃝ No 
 
SOCIAL ACTIVITIES: 
6. Emotional problems interfered with your normal social activities with family, friends, 
neighbours, or groups? 
    ⃝ Not at all               ⃝ Slightly             ⃝ Moderately             ⃝ Severe              ⃝ Very Severe 
 
PAIN: 
7. How much bodily pain have you had during the past 4 weeks? 
    ⃝ Not at all               ⃝ Slightly             ⃝ Moderately             ⃝ Severe              ⃝ Very Severe 
 
8. During the past 4 weeks, how much did pain interfere with your normal work (including both 
work outside the home and housework)? 
    ⃝ Not at all               ⃝ Slightly             ⃝ Moderately             ⃝ Severe              ⃝ Very Severe 
 
ENERGY AND EMOTIONS: 
9. These questions are about how you feel and how things have been with you during the last 4 
weeks. For each question, please give the answer that comes closest to the way you have been 
feeling. 
(1) Did you feel full of pep? 
    ⃝ All of the time 
    ⃝ Most of the time 
    ⃝ A good Bit of the Time 
    ⃝ Some of the time 
    ⃝ A little bit of the time 




(2) Have you been a very nervous person?  
    ⃝ All of the time 
    ⃝ Most of the time 
    ⃝ A good Bit of the Time 
    ⃝ Some of the time 
    ⃝ A little bit of the time 
    ⃝ None of the Time 
 
(3) Have you felt so down in the dumps that nothing could cheer you up?  
    ⃝ All of the time 
    ⃝ Most of the time 
    ⃝ A good Bit of the Time 
    ⃝ Some of the time 
    ⃝ A little bit of the time 
    ⃝ None of the Time 
 
(4) Have you felt calm and peaceful?  
    ⃝ All of the time 
    ⃝ Most of the time 
    ⃝ A good Bit of the Time 
    ⃝ Some of the time 
⃝ A little bit of the time                                     
    ⃝ None of the Time 
(5) Did you have a lot of energy?  
    ⃝ All of the time 
    ⃝ Most of the time 
    ⃝ A good Bit of the Time 
    ⃝ Some of the time 
    ⃝ A little bit of the time 
    ⃝ None of the Time 
 
(6) Have you felt downhearted and blue?  
    ⃝ All of the time 
    ⃝ Most of the time 
    ⃝ A good Bit of the Time 
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    ⃝ Some of the time 
    ⃝ A little bit of the time 
    ⃝ None of the Time 
 
(7) Did you feel worn out?  
    ⃝ All of the time 
    ⃝ Most of the time 
    ⃝ A good Bit of the Time 
    ⃝ Some of the time 
    ⃝ A little bit of the time 
    ⃝ None of the Time 
 
(8) Have you been a happy person?  
    ⃝ All of the time 
    ⃝ Most of the time 
    ⃝ A good Bit of the Time 
    ⃝ Some of the time 
    ⃝ A little bit of the time 
    ⃝ None of the Time 
 
 
(9) Did you feel tired?  
    ⃝ All of the time 
    ⃝ Most of the time 
    ⃝ A good Bit of the Time 
    ⃝ Some of the time 
    ⃝ A little bit of the time 
    ⃝ None of the Time 
 
SOCIAL ACTIVITIES: 
10. During the past 4 weeks, how much of the time has your physical health or emotional problems 
interfered with your social activities (like visiting with friends, relatives, etc.)? 
    ⃝ All of the time 
    ⃝ Most of the time 
    ⃝ A good Bit of the Time 
    ⃝ Some of the time 
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    ⃝ A little bit of the time 
    ⃝ None of the Time 
 
GENERAL HEALTH: 
11. How true or false is each of the following statements for you? 
(1) I seem to get sick a little easier than other people 
    ⃝ Definitely true          ⃝ Mostly true        ⃝ Don't know        ⃝ Mostly false         ⃝ Definitely false 
 
(2) I am as healthy as anybody I know 
    ⃝ Definitely true          ⃝ Mostly true        ⃝ Don't know        ⃝ Mostly false         ⃝ Definitely false 
  
(3) I expect my health to get worse 
    ⃝ Definitely true          ⃝ Mostly true        ⃝ Don't know        ⃝ Mostly false         ⃝ Definitely false 
 
(4) My health is excellent 














姓名：__________受试者编号：________  填表日期：_____年____月___日 
 
□基线          □12周              □24周 
 
1. 总的来说，您的健康状况是： 
   □非常好        □很好        □好       □一般       □差 
 
2. 跟1年前相比您觉得自己的健康状况是： 
□比1年前好多了         □比1年前好一些         □跟1年前差不多 






      □很大程度受限制       □有些限制          □毫无限制 
（2） 适度的活动。如移动一张桌子、扫地、打太极拳、做简单体操等： 
      □很大程度受限制       □有些限制          □毫无限制 
（3） 手提日用品。如买菜、购物等： 
      □很大程度受限制       □有些限制           □毫无限制 
（4） 上几层楼：□很大程度受限制    □有些限制        □毫无限制 
（5） 上一层楼：□很大程度受限制    □有些限制        □毫无限制 
（6） 弯腰、屈膝、下蹲：□很大程度受限制   □有些限制    □毫无限制 
（7） 步行1500米以上的路程： 
      □很大程度受限制       □有些限制           □毫无限制 
（8） 步行1000米以上的路程： 
      □很大程度受限制       □有些限制         □毫无限制 
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（9） 步行100米的路程：□很大程度受限制   □有些限制    □毫无限制 
（10） 自己洗澡、穿衣：□很大程度受限制   □有些限制    □毫无限制 
4. 在过去4个星期里，您的工作和日常活动有无因为身体健康的原因而出现以下这些
问题？ 
（1）减少了工作或其他活动时间：□是          □不是 
（2）本来想要做的事情只能完成一部分：□是    □不是 
（3）想要干的工作或活动种类受到限制：□是    □不是 
（4）完成工作或其他活动困难增多（比如需要额外努力）：□是      □不是 
5. 在过去4个星期里，您的工作和日常活动有无因为情绪的原因（如压抑或忧虑）而
出现以下这些问题？ 
（1）减少了工作或活动时间：□是      □不是 
（2）本来想要做的事情只能完成一部分：□是     □不是 
（3）干事情不如平时仔细：□是        □不是 
6. 在过去4个星期里，您的健康或情绪不好在多大程度上影响了您与家人、朋友、邻
居或集体的正常社会交往？ 
□没有影响   □有一点影响   □中等影响   □影响很大    □影响非常大 
7. 在过去4个星期里，您有身体疼痛吗？ 
□没有疼痛    □有一点疼痛   □中等疼痛   □严重疼痛   □很严重疼痛 
8. 在过去4个星期里，您的身体疼痛影响了您的工作和家务吗？ 






      □所有的时间         □大部分时间         □比较多时间 
      □一部分时间         □小部分时间         □没有这种感觉 
（2） 您是一个敏感的人： 
      □所有的时间         □大部分时间         □比较多时间 
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      □一部分时间         □小部分时间         □没有这种感觉 
（3） 您的情绪非常不好，什么事都不能使您高兴起来： 
      □所有的时间         □大部分时间         □比较多时间 
      □一部分时间         □小部分时间         □没有这种感觉 
（4） 您的心理很平静： 
      □所有的时间         □大部分时间         □比较多时间 
      □一部分时间         □小部分时间         □没有这种感觉 
（5） 您做事精力充沛： 
      □所有的时间         □大部分时间         □比较多时间 
      □一部分时间         □小部分时间         □没有这种感觉 
（6） 您的情绪低落： 
      □所有的时间         □大部分时间         □比较多时间 
      □一部分时间         □小部分时间         □没有这种感觉 
（7） 您觉得筋疲力尽： 
      □所有的时间         □大部分时间         □比较多时间 
      □一部分时间         □小部分时间         □没有这种感觉 
（8） 您是个快乐的人： 
      □所有的时间         □大部分时间         □比较多时间 
      □一部分时间         □小部分时间         □没有这种感觉 
（9） 您感觉厌烦： 
      □所有的时间         □大部分时间         □比较多时间 
      □一部分时间         □小部分时间         □没有这种感觉 
10. 不健康影响了您的社会活动（比如走亲访友）： 
     □所有的时间         □大部分时间        □比较多时间 





      □绝对正确           □大部分正确         □不能肯定 
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      □大部分错误         □绝对错误 
（2） 我跟周围人一样健康： 
      □绝对正确           □大部分正确         □不能肯定 
      □大部分错误         □绝对错误 
（3） 我认为我的健康状况在变坏： 
      □绝对正确           □大部分正确         □不能肯定 
      □大部分错误         □绝对错误 
（4） 我的健康状况非常好： 
      □绝对正确           □大部分正确         □不能肯定 





Appendix 10 – Weekly Status Check 
Instruction:  This form should be completed in the last session each week by participants. 
Name: _____________________________ Study ID #: _______________________ 
Date: ______________________________ Week #: _________________________ 
Telephone: _________________________   Email: __________________________ 
 
During the past week have you had any of the following? 
 
 Yes No 
1.  Acute illnesses   
Please specify_______________________________   
2.  Change in medication (prescribed, over-the- 
Counter, herbal, nutritional supplement) 
  
Please specify_______________________________   
3.  Visits to a health care professional   
Kind______________________________________   
Indication__________________________________   
Treatment__________________________________   
4.  New physical, mental, or emotional 
symptoms of any kind 
  
Please describe: ____________________________   
5.  Smoking or Alcohol use   
Describe the frequency and amount: ____________   
6.  Have you attended all exercise sessions?   
If not, number attended_______________________   
Reason for missed session(s): _________________   




❑ protocol completed 
❑ not completed due to death 
❑ not completed due to refusal, drop-out or loss to follow-up 
❑ not completed due to medical illness or incapacity 
❑ not completed due to examiner failure or error 





Chinese version 中文版本-每周情况调查 
说明: 请在每周最后一次太极课填写此表格。 
姓名: ____________              患者编号#: _____________ 
日期: ____________              第几周#: _______________ 
电话: ____________              电子邮箱: ______________ 
 
在过去一周内您是否出现如下情况？ 
 是 否 
1.  急性疾病    
具体情况描述___________________________________   
2.  变换用药 (处方药，非处方药，草药，保健品)   
具体情况描述___________________________________   
3.  看医生   
病名__________________________   
症状__________________________   
治疗方案______________________   
4.  出现任何新的身体、心里或情绪上的症状   
请描述:________________________________________   
5.  吸烟或饮酒                    
请描述频次和用量: _____________________________   
6.  您参加了本周所有的太极课程吗?   
如果没有全参加，那么参加的次数_________________   
没参加太极课的原因_____________________________   
 7.  其他问题、意见、感受: 






❑ 由于其他原因未能完成方案: ______________   
267 
 
Appendix 11 – Checklist of Risk Contraindications 
 
Contraindications to exercise testing    
-Absolute Acute myocardial infarction (within two days)  
-High-risk unstable angina  
-Uncontrolled cardiac arrhythmias causing symptoms or hemodynamic compromise  
-Symptomatic severe aortic stenosis  
-Uncontrolled symptomatic heart failure  
-Acute pulmonary embolus or pulmonary infarction  
-Acute myocarditis or pericarditis  
-Acute aortic dissection  
 
Relative*  
-Left main coronary stenosis  
-Moderate stenotic valvular heart disease  
-Electrolyte abnormalities  
-Severe arterial hypertension†  
-Tachyarrhythmias or bradyarrhythmias  
-Hypertrophic cardiomyopathy and other forms of outflow tract obstruction  
-Mental or physical impairment leading to inability to exercise adequately  
-High-degree atrioventricular block    
* Relative contraindications can be superseded if the benefits of exercise outweigh the risks.  
† In the absence of definitive evidence, the committee suggests systolic blood pressure of >200mmHg 












Onset Date   /    /     
 












Indicate the frequency of the event 
 Intermittent 
 Single Episode 
Action Taken with Study Intervention  
Please indicate what action was taken 
regarding the Study Treatment 
 None 







This AE report has been 
carried out by: 
 
Signature 
 Study Intervention Permanently Discontinued 
 Additional Treatment Given  
Action Taken with Participant  
Indicate what action was taken regarding 
the participant  
(Check all relevant options) 
 Withdrawn 
 Treatment Given, Specify ______________ 
 Other, Specify _________________ 
 No Action 
Causality   
In the investigator’s judgment, 
what was the most likely cause of 
the Adverse Event 
 Study Intervention 
 Disease under study 
 Other Illness ______________________ 
 Concomitant Treatment ______________________ 
 Other ______________________ 
Serious Adverse Event  
Is this a serious adverse event? 




Date   /    /     
 
 
Investigator Sign Off 
Investigator Sign Off 
 
Signature 




































Appendix 16 – Standards for Reporting Qualitative Research 
(SRQR) 
 http://www.equator-network.org/reporting-guidelines/srqr/ 
  Page/line no(s). 
Title and abstract  
 
Title - Concise description of the nature and topic of the study Identifying the 
study as qualitative or indicating the approach (e.g., ethnography, grounded 
theory) or data collection methods (e.g., interview, focus group) is recommended  164 
 
Abstract  - Summary of key elements of the study using the abstract format of the 
intended publication; typically includes background, purpose, methods, results, 
and conclusions  xii-xv 
   
Introduction  
 
Problem formulation - Description and significance of the problem/phenomenon 
studied; review of relevant theory and empirical work; problem statement  164-166 
 
Purpose or research question - Purpose of the study and specific objectives or 
questions  166 
   
Methods  
 
Qualitative approach and research paradigm - Qualitative approach (e.g., 
ethnography, grounded theory, case study, phenomenology, narrative research) 
and guiding theory if appropriate; identifying the research paradigm (e.g., 
postpositivist, constructivist/ interpretivist) is also recommended; rationale**  167 
 
Researcher characteristics and reflexivity - Researchers’ characteristics that may 
influence the research, including personal attributes, qualifications/experience, 
relationship with participants, assumptions, and/or presuppositions; potential or 
actual interaction between researchers’ characteristics and the research 
questions, approach, methods, results, and/or transferability  N/A 
 Context - Setting/site and salient contextual factors; rationale**   
 
Sampling strategy - How and why research participants, documents, or events 
were selected; criteria for deciding when no further sampling was necessary (e.g., 
sampling saturation); rationale**  167 
 
Ethical issues pertaining to human subjects - Documentation of approval by an 
appropriate ethics review board and participant consent, or explanation for lack 
thereof; other confidentiality and data security issues  167 
 
Data collection methods - Types of data collected; details of data collection 
procedures including (as appropriate) start and stop dates of data collection and 
analysis, iterative process, triangulation of sources/methods, and modification of 




Data collection instruments and technologies - Description of instruments (e.g., 
interview guides, questionnaires) and devices (e.g., audio recorders) used for data 
collection; if/how the instrument(s) changed over the course of the study  169 
 
Units of study - Number and relevant characteristics of participants, documents, 
or events included in the study; level of participation (could be reported in results)  167 
 
Data processing - Methods for processing data prior to and during analysis, 
including transcription, data entry, data management and security, verification of 
data integrity, data coding, and anonymization/de-identification of excerpts  169 
 
Data analysis - Process by which inferences, themes, etc., were identified and 
developed, including the researchers involved in data analysis; usually references a 
specific paradigm or approach; rationale**  170-172 
 
Techniques to enhance trustworthiness - Techniques to enhance trustworthiness 
and credibility of data analysis (e.g., member checking, audit trail, triangulation); 
rationale**  170-171 
   
Results/findings  
 
Synthesis and interpretation - Main findings (e.g., interpretations, inferences, and 
themes); might include development of a theory or model, or integration with 
prior research or theory  173-182 
 
Links to empirical data - Evidence (e.g., quotes, field notes, text excerpts, 
photographs) to substantiate analytic findings  173-182 
   
Discussion  
 
Integration with prior work, implications, transferability, and contribution(s) to 
the field - Short summary of main findings; explanation of how findings and 
conclusions connect to, support, elaborate on, or challenge conclusions of earlier 
scholarship; discussion of scope of application/generalizability; identification of 
unique contribution(s) to scholarship in a discipline or field  182-190 
 Limitations - Trustworthiness and limitations of findings  188 
   
Other  
 
Conflicts of interest - Potential sources of influence or perceived influence on 
study conduct and conclusions; how these were managed 188  
 
Funding - Sources of funding and other support; role of funders in data collection, 
interpretation, and reporting  N/A 
   
 
*The authors created the SRQR by searching the literature to identify guidelines, reporting 
standards, and critical appraisal criteria for qualitative research; reviewing the reference 
lists of retrieved sources; and contacting experts to gain feedback. The SRQR aims to 
improve the transparency of all aspects of qualitative research by providing clear standards 
for reporting qualitative research.  




**The rationale should briefly discuss the justification for choosing that theory, approach, 
method, or technique rather than other options available, the assumptions and limitations 
implicit in those choices, and how those choices influence study conclusions and 
transferability. As appropriate, the rationale for several items might be discussed together.  
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O'Brien BC, Harris IB, Beckman TJ, Reed DA, Cook DA. Standards for reporting qualitative 
research: a synthesis of recommendations. Academic Medicine, Vol. 89, No. 9 / Sept 2014 
DOI: 10.1097/ACM.0000000000000388  
   





Appendix 17 – Examples of the Coding Process 
Transcript-Participant No. 235 
Interviewer: I am very glad to see you complete the half year Tai Chi class. Many thanks for your cooperation. 
In the coming minutes, I will ask you several questions on your experience, feeling and feedback about the Tai 
Chi program. Could you please introduce your health status before you starting the Tai Chi class? 
Participant No. 235: Sure. It’s like this. I was diagnosed as atrial fibrillation by the doctor. The doctor 
introduced and I was invited to participate in this program, so I came. At the beginning, I was a layman for Tai 
Chi because I haven't learnt it before. So I was a zero beginner at first and it was a process that I came to Tai 
Chi. In the learning process, I gradually entered the door of Tai Chi because of the patience, earnest, serious and 
responsible instruction of the Tai Chi instructor.  We practiced step by step, according to the requirements of the 
Tai Chi instructor. Firstly, we practiced the 13-Form Thumping Techniques. After practicing the 13-Form 
Thumping Techniques, I feel, most importantly, I need to calm down. Another thing is, when I practice Tai Chi I 
should get rid of my wandering ideas. The wandering mind is not good for my health. I think the major function 
of the 13-Form Thumping Techniques is helping me to calm down. After calming down, you need to realize the 
essence. I think these two points played the major function. In addition, when practice the 13-Form Thumping 
Techniques you will get the benefits, gradually, not immediately. I experienced it. At the beginning, although I 
sit there when I practiced the 13-Form Thumping Techniques, my mind was wandering. I didn’t know what I 
was thinking, right? Hehehe, I couldn’t calm down and be mindful. Since I have been busy in working at 
Australia for around thirty years, at the beginning it is difficult for me that I suddenly came to this quiet 
environment to practice the 13-Form Thumping Techniques. However, it is hard and it is easy. If you really want 
to enter the door and realize the essence of the 13-Form Thumping Techniques, I think it needs time. During the 
half year of learning, I gradually know myself better, which is beneficial to my health.  
Interviewer: I am very glad that you share it with me. Hehehe. How did you know about Tai Chi before your 
participation in this program?  
Participant No. 235: As I mentioned before, when I received the invitation I was a layman of Tai Chi. Hehehe, I 
actually know nothing about Tai Chi. Hehehe, the reason why I can continue to learn it for a half year, there are 
two factors, two premises, I think they play the most important roles. Firstly, I met a good teacher. She taught us 
Tai Chi patiently and seriously. In addition, after the instruction of each movement, she explained the potential 
effects of each movement for the body, which enhanced my understanding of Tai Chi. Secondly, although I 
haven’t learnt Tai Chi before, I know Tai Chi is the essence of the thousands of years of Chinese culture legacy, 
and part of the treasure of Chinese culture. Promoting Tai Chi in Australia is a promotion of Chinese culture. 
Moreover, our Tai Chi instructor taught us diligently, earnestly, seriously, and patiently. So I had a deeper 
understanding of Tai Chi and became more interested in learning Tai Chi.  
Interviewer: Thanks for sharing with me. What was your expectation for participating in this program?  
Participant No. 235: As I always say,at the beginning I was a zero beginner. For my health, hehehehe, I wanted 
to try and see whether it can help me. Hehehe, I wanted to try and see what on earth is Tai Chi? I heard that Tai 
Chi could be beneficial for this or that, for health, for peaceful mind and calm, so I participated in this program. 
Through the half year of learning, I felt Tai Chi indeed could help calm down the mind. It was my main 
experience. Once calming down the mind, one’s spiritual world would be unconventional.  
Interviewer: Yeah. Many things come very naturally after that.  
Participant No. 235: Yeah. Many things come naturally. Once calming down the mind, one will think and then 
a comprehension and understanding comes out. The environment of Tzu Chi Foundation is good. When we enter 
the front gate, we will see the couplet reads “The Jing Si Dharma-lineage is a path of diligent spiritual practice; 
the Tzu Chi School of Buddhism is a road through the world”. It requires beyond the worldly fickleness, 
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completely calm down the mind and heart, return back to nature, and return back to human pure nature. “Man’s 
nature at birth is good”.  
Interviewer: Practicing Tai Chi is doing subtraction.   
Participant No. 235: This process is it doesn’t happen at once, and it needs slowly learn and experience it. In 
addition, I would like to repeat it again; it is such an honour for us to have such a serious and dedicated teacher.  
Interviewer: Thanks. Did participating in the Tai Chi program have any impacts on your daily life? 
Participant No. 235: Yes, there are some changes. When I, if, learn Tai Chi at the class, because some 
movements, there are two parts, I want to say. I learn Tai Chi for 2 hours each class, and because the movements 
are not easy to master, so when I come back home I continue to practice again and again. Gradually, I merged 
the things I learnt from the teacher to my own movements. There are always some parts I am not familiar with. It 
is not possible I stop learning at home after the 2-hour learning at class. It’s not possible. It’s one hand of the 
learning and practicing process. Another hand, I think it plays the major role. When I was in trouble, when I felt 
moody, or when I was angry, I would think what my Tai Chi teacher said. I mean Tai Chi can help one to calm 
down. Then I would do what my Tai Chi teacher told me. What is it? I would do standing postures. Standing 
posture, it is easy to say, and it seems easy to do. However, it you can truly carry out standing posture and calm 
down the mind, it needs perseverance. I would think what my teacher told me; sometimes I closed my eyes when 
doing standing posture, and try not to think anything. By doing so, I can gradually calm down my fickle mind 
and become not easy to lose my temper. I would do as much as I can. It reduced my unnecessary stress and 
helped me a lot. After this, I would practice Tai Chi. Actually, what I think the process of practicing Tai Chi? I 
think it is an activity which gradually improve one’s lifestyle. It can bring you into a quiet and peaceful world. It 
is beneficial for my mental and emotional health. Especially, for people like me who have some problem with 
heart and atrial fibrillation, When I feel unwell because of atrial fibrillation, I will practice Tai Chi immediately. 
I practice it slowly, feel it slowly, and gradually calm down myself. 
Interviewer: I know you are handling some issues of your company and it is a stress for you. Were there any 
benefits from practicing in the Tai Chi program on coping with stress or any other emotional feelings? 
Participant No. 235: I think Tai Chi is the main facilitator for me to deal with my stress. Tai Chi, as I mentioned 
before, the main effect of Tai Chi is helping people to calm down and become quiet. No matter how great the 
stress you bear, if you integrate the essence of Tai Chi into your blood and put it into your practice, you will 
gradually digest the stress. But how can you digest the stress? It depends on your daily practice, step by step, 
continuous practice. Tai Chi will help you to some extent.  
Interviewer: Did participating in the Tai Chi program have any influence on your social life?  
Participant No. 235: It’s related to the essence of Tai Chi. Tai Chi itself can help people to calm down. To some 
extent, Tai Chi helps to deal with the relationships between people and people, people and things, and people and 
family. 
 
Interviewer: Would you recommend the Tai Chi program to other cardiovascular patients? I would like to see 
whether you are satisfied with the Tai Chi program.  
Participant No. 235: Satisfied. The teacher taught us such seriously and dedicatedly, with compassion. We are 
very satisfied during the learning process. The only thing is, is it possible that we can learn more movements 
than just the 13 movements? It seems the time to practice the 13-form Tai Chi is a bit short. It takes around three 
minutes. Sometimes it takes only two minutes because the speed of different people is different. Is it possible we 
extend a bit longer and add more movements, according to the health status of older people?  
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Interviewer: Yes. We actually have more forms, such as 24-form and 83-form. The reason why we provide the 
13-form Tai Chi here because it is not hard to practice for one time and you can practice anytime. So it takes not 
too much effort to remember the movements. It is easy to remember the movements and sequence. However, the 
practice needs to be correct and master the essence. The key is not about how many movements you practice. 
The key is how to practice the movement correctly, and feel how to use the mind to lead the qi and blood and the 
movement of whole body.   
Participant No. 235: What you said reminder me about my experience and feeling at first. At the beginning, I 
thought, wow, so many things, so many movements, 13 movements, I can’t learn it. When the teacher asked us 
‘Did you get it’ , I always the first one to say ‘No’. Ho ho ho, however, after a half year of learning, I mastered 
the 13 movements. Then I have higher requirements to myself. I have a higher goal to achieve, so I think the 13 
movements are not enough for me. Hohoho, is it possible to add more movement? What does this mean? It’s 
hard at the beginning. It means the process of learning Tai Chi for me is that I had no idea of Tai Chi at first and 
gradually entered the door of Tai Chi. After I know the basics of Tai Chi, Wow, I see, Tai Chi is such an 
unlimited world. So I gradually know Tai Chi, gradually entered the role, and have higher and higher goals. So I 
proposed my expectation to you about adding more movements. Of course, my idea may be wrong. 
Interviewer: Sure. We have many forms. We hope our students not only learn the movements but also go 
deeper. Could each movement, especially the junctions between movements be practiced very smoothly? The 
first requirement is change the hardness into softness. The body becomes flexible and the heart tender.  
Participant No. 235: Hehehe, I am not flexible. I am inflexible. As you can see, my Tai Chi performance is 
inflexible. As I told you just now, I have been in Australia for 30 years. I work every day, and I never go for Tai 
Chi. I am very happy to see Tai Chi gradually help me soften my inflexible body. 
Interviewer: Hehehe. So it is better just practising this form again and again. You can practise it several times. 
When practise each movement, you can think the principle such as how to move as a whole and how to use the 
waist as the leader to move the whole body.  
Participant No. 235: Yeah. I found my mistake and the teacher pointed it out to me too. It is that when I practice 
Tai Chi I move my hands first not my waist.  
Interviewer: Hehehe. As we mentioned just now, practicing Tai Chi is doing subtraction. You need to know 
what dominate the movements. Life is the same. If you find it in Tai Chi, you can find your life is in the same 
way. What is the most important thing to you? If you master the main thing, other things often come naturally. 
This rule can be used in our daily life. If we continue to hold a similar Tai Chi class, would you like to 
recommend other people to practice Tai Chi? 
Participant No. 235: Yes, definitely. I have a habit that when I want to practice Tai Chi, I don’t mind where it 
is, even in public space. So when people ask me about Tai Chi, I will definitely recommend it to them. This is a 
promotion, especially at Australia, a promotion of Chinese traditional Tai Chi culture. I think it is a good deed. 
Interviewer: Yeah. It is a treasure of Chinese culture. We share it with more people.  
Participant No. 235: Treasure! Tai Chi is a treasure of our Chinese culture, with a history of thousands of years. 
Without this belief I don’t think I would join the class. Hehehe. 
Interviewer: Many thanks for sharing it with me. Would you like to continue the Tai Chi practice after the 
completion of the study?  
Participant No. 235: I will definitely continue to practice Tai Chi. For me, Tai Chi and the 13-form Thumping 
Techniques, I would practice them for the rest of my life. I would say, they will be a part for the rest of my life, 
an important part. Particularly, for the elderly, it’s much necessary for us to learn Tai Chi and the 13-form 
Thumping Techniques, so that we can be peace and calm. 
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Interviewer: Great. We also hope to bring Tai Chi to more people. Hope it can become a daily self-care method, 
and people can continue use it for their health.  
Participant No. 235: Thanks, many thanks! Tai Chi is such a gift from our teacher. It is a precious wealth for us. 
Interviewer: What do you think would be the main possible barriers to hindering your future Tai Chi practice?  
Participant No. 235: So far, it seems no barriers. For now though, I think there is no factors inhibiting my 
practice. You can practice Tai Chi anytime anywhere. I often practice it no matter where it is. Particularly, the 
standing posture you taught us needs no special venue or site, and you can practice it anytime anywhere. 
Interviewer: Thanks. That’s it. Is there anything else you would like to tell me? 
Participant No. 235: No. I think I want to say it again. I am so glad to meet such a good teacher. Many thanks!  
Interviewer: Thanks. Thanks for your perseverance and cooperation.  
 
 
 
 
 
 
 
